Contrast,Database,Pathway,pvalue,p.adjust,GeneRatio,neg_log10_pvalue,neg_log10_padj,pathway_short,contrast_clean,database_clean
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,4.7933036173360705e-76,3.949682180684922e-73,259/2407,75.31936506106507,72.40343784936796,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_MICROGLIA,3.272504097905985e-60,8.988477922248439e-58,200/2407,59.48511980094318,57.04631384396573,DESCARTES_FETAL_CEREBRUM_MICROGLIA,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,1.8149118428055172e-52,3.7387183961793657e-50,190/2407,51.74114446545594,49.427277245086785,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,7.111140324211967e-49,1.1719159254301322e-46,167/2407,48.14806075133728,45.931103543976185,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,HU_FETAL_RETINA_MICROGLIA,9.064699797534638e-48,1.2448854388614237e-45,168/2407,47.04264657418657,44.9048706128731,HU_FETAL_RETINA_MICROGLIA,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_MICROGLIA,2.846368789287655e-28,2.345407882373028e-26,80/2407,27.54570883131554,25.629781619618424,DESCARTES_MAIN_FETAL_MICROGLIA,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_EYE_MICROGLIA,7.590824903708184e-19,3.292020905608181e-17,65/2407,18.11971102625708,16.48253741551279,DESCARTES_FETAL_EYE_MICROGLIA,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_BP,cytokine production,1.5030906675387285e-17,2.862260403660624e-14,184/2058,16.823014821659182,13.54329085739376,cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of cytokine production,2.6385555894300798e-17,4.0195755849377835e-14,182/2058,16.578633751618213,13.395819800360847,regulation of cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_2,2.1463249028698112e-14,5.705070064402337e-13,59/2407,13.66830453547207,12.243739017609226,FAN_EMBRYONIC_CTX_ASTROCYTE_2,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,2.607838741801751e-13,6.1395974949846945e-12,96/2407,12.58371926712375,11.21186009977691,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_BP,positive regulation of cytokine production,2.3569709233373846e-14,1.994783058117873e-11,123/2058,13.627645775096388,10.700104328942327,positive regulation of cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,response to cytokine,3.8094939095652905e-14,2.9016915109158818e-11,200/2058,13.419132716419439,10.537348760826054,response to cytokine,OUD vs Control Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,6.720061984788411e-14,5.0064461786673665e-11,34/1231,13.172626721064118,10.300470448315826,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,C8_CellType,HU_FETAL_RETINA_MICROGLIA,6.849078648898008e-12,5.60254633479857e-10,93/2057,11.164367846699097,9.251614543027774,HU_FETAL_RETINA_MICROGLIA,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_BP,cellular response to cytokine stimulus,1.2678570086555964e-12,5.680745197017457e-10,180/2058,11.896929724256811,9.2455946900417,cellular response to cytokine stimulus,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,1.1174379666266507e-11,8.309675060914547e-10,83/2057,10.951776576920428,9.08041595840733,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_BP,regulation of immune response,4.8277872510861915e-12,1.4709302196609409e-9,196/2058,11.316251876460996,8.832407929539649,regulation of immune response,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_2,3.423485735073683e-10,1.7502570820564206e-8,47/2057,9.465531477404284,7.7568981563888855,FAN_EMBRYONIC_CTX_ASTROCYTE_2,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,C8_CellType,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,5.172255725704715e-10,2.324644489868386e-8,64/2057,9.286320010953887,7.633643454771357,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STR...,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,2.3266035790096853e-9,2.6626685404221956e-8,60/2407,8.63327760816789,7.574682892902044,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,1.025096908335728e-9,3.992996528660121e-8,119/2057,8.989235076299893,7.398701067362489,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,1.1457913648749628e-9,4.260260620307816e-8,55/2057,8.94089445508456,7.370563832235444,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,5.823519230940604e-9,6.07415170417096e-8,50/2407,8.234814486024694,7.21651436561802,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_BP,synapse organization,6.991670186538062e-10,1.298915897825864e-7,129/2058,9.15541906657859,6.886418967704941,synapse organization,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,4.053350414853852e-9,1.4142472204276355e-7,84/2057,8.39218584958694,6.849474666152429,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,4.26162981145442e-9,1.4142472204276355e-7,95/2057,8.370424278184728,6.849474666152429,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,3.049368195928244e-9,2.358178071517842e-7,53/2332,8.515790133586204,6.6274234034149675,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_...,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,C8_CellType,BUSSLINGER_DUODENAL_IMMUNE_CELLS,2.9541980151038866e-8,2.675010070819343e-7,187/2407,7.5295603979933405,6.572674578617319,BUSSLINGER_DUODENAL_IMMUNE_CELLS,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,3.670893016895191e-8,3.217889197788976e-7,114/2407,7.435228272224181,6.492428914126765,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_BP,negative regulation of immune system process,2.1526703548315556e-9,3.3463041005616244e-7,115/2058,8.667022469962202,6.47543459439733,negative regulation of immune system process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of immune response,4.301778174928949e-9,6.182385728006377e-7,153/2058,8.36635198815779,6.208843902165195,positive regulation of immune response,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_MICROGLIA,3.03315351860283e-8,7.297410524167985e-7,92/2057,7.518105607956798,6.136831221327729,DESCARTES_FETAL_CEREBRUM_MICROGLIA,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_CC,glutamatergic synapse,2.4337884676606167e-9,8.258410941838702e-7,116/1867,8.61371717110182,6.083103510256122,glutamatergic synapse,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,GO_BP,cytokine-mediated signaling pathway,2.2762210026411248e-8,2.4419683629742885e-6,111/2058,7.642785573749759,5.61225996687545,cytokine-mediated signaling pathway,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,adaptive immune response,2.386347476226897e-8,2.5245567675583717e-6,102/2058,7.622266318410602,5.597814859248485,adaptive immune response,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_MICROGLIA,1.317256056691586e-7,2.6280864740822373e-6,43/2057,6.880329795881622,5.580360348930034,DESCARTES_MAIN_FETAL_MICROGLIA,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_BP,immune response-regulating cell surface receptor signaling pathway,3.240845712469842e-8,3.248094972616156e-6,82/2058,7.489341644011893,5.488371280699299,immune response-regulating cell surface recepto...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of immune effector process,3.322270243622366e-8,3.2864587591781245e-6,89/2058,7.478565043606356,5.483271813185453,regulation of immune effector process,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_CC,GABA-ergic synapse,2.95236128449962e-8,3.4241497998405687e-6,34/1867,7.529830498385609,5.4654472440471435,GABA-ergic synapse,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,dendrite,4.805947016748456e-8,4.53894996026243e-6,119/1867,7.318221021393255,5.343044605118286,dendrite,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,GO_BP,tumor necrosis factor superfamily cytokine production,6.209255142609549e-8,5.5642231083831685e-6,48/2058,7.206960494325248,5.254595464446156,tumor necrosis factor superfamily cytokine prod...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of tumor necrosis factor superfamily cytokine production,6.209255142609549e-8,5.5642231083831685e-6,48/2058,7.206960494325248,5.254595464446156,regulation of tumor necrosis factor superfamily...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,7.162672015992351e-8,6.090027149356474e-6,53/2058,7.1449249350490955,5.215380771276908,regulation of adaptive immune response based on...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of adaptive immune response,7.32597095599599e-8,6.090027149356474e-6,56/2058,7.1351348074399255,5.215380771276908,regulation of adaptive immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,immune response-regulating signaling pathway,7.456291032280078e-8,6.106942880954555e-6,116/2058,7.127477149038386,5.214176141998936,immune response-regulating signaling pathway,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,immune effector process,2.2702471282852189e-7,1.6011548496433805e-5,126/2058,6.643926865005619,4.795566664899184,immune effector process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,4.842219413378754e-7,1.8147148447677918e-5,50/2332,6.314955535451762,4.74119160813378,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_C...,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,2.8165745814919913e-6,1.8566859641195204e-5,42/2407,5.550278744374812,4.7312615456857525,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_CC,postsynapse,2.4762991891199547e-7,2.1048543107519616e-5,138/1867,6.6061968845574075,4.676777958843115,postsynapse,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,1.1528890806462765e-7,2.3882797870535e-5,49/2013,6.938212474128093,4.621914796949822,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_N...,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,positive regulation of programmed cell death,5.356384141951688e-7,3.114471603759237e-5,111/2058,6.2711282843957505,4.506615624458131,positive regulation of programmed cell death,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_1,5.2832261206697815e-6,3.1546219735013767e-5,27/2407,5.277100801227206,4.5010526759313265,FAN_EMBRYONIC_CTX_ASTROCYTE_1,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,5.490597561003726e-6,3.2316088501907646e-5,60/2407,5.260380387184897,4.4905812111660195,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STR...,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,DO,bone inflammation disease,1.333444948320215e-7,3.259437200928018e-5,63/1094,6.8750249095836145,4.486857382027741,bone inflammation disease,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,GO_CC,neuronal cell body,5.559402410401934e-7,3.93791004070137e-5,94/1867,6.254971888959855,4.404734209293188,neuronal cell body,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,GO_BP,cytokine production involved in immune response,7.440951259878972e-7,4.048408981892723e-5,37/2058,6.128371540192313,4.3927156202771664,cytokine production involved in immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,1.6270335289809481e-6,4.69047772378413e-5,51/2332,5.7886034972774185,4.328782922266273,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,immune response-activating signaling pathway,8.76880763074139e-7,4.703662515729378e-5,105/2058,6.057059457328979,4.32756384611865,immune response-activating signaling pathway,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neuron projection development,8.976385523332653e-7,4.776220883990524e-5,186/2058,6.046898503340531,4.320915596769809,neuron projection development,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of immune response,1.1276173047352207e-6,5.7260406734454504e-5,51/2058,5.947838267942905,4.242145571405202,negative regulation of immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,immune response-activating cell surface receptor signaling pathway,1.356195584200335e-6,6.621885746701252e-5,72/2058,5.867677674028136,4.179018316789213,immune response-activating cell surface recepto...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,activation of immune response,1.4758163064631445e-6,6.982169444925324e-5,114/2058,5.830967695395161,4.156009615833626,activation of immune response,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,synapse organization,6.43516203151471e-8,7.888436123631781e-5,109/1775,7.191440513482702,4.103009086802796,synapse organization,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of cytokine production involved in immune response,1.7275432395450357e-6,7.926925816635262e-5,36/2058,5.762571073643607,4.100895206090278,regulation of cytokine production involved in i...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,3.794734288683154e-6,9.480997668956064e-5,50/2332,5.4208186284638105,4.02314596020151,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_N...,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,2.2736512581183804e-6,9.953104386832013e-5,70/2058,5.643276148394864,4.002041441084079,adaptive immune response based on somatic recom...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C8_CellType,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,2.185911138656634e-5,1.1472552727726537e-4,88/2407,4.6603674969039215,3.9403399376160397,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL...,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_BP,regulation of production of molecular mediator of immune response,2.8167876601040597e-6,1.1853851716581561e-4,48/2058,5.550245890508325,3.9261405097841253,regulation of production of molecular mediator ...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,9.461922347691255e-6,1.2483633032921688e-4,35/2057,5.024020620450165,3.903659006277096,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_CC,axon,2.8243546481139008e-6,1.3822723924886854e-4,128/2168,5.549080770775903,3.8594063658634523,axon,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_BP,negative regulation of programmed cell death,3.4834647369087704e-6,1.426534994679253e-4,158/2058,5.457988581467419,3.8457175700919515,negative regulation of programmed cell death,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_CC,main axon,3.608073005870345e-6,1.5799561794126984e-4,25/2168,5.442724683512062,3.8013549581741675,main axon,OUD vs Control Female,GO CC
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,3.291856172297035e-5,1.614577074983784e-4,13/2407,4.482559148229604,3.791941218258351,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_BP,negative regulation of immune effector process,6.000270327624743e-6,2.3270348390890344e-4,35/2058,5.221829183091179,3.6331971146458617,negative regulation of immune effector process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,production of molecular mediator of immune response,6.055267732094795e-6,2.3294431472407098e-4,53/2058,5.217866649878347,3.632747884546493,production of molecular mediator of immune resp...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,innate immune response,6.5360023418447854e-6,2.4892364918915866e-4,163/2058,5.184687800868223,3.603933840938819,innate immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cell activation involved in immune response,7.593524960851374e-6,2.7282962088115523e-4,67/2058,5.1195565751359,3.5641084804712673,cell activation involved in immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,axon development,8.536238595511747e-6,2.996337759539768e-4,102/2058,5.068733454494318,3.5234092327494624,axon development,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,1.6461042371131767e-5,3.0149698658704497e-4,48/2332,4.7835426671980406,3.5207170242042882,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCEL...,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,DO,immune system disease,5.314805706042543e-6,3.164725215870787e-4,121/1094,5.274512607403325,3.4996639925697663,immune system disease,OUD vs Control Female,DO
OUD_vs_Control_Female,GO_BP,leukocyte activation involved in immune response,9.201104501408053e-6,3.2002197711061706e-4,66/2058,5.036160036776698,3.4948201960234315,leukocyte activation involved in immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,axon guidance,9.691516570637156e-6,3.355467350842874e-4,55/2058,5.0136082573431295,3.4742469825719513,axon guidance,OUD vs Control Female,GO BP
OUD_vs_Control_Female,Hallmark,HALLMARK_APOPTOSIS,6.164623426299144e-5,3.602451593580952e-4,45/703,4.21009344767739,3.4434018461231117,HALLMARK_APOPTOSIS,OUD vs Control Female,Hallmark
OUD_vs_Control_Female,GO_BP,neuron projection guidance,1.1130444075220954e-5,3.785568148540046e-4,55/2058,4.953487508120757,3.421868931154946,neuron projection guidance,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_CC,axon,6.689591406005086e-6,3.790768463402882e-4,112/1867,5.174600407723427,3.4212727410648154,axon,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_1,3.671989137750495e-5,3.802135588202411e-4,23/2057,4.4350986121717755,3.4199723997908937,FAN_EMBRYONIC_CTX_ASTROCYTE_1,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,4.014262893803415e-5,4.1045838089139914e-4,34/2057,4.396394189001133,3.386730872321753,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_STOMACH_ENS_NEURONS,1.0605769912014556e-4,4.436118988578677e-4,23/2407,3.9744577989623506,3.3529968134268278,DESCARTES_FETAL_STOMACH_ENS_NEURONS,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_CC,dendrite,1.2513199042986425e-5,4.526513740767263e-4,123/2168,4.902631647212405,3.344236156939274,dendrite,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_BP,positive regulation of tumor necrosis factor superfamily cytokine production,1.424502459847048e-5,4.6769117399374845e-4,30/2058,4.846336796479206,3.3300408257767216,positive regulation of tumor necrosis factor su...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of cytokine production,1.4485242897754901e-5,4.7151322714614994e-4,63/2058,4.839074217873394,3.3265061196901526,negative regulation of cytokine production,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,5.14538684361655e-5,5.01062671199802e-4,29/2057,4.288581968281067,3.3001079506716255,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_BP,neuron projection morphogenesis,1.5822491679970584e-5,5.106776234166777e-4,124/2058,4.800725124020856,3.2918531713975776,neuron projection morphogenesis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,DO,autoimmune disease,1.1284713521993643e-5,5.685759505312182e-4,73/1094,4.9475094616102835,3.2452115139253372,autoimmune disease,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,C8_CellType,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,6.50570731747628e-5,5.847987456808348e-4,76/2057,4.186705478906028,3.2329935675557984,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL...,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_BP,T cell activation involved in immune response,1.9516319900866235e-5,5.970112798590286e-4,34/2058,4.709602071783264,3.224017463285616,T cell activation involved in immune response,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,7.09135071487656e-5,6.049922715986409e-4,36/2057,4.149271035318018,3.2182501731549724,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_CC,neuronal cell body,1.9397744700896947e-5,6.724551496310942e-4,99/2168,4.712248760837428,3.1723366762583103,neuronal cell body,OUD vs Control Female,GO CC
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_3,1.8412284109015732e-4,7.294097166263924e-4,10/2407,3.734892332386263,3.1370284556519086,FAN_EMBRYONIC_CTX_MICROGLIA_3,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_CC,distal axon,2.4206197350475488e-5,7.627017065672438e-4,61/2168,4.616073430278067,3.1176452818636684,distal axon,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_BP,positive regulation of immune effector process,2.9994065292128964e-5,8.621313031326275e-4,56/2058,4.52296466747534,3.064426585818763,positive regulation of immune effector process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,chemokine production,3.6773227479861874e-5,0.0010111973780292704,27/2058,4.43446825168724,2.995164065158304,chemokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of chemokine production,3.6773227479861874e-5,0.0010111973780292704,27/2058,4.43446825168724,2.995164065158304,regulation of chemokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,2.857816289438488e-4,0.0010902039918969048,24/2407,3.5439656926365433,2.962492232090358,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_BP,central nervous system neuron differentiation,4.023431038262202e-5,0.0010906218583075868,47/2058,4.3954034380946645,2.9623258024063595,central nervous system neuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of microglial cell migration,4.0683029205795805e-5,0.001098874586739527,6/2058,4.3905867175392945,2.959051870265271,positive regulation of microglial cell migration,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C3_MICROGLIA,1.331620226209728e-4,0.0011002680252924825,85/2057,3.875619616891337,2.958501507817564,ZHONG_PFC_C3_MICROGLIA,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,synapse assembly,2.3685838056347645e-6,0.0012443524207459782,58/1775,5.625511244383002,2.9050566029976914,synapse assembly,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_CC,glutamatergic synapse,4.7870616916732265e-5,0.001254898032047897,112/2168,4.319930975655586,2.9013915617670505,glutamatergic synapse,OUD vs Control Female,GO CC
OUD_Effect_Male_vs_Female,C8_CellType,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,1.622859142955065e-4,0.0012888337659584883,87/2057,3.7897191733913087,2.889803094425158,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_BP,synapse assembly,5.2271301621584854e-5,0.0013041258462124035,60/2058,4.281736685285192,2.884680497807703,synapse assembly,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of production of molecular mediator of immune response,5.733811013413114e-5,0.0013998217464476826,35/2058,4.241556625513084,2.853927263938142,positive regulation of production of molecular ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,axonogenesis,6.254472890639285e-5,0.0014841221186292657,89/2058,4.203809285544157,2.828530362355645,axonogenesis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of complement activation,6.469022413408483e-5,0.001516139806859459,10/2058,4.189161344144291,2.819260749529781,regulation of complement activation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_MF,cytokine activity,5.988016110620572e-6,0.0015863020583903,45/2121,5.22271703986803,2.7996141122254277,cytokine activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_BP,multicellular organismal response to stress,6.987490409763222e-5,0.001607967203962733,27/2058,4.155678775168457,2.793722813350791,multicellular organismal response to stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of type 2 immune response,7.089889243137927e-5,0.001626482744218953,13/2058,4.149360549227334,2.78875053990149,regulation of type 2 immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,1.3603973877723886e-4,0.0016528319384606176,45/2332,3.8663342106683998,2.781771303663763,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,"synaptic transmission, glutamatergic",7.282984234606534e-5,0.0016559549526865066,30/2058,4.137690630157057,2.7809514816005176,"synaptic transmission, glutamatergic",OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,type 2 immune response,7.383521323635586e-5,0.0016712727699533631,15/2058,4.131736466538241,2.7769526627230876,type 2 immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,KEGG,Cytokine-cytokine receptor interaction,1.5045888544200088e-5,0.0017252618864016102,59/1075,4.822582159638868,2.7631449717870002,Cytokine-cytokine receptor interaction,OUD vs Control Female,KEGG
OUD_vs_Control_Female,GO_BP,"regulation of synaptic transmission, glutamatergic",8.971434598896255e-5,0.001975012061843722,23/2058,4.047138104495763,2.7044302476951545,"regulation of synaptic transmission, glutamatergic",OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_STOMACH_ENS_NEURONS,2.792635721328277e-4,0.0020579964144563337,20/2057,3.5539857111070297,2.686555386222364,DESCARTES_FETAL_STOMACH_ENS_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,neuron projection development,7.239918891534538e-6,0.002129984137889461,160/1775,5.1402662991559325,2.6716236307644214,neuron projection development,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of T-helper 1 type immune response,9.995488599548809e-5,0.002150724199513087,12/2058,4.000195971840858,2.667415278273261,regulation of T-helper 1 type immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cell morphogenesis involved in neuron differentiation,1.1196507139017076e-4,0.0023755931720861575,109/2058,3.9509174386545527,2.624227931639487,cell morphogenesis involved in neuron different...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,2.5876152154803266e-4,0.0027828648711514694,43/2332,3.587100303821657,2.555507881390734,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,microglial cell migration,1.437162323329929e-4,0.002918355278098464,6/2058,3.842494176789118,2.534861838581898,microglial cell migration,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of microglial cell migration,1.437162323329929e-4,0.002918355278098464,6/2058,3.842494176789118,2.534861838581898,regulation of microglial cell migration,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of type 2 immune response,1.4384111216165756e-4,0.002918355278098464,9/2058,3.842116967686739,2.534861838581898,positive regulation of type 2 immune response,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_CC,neuron projection membrane,7.260273405615028e-5,0.00293868209274894,19/1867,4.139047024435693,2.53184739345532,neuron projection membrane,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_BP,response to cytokine,1.3427726432579809e-5,0.002992755391261348,145/1775,4.871997515356053,2.523928778170392,response to cytokine,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,T cell differentiation involved in immune response,1.5364790938988637e-4,0.003071748361739539,26/2058,3.8134733445948017,2.5126143646770362,T cell differentiation involved in immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_CC,neuron spine,1.393970479612284e-4,0.003134549835236271,43/2168,3.855746423280505,2.503824821056776,neuron spine,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_MF,immune receptor activity,1.6935414511953705e-5,0.003149987099223389,37/2121,4.771204169078337,2.501691224860421,immune receptor activity,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,GO_BP,cellular response to cytokine stimulus,1.5296495384886917e-5,0.003308991869289508,133/1775,4.815408059989588,2.480304299968294,cellular response to cytokine stimulus,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1.74944538353543e-4,0.0033650316884821637,31/2058,3.757099611340226,2.4730108416723535,positive regulation of adaptive immune response...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_CC,neuron projection terminus,1.581966310707166e-4,0.0033748614628419543,32/2168,3.800802769403302,2.4717440501390775,neuron projection terminus,OUD vs Control Female,GO CC
OUD_vs_Control_Female,WikiPathways,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,3.188276947457411e-5,0.0033932376083653875,41/1231,4.496443960949545,2.4693857282155087,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,GO_BP,astrocyte differentiation,1.848629973007528e-4,0.0034940482641186953,25/2058,3.7331500097510832,2.456671100298808,astrocyte differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_CC,GABA-ergic synapse,1.7106601923847262e-4,0.003558173200160231,29/2168,3.7668362506743565,2.448772915711595,GABA-ergic synapse,OUD vs Control Female,GO CC
OUD_vs_Control_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL,0.0010531245766868687,0.003600724693734356,30/2407,2.9775202520172024,2.4436100828949554,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NE...,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,DO,glucose metabolism disease,1.8790608404174597e-4,0.003907253493566464,122/1094,3.726059158042201,2.408128411840018,glucose metabolism disease,OUD vs Control Female,DO
OUD_vs_Control_Female,GO_BP,"CD4-positive, alpha-beta T cell differentiation involved in immune response",2.222226875438108e-4,0.00402059432546605,24/2058,3.6532116043866036,2.3957097446288875,"CD4-positive, alpha-beta T cell differentiation...",OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL,6.011302290698751e-4,0.00414168169226212,16/2057,3.221031432091037,2.382823281735696,HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,Reactome,Metabolism of carbohydrates and carbohydrate derivatives,2.5266500700442894e-5,0.004444377473207905,64/1379,4.5974549017967865,2.3521890623393253,Metabolism of carbohydrates and carbohydrate de...,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,GO_BP,neuron projection morphogenesis,2.61282622239694e-5,0.004451492600750309,109/1775,4.582889473993986,2.3514943441694474,neuron projection morphogenesis,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,alpha-beta T cell activation involved in immune response,2.71263108258063e-4,0.004688134818664818,24/2058,3.5666092662066613,2.3289999076213026,alpha-beta T cell activation involved in immune...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,alpha-beta T cell differentiation involved in immune response,2.71263108258063e-4,0.004688134818664818,24/2058,3.5666092662066613,2.3289999076213026,alpha-beta T cell differentiation involved in i...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of neuron differentiation,2.71263108258063e-4,0.004688134818664818,24/2058,3.5666092662066613,2.3289999076213026,positive regulation of neuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,KEGG,Morphine addiction,5.880919815146774e-5,0.004980402793585666,28/1075,4.230554742052935,2.302735531947597,Morphine addiction,OUD vs Control Female,KEGG
OUD_vs_Control_Female,GO_BP,T cell cytokine production,3.013677763368178e-4,0.005089841136047763,14/2058,3.5209031863520512,2.293295772636627,T cell cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of T cell cytokine production,3.013677763368178e-4,0.005089841136047763,14/2058,3.5209031863520512,2.293295772636627,regulation of T cell cytokine production,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_CC,neuron to neuron synapse,1.7705310794968244e-4,0.005788274682970387,73/1867,3.751896445333149,2.2374508675896743,neuron to neuron synapse,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL,9.239972277018389e-4,0.005904919783282064,27/2057,3.0343293318054343,2.2287859977819795,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NE...,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,Hallmark,HALLMARK_APOPTOSIS,5.955957955677085e-4,0.005955957955677085,36/572,3.2250483766824347,2.2250483766824347,HALLMARK_APOPTOSIS,OUD Effect Male vs Female,Hallmark
OUD_vs_Control_Female,GO_BP,negative regulation of neuron projection development,4.3338280338752307e-4,0.0067095057182982995,32/2058,3.363128325462156,2.1733094726361317,negative regulation of neuron projection develo...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,8.137992057383273e-4,0.006968066309942233,42/2332,3.089482738350551,2.1568877251208036,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,positive regulation of adaptive immune response,4.549989634736718e-4,0.006987353033828545,31/2058,3.3419895927015193,2.155687313598332,positive regulation of adaptive immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_CC,postsynapse,4.686046534690743e-4,0.0070887103942958146,138/2168,3.3291934029650356,2.1494327661685553,postsynapse,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_BP,regulation of innate immune response,4.7281140464509554e-4,0.007152271905305809,86/2058,3.325312056418896,2.145555983483776,regulation of innate immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,sensory perception of pain,4.8004047673484576e-4,0.00717083245277216,22/2058,3.3187221416213917,2.144430424714372,sensory perception of pain,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of cytokine production involved in immune response,4.823818218311207e-4,0.007176371751733685,23/2058,3.3166090665959023,2.1440950719783483,positive regulation of cytokine production invo...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,DO,adult respiratory distress syndrome,4.286594051335787e-4,0.007178865782877121,15/1094,3.3678876430609965,2.143944166224044,adult respiratory distress syndrome,OUD vs Control Female,DO
OUD_vs_Control_Female,GO_BP,positive regulation of T cell cytokine production,4.899076608551829e-4,0.007253866443642759,11/2058,3.309885769277862,2.1394304448023083,positive regulation of T cell cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_EXCITATORY_NEURONS,0.002434854283668076,0.007542556126851484,5/2407,2.613527024466793,2.1224814494007442,DESCARTES_MAIN_FETAL_EXCITATORY_NEURONS,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,KEGG,Viral protein interaction with cytokine and cytokine receptor,3.0974792157815176e-4,0.007605234384764356,23/1075,3.5089915990767357,2.11888739693758,Viral protein interaction with cytokine and cyt...,OUD vs Control Female,KEGG
OUD_vs_Control_Female,GO_BP,regulation of neurotransmitter transport,5.515227899661789e-4,0.008094314241179932,26/2058,3.258436536982524,2.091819939237597,regulation of neurotransmitter transport,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,response to chemokine,5.668549141315523e-4,0.008239950154465714,20/2058,3.246528084061324,2.0840754154516663,response to chemokine,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cellular response to chemokine,5.668549141315523e-4,0.008239950154465714,20/2058,3.246528084061324,2.0840754154516663,cellular response to chemokine,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,myeloid cell activation involved in immune response,5.757659437449616e-4,0.0083060780180026,24/2058,3.239754026990157,2.0806039939305845,myeloid cell activation involved in immune resp...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of neuron projection development,6.101641762144577e-4,0.008674925470250828,83/2058,3.214553294119199,2.0617342477183964,regulation of neuron projection development,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTIATION,0.002877932327947228,0.00871844205231072,18/2407,2.54091942233292,2.059561114670003,ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTI...,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,KEGG,Nicotine addiction,4.3709356548600123e-4,0.00884471685454026,15/1075,3.359425586771597,2.0533160655783407,Nicotine addiction,OUD vs Control Female,KEGG
OUD_vs_Control_Female,C8_CellType,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.002995511730907444,0.009008400241853043,21/2407,2.5235289753029955,2.0453523264262676,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,regulation of synapse organization,7.69307779839341e-5,0.009126223743094117,59/1775,4.1138998756160525,2.039708888050758,regulation of synapse organization,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,KEGG,Nicotine addiction,4.954448120914663e-5,0.009166326704211388,15/889,4.30500471481945,2.0378046677864474,Nicotine addiction,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,0.0016099018715746737,0.009406426649629164,19/2057,2.793200594733627,2.026575326740542,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.0011662252450598052,0.009453992335992298,43/2332,2.9332175617217806,2.0243847540997013,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,KEGG,GABAergic synapse,9.293489823769327e-5,0.009540974832028998,24/889,4.031821172270669,2.020407249767393,GABAergic synapse,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Morphine addiction,1.378753588443497e-4,0.009540974832028998,24/889,3.860513344224151,2.020407249767393,Morphine addiction,OUD Effect Male vs Female,KEGG
OUD_vs_Control_Female,GO_BP,forebrain neuron differentiation,6.969307299187609e-4,0.009704792266528706,20/2058,3.1568103856165455,2.013013756356592,forebrain neuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,DO,"autoimmune disease of eyes, ear, nose and throat",6.601206807724401e-4,0.009716383054066254,9/1094,3.1803766611210698,2.0124953721102186,"autoimmune disease of eyes, ear, nose and throat",OUD vs Control Female,DO
OUD_vs_Control_Female,GO_BP,complement receptor mediated signaling pathway,7.224879392251292e-4,0.009757430200492568,7/2058,3.141169398359225,2.0106645467491826,complement receptor mediated signaling pathway,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of complement activation,7.224879392251292e-4,0.009757430200492568,7/2058,3.141169398359225,2.0106645467491826,negative regulation of complement activation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,0.0035736801608304753,0.010516830187586828,37/2407,2.4468843188147353,1.9781151384598388,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,cell morphogenesis involved in neuron differentiation,9.209680217770006e-5,0.010559452504737917,97/1775,4.035755449289469,1.9763585988794075,cell morphogenesis involved in neuron different...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of response to cytokine stimulus,8.124113486094772e-4,0.010724674596808297,18/2058,3.0902240185463437,1.9696158761086904,positive regulation of response to cytokine sti...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neuronal action potential,8.315938971946596e-4,0.010920976887307315,13/2058,3.080088706479107,1.9617385120166806,neuronal action potential,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of T-helper 17 type immune response,8.315938971946596e-4,0.010920976887307315,13/2058,3.080088706479107,1.9617385120166806,regulation of T-helper 17 type immune response,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.0021500908744572795,0.011725162235373697,64/2057,2.6675431840651846,1.9308811394495429,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_BP,positive regulation of cytokine-mediated signaling pathway,9.693409030219589e-4,0.012204082079864894,17/2058,3.0135234610665376,1.9134948801256215,positive regulation of cytokine-mediated signal...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,9.693409030219589e-4,0.012204082079864894,17/2058,3.0135234610665376,1.9134948801256215,negative regulation of adaptive immune response...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,lymphocyte activation involved in immune response,9.786231756302782e-4,0.012300615063986515,45/2058,3.0093845035473006,1.9100731721202024,lymphocyte activation involved in immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of adaptive immune response,0.001007080476084466,0.012554716835246116,18/2058,2.9969358234653227,1.9011930781144923,negative regulation of adaptive immune response,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of synapse structure or activity,1.348352924750657e-4,0.012850748174079983,59/1775,3.8701964184752358,1.8910715868528765,regulation of synapse structure or activity,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_EYE_ASTROCYTES,0.002501847687033078,0.0128511733159452,11/2057,2.601739133769133,1.891057219307152,DESCARTES_FETAL_EYE_ASTROCYTES,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,0.0018786303282406433,0.013131545135134023,41/2332,2.72615867077766,1.8816841692508501,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_CC,asymmetric synapse,4.222586074331354e-4,0.013293326530302409,66/1867,3.374421488891083,1.8763663273357776,asymmetric synapse,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.0019369018714669361,0.013423308560152081,38/2332,2.712892381222007,1.872140426617012,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_...,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of immune system process,1.6246840489113554e-4,0.013659643265895137,85/1775,3.7892310833962535,1.864560642504872,negative regulation of immune system process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of neuron projection development,1.6343284940839866e-4,0.013659643265895137,30/1775,3.7866606474182523,1.864560642504872,negative regulation of neuron projection develo...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,ensheathment of neurons,0.0011215150244421074,0.013756167377094255,36/2058,2.950194903990426,1.8615025485736212,ensheathment of neurons,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,axon ensheathment,0.0011215150244421074,0.013756167377094255,36/2058,2.950194903990426,1.8615025485736212,axon ensheathment,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of innate immune response,0.0011437079820612376,0.013942206746763879,24/2058,2.941684847893054,1.8556684814680409,negative regulation of innate immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,T-helper 17 type immune response,0.0011531561310832669,0.013942206746763879,16/2058,2.938111887607844,1.8556684814680409,T-helper 17 type immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_CC,presynapse,0.0010306604066973694,0.014057532104462481,112/2168,2.986884407259642,1.852090915979685,presynapse,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_BP,positive regulation of synapse assembly,0.0012401507146607743,0.014852559738319369,18/2058,2.90652553212161,1.828198692176639,positive regulation of synapse assembly,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.0022119053348108276,0.01502985047586939,39/2332,2.655233463917539,1.8230453399605202,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARRO...,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,7.159440599259347e-4,0.015034825258444628,35/2013,3.145120909835412,1.8229016151014925,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_...,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,axonogenesis,1.973821609626067e-4,0.015444104190212473,77/1775,3.704692100630868,1.8112372771670178,axonogenesis,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,immunoglobulin mediated immune response,0.001310848792664551,0.015504247288394231,30/2058,2.8824474015965045,1.809549313362932,immunoglobulin mediated immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C1_ASTROCYTE,0.005773665607125605,0.015547387125070257,10/2407,2.2385483727215862,1.8083425875060506,ZHONG_PFC_C1_ASTROCYTE,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,7.789126224491512e-4,0.015878084922896506,38/2013,3.108511258266531,1.7992018795898497,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,negative regulation of cytokine production involved in immune response,0.0013860240169646938,0.01629219897719147,11/2058,2.8582292442228634,1.7880202945000723,negative regulation of cytokine production invo...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,0.0061743854260661694,0.016411914809930723,31/2407,2.209406263874148,1.7848407460113047,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of neuron differentiation,2.2401923485679633e-4,0.01681287216705854,22/1775,3.6497146904447373,1.7743580890736834,positive regulation of neuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of cytokine production,2.2831157488472083e-4,0.016961935689667893,117/1775,3.641472070195554,1.7705245877295552,regulation of cytokine production,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,forebrain generation of neurons,0.001479463400874719,0.01706043459480621,21/2058,2.829895773994226,1.7680099098788014,forebrain generation of neurons,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,L-glutamate import across plasma membrane,0.001491087864604075,0.01706043459480621,8/2058,2.8264967643348053,1.7680099098788014,L-glutamate import across plasma membrane,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cerebral cortex neuron differentiation,0.0014939359163365815,0.01706043459480621,10/2058,2.825668031555637,1.7680099098788014,cerebral cortex neuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of chemokine production,0.0015205103188411704,0.017234712944364874,19/2058,2.818010628199511,1.763595945659952,positive regulation of chemokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_MF,cytokine binding,3.1784770912716753e-4,0.01759838746167887,33/2121,3.4977809143798675,1.7545271247187313,cytokine binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_BP,microglial cell activation involved in immune response,0.0015666891675022551,0.017613001905859765,4/2058,2.8050171593891187,1.75416661790873,microglial cell activation involved in immune r...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of neuron differentiation,0.0015846459523950992,0.017690693171863947,39/2058,2.8000677543274817,1.752255149859207,regulation of neuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_COMPLEMENT_SYSTEM,4.2810289601775937e-4,0.017718703196290594,26/1231,3.368451834253338,1.751568066608351,WP_COMPLEMENT_SYSTEM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,GO_CC,neuron projection membrane,0.0014509030103379247,0.017772445256471696,18/2168,2.838361618218979,1.7502528148321137,neuron projection membrane,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,axon initial segment,0.0015008984687276126,0.017827689767938908,9/2168,2.82364868548007,1.7489049319812235,axon initial segment,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_BP,T-helper 1 type immune response,0.0016119521956776994,0.017872256003605584,14/2058,2.79264784184931,1.7478206233154756,T-helper 1 type immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,KEGG,Starch and sucrose metabolism,0.001171601749435036,0.018319590991166017,12/1075,2.9312199885016925,1.7370842267523687,Starch and sucrose metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,GO_BP,dendrite development,0.0017067965333339814,0.018679122405754218,49/2058,2.7678182479052094,1.728643531922387,dendrite development,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neuron migration,0.0017667751203908498,0.019061651688409495,39/2058,2.7528187250764513,1.7198394705348705,neuron migration,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_CC,dendrite membrane,7.437472030354202e-4,0.019157124926669915,13/1867,3.128574654484997,1.7176696686485915,dendrite membrane,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_BP,regulation of synapse assembly,2.708616408526861e-4,0.019341624936616564,35/1775,3.567252494950517,1.71350704259214,regulation of synapse assembly,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,microglial cell proliferation,0.0018777655428302712,0.019837642357473196,5/2058,2.7263586345468047,1.7025099436728492,microglial cell proliferation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of production of molecular mediator of immune response,0.0018892491390768494,0.019903749228697594,13/2058,2.7237107670163714,1.7010651087175175,negative regulation of production of molecular ...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_INTERNEURON,0.0044446090228537245,0.020311118327901376,6/2057,2.3521664364227415,1.6922661637313114,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_IN...,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,0.008139567174414478,0.020448180950358323,30/2407,2.089398688324697,1.68934532033926,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,Reactome,Cytokine Signaling in Immune system,2.751348316609778e-4,0.020694927457318265,131/1379,3.560454425093496,1.6841360916087924,Cytokine Signaling in Immune system,OUD vs Control Female,Reactome
OUD_vs_Control_Female,GO_BP,regulation of synapse structure or activity,0.002011289511392746,0.020986290696271982,61/2058,2.6965254111781634,1.6780643157052344,regulation of synapse structure or activity,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of synapse organization,0.002024695777603681,0.021097274607397045,60/2058,2.6936402228362537,1.6757736442007296,regulation of synapse organization,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,5.5999218474108356e-5,0.021139704973975906,35/1002,4.251818033971489,1.674901078006282,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,axon development,3.0212584086848686e-4,0.021366688072958853,84/1775,3.5198121278659293,1.6702627901011609,axon development,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_CC,presynapse,9.076114184523942e-4,0.021429714046792638,99/1867,3.042100048992839,1.6689836240458336,presynapse,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,excitatory synapse,9.585584327010376e-4,0.02144143862620742,18/1867,3.0183814078499456,1.668746078752463,excitatory synapse,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,Hallmark,HALLMARK_COMPLEMENT,0.004354284914129546,0.021597729719163634,47/703,2.3610831571539146,1.6655918980277145,HALLMARK_COMPLEMENT,OUD vs Control Female,Hallmark
OUD_vs_Control_Female,GO_BP,neurotransmitter transport,0.00212767695875122,0.02190069647947033,43/2058,2.6720943094980423,1.6595420736356339,neurotransmitter transport,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,0.0036691590648055745,0.02190703794575093,39/2332,2.435433460369996,1.6594163394990384,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CEL...,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,cytokine production involved in inflammatory response,0.002216269772872567,0.022508435813293794,16/2058,2.6543773767328687,1.647654684531184,cytokine production involved in inflammatory re...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of cytokine production involved in inflammatory response,0.002216269772872567,0.022508435813293794,16/2058,2.6543773767328687,1.647654684531184,regulation of cytokine production involved in i...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_CC,excitatory synapse,0.0021016352343594807,0.02270857811671543,19/2168,2.677442659122051,1.6438100580038089,excitatory synapse,OUD vs Control Female,GO CC
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C3_MICROGLIA,0.009336687053973745,0.022897113489507043,86/2407,2.029807197582781,1.6402192632755095,ZHONG_PFC_C3_MICROGLIA,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,Reactome,Chondroitin sulfate/dermatan sulfate metabolism,3.559596827768428e-4,0.023190114148313574,17/1379,3.448599188934713,1.634697113636239,Chondroitin sulfate/dermatan sulfate metabolism,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,GO_BP,cytokine production,3.358407897034013e-4,0.023207095421350358,117/1775,3.4738665575509007,1.6343792120394287,cytokine production,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,Reactome,Glycosaminoglycan metabolism,3.7640289293534596e-4,0.023646167452616912,32/1379,3.424347047356818,1.626239239241576,Glycosaminoglycan metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,GO_BP,excitatory synapse assembly,0.0024245696296543297,0.02401553559047728,13/2058,2.6153653391457223,1.6195077233537687,excitatory synapse assembly,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of axonogenesis,0.002440057529781372,0.024106249292275887,32/2058,2.612599934082559,1.6178703565401316,regulation of axonogenesis,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_CC,main axon,0.0011453993656708747,0.024963832328724192,18/1867,2.941043061737545,1.6026887430497512,main axon,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,Reactome,Axon guidance,4.2178265868655375e-4,0.02558329988378097,100/1379,3.3749112799582144,1.592043438399709,Axon guidance,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of microglial cell migration,3.9214619541093224e-4,0.025733624273640673,5/1775,3.4065519941437628,1.5894990442910855,positive regulation of microglial cell migration,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_2_INTERNEURON,0.00602767320408328,0.026088024766878957,4/2057,2.219850301398976,1.5835588019008973,FAN_EMBRYONIC_CTX_IN_2_INTERNEURON,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Male,GO_MF,G protein-coupled neurotransmitter receptor activity,0.003527220266453357,0.026454151998400177,1/5,2.452567418835971,1.5775061554442709,G protein-coupled neurotransmitter receptor act...,OUD vs Control Male,GO MF
OUD_vs_Control_Female,GO_MF,complement receptor activity,8.136306953195721e-4,0.02670623105813654,6/2121,3.0895726754289132,1.5733873978696085,complement receptor activity,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,Reactome,Neuronal System,1.771512093897418e-5,0.02789311917713886,77/1194,4.751655878445122,1.5545029175849876,Neuronal System,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.0066393831120759705,0.028286538467073668,6/2057,2.1778722705517475,1.5484201955839743,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of cytokine production,4.612611761389559e-4,0.029246344400879486,78/1775,3.3360530979566225,1.5339284101199921,positive regulation of cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,0.007035849857816106,0.0296666246582143,5/2057,2.1526834367838905,1.5277318630427936,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_MF,neurotransmitter receptor activity,2.993098298718937e-4,0.030903739934273023,23/1824,3.5238790199155097,1.509988959587071,neurotransmitter receptor activity,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,GO_CC,asymmetric synapse,0.0031625086623739192,0.031323895322560726,70/2168,2.499968276245836,1.5041242360169937,asymmetric synapse,OUD vs Control Female,GO CC
OUD_vs_Control_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,0.013454345348465666,0.03149539933845372,25/2407,1.8711374289641975,1.5017528807452127,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,0.01375186107674995,0.032100661550260506,5/2407,1.8616385236032649,1.4934860172939717,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,0.014264139312131328,0.03302019113440537,9/2407,1.8457544282318574,1.481220417191417,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.014266004907582903,0.03302019113440537,6/2407,1.8456976309156574,1.481220417191417,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_CC,distal axon,0.0015933308210597998,0.033032468241483655,48/1867,2.7976940428778736,1.4810589738833164,distal axon,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,0.008104009823223336,0.03331195997686778,18/2057,2.0913000412201965,1.4773998139585802,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_BP,central nervous system neuron development,0.003720462392938956,0.03367323124819095,22/2058,2.429403081026075,1.472715207166215,central nervous system neuron development,OUD vs Control Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,0.0014657496856405896,0.0352720676166185,49/1231,2.833940190286315,1.4525690816376153,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,0.0015246929718451187,0.0352720676166185,28/1231,2.816817601601121,1.4525690816376153,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AN...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,GO_CC,neuronal cell body membrane,0.0037131031480340487,0.035509216312233666,10/2168,2.430262986136139,1.4496589124640336,neuronal cell body membrane,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,axon terminus,0.003858602289180751,0.03617661696330269,25/2168,2.4135699823810013,1.4415720483901049,axon terminus,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_BP,mast cell cytokine production,0.004188243332915932,0.036459256533509316,4/2058,2.377968094167814,1.4381921915967428,mast cell cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of mast cell cytokine production,0.004188243332915932,0.036459256533509316,4/2058,2.377968094167814,1.4381921915967428,regulation of mast cell cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.007677796735546992,0.03793734857564396,39/2332,2.1147633897178104,1.4209330250342025,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,"regulation of synaptic transmission, glutamatergic",7.641243795534421e-4,0.03945224683570863,19/1775,3.1168359438363864,1.4039282583464867,"regulation of synaptic transmission, glutamatergic",OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_MF,cytokine receptor binding,0.0018918687771988748,0.03958735416288646,43/2121,2.723108990193642,1.4024435235283443,cytokine receptor binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_BP,regulation of humoral immune response,0.00463228261471961,0.03968964755491482,12/2058,2.3342049522449893,1.4013227576218181,regulation of humoral immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,chemokine-mediated signaling pathway,0.004795633250337638,0.04040745405732499,16/2058,2.3191540373006445,1.393538512182623,chemokine-mediated signaling pathway,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of neurotransmitter secretion,0.004818239455901099,0.04050831118719501,20/2058,2.317111620321005,1.3924558624044334,regulation of neurotransmitter secretion,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,mast cell activation involved in immune response,0.004885917713337711,0.04094173291803448,14/2058,2.311053851514096,1.3878337791426785,mast cell activation involved in immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_CC,neuron to neuron synapse,0.0045244850938817235,0.041001430333905,75/2168,2.3444308382510206,1.387200992663507,neuron to neuron synapse,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_BP,positive regulation of T-helper 1 type immune response,0.004965875137043769,0.04133887532116108,7/2058,2.30400420463136,1.3836413431044237,positive regulation of T-helper 1 type immune r...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of humoral immune response,0.004965875137043769,0.04133887532116108,7/2058,2.30400420463136,1.3836413431044237,negative regulation of humoral immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,"CD4-positive, alpha-beta T cell cytokine production",0.004965875137043769,0.04133887532116108,7/2058,2.30400420463136,1.3836413431044237,"CD4-positive, alpha-beta T cell cytokine produc...",OUD vs Control Female,GO BP
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_2,0.018944075659833845,0.04162644891654157,4/2407,1.7225265804458396,1.3806306364764427,FAN_EMBRYONIC_CTX_MICROGLIA_2,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_BP,regulation of astrocyte differentiation,0.005040856634552898,0.04187154305931235,10/2058,2.297495654021473,1.3780810340981093,regulation of astrocyte differentiation,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,forebrain neuron differentiation,8.509813220786228e-4,0.041876341532952506,18/1775,3.070079972003788,1.3780312668559658,forebrain neuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cytokine-mediated signaling pathway,8.651432385044414e-4,0.041876341532952506,81/1775,3.0629119820819555,1.3780312668559658,cytokine-mediated signaling pathway,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,central nervous system neuron differentiation,9.288350285573735e-4,0.042735394995351936,38/1775,3.032061414692481,1.3692122775827185,central nervous system neuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,tumor necrosis factor superfamily cytokine production,9.434451197302456e-4,0.042735394995351936,33/1775,3.0252833577052236,1.3692122775827185,tumor necrosis factor superfamily cytokine prod...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of tumor necrosis factor superfamily cytokine production,9.434451197302456e-4,0.042735394995351936,33/1775,3.0252833577052236,1.3692122775827185,regulation of tumor necrosis factor superfamily...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,microglial cell migration,9.436110502216437e-4,0.042735394995351936,5/1775,3.025206981921474,1.3692122775827185,microglial cell migration,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of microglial cell migration,9.436110502216437e-4,0.042735394995351936,5/1775,3.025206981921474,1.3692122775827185,regulation of microglial cell migration,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,axon guidance,9.449744328362775e-4,0.042735394995351936,43/1775,3.0245799415736276,1.3692122775827185,axon guidance,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_EXCITATORY_NEURONS,0.010879024663438878,0.042990541906729476,4/2057,1.9634100386703452,1.3666270804559402,DESCARTES_MAIN_FETAL_EXCITATORY_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,0.009144911480137387,0.04342495977702666,37/2332,2.038820494001007,1.3622605751519854,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_MF,ionotropic glutamate receptor binding,6.072410837965915e-4,0.044300585090259505,10/1824,3.2166388532809513,1.3535905378899526,ionotropic glutamate receptor binding,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,GO_BP,"positive regulation of synaptic transmission, glutamatergic",0.005523019914285502,0.0454307156448301,11/2058,2.2578233908431864,1.3426504219317361,"positive regulation of synaptic transmission, g...",OUD vs Control Female,GO BP
OUD_vs_Control_Female,Reactome,Neuronal System,0.0011138631471401047,0.045564773856266144,78/1379,2.9531681647214376,1.3413707808435626,Neuronal System,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,GO_BP,neuron projection guidance,0.0010366228247179208,0.045654855543714415,43/1775,2.984379232945925,1.3405130270299594,neuron projection guidance,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_IRON_METABOLISM_DISORDERS,0.0025944705769552516,0.04602096618646815,8/1231,2.5859512501332214,1.337044267782829,WP_IRON_METABOLISM_DISORDERS,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.009951839053696065,0.04614669045330111,38/2332,2.0020966562321245,1.3358594402373856,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12...,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_CC,axon initial segment,0.00250840233563882,0.04635091272376081,8/1867,2.6006028035135835,1.3339417094808648,axon initial segment,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Male,Hallmark,HALLMARK_COMPLEMENT,0.046421663442940075,0.046421663442940075,1/1,1.333279301382336,1.333279301382336,HALLMARK_COMPLEMENT,OUD vs Control Male,Hallmark
OUD_vs_Control_Female,GO_BP,glutamate receptor signaling pathway,0.005869045054459452,0.04735647900404412,15/2058,2.2314325565576447,1.324620595262329,glutamate receptor signaling pathway,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,integrated stress response signaling,0.005947680034925867,0.0477884797742936,14/2058,2.2256524030962495,1.3206767848409309,integrated stress response signaling,OUD vs Control Female,GO BP
OUD_vs_Control_Female,KEGG,Central carbon metabolism in cancer,0.005561442315097679,0.04905477324086158,19/1075,2.2548125630480613,1.3093187275030302,Central carbon metabolism in cancer,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,0.004268159260268003,0.04942304651050662,35/2013,2.369759383866792,1.3060704875473985,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_EYE_ASTROCYTES,0.023420271405788957,0.04948282984197462,10/2407,1.6304080764133768,1.3055454717427601,DESCARTES_FETAL_EYE_ASTROCYTES,OUD vs Control Female,C8 CellType
OUD_vs_Control_Male,Reactome,Cellular response to heat stress,0.026208731151407982,0.05087577223508608,1/3,1.5815540041308818,1.2934889856312684,Cellular response to heat stress,OUD vs Control Male,Reactome
OUD_vs_Control_Female,GO_BP,response to fluid shear stress,0.0065434248679416525,0.051598522118900425,10/2058,2.184194879822064,1.2873627372254643,response to fluid shear stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neuronal action potential propagation,0.0066560570781255815,0.05168112819988028,5/2058,2.176782962467229,1.2866680142537925,neuronal action potential propagation,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of response to cytokine stimulus,0.0012576193029193111,0.05225870041226855,16/1775,2.9004508053639824,1.28184139466224,positive regulation of response to cytokine sti...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,0.01385868167054667,0.052483340770866554,8/2057,1.8582780807226318,1.2799785282022396,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,0.01176140326186706,0.05269572575391855,38/2332,1.9295408591673315,1.2782246097735752,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,regulation of neuron projection development,0.0012754999695330105,0.05270389467263587,72/1775,2.894319547427884,1.2781572904357106,regulation of neuron projection development,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,postsynaptic neurotransmitter receptor diffusion trapping,0.001325457724343556,0.0530187577205498,6/1775,2.877634119592229,1.2755704524126354,postsynaptic neurotransmitter receptor diffusio...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter receptor diffusion trapping,0.001325457724343556,0.0530187577205498,6/1775,2.877634119592229,1.2755704524126354,neurotransmitter receptor diffusion trapping,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Male,GO_MF,postsynaptic neurotransmitter receptor activity,0.021330001767397522,0.053325004418493804,1/5,1.6710091085650598,1.2730690998930223,postsynaptic neurotransmitter receptor activity,OUD vs Control Male,GO MF
OUD_Effect_Male_vs_Female,GO_BP,"synaptic transmission, glutamatergic",0.0013635813261227187,0.05376393355948832,24/1775,2.865318954947833,1.2695089642718465,"synaptic transmission, glutamatergic",OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,KEGG,Apoptosis,0.007032637546248625,0.05385175932609931,31/1075,2.152881765029435,1.2688001038212322,Apoptosis,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Glutamatergic synapse,0.0070462742347355825,0.05385175932609931,27/1075,2.1520404584703066,1.2688001038212322,Glutamatergic synapse,OUD vs Control Female,KEGG
OUD_vs_Control_Female,GO_BP,neuron projection regeneration,0.007022948859452094,0.05393575950045058,15/2058,2.153480494069634,1.268123201337863,neuron projection regeneration,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,dendrite development,0.0013963093744129773,0.054018057231915,44/1775,2.855018346243981,1.2674610393383356,dendrite development,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,macrophage activation involved in immune response,0.00717710340132358,0.05455887885018135,7/2058,2.1440507967939118,1.263134562731754,macrophage activation involved in immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of sensory perception of pain,0.00717710340132358,0.05455887885018135,7/2058,2.1440507967939118,1.263134562731754,regulation of sensory perception of pain,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,astrocyte development,0.007207854083929171,0.05457477590187723,12/2058,2.142194013813929,1.263008038940453,astrocyte development,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,"complement activation, alternative pathway",0.007372143240583061,0.055160722066327286,6/2058,2.1324062350386326,1.258370057445988,"complement activation, alternative pathway",OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,pyramidal neuron differentiation,0.007372143240583061,0.055160722066327286,6/2058,2.1324062350386326,1.258370057445988,pyramidal neuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,0.027502323523573298,0.05665478645856099,28/2407,1.5606306134119623,1.246763393042809,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,integrated stress response signaling,0.0014951342989438599,0.05667891244977509,14/1775,2.8253197955197122,1.246578491550774,integrated stress response signaling,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,forebrain generation of neurons,0.0015104101754120894,0.05667891244977509,19/1775,2.820905097257847,1.246578491550774,forebrain generation of neurons,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_CC,neuron spine,0.0034055246403734167,0.05675874400622361,34/1867,2.467815973070554,1.2459672234541974,neuron spine,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,GO_BP,"synaptic transmission, dopaminergic",0.007680154277988373,0.05679585935479362,9/2058,2.114630055827074,1.2456833249388615,"synaptic transmission, dopaminergic",OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,ionotropic glutamate receptor signaling pathway,0.007680154277988373,0.05679585935479362,9/2058,2.114630055827074,1.2456833249388615,ionotropic glutamate receptor signaling pathway,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON,0.02781698587736967,0.057160090680679815,12/2407,1.5556899299781615,1.242907090901228,FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_BP,neuron apoptotic process,0.007755913284502333,0.05730047671004294,54/2058,2.110367055224155,1.241841764914287,neuron apoptotic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.0037758235409550717,0.05740792934717405,5/1231,2.4229883101844023,1.2410281174646232,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,GO_BP,dendrite morphogenesis,0.00779817370801515,0.05744554074850232,30/2058,2.1080070949248735,1.2407436780894123,dendrite morphogenesis,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,DO,withdrawal disorder,0.00187501662867599,0.057668194360010326,12/920,2.7269948763574887,1.2390636465041427,withdrawal disorder,OUD Effect Male vs Female,DO
OUD_vs_Control_Female,KEGG,Arachidonic acid metabolism,0.008295006407498418,0.059447545920405326,15/1075,2.0811832741676337,1.2258660689716907,Arachidonic acid metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,GO_BP,neuron projection extension,0.008196353379822705,0.05985774083807243,34/2058,2.0863793255760434,1.2228796784091893,neuron projection extension,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of neurotransmitter receptor activity,0.008371334134502847,0.060728049621436374,10/2058,2.077205323239672,1.2166106667162255,regulation of neurotransmitter receptor activity,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_MF,lipopolysaccharide immune receptor activity,0.004092034141335743,0.06171229867203634,4/2121,2.3880607514672425,1.2096282765966586,lipopolysaccharide immune receptor activity,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,GO_BP,"positive regulation of synaptic transmission, glutamatergic",0.0017050919850793837,0.06208391856563795,11/1775,2.768252187032296,1.2070208794153707,"positive regulation of synaptic transmission, g...",OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_APOPTOSIS,0.004455643663304316,0.06233732774923014,23/1231,2.3510895488147314,1.2052518188162868,WP_APOPTOSIS,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,GO_BP,T-helper 1 cell cytokine production,0.008713921478444544,0.06244020686859087,4/2058,2.0597863578305944,1.2045356667605063,T-helper 1 cell cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of T-helper 1 cell cytokine production,0.008713921478444544,0.06244020686859087,4/2058,2.0597863578305944,1.2045356667605063,regulation of T-helper 1 cell cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of T-helper 1 cell cytokine production,0.008713921478444544,0.06244020686859087,4/2058,2.0597863578305944,1.2045356667605063,positive regulation of T-helper 1 cell cytokine...,OUD vs Control Female,GO BP
OUD_vs_Control_Male,GO_MF,neurotransmitter receptor activity,0.029195060026889763,0.06256084291476377,1/5,1.5346906274748555,1.2036974084334313,neurotransmitter receptor activity,OUD vs Control Male,GO MF
OUD_vs_Control_Female,GO_BP,regulation of dopamine secretion,0.008885326808208499,0.06272431352930874,8/2058,2.0513265939260514,1.2025640830155775,regulation of dopamine secretion,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,astrocyte activation,0.008885326808208499,0.06272431352930874,8/2058,2.0513265939260514,1.2025640830155775,astrocyte activation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,0.004642344411082082,0.0628826652046573,12/1231,2.3332626427935277,1.2014690595394788,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,GO_BP,humoral immune response,0.009031294787037942,0.06363679222281962,39/2058,2.0442499818509474,1.196291720210873,humoral immune response,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,0.017345137123703093,0.064200552792711,8/2057,1.7608222624502181,1.1924612324640058,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of synapse assembly,0.001828969227310903,0.06467340705226773,16/1775,2.737793601533696,1.1892742594329089,positive regulation of synapse assembly,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_EYE_MICROGLIA,0.01776131807961495,0.06515138201401359,27/2057,1.7505248080696605,1.186076367446498,DESCARTES_FETAL_EYE_MICROGLIA,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,0.033118572717134476,0.0657583226961899,8/2407,1.479928387902533,1.1820492729175096,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.006854733878218634,0.06706076998931966,33/2013,2.1640094011902415,1.1735314643251402,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_C...,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,regulation of axonogenesis,0.0019459333488433311,0.06744070696881928,29/1775,2.7108720390549608,1.171077885728394,regulation of axonogenesis,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_MF,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,0.001257038168181482,0.06833726415125442,15/1824,2.900651535377732,1.1653424119551223,neurotransmitter receptor activity involved in ...,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,WikiPathways,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.005417408874225476,0.06840626459827084,24/1231,2.2662083851772965,1.1649041240711477,WP_APOPTOSIS_MODULATION_AND_SIGNALING,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,DO,bone inflammation disease,0.002285028585646697,0.06860526301191631,43/920,2.641108362547755,1.163642566372574,bone inflammation disease,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,GO_BP,maintenance of synapse structure,0.0022055674737725024,0.0699674856343316,10/1775,2.6564796515383358,1.1551037327014904,maintenance of synapse structure,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of complement activation,0.0022165090622432715,0.0699674856343316,6/1775,2.6543304887390202,1.1551037327014904,negative regulation of complement activation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,Hallmark,HALLMARK_HEME_METABOLISM,0.018447179408295204,0.07095069003190463,36/572,1.7340700284782367,1.1490433764490546,HALLMARK_HEME_METABOLISM,OUD Effect Male vs Female,Hallmark
OUD_vs_Control_Male,GO_BP,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.005979652021753767,0.07108341507017486,1/5,2.223324088491412,1.1482317154966715,negative regulation of endoplasmic reticulum st...,OUD vs Control Male,GO BP
OUD_vs_Control_Male,GO_BP,retrograde axonal transport,0.007635579482175192,0.07108341507017486,1/5,2.117157997722027,1.1482317154966715,retrograde axonal transport,OUD vs Control Male,GO BP
OUD_vs_Control_Male,GO_BP,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.010610687221172976,0.07108341507017486,1/5,1.974256487286405,1.1482317154966715,regulation of endoplasmic reticulum stress-indu...,OUD vs Control Male,GO BP
OUD_vs_Control_Male,GO_BP,postsynaptic neurotransmitter receptor internalization,0.010940813785330072,0.07108341507017486,1/5,1.9609503736758902,1.1482317154966715,postsynaptic neurotransmitter receptor internal...,OUD vs Control Male,GO BP
OUD_vs_Control_Male,GO_BP,mitochondrial outer membrane permeabilization involved in programmed cell death,0.012260438940868368,0.07108341507017486,1/5,1.9114939811891722,1.1482317154966715,mitochondrial outer membrane permeabilization i...,OUD vs Control Male,GO BP
OUD_vs_Control_Male,GO_BP,neurotransmitter receptor internalization,0.012919723104963365,0.07108341507017486,1/5,1.8887467940247666,1.1482317154966715,neurotransmitter receptor internalization,OUD vs Control Male,GO BP
OUD_vs_Control_Male,GO_BP,dopamine transport,0.013578655181394783,0.07108341507017486,1/5,1.8671432400864618,1.1482317154966715,dopamine transport,OUD vs Control Male,GO BP
OUD_Effect_Male_vs_Female,GO_BP,radial glia-guided pyramidal neuron migration,0.002395248753459358,0.07132410761819262,4/1775,2.620649377178508,1.1467636533746248,radial glia-guided pyramidal neuron migration,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of axon extension,0.010490127852748386,0.07166215592321476,19/2058,1.9792192186315378,1.1447101304223326,regulation of axon extension,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,response to axon injury,0.010490127852748386,0.07166215592321476,19/2058,1.9792192186315378,1.1447101304223326,response to axon injury,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neuron recognition,0.01059549810815968,0.07212324315447032,13/2058,1.9748786217242875,1.1419247526592529,neuron recognition,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of astrocyte differentiation,0.010881234193331478,0.07219717844129431,6/2058,1.9633218424177574,1.1414797748863275,negative regulation of astrocyte differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Male,GO_BP,negative regulation of response to endoplasmic reticulum stress,0.015553340294934492,0.07226421332124418,1/5,1.80817632587374,1.1410767207527397,negative regulation of response to endoplasmic ...,OUD vs Control Male,GO BP
OUD_vs_Control_Male,GO_BP,anterograde axonal transport,0.016539496221295025,0.07226421332124418,1/5,1.7814777228151342,1.1410767207527397,anterograde axonal transport,OUD vs Control Male,GO BP
OUD_Effect_Male_vs_Female,GO_CC,neuronal cell body membrane,0.0046839135621524995,0.07238775505144772,9/1867,2.329391128080156,1.140334891860107,neuronal cell body membrane,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,DO,autoimmune disease,0.0026000860714642787,0.07286018969147678,55/920,2.5850122752048468,1.1375097024071088,autoimmune disease,OUD Effect Male vs Female,DO
OUD_vs_Control_Male,WikiPathways,WP_APOPTOSIS_MODULATION_BY_HSP70,0.007376701181851075,0.07308965747755164,1/3,2.132137808747344,1.1361440733596693,WP_APOPTOSIS_MODULATION_BY_HSP70,OUD vs Control Male,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,0.006327913594266851,0.07321945975149294,11/1231,2.1987394596287917,1.135373479876928,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_IRON_METABOLISM_IN_PLACENTA,0.006343355019459044,0.07321945975149294,6/1231,2.197680981700856,1.135373479876928,WP_IRON_METABOLISM_IN_PLACENTA,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_MF,postsynaptic neurotransmitter receptor activity,0.0014778390972655909,0.07398152086917444,17/1824,2.830372848061394,1.1308767449549182,postsynaptic neurotransmitter receptor activity,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_CC,proximal dendrite,0.004964189782540322,0.07402739149402235,4/1867,2.3041516236409745,1.130607553599173,proximal dendrite,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,GO_MF,glutamate receptor activity,0.005579598332601681,0.07426699466864681,9/2121,2.2533970641831047,1.1292041501416408,glutamate receptor activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,0.03784023167481519,0.0744161119332881,17/2407,1.422046213317131,1.1283330245863106,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,ensheathment of neurons,0.002717528095413153,0.0750339278371336,31/1775,2.565825957225173,1.1247423187325087,ensheathment of neurons,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,axon ensheathment,0.002717528095413153,0.0750339278371336,31/1775,2.565825957225173,1.1247423187325087,axon ensheathment,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuronal action potential,0.0027975830802460626,0.07519543416321635,11/1775,2.553217007299466,1.1238085287955941,neuronal action potential,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,Reactome,Selenoamino acid metabolism,0.0021428539316211944,0.07538560131443361,26/1379,2.669007431782688,1.1227115966612453,Selenoamino acid metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,GO_CC,Schaffer collateral - CA1 synapse,0.009160144703990547,0.07621240393720136,22/2168,2.0380976656718635,1.1179743393811392,Schaffer collateral - CA1 synapse,OUD vs Control Female,GO CC
OUD_vs_Control_Male,GO_BP,positive regulation of cytokine-mediated signaling pathway,0.018509437190578293,0.07668195407525294,1/5,1.7326067864735812,1.1153068285888819,positive regulation of cytokine-mediated signal...,OUD vs Control Male,GO BP
OUD_vs_Control_Male,GO_BP,positive regulation of response to cytokine stimulus,0.019820976485398267,0.07703616634015616,1/5,1.702874953696672,1.113305337757124,positive regulation of response to cytokine sti...,OUD vs Control Male,GO BP
OUD_vs_Control_Female,GO_BP,regulation of synapse assembly,0.01180331179499444,0.07737162301417612,33/2058,1.9279961204487244,1.1114182929096517,regulation of synapse assembly,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.03955126747586563,0.07741150688863012,65/2407,1.4028395943672098,1.1111944785057624,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON,0.022346488037269643,0.07827692468217798,11/2057,1.6507907206698542,1.1063662450962546,FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Male,GO_BP,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.0208037105473734,0.07842998876359772,1/5,1.6818591974156163,1.1055178472098235,intrinsic apoptotic signaling pathway in respon...,OUD vs Control Male,GO BP
OUD_vs_Control_Female,GO_CC,axonal growth cone,0.0097187129388200209,0.07862004668650416,9/2168,2.0123912454213406,1.1044667026211812,axonal growth cone,OUD vs Control Female,GO CC
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,0.008897643771145944,0.07924921472216277,34/2013,2.0507249857898784,1.1010050324984904,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,negative regulation of axonogenesis,0.0121655497506195,0.07926859918774057,14/2058,1.9148682608995535,1.1008988164680091,negative regulation of axonogenesis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,0.040599142344163744,0.07927415471940977,34/2407,1.3914831407856456,1.1008683800502037,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_...,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL,0.041791844452937606,0.08083680711084644,13/2407,1.3789084611594107,1.0923908485650138,HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,postsynapse organization,0.0033816524976372155,0.08177286767370794,42/1775,2.4708710230282267,1.0873907718084983,postsynapse organization,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,pyramidal neuron differentiation,0.003493750447393372,0.08177286767370794,6/1775,2.456708119155774,1.0873907718084983,pyramidal neuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,dendrite morphogenesis,0.00351207800745189,0.08177286767370794,28/1775,2.4544358464590834,1.0873907718084983,dendrite morphogenesis,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of innate immune response,0.012653775057285831,0.08198179061579648,65/2058,1.8977798901430165,1.0862826002172856,positive regulation of innate immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Male,GO_BP,axonal transport,0.022439848896724013,0.08213420421422285,1/5,1.64898007181605,1.0854759463154293,axonal transport,OUD vs Control Male,GO BP
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C2_ASCL1_POS_ASTROCYTE,0.04325073532324501,0.0828804788519858,3/2407,1.3640065045202527,1.0815477484027236,ZHONG_PFC_C2_ASCL1_POS_ASTROCYTE,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_MAJOR_TYPES_EXCITATORY_NEURON,0.04325073532324501,0.0828804788519858,3/2407,1.3640065045202527,1.0815477484027236,ZHONG_PFC_MAJOR_TYPES_EXCITATORY_NEURON,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_BP,L-glutamate transmembrane transport,0.013173260954968319,0.08446189284006203,10/2058,1.8803067049587445,1.0733391900105347,L-glutamate transmembrane transport,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of axon extension,0.013173260954968319,0.08446189284006203,10/2058,1.8803067049587445,1.0733391900105347,negative regulation of axon extension,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of immunoglobulin mediated immune response,0.013561430171147392,0.08636907492778402,15/2058,1.8676945079110412,1.0636417319700486,regulation of immunoglobulin mediated immune re...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_MF,glutamate-gated calcium ion channel activity,0.0018383756827764965,0.08677133222705063,5/1824,2.7355657332738437,1.0616237346397557,glutamate-gated calcium ion channel activity,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,WikiPathways,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,0.008280020923541102,0.08844921103036327,11/1231,2.081968565755342,1.0533060366568903,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,Reactome,Transmission across Chemical Synapses,2.0373052037201813e-4,0.08862277636182789,52/1194,3.6909439055297,1.0524546485750625,Transmission across Chemical Synapses,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,GO_MF,glutamate receptor binding,0.00226570630511583,0.08889725269646974,13/1824,2.6447963867648174,1.0511116603706148,glutamate receptor binding,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,lipopolysaccharide immune receptor activity,0.002313911541130871,0.08889725269646974,4/1824,2.635653247775392,1.0511116603706148,lipopolysaccharide immune receptor activity,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,GO_CC,neuronal dense core vesicle,0.0114881611567652,0.08909493889438513,8/2168,1.939749480744277,1.0501469656900557,neuronal dense core vesicle,OUD vs Control Female,GO CC
OUD_vs_Control_Male,WikiPathways,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.034240914319861426,0.08938336671682007,1/3,1.465454647068223,1.0487432912173904,WP_APOPTOSIS_MODULATION_AND_SIGNALING,OUD vs Control Male,WikiPathways
OUD_vs_Control_Male,GO_BP,regulation of response to endoplasmic reticulum stress,0.028637240664192154,0.09023867745137154,1/5,1.5430688307094087,1.0446072783848954,regulation of response to endoplasmic reticulum...,OUD vs Control Male,GO BP
OUD_vs_Control_Male,C8_CellType,FAN_EMBRYONIC_CTX_IN_6_INTERNEURON,0.0024073171475197386,0.0902743930319902,1/8,2.618466690637091,1.044435422909372,FAN_EMBRYONIC_CTX_IN_6_INTERNEURON,OUD vs Control Male,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,regulation of complement activation,0.004420291665925519,0.09277791177666837,7/1775,2.354549073473782,1.0325554067049076,regulation of complement activation,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of humoral immune response,0.015424901154879076,0.09437843797839524,6/2058,1.8117776103111307,1.0251272147762578,positive regulation of humoral immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,"regulation of complement activation, classical pathway",0.01555007741405882,0.09437843797839524,4/2058,1.8082674445525855,1.0251272147762578,"regulation of complement activation, classical ...",OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,antibacterial innate immune response,0.01555007741405882,0.09437843797839524,4/2058,1.8082674445525855,1.0251272147762578,antibacterial innate immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,KEGG,Axon guidance,0.016843721014248577,0.0949875414574018,38/1075,1.7735619604942199,1.0223333529334568,Axon guidance,OUD vs Control Female,KEGG
OUD_vs_Control_Female,GO_BP,postsynapse organization,0.015937868954143144,0.09634821255849867,44/2058,1.7975697483933422,1.0161563379175205,postsynapse organization,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,synapse maturation,0.016050948867792375,0.0964196194999799,11/2058,1.7944992887503524,1.0158345867026815,synapse maturation,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of cytokine-mediated signaling pathway,0.004700654295343581,0.09657349816271518,14/1775,2.3278416873663894,1.015142036946715,positive regulation of cytokine-mediated signal...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_MF,chemokine receptor binding,0.008346298159321659,0.09684638605769753,11/2121,2.0785061048106033,1.0139165808765556,chemokine receptor binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,CCR chemokine receptor binding,0.008562285027801216,0.09684638605769753,8/2121,2.0674103191388395,1.0139165808765556,CCR chemokine receptor binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_CC,astrocyte projection,0.01336998533754354,0.09757743684944056,7/2168,1.87386906901531,1.0106505940610586,astrocyte projection,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_BP,postsynaptic neurotransmitter receptor diffusion trapping,0.016511873059780552,0.0977241158479786,5/2058,1.782203658815525,1.009998250126527,postsynaptic neurotransmitter receptor diffusio...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neurotransmitter receptor diffusion trapping,0.016511873059780552,0.0977241158479786,5/2058,1.782203658815525,1.009998250126527,neurotransmitter receptor diffusion trapping,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of neuron migration,0.016511873059780552,0.0977241158479786,5/2058,1.782203658815525,1.009998250126527,negative regulation of neuron migration,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,inhibitory synapse assembly,0.0048588852364260205,0.09844931381243356,9/1775,2.3134633585569784,1.006787306529542,inhibitory synapse assembly,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Male,GO_BP,regulation of postsynaptic membrane neurotransmitter receptor levels,0.03835856718147679,0.10042485991261631,1/5,1.4161376235243115,0.9981587654137682,regulation of postsynaptic membrane neurotransm...,OUD vs Control Male,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of tumor necrosis factor superfamily cytokine production,0.005292815973456855,0.10298587694384967,21/1775,2.2763132057823197,0.9872223285559961,positive regulation of tumor necrosis factor su...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,0.05716814759296123,0.10307779784814017,27/2407,1.2428458799072755,0.9868348682800098,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATUR...,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_CHODL_POS_NEURON_CELL,0.05747233688506913,0.10317473985467747,12/2407,1.2405411436413727,0.986426617481518,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_CHODL_POS_N...,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,neuron projection extension,0.0053568315976558,0.10395645488326757,31/1775,2.2710920062981135,0.9831485392026371,neuron projection extension,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,DO,glucose intolerance,0.019786101908803352,0.10409555622703771,6/1094,1.703639758408464,0.982567809848436,glucose intolerance,OUD vs Control Female,DO
OUD_vs_Control_Female,KEGG,Cholinergic synapse,0.021605892906731695,0.10538067543213013,25/1075,1.6654277808939066,0.9772390221657078,Cholinergic synapse,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Galactose metabolism,0.023323523058185004,0.10538067543213013,9/1075,1.6322058480311448,0.9772390221657078,Galactose metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,GO_BP,negative regulation of tumor necrosis factor superfamily cytokine production,0.018239917198702955,0.10597073094426747,15/2058,1.7389771375113319,0.9748140700623319,negative regulation of tumor necrosis factor su...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.03063231185044431,0.10759958423602356,35/2332,1.5138202253285018,0.9681894067769679,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H...,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,pyramidal neuron development,0.005731840835280324,0.10782017734907107,5/1775,2.24170587782096,0.9672999581532776,pyramidal neuron development,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of immune effector process,0.005885836466720312,0.10959576509551366,24/1775,2.2301918085951584,0.9602062271580698,negative regulation of immune effector process,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of immunoglobulin mediated immune response,0.019293416955208868,0.11082802183093962,11/2058,1.7145908499416116,0.9553504184169813,positive regulation of immunoglobulin mediated ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,KEGG,Chemokine signaling pathway,0.02538693723216578,0.110914420877089,35/1075,1.595389690753023,0.9550119840566037,Chemokine signaling pathway,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Fluid shear stress and atherosclerosis,0.02547162572468032,0.110914420877089,28/1075,1.5939433353376924,0.9550119840566037,Fluid shear stress and atherosclerosis,OUD vs Control Female,KEGG
OUD_vs_Control_Female,DO,withdrawal disorder,0.02144045109570645,0.11101577444812431,11/1094,1.6687660815578496,0.9546153070779032,withdrawal disorder,OUD vs Control Female,DO
OUD_vs_Control_Female,GO_BP,axon ensheathment in central nervous system,0.01945459889172786,0.1113106351578796,8/2058,1.7109777189031588,0.9534633390819723,axon ensheathment in central nervous system,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of dendrite extension,0.01945459889172786,0.1113106351578796,8/2058,1.7109777189031588,0.9534633390819723,regulation of dendrite extension,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of astrocyte differentiation,0.006226188241923657,0.111488381046634,9/1775,2.2057777530410965,0.9527703910038426,regulation of astrocyte differentiation,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of neuron projection regeneration,0.019912408893654646,0.11168058001917935,9/2058,1.7008761982378213,0.9520223391829945,regulation of neuron projection regeneration,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,maintenance of synapse structure,0.019912408893654646,0.11168058001917935,9/2058,1.7008761982378213,0.9520223391829945,maintenance of synapse structure,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,T cell proliferation involved in immune response,0.02071742937732709,0.11168058001917935,3/2058,1.6836641329278206,0.9520223391829945,T cell proliferation involved in immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,commitment of neuronal cell to specific neuron type in forebrain,0.02071742937732709,0.11168058001917935,3/2058,1.6836641329278206,0.9520223391829945,commitment of neuronal cell to specific neuron ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of hippocampal neuron apoptotic process,0.02071742937732709,0.11168058001917935,3/2058,1.6836641329278206,0.9520223391829945,regulation of hippocampal neuron apoptotic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,pyroptotic cell death,0.02071742937732709,0.11168058001917935,3/2058,1.6836641329278206,0.9520223391829945,pyroptotic cell death,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.020997011160115153,0.11294447209766925,15/2058,1.6778425209351304,0.947135020132977,intrinsic apoptotic signaling pathway in respon...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of humoral immune response mediated by circulating immunoglobulin,0.021129824437334736,0.11294447209766925,6/2058,1.6751041113818326,0.947135020132977,regulation of humoral immune response mediated ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of axon extension involved in axon guidance,0.021129824437334736,0.11294447209766925,6/2058,1.6751041113818326,0.947135020132977,regulation of axon extension involved in axon g...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,glutamatergic neuron differentiation,0.021129824437334736,0.11294447209766925,6/2058,1.6751041113818326,0.947135020132977,glutamatergic neuron differentiation,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,excitatory synapse assembly,0.0066387694760778335,0.1162574988013154,11/1775,2.177912411486461,0.9345790248208126,excitatory synapse assembly,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Male,GO_BP,regulation of cytokine-mediated signaling pathway,0.05215658373315779,0.11659669564799965,1/5,1.2826908627214473,0.9333137573143517,regulation of cytokine-mediated signaling pathway,OUD vs Control Male,GO BP
OUD_vs_Control_Male,GO_BP,regulation of response to cytokine stimulus,0.05470609049261932,0.11659669564799965,1/5,1.2619643204656192,0.9333137573143517,regulation of response to cytokine stimulus,OUD vs Control Male,GO BP
OUD_Effect_Male_vs_Female,Reactome,Neurotransmitter receptors and postsynaptic signal transmission,8.405370579577961e-4,0.1166626351271422,40/1194,3.075443134441292,0.9330682181318561,Neurotransmitter receptors and postsynaptic sig...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.016228067105071322,0.11708869271898603,32/2013,1.7897332051024213,0.9314850428170925,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Male,KEGG,Cholinergic synapse,0.04574981084369423,0.11800141307750299,1/3,1.3396106972196016,0.9281127919473702,Cholinergic synapse,OUD vs Control Male,KEGG
OUD_vs_Control_Male,KEGG,Dopaminergic synapse,0.05187812930872793,0.11800141307750299,1/3,1.2850156926794087,0.9281127919473702,Dopaminergic synapse,OUD vs Control Male,KEGG
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_EX_1_EXCITATORY_NEURON,0.06767168808686551,0.1181155151110723,3/2407,1.1695929897989814,0.9276930517128126,FAN_EMBRYONIC_CTX_EX_1_EXCITATORY_NEURON,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_2_INTERNEURON,0.06767168808686551,0.1181155151110723,3/2407,1.1695929897989814,0.9276930517128126,FAN_EMBRYONIC_CTX_IN_2_INTERNEURON,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,KEGG,Fructose and mannose metabolism,0.028981209839971288,0.11945007832530101,9/1075,1.5378834885730492,0.922813561140266,Fructose and mannose metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,GABAergic synapse,0.029703094444483574,0.11945007832530101,20/1075,1.5271983038761168,0.922813561140266,GABAergic synapse,OUD vs Control Female,KEGG
OUD_vs_Control_Male,GO_CC,axon,0.02163496977624604,0.11996725024454515,2/6,1.664843707168226,0.9209372954462793,axon,OUD vs Control Male,GO CC
OUD_vs_Control_Male,GO_CC,axon cytoplasm,0.023197505215431957,0.11996725024454515,1/6,1.6345587189638637,0.9209372954462793,axon cytoplasm,OUD vs Control Male,GO CC
OUD_vs_Control_Male,GO_CC,postsynapse,0.031210914517939507,0.11996725024454515,2/6,1.5056935057891405,0.9209372954462793,postsynapse,OUD vs Control Male,GO CC
OUD_vs_Control_Male,GO_CC,neuron projection cytoplasm,0.03242358114717436,0.11996725024454515,1/6,1.4891390195132743,0.9209372954462793,neuron projection cytoplasm,OUD vs Control Male,GO CC
OUD_Effect_Male_vs_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURON_CELL,0.039249551776552316,0.12024769046149736,5/2057,1.406165298462206,0.9199232561554581,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURO...,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,0.017458215445661854,0.12137662121071838,33/2013,1.7580001513355579,0.9158649562339548,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,0.017464082813775365,0.12137662121071838,32/2013,1.757854217892115,0.9158649562339548,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CEL...,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,retinal ganglion cell axon guidance,0.0234918137194679,0.12279592868311319,7/2058,1.629083451594104,0.9108160320529076,retinal ganglion cell axon guidance,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of chemokine production,0.0234918137194679,0.12279592868311319,7/2058,1.629083451594104,0.9108160320529076,negative regulation of chemokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of excitatory synapse assembly,0.0234918137194679,0.12279592868311319,7/2058,1.629083451594104,0.9108160320529076,regulation of excitatory synapse assembly,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,central nervous system neuron development,0.007219625511269802,0.12351803573794011,19/1775,2.141485329107243,0.9082696233794255,central nervous system neuron development,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,dopamine secretion,0.02441225978172345,0.12421344762443778,8/2058,1.6123920171699466,0.9058313839264392,dopamine secretion,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.024428481625496625,0.12421344762443778,9/2058,1.6121035261563763,0.9058313839264392,regulation of endoplasmic reticulum stress-indu...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,"regulation of synaptic transmission, dopaminergic",0.02499106883476724,0.1244976921611655,4/2058,1.6022151692791138,0.9048386990980491,"regulation of synaptic transmission, dopaminergic",OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_MF,chemokine binding,0.012247715791383233,0.12578328978389897,9/2121,1.9119449000095066,0.9003770507562231,chemokine binding,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,GO_BP,neuron cell-cell adhesion,0.007565151110284901,0.1261716245264069,6/1775,2.121182392729035,0.8990383051333248,neuron cell-cell adhesion,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.0187413220789031,0.12617468087052208,33/2013,1.727199775704391,0.8990277850396623,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,0.04204794954179925,0.1264530247249698,7/2057,1.376255177616228,0.8980707779791036,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_CC,ionotropic glutamate receptor complex,0.018775967842286297,0.12700492068928618,11/2168,1.7263976672276131,0.8961794523762872,ionotropic glutamate receptor complex,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_BP,complement activation,0.025680042695038888,0.12742989264372065,12/2058,1.5904042585547271,0.8947286827745479,complement activation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,myeloid leukocyte cytokine production,0.025680042695038888,0.12742989264372065,12/2058,1.5904042585547271,0.8947286827745479,myeloid leukocyte cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,Reactome,Arachidonate metabolism,0.004785592324724193,0.12762302576485532,15/1379,2.320064300846651,0.8940709630720144,Arachidonate metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Heparan sulfate/heparin (HS-GAG) metabolism,0.004788584252689284,0.12762302576485532,16/1379,2.319792866987607,0.8940709630720144,Heparan sulfate/heparin (HS-GAG) metabolism,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTIATION,0.042894391013204324,0.1280569775503691,13/2057,1.3675994936258429,0.8925967527749079,ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTI...,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,DO,opioid abuse,0.027587754772097777,0.12861195285212842,6/1094,1.5592836431150987,0.8907186673644144,opioid abuse,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,GO_BP,cerebral cortex neuron differentiation,0.008252798288872765,0.13054356479985627,8/1775,2.0833987695883462,0.8842445320432273,cerebral cortex neuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,axon ensheathment in central nervous system,0.008252798288872765,0.13054356479985627,8/1775,2.0833987695883462,0.8842445320432273,axon ensheathment in central nervous system,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Male,GO_BP,cellular response to oxidative stress,0.07396622618084403,0.1320249534666683,1/5,1.13096653880309,0.8793439769102704,cellular response to oxidative stress,OUD vs Control Male,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C6_PLXNA4_POS_EXCITATORY_NEURON,0.045223475281983005,0.13259069097011505,3/2057,1.3446360665418648,0.8774869661441395,ZHONG_PFC_C6_PLXNA4_POS_EXCITATORY_NEURON,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,Reactome,Diseases associated with glycosaminoglycan metabolism,0.005386905396276327,0.13536523702928657,12/1379,2.2686606513773655,0.868492851934161,Diseases associated with glycosaminoglycan meta...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,KEGG,Complement and coagulation cascades,0.036110509624705855,0.1357723554145604,18/1075,1.4423663823669757,0.8671886476776574,Complement and coagulation cascades,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,dendrite arborization,0.0088792573430923,0.1362527581872246,5/1775,2.051623356888605,0.8656546974669727,dendrite arborization,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of neuronal synaptic plasticity,0.008962675671797296,0.1362527581872246,14/1775,2.047562318906347,0.8656546974669727,regulation of neuronal synaptic plasticity,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of postsynapse organization,0.009059117479758547,0.1362527581872246,27/1775,2.0429141083209004,0.8656546974669727,regulation of postsynapse organization,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,antibacterial innate immune response,0.009188493278159538,0.1362527581872246,4/1775,2.036755698040324,0.8656546974669727,antibacterial innate immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of neuron differentiation,0.009221545920683942,0.13646774697511146,32/1775,2.0351962667399586,0.8649699784097415,regulation of neuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C3_ASTROCYTE,0.04760033334765759,0.13758682925223997,57/2057,1.3223900058815798,0.861423137734547,ZHONG_PFC_C3_ASTROCYTE,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Male,GO_BP,vesicle-mediated transport in synapse,0.08052362810323399,0.13789492526554964,1/5,1.094076665605081,0.8604517162006718,vesicle-mediated transport in synapse,OUD vs Control Male,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of postsynaptic membrane neurotransmitter receptor levels,0.009457607682861843,0.1388437215717542,23/1775,2.024218705197105,0.8574737540008017,regulation of postsynaptic membrane neurotransm...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,antimicrobial humoral immune response mediated by antimicrobial peptide,0.028655768416501644,0.13893761173042204,16/2058,1.542787941260602,0.8571801707071907,antimicrobial humoral immune response mediated ...,OUD vs Control Female,GO BP
OUD_vs_Control_Male,GO_BP,response to endoplasmic reticulum stress,0.08642445681344635,0.14104770657432586,1/5,1.0633633413622317,0.8506339710485831,response to endoplasmic reticulum stress,OUD vs Control Male,GO BP
OUD_vs_Control_Female,GO_BP,regulation of neuronal synaptic plasticity,0.029705534129545345,0.14218227799755917,14/2058,1.5271626342508138,0.8471545319291036,regulation of neuronal synaptic plasticity,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of dendrite extension,0.02988215174314391,0.14218227799755917,7/2058,1.5245881332111284,0.8471545319291036,positive regulation of dendrite extension,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,axon regeneration,0.029903637830128636,0.14218227799755917,12/2058,1.5242759757742694,0.8471545319291036,axon regeneration,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,glutamate secretion,0.030189803349924427,0.14247567045624188,8/2058,1.520139715871266,0.8462592906639328,glutamate secretion,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_MF,chemokine activity,0.014726052645302752,0.14249371172391218,8/2121,1.8319136512636622,0.8462043007352165,chemokine activity,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,GO_BP,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.009826643918203901,0.1425541736062913,9/1775,2.00759478091358,0.8460200631833671,regulation of endoplasmic reticulum stress-indu...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,response to toxic substance,0.030366857534251893,0.14319676786936206,42/2058,1.5176001480272834,0.8440667844886544,response to toxic substance,OUD vs Control Female,GO BP
OUD_vs_Control_Male,GO_BP,innate immune response-activating signaling pathway,0.08920899143962191,0.14360967082888082,1/5,1.049591370558686,0.8428163132538901,innate immune response-activating signaling pat...,OUD vs Control Male,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuron migration,0.010004980950181446,0.14372389626676665,32/1775,1.99978373393821,0.842471017850492,neuron migration,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,DO,metal metabolism disorder,0.033090701156758856,0.14497932613830805,15/1094,1.4802940305045413,0.8386939231732066,metal metabolism disorder,OUD vs Control Female,DO
OUD_vs_Control_Female,DO,glycogen metabolism disorder,0.03411454342334572,0.145292905943595,7/1094,1.4670604367847324,0.8377555900017986,glycogen metabolism disorder,OUD vs Control Female,DO
OUD_vs_Control_Female,WikiPathways,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.016271190204851058,0.14529318586993578,8/1231,1.788580678132987,0.837754753275826,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_MF,G protein-coupled neurotransmitter receptor activity,0.005508737477813627,0.14661525702670578,5/1824,2.2589479236973866,0.8338208339395148,G protein-coupled neurotransmitter receptor act...,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,GO_CC,dendrite membrane,0.022390000686209017,0.1466809493773693,11/2168,1.649945893110707,0.8336262877759398,dendrite membrane,OUD vs Control Female,GO CC
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of humoral immune response,0.0105402713225203,0.14682518101730457,6/1775,1.9771482095829827,0.8331994550532461,negative regulation of humoral immune response,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Male,GO_BP,cellular response to chemical stress,0.09506515790434955,0.14735839274603094,1/5,1.0219786260960946,0.831625124018402,cellular response to chemical stress,OUD vs Control Male,GO BP
OUD_vs_Control_Male,GO_BP,activation of innate immune response,0.09537254066321366,0.14735839274603094,1/5,1.0205766478854654,0.831625124018402,activation of innate immune response,OUD vs Control Male,GO BP
OUD_vs_Control_Female,GO_BP,microglial cell activation,0.031909614748980845,0.1495726372572228,11/2058,1.4960784390970492,0.8251478488185578,microglial cell activation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,L-glutamate import,0.031909614748980845,0.1495726372572228,11/2058,1.4960784390970492,0.8251478488185578,L-glutamate import,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of excitatory synapse assembly,0.010892441048827138,0.1500260372923663,7/1775,1.9628747818386951,0.8238333618037027,regulation of excitatory synapse assembly,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_CC,kainate selective glutamate receptor complex,0.013497178415893835,0.1509552849146021,3/1867,1.8697570112444999,0.8211516778109984,kainate selective glutamate receptor complex,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_BP,regulation of axon extension,0.011184213506953561,0.15205155331542225,17/1775,1.9513945508252613,0.8180091388682819,regulation of axon extension,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,commissural neuron axon guidance,0.03301602612615748,0.1526916035233403,5/2058,1.4812752004657042,0.8161848440420739,commissural neuron axon guidance,OUD vs Control Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,0.01860332725042386,0.15296920854123094,10/1231,1.7304093742084374,0.8153959803355826,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,0.018890366744379626,0.15296920854123094,12/1231,1.7237596104469213,0.8153959803355826,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,0.01909548509306641,0.15296920854123094,15/1231,1.7190693045299403,0.8153959803355826,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,DO,autoimmune disease of peripheral nervous system,0.03814997687104994,0.1554943090338039,4/1094,1.418505721006045,0.8082855011737583,autoimmune disease of peripheral nervous system,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,GO_CC,neuron projection terminus,0.014534603026851221,0.15638496927624732,23/1867,1.8375968253041017,0.8058049908802505,neuron projection terminus,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C3_ASTROCYTE,0.09487969555645533,0.15762272003733707,63/2407,1.022826717512313,0.8023811823053946,ZHONG_PFC_C3_ASTROCYTE,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_BP,regulation of neuron migration,0.03460540074970068,0.1583846905418276,12/2058,1.460856117023547,0.8002867996059436,regulation of neuron migration,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,response to pain,0.03554974929319194,0.1583846905418276,9/2058,1.4491634576899741,0.8002867996059436,response to pain,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,innate immune response-activating signaling pathway,0.036809761728117917,0.1583846905418276,49/2058,1.4340369937594866,0.8002867996059436,innate immune response-activating signaling pat...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of axon regeneration,0.036839625328615726,0.1583846905418276,8/2058,1.4336847953737273,0.8002867996059436,regulation of axon regeneration,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,inhibitory synapse assembly,0.036839625328615726,0.1583846905418276,8/2058,1.4336847953737273,0.8002867996059436,inhibitory synapse assembly,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,G protein-coupled opioid receptor signaling pathway,0.03721441000586165,0.1583846905418276,4/2058,1.4292888618858612,0.8002867996059436,G protein-coupled opioid receptor signaling pat...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,complement-dependent cytotoxicity,0.03721441000586165,0.1583846905418276,4/2058,1.4292888618858612,0.8002867996059436,complement-dependent cytotoxicity,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,motor neuron migration,0.03721441000586165,0.1583846905418276,4/2058,1.4292888618858612,0.8002867996059436,motor neuron migration,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of T-helper 1 type immune response,0.03724661542173831,0.1583846905418276,3/2058,1.4289131852095205,0.8002867996059436,negative regulation of T-helper 1 type immune r...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of dopamine secretion,0.03724661542173831,0.1583846905418276,3/2058,1.4289131852095205,0.8002867996059436,positive regulation of dopamine secretion,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,glutamate reuptake,0.03724661542173831,0.1583846905418276,3/2058,1.4289131852095205,0.8002867996059436,glutamate reuptake,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,chemorepulsion of axon,0.03724661542173831,0.1583846905418276,3/2058,1.4289131852095205,0.8002867996059436,chemorepulsion of axon,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,anterograde axonal transport of mitochondrion,0.03724661542173831,0.1583846905418276,3/2058,1.4289131852095205,0.8002867996059436,anterograde axonal transport of mitochondrion,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of translation at postsynapse,0.03724661542173831,0.1583846905418276,3/2058,1.4289131852095205,0.8002867996059436,regulation of translation at postsynapse,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of cardiac muscle hypertrophy in response to stress,0.03724661542173831,0.1583846905418276,3/2058,1.4289131852095205,0.8002867996059436,negative regulation of cardiac muscle hypertrop...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_CC,Schaffer collateral - CA1 synapse,0.015283304886483553,0.1588895774304278,19/1867,1.8157827230661667,0.7989045899726638,Schaffer collateral - CA1 synapse,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Male,DO,autoimmune disease,0.11904771510755319,0.16106455573374845,1/3,0.9242789356283087,0.7930000209889897,autoimmune disease,OUD vs Control Male,DO
OUD_Effect_Male_vs_Female,GO_BP,immune response-regulating cell surface receptor signaling pathway,0.012314148356922803,0.16260423907570415,53/1775,1.9095956184719365,0.7888681365821164,immune response-regulating cell surface recepto...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,0.028352639257432213,0.1638600930749819,32/2013,1.547406507790873,0.7855268027907963,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Male,GO_BP,positive regulation of innate immune response,0.11487202951212072,0.16404073911389966,1/5,0.9397857059272632,0.7850482825913014,positive regulation of innate immune response,OUD vs Control Male,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C1_ASTROCYTE,0.05946595658649285,0.16433497462078092,7/2057,1.225731590538455,0.7842699979260704,ZHONG_PFC_C1_ASTROCYTE,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,regulation of forebrain neuron differentiation,0.01370772900133932,0.16637723733567986,3/1775,1.8630344900596725,0.7789060913609545,regulation of forebrain neuron differentiation,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Male,GO_BP,response to oxidative stress,0.118490453411779,0.16648467679589357,1/5,0.9263166386631639,0.7786257326635551,response to oxidative stress,OUD vs Control Male,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter transport,0.013783010894732281,0.16650108804926167,35/1775,1.86065590056095,0.7785829241261513,neurotransmitter transport,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.012874183106984826,0.16658777262062638,4/1002,1.8902803182777665,0.7783568785491,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSC...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.012874183106984826,0.16658777262062638,4/1002,1.8902803182777665,0.7783568785491,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_IRON_METABOLISM_IN_PLACENTA,0.01321963546278943,0.16658777262062638,5/1002,1.8787805205449173,0.7783568785491,WP_IRON_METABOLISM_IN_PLACENTA,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,GO_MF,C-X3-C chemokine binding,0.020364593496997575,0.16710945840183303,3/2121,1.6911242545577438,0.7769989683264015,C-X3-C chemokine binding,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_MAJOR_TYPES_INTERNEURON,0.06253926499584951,0.16995720520466742,5/2057,1.2038472271884246,0.769660419110945,ZHONG_PFC_MAJOR_TYPES_INTERNEURON,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_CC,apical dendrite,0.027612515636701435,0.172733932404027,6/2168,1.5588940251836603,0.7626223398600221,apical dendrite,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_MF,neurotransmitter receptor activity,0.021475363774896575,0.17283537961142725,20/2121,1.6680594708451644,0.7623673521506847,neurotransmitter receptor activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,0.059841910909793766,0.17426765687538268,32/2332,1.222994546755756,0.7587832080933314,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,anterograde axonal protein transport,0.015006109424921725,0.1743600866039483,4/1775,1.823731890988185,0.7585529239419911,anterograde axonal protein transport,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,Reactome,Modulation by Mtb of host immune system,0.00933124328968508,0.17634768974221107,4/1379,2.030060487242089,0.753630225470728,Modulation by Mtb of host immune system,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Sialic acid metabolism,0.009524178809272343,0.17634768974221107,10/1379,2.0211724596393417,0.753630225470728,Sialic acid metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Regulation of necroptotic cell death,0.009524178809272343,0.17634768974221107,10/1379,2.0211724596393417,0.753630225470728,Regulation of necroptotic cell death,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_2,0.06583014565310931,0.17655429227620792,3/2057,1.1815751840045083,0.7531217196799712,FAN_EMBRYONIC_CTX_MICROGLIA_2,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,KEGG,Amino sugar and nucleotide sugar metabolism,0.05160756889458255,0.17753003699736397,10/1075,1.2872865989911946,0.7507281564196645,Amino sugar and nucleotide sugar metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Male,GO_CC,distal axon,0.09638494340895143,0.17831214530656014,1/6,1.0159908032872147,0.7488190748842009,distal axon,OUD vs Control Male,GO CC
OUD_Effect_Male_vs_Female,WikiPathways,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,0.01594206484782066,0.1800044688742791,13/1002,1.7974554286150992,0.7447167127669837,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTC...,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,GO_BP,response to laminar fluid shear stress,0.044083422092570504,0.18004473248209624,5/2058,1.3557246995865462,0.7446195801378679,response to laminar fluid shear stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of T-helper 17 type immune response,0.044083422092570504,0.18004473248209624,5/2058,1.3557246995865462,0.7446195801378679,negative regulation of T-helper 17 type immune ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,0.06373963102231835,0.18245563004743537,32/2332,1.1955904549105274,0.7388427310342776,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H...,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,0.06978224029900762,0.1829286505152092,24/2057,1.1562550920120294,0.7377182694486364,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,DO,autoimmune disease of endocrine system,0.051214321028749614,0.1834446523372854,13/1094,1.2906085805457221,0.7364949440021142,autoimmune disease of endocrine system,OUD vs Control Female,DO
OUD_vs_Control_Female,GO_BP,negative regulation of cytokine production involved in inflammatory response,0.045934844806226414,0.1848096930034851,7/2058,1.33785774657758,0.7332752543955089,negative regulation of cytokine production invo...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of neurotransmitter uptake,0.04621195233512808,0.1848096930034851,6/2058,1.335245683278262,0.7332752543955089,regulation of neurotransmitter uptake,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,dopamine transport,0.046366197102489175,0.1848096930034851,10/2058,1.3337985229338807,0.7332752543955089,dopamine transport,OUD vs Control Female,GO BP
OUD_vs_Control_Female,Reactome,Diseases of Immune System,0.01122875364053559,0.18533847854926455,9/1379,1.949668446505898,0.732034406440464,Diseases of Immune System,OUD vs Control Female,Reactome
OUD_vs_Control_Male,C8_CellType,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.011508940828548808,0.1855475912799026,1/8,1.9389646427892013,0.7315446791520979,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,OUD vs Control Male,C8 CellType
OUD_vs_Control_Male,C8_CellType,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,0.012939376872868391,0.1855475912799026,1/8,1.8880866376697045,0.7315446791520979,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,OUD vs Control Male,C8 CellType
OUD_vs_Control_Male,GO_BP,regulation of innate immune response,0.1393628125091344,0.18565293397859953,1/5,0.8558530976631051,0.7312981829816025,regulation of innate immune response,OUD vs Control Male,GO BP
OUD_Effect_Male_vs_Female,GO_BP,sensory perception of pain,0.016725480810337066,0.1863202308038637,16/1775,1.7766213886408684,0.7297399864915041,sensory perception of pain,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,receptor localization to synapse,0.016725480810337066,0.1863202308038637,16/1775,1.7766213886408684,0.7297399864915041,receptor localization to synapse,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.06611917978444261,0.18652729815275298,33/2332,1.1796725425370689,0.7292576004797088,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,DO,immune system disease,0.016197065804789502,0.18743629932168027,87/920,1.7905636533713036,0.7271462988884694,immune system disease,OUD Effect Male vs Female,DO
OUD_vs_Control_Male,GO_BP,positive regulation of cytokine production,0.14290088457323047,0.18903029292669432,1/5,0.8449650828669457,0.7234685926696631,positive regulation of cytokine production,OUD vs Control Male,GO BP
OUD_vs_Control_Female,GO_MF,glutamate-gated calcium ion channel activity,0.02447035369728442,0.19141762658529962,4/2121,1.611359753260849,0.7180180729527986,glutamate-gated calcium ion channel activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_BP,cellular response to toxic substance,0.04935030220860097,0.1951719895757599,23/2058,1.3067101834781152,0.7095825106732462,cellular response to toxic substance,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of axon extension,0.04971838614232241,0.19591564782517837,9/2058,1.303482976990555,0.7079308754257233,positive regulation of axon extension,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,dendrite extension,0.04971838614232241,0.19591564782517837,9/2058,1.303482976990555,0.7079308754257233,dendrite extension,OUD vs Control Female,GO BP
OUD_vs_Control_Male,C8_CellType,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,0.06233297536981275,0.19605317849214415,1/8,1.205282142226395,0.7076261123517412,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,OUD vs Control Male,C8 CellType
OUD_vs_Control_Male,C8_CellType,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,0.06369884118110059,0.19605317849214415,1/8,1.1958684683433196,0.7076261123517412,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,OUD vs Control Male,C8 CellType
OUD_vs_Control_Male,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,0.06415374275224983,0.19605317849214415,1/8,1.1927780016548601,0.7076261123517412,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATUR...,OUD vs Control Male,C8 CellType
OUD_vs_Control_Male,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,0.08084973453574651,0.19605317849214415,1/8,1.0923214017297471,0.7076261123517412,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_...,OUD vs Control Male,C8 CellType
OUD_vs_Control_Male,C8_CellType,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,0.08887744091643868,0.19605317849214415,1/8,1.0512084587011863,0.7076261123517412,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,OUD vs Control Male,C8 CellType
OUD_Effect_Male_vs_Female,WikiPathways,WP_NEUROINFLAMMATION,0.019223594604136304,0.19613262062328257,5/1002,1.7161654007061853,0.7074501688079733,WP_NEUROINFLAMMATION,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Male,GO_BP,immune response-activating signaling pathway,0.15169517830893542,0.19622988555492152,1/5,0.8190282232152621,0.7072348494372708,immune response-activating signaling pathway,OUD vs Control Male,GO BP
OUD_vs_Control_Male,GO_BP,cytokine-mediated signaling pathway,0.15198707316190208,0.19622988555492152,1/5,0.8181933481946453,0.7072348494372708,cytokine-mediated signaling pathway,OUD vs Control Male,GO BP
OUD_vs_Control_Female,DO,opiate dependence,0.05733434743960857,0.19713384552726307,14/1094,1.2415851261226185,0.7052388061424735,opiate dependence,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,GO_CC,hippocampal mossy fiber to CA3 synapse,0.021208933399997618,0.19729391345252426,11/1867,1.6734811716599067,0.7048863125924925,hippocampal mossy fiber to CA3 synapse,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,perineuronal net,0.022282606695814507,0.19729391345252426,4/1867,1.6520340052672167,0.7048863125924925,perineuronal net,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,GO_BP,neurotransmitter secretion,0.05030138221221403,0.1975343469251862,27/2058,1.298420080970121,0.7043573791101261,neurotransmitter secretion,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,signal release from synapse,0.05030138221221403,0.1975343469251862,27/2058,1.298420080970121,0.7043573791101261,signal release from synapse,OUD vs Control Female,GO BP
OUD_vs_Control_Female,Reactome,Protein-protein interactions at synapses,0.013476754344797275,0.1975467574374867,20/1379,1.8704146879095271,0.7043300944996906,Protein-protein interactions at synapses,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,0.0394457590119309,0.19873809504253084,31/2013,1.4039996828658345,0.7017188773240172,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,0.07917821798922743,0.19914703371021025,23/2057,1.1013942768469382,0.7008261580112766,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATUR...,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,0.0399591655363585,0.1992641294709709,30/2013,1.398383589683764,0.7005708737777182,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,regulation of neurotransmitter transport,0.019811432713242698,0.2010592935146359,19/1775,1.7030841162354946,0.6966758478093065,regulation of neurotransmitter transport,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Male,GO_BP,regulation of cellular response to stress,0.1569370046557662,0.20130244273638065,1/5,0.8042746407154875,0.696150955064181,regulation of cellular response to stress,OUD vs Control Male,GO BP
OUD_Effect_Male_vs_Female,GO_CC,astrocyte projection,0.023642959300200772,0.20177960288596047,6/1867,1.6262981653833446,0.6951227370177767,astrocyte projection,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Male,C8_CellType,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,0.107806893822318,0.20213792591684626,1/8,0.967353466855548,0.6943521947918103,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STR...,OUD vs Control Male,C8 CellType
OUD_vs_Control_Female,GO_BP,pyramidal neuron development,0.052286322940700306,0.20259474110166753,4/2058,1.2816118990522427,0.6933718321256347,pyramidal neuron development,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,T-helper 2 cell cytokine production,0.052286322940700306,0.20259474110166753,4/2058,1.2816118990522427,0.6933718321256347,T-helper 2 cell cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of T-helper 2 cell cytokine production,0.052286322940700306,0.20259474110166753,4/2058,1.2816118990522427,0.6933718321256347,regulation of T-helper 2 cell cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,DO,heroin dependence,0.06032030862846893,0.20418502403952016,10/1094,1.2195364450676902,0.6899761144308374,heroin dependence,OUD vs Control Female,DO
OUD_vs_Control_Male,GO_BP,immune response-regulating signaling pathway,0.1633084581093961,0.20522429569080775,1/5,0.7869913216006744,0.6877712261145441,immune response-regulating signaling pathway,OUD vs Control Male,GO BP
OUD_vs_Control_Female,GO_BP,activation of innate immune response,0.05325343351700321,0.20559118251343814,51/2058,1.2736523858344686,0.686995515493275,activation of innate immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_CC,neurotransmitter receptor complex,0.03625549342347505,0.20578810228401256,11/2168,1.4406261799137408,0.6865797377454371,neurotransmitter receptor complex,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,perineuronal net,0.036731535781002606,0.20578810228401256,4/2168,1.4349609130031658,0.6865797377454371,perineuronal net,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,basal dendrite,0.03685387889461283,0.20578810228401256,3/2168,1.433516795623887,0.6865797377454371,basal dendrite,OUD vs Control Female,GO CC
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,0.043101889820641184,0.20915578406988433,29/2013,1.3655036875960394,0.6795301207802209,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_INTERNEURON,0.13335334282945135,0.20930124665041508,4/2407,0.8749960931785415,0.6792281848873827,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_IN...,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_MF,glutamate-gated receptor activity,0.027339408355874874,0.20993655774190156,6/2121,1.5632108881061277,0.6779119280534913,glutamate-gated receptor activity,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,GO_BP,multicellular organismal response to stress,0.02102567830155614,0.21036176846107943,18/1775,1.6772499846919462,0.6770331868333858,multicellular organismal response to stress,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,Reactome,Innate Immune System,0.014778866558775496,0.21036239835306458,151/1379,1.830358872175627,0.6770318864155114,Innate Immune System,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,TP53 Regulates Transcription of Cell Death Genes,0.014980934266855421,0.21036239835306458,12/1379,1.824461101570616,0.6770318864155114,TP53 Regulates Transcription of Cell Death Genes,OUD vs Control Female,Reactome
OUD_vs_Control_Female,GO_BP,axon extension,0.05483069134217578,0.210825530516584,21/2058,1.2609762782055363,0.6760767981506987,axon extension,OUD vs Control Female,GO BP
OUD_vs_Control_Male,GO_BP,activation of immune response,0.16849276155047,0.21103578440042256,1/5,0.7734187516841107,0.6756438970721612,activation of immune response,OUD vs Control Male,GO BP
OUD_vs_Control_Female,GO_BP,regulation of neuron apoptotic process,0.05658847274593854,0.21241446361955874,41/2058,1.2472720269864215,0.6728159148207923,regulation of neuron apoptotic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of immune response to tumor cell,0.05711002251879395,0.21241446361955874,5/2058,1.2432876685905072,0.6728159148207923,positive regulation of immune response to tumor...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of glutamate secretion,0.05711002251879395,0.21241446361955874,5/2058,1.2432876685905072,0.6728159148207923,regulation of glutamate secretion,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of neuron projection regeneration,0.05711002251879395,0.21241446361955874,5/2058,1.2432876685905072,0.6728159148207923,negative regulation of neuron projection regene...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,dendrite self-avoidance,0.05711002251879395,0.21241446361955874,5/2058,1.2432876685905072,0.6728159148207923,dendrite self-avoidance,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,synapse pruning,0.05711002251879395,0.21241446361955874,5/2058,1.2432876685905072,0.6728159148207923,synapse pruning,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,axonal fasciculation,0.05745357826493008,0.21241446361955874,6/2058,1.240682917849152,0.6728159148207923,axonal fasciculation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,0.05745357826493008,0.21241446361955874,6/2058,1.240682917849152,0.6728159148207923,neuron intrinsic apoptotic signaling pathway in...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,axon extension involved in axon guidance,0.05745357826493008,0.21241446361955874,6/2058,1.240682917849152,0.6728159148207923,axon extension involved in axon guidance,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neuron projection fasciculation,0.05745357826493008,0.21241446361955874,6/2058,1.240682917849152,0.6728159148207923,neuron projection fasciculation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neuron projection extension involved in neuron projection guidance,0.05745357826493008,0.21241446361955874,6/2058,1.240682917849152,0.6728159148207923,neuron projection extension involved in neuron ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of natural killer cell mediated immune response to tumor cell,0.05864613587920861,0.21241446361955874,3/2058,1.2317605977278558,0.6728159148207923,positive regulation of natural killer cell medi...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of humoral immune response mediated by circulating immunoglobulin,0.05864613587920861,0.21241446361955874,3/2058,1.2317605977278558,0.6728159148207923,positive regulation of humoral immune response ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,forebrain neuron fate commitment,0.05864613587920861,0.21241446361955874,3/2058,1.2317605977278558,0.6728159148207923,forebrain neuron fate commitment,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,"negative regulation of complement activation, classical pathway",0.05864613587920861,0.21241446361955874,3/2058,1.2317605977278558,0.6728159148207923,"negative regulation of complement activation, c...",OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of axon extension involved in axon guidance,0.05864613587920861,0.21241446361955874,3/2058,1.2317605977278558,0.6728159148207923,positive regulation of axon extension involved ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,spontaneous neurotransmitter secretion,0.05864613587920861,0.21241446361955874,3/2058,1.2317605977278558,0.6728159148207923,spontaneous neurotransmitter secretion,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,hippocampal neuron apoptotic process,0.05864613587920861,0.21241446361955874,3/2058,1.2317605977278558,0.6728159148207923,hippocampal neuron apoptotic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of complement-dependent cytotoxicity,0.05864613587920861,0.21241446361955874,3/2058,1.2317605977278558,0.6728159148207923,regulation of complement-dependent cytotoxicity,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of microglial cell activation,0.05864613587920861,0.21241446361955874,3/2058,1.2317605977278558,0.6728159148207923,positive regulation of microglial cell activation,OUD vs Control Female,GO BP
OUD_vs_Control_Male,Reactome,Cellular responses to stress,0.19801430120683428,0.21274281184884222,1/3,0.7033034425115963,0.6721451049313724,Cellular responses to stress,OUD vs Control Male,Reactome
OUD_vs_Control_Male,Reactome,Metabolism of RNA,0.199587335812345,0.21274281184884222,1/3,0.6998670189670088,0.6721451049313724,Metabolism of RNA,OUD vs Control Male,Reactome
OUD_vs_Control_Male,Reactome,Cytokine Signaling in Immune system,0.19984930810042756,0.21274281184884222,1/3,0.6992973509749871,0.6721451049313724,Cytokine Signaling in Immune system,OUD vs Control Male,Reactome
OUD_Effect_Male_vs_Female,DO,"autoimmune disease of eyes, ear, nose and throat",0.022672356888970523,0.2133570301268047,6/920,1.644503330748227,0.6708930425399532,"autoimmune disease of eyes, ear, nose and throat",OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,GO_BP,neuronal action potential propagation,0.022702783025803683,0.21601419036841665,4/1775,1.6439209014559952,0.6655177183107713,neuronal action potential propagation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of translation in response to endoplasmic reticulum stress,0.022702783025803683,0.21601419036841665,4/1775,1.6439209014559952,0.6655177183107713,regulation of translation in response to endopl...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,AMPA glutamate receptor clustering,0.022702783025803683,0.21601419036841665,4/1775,1.6439209014559952,0.6655177183107713,AMPA glutamate receptor clustering,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,glutamate receptor clustering,0.022702783025803683,0.21601419036841665,4/1775,1.6439209014559952,0.6655177183107713,glutamate receptor clustering,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,0.04588810597472713,0.21663454681092112,29/2013,1.33829986738052,0.6642722850468936,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H...,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,0.0840238955918597,0.21973398782798736,26/2332,1.0755971871775956,0.6581027624490192,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCEL...,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,0.04730105767259041,0.2211619510372941,31/2013,1.3251291481367318,0.6552895874754185,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,regulation of translation in response to stress,0.024233679679542004,0.22198267675272315,6/1775,1.6155806369071564,0.6536809160189618,regulation of translation in response to stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,protein localization to synapse,0.024737283501134896,0.22198267675272315,17/1775,1.6066479936819151,0.6536809160189618,protein localization to synapse,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,astrocyte differentiation,0.024737283501134896,0.22198267675272315,17/1775,1.6066479936819151,0.6536809160189618,astrocyte differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,glutamate receptor signaling pathway,0.024866274870479297,0.22198267675272315,12/1775,1.604389269992142,0.6536809160189618,glutamate receptor signaling pathway,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,0.03060414303210559,0.22280475765768304,5/1231,1.5142197769763752,0.6520755396993059,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREA...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,Reactome,Vitamin C (ascorbate) metabolism,0.016615118101989824,0.22363204262819114,4/1379,1.7794965673638925,0.6504659693920356,Vitamin C (ascorbate) metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,DO,drug dependence,0.06809757308510955,0.22406705156883455,16/1094,1.1668683655398773,0.6496220005549155,drug dependence,OUD vs Control Female,DO
OUD_vs_Control_Female,GO_MF,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,0.0307018674224872,0.22842189362330478,13/2121,1.5128352080206495,0.6412622724747706,neurotransmitter receptor activity involved in ...,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,GO_BP,neuron apoptotic process,0.025929685242444604,0.2286724639786332,45/1775,1.5862027550509,0.6407861286250898,neuron apoptotic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,response to chemokine,0.026078968910876035,0.22889118894927593,14/1775,1.583709583383717,0.6403709249504446,response to chemokine,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cellular response to chemokine,0.026078968910876035,0.22889118894927593,14/1775,1.583709583383717,0.6403709249504446,cellular response to chemokine,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,0.026062859190667573,0.23228802998687598,9/1002,1.5839779423219777,0.6339731692121957,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,0.02615163251507875,0.23228802998687598,11/1002,1.5825011951270913,0.6339731692121957,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUT...,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,Reactome,Chemokine receptors bind chemokines,0.01827093316349375,0.23288819880134423,11/1379,1.7382392710707453,0.6328525180145206,Chemokine receptors bind chemokines,OUD vs Control Female,Reactome
OUD_vs_Control_Female,WikiPathways,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,0.032903465220505204,0.23345791989787024,12/1231,1.4827583620227995,0.6317913883444448,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Male,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,0.16048108665443672,0.23351826433248976,1/8,0.7945761436056372,0.6316791459817732,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,OUD vs Control Male,C8 CellType
OUD_vs_Control_Male,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.16213393663818942,0.23351826433248976,1/8,0.7901260724302156,0.6316791459817732,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,OUD vs Control Male,C8 CellType
OUD_vs_Control_Male,C8_CellType,HU_FETAL_RETINA_MICROGLIA,0.1641959945062046,0.23351826433248976,1/8,0.7846374415227317,0.6316791459817732,HU_FETAL_RETINA_MICROGLIA,OUD vs Control Male,C8 CellType
OUD_vs_Control_Male,C8_CellType,ZHONG_PFC_C3_ASTROCYTE,0.1650195734616261,0.23351826433248976,1/8,0.7824645397726842,0.6316791459817732,ZHONG_PFC_C3_ASTROCYTE,OUD vs Control Male,C8 CellType
OUD_Effect_Male_vs_Female,GO_MF,kainate selective glutamate receptor activity,0.01336138853687964,0.2348192964140975,3/1824,1.8741484069376035,0.6292662175529389,kainate selective glutamate receptor activity,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,C-X3-C chemokine binding,0.01336138853687964,0.2348192964140975,3/1824,1.8741484069376035,0.6292662175529389,C-X3-C chemokine binding,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,GO_MF,L-glutamate transmembrane transporter activity,0.03223142962353397,0.2350246294377248,5/2121,1.4917204309492758,0.6288866233946049,L-glutamate transmembrane transporter activity,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,glutamate-gated receptor activity,0.01366087995314598,0.23681052387888937,6/1824,1.8645213250697745,0.6255990014382542,glutamate-gated receptor activity,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,glutamate binding,0.014536325430586368,0.237185464269979,4/1824,1.8375453628652771,0.6249119298978753,glutamate binding,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,chemokine binding,0.01563218863755248,0.237185464269979,8/1824,1.8059802128529236,0.6249119298978753,chemokine binding,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Male,C8_CellType,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,0.1869894709480323,0.23781093228031067,1/8,0.7281828471421506,0.6237681845369997,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,OUD vs Control Male,C8 CellType
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_NEURONS,0.15559727227821268,0.23831255084990197,2/2407,0.8079980207454561,0.6228530847147294,DESCARTES_MAIN_FETAL_INHIBITORY_NEURONS,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,regulation of dendrite extension,0.027620891766763984,0.2387211033425959,7/1775,1.5587623039205782,0.6221091869416172,regulation of dendrite extension,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Male,C8_CellType,ZHONG_PFC_C3_MICROGLIA,0.20333084435662885,0.24059050266948845,1/8,0.6917967358833099,0.6187215204693375,ZHONG_PFC_C3_MICROGLIA,OUD vs Control Male,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of programmed cell death,0.028119937675260945,0.24161465140367316,115/1775,1.5509856462169453,0.6168767338305496,negative regulation of programmed cell death,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_MF,postsynaptic neurotransmitter receptor activity,0.03358932948150431,0.24236438600016472,15/2121,1.473798665565576,0.6155311967992345,postsynaptic neurotransmitter receptor activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,complement binding,0.035476269090332316,0.2424134145270824,6/2121,1.450062059603541,0.6154433511151061,complement binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_BP,negative regulation of type 2 immune response,0.07017354788116012,0.2431248025682207,4/2058,1.1538265655652618,0.6141707340029867,negative regulation of type 2 immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,peripheral nervous system neuron development,0.07017354788116012,0.2431248025682207,4/2058,1.1538265655652618,0.6141707340029867,peripheral nervous system neuron development,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of cytokine production involved in inflammatory response,0.07018923996947844,0.2431248025682207,6/2058,1.153729460235581,0.6141707340029867,positive regulation of cytokine production invo...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neurotransmitter uptake,0.07045329645478973,0.24352792889569153,10/2058,1.1520986817791525,0.6134512247173864,neurotransmitter uptake,OUD vs Control Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,0.03547663104356221,0.24390704714037023,8/1231,1.4500576286559643,0.612775651551944,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_...,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_CC,inhibitory synapse,0.032092588546443986,0.24684792316377627,5/1867,1.4935952518637468,0.6075705223326658,inhibitory synapse,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,GO_BP,stress response to metal ion,0.07210177171940185,0.2469420841666744,5/2058,1.1420540634566319,0.6074048907732671,stress response to metal ion,OUD vs Control Female,GO BP
OUD_vs_Control_Male,GO_BP,positive regulation of immune response,0.21592576162654442,0.2481829638207538,1/5,0.6656955398574744,0.6052280333633606,positive regulation of immune response,OUD vs Control Male,GO BP
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_PURKINJE_NEURONS,0.16535296640520097,0.24867876339770753,12/2407,0.7815880095083435,0.6043613009101517,DESCARTES_FETAL_CEREBELLUM_PURKINJE_NEURONS,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_4_INTERNEURON,0.16689242252297604,0.24867876339770753,3/2407,0.7775633813025693,0.6043613009101517,FAN_EMBRYONIC_CTX_IN_4_INTERNEURON,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,0.16689242252297604,0.24867876339770753,3/2407,0.7775633813025693,0.6043613009101517,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_BP,dopaminergic neuron differentiation,0.07292073209805948,0.2487403566461796,8/2058,1.1371489798339647,0.604253747312018,dopaminergic neuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neurotransmitter reuptake,0.07292073209805948,0.2487403566461796,8/2058,1.1371489798339647,0.604253747312018,neurotransmitter reuptake,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of presynapse assembly,0.029333771062542594,0.24913381774249513,8/1775,1.5326321018207978,0.6035673167745956,regulation of presynapse assembly,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,neuron projection organization,0.07319841403856221,0.24957579218071996,18/2058,1.1354983285285287,0.6027975417147343,neuron projection organization,OUD vs Control Female,GO BP
OUD_vs_Control_Male,DO,immune system disease,0.21162648205545742,0.24961072242438567,1/3,0.6744299874358578,0.6027367627807829,immune system disease,OUD vs Control Male,DO
OUD_vs_Control_Male,GO_BP,regulation of cytokine production,0.21893637546139477,0.250028438470472,1/5,0.6596820760303942,0.6020105914544237,regulation of cytokine production,OUD vs Control Male,GO BP
OUD_vs_Control_Male,GO_BP,cytokine production,0.22084740055879892,0.250028438470472,1/5,0.6559077081538967,0.6020105914544237,cytokine production,OUD vs Control Male,GO BP
OUD_vs_Control_Female,DO,autoimmune lymphoproliferative syndrome,0.0806207507692846,0.2502682073643669,3/1094,1.093553161858491,0.6015943171644006,autoimmune lymphoproliferative syndrome,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,GO_BP,T cell cytokine production,0.029945117941465624,0.25228676112196985,9/1775,1.523673972069609,0.59810553871163,T cell cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of T cell cytokine production,0.029945117941465624,0.25228676112196985,9/1775,1.523673972069609,0.59810553871163,regulation of T cell cytokine production,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Male,Reactome,Innate Immune System,0.2541066007924866,0.2541066007924866,1/3,0.5949840533655315,0.5949840533655315,Innate Immune System,OUD vs Control Male,Reactome
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.06066278055604626,0.25588663798186784,30/2013,1.2170776871267137,0.5919523917300579,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12...,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,immune response-activating cell surface receptor signaling pathway,0.030759724716394838,0.2560604256340553,47/1775,1.5120175555638982,0.5916575369427914,immune response-activating cell surface recepto...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.030775991333855186,0.2560604256340553,13/1775,1.5117879489932673,0.5916575369427914,intrinsic apoptotic signaling pathway in respon...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,0.03230274198467642,0.2567217915624284,3/1002,1.4907606114685297,0.5905372651281892,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Male,GO_BP,cellular response to cytokine stimulus,0.23787887769368743,0.25844477490063444,1/5,0.6236441191579138,0.5876322437429947,cellular response to cytokine stimulus,OUD vs Control Male,GO BP
OUD_vs_Control_Female,WikiPathways,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,0.03884099682648057,0.26068957329484704,7/1231,1.4107096327628836,0.5838763388012481,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,presynapse organization,0.03218976948565408,0.26216217245461215,12/1775,1.492282133331997,0.5814299727504095,presynapse organization,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of astrocyte differentiation,0.032400464277531266,0.26216217245461215,4/1775,1.489448766591991,0.5814299727504095,positive regulation of astrocyte differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,granzyme-mediated programmed cell death signaling pathway,0.032400464277531266,0.26216217245461215,4/1775,1.489448766591991,0.5814299727504095,granzyme-mediated programmed cell death signali...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,protein localization to presynapse,0.032400464277531266,0.26216217245461215,4/1775,1.489448766591991,0.5814299727504095,protein localization to presynapse,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Male,GO_BP,negative regulation of programmed cell death,0.24508627614484502,0.26324081511853725,1/5,0.6106810068280311,0.5796467730880622,negative regulation of programmed cell death,OUD vs Control Male,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of neuron projection regeneration,0.0327797151236992,0.26377987388928625,5/1775,1.484394825040781,0.5787583437110635,negative regulation of neuron projection regene...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of programmed cell death,0.03306679232702134,0.2655090148092161,75/1775,1.4806079321573709,0.5759207287616723,positive regulation of programmed cell death,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,detection of stimulus involved in sensory perception of pain,0.07878764910253452,0.26554226690885196,7/2058,1.1035418579802843,0.5758663415343006,detection of stimulus involved in sensory perce...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_4_INTERNEURON,0.11702630687737718,0.26739530454104615,3/2057,0.9317165002414151,0.5728462232139665,FAN_EMBRYONIC_CTX_IN_4_INTERNEURON,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,0.06544162396015134,0.2674761677297461,29/2013,1.1841459320112198,0.5727149077906183,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of T cell cytokine production,0.033600246380889445,0.26803667259375474,7/1775,1.4736575380426433,0.5718057820327237,positive regulation of T cell cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,ionotropic glutamate receptor signaling pathway,0.033600246380889445,0.26803667259375474,7/1775,1.4736575380426433,0.5718057820327237,ionotropic glutamate receptor signaling pathway,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_NEURONS,0.11886580706921922,0.26934135784659646,2/2057,0.9249430565402644,0.5696969547745994,DESCARTES_MAIN_FETAL_INHIBITORY_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Male,GO_BP,innate immune response,0.255663574609272,0.2699864639431248,1/5,0.5923311432019122,0.5686580091083125,innate immune response,OUD vs Control Male,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of immune response,0.03410537586605726,0.27089097137672913,124/1775,1.4671771598652739,0.5672054694836592,regulation of immune response,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,0.11286791541680238,0.27128390918138195,32/2332,0.9474294959648224,0.5665759650330121,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Male,GO_BP,response to cytokine,0.26012286517718086,0.2724064449216589,1/5,0.5848214710112621,0.5647826215727565,response to cytokine,OUD vs Control Male,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of presynapse organization,0.03483997500715639,0.2726536583196018,8/1775,1.45792216521024,0.5643886708091522,regulation of presynapse organization,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of humoral immune response,0.034984035262659696,0.2726536583196018,9/1775,1.4561300979096319,0.5643886708091522,regulation of humoral immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter receptor internalization,0.034984035262659696,0.2726536583196018,9/1775,1.4561300979096319,0.5643886708091522,neurotransmitter receptor internalization,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Male,GO_BP,regulation of immune response,0.2653416998166084,0.2740652625503051,1/5,0.5761944930363859,0.5621460072870678,regulation of immune response,OUD vs Control Male,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of myeloid leukocyte cytokine production involved in immune response,0.08441949603801864,0.27460120451764475,8/2058,1.0735572447966413,0.561297562094824,positive regulation of myeloid leukocyte cytoki...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,immune response-inhibiting cell surface receptor signaling pathway,0.08450377095829845,0.27460120451764475,3/2058,1.0731239103421555,0.561297562094824,immune response-inhibiting cell surface recepto...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of glutamate secretion,0.08450377095829845,0.27460120451764475,3/2058,1.0731239103421555,0.561297562094824,positive regulation of glutamate secretion,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,"neurotransmitter receptor transport, postsynaptic endosome to lysosome",0.08450377095829845,0.27460120451764475,3/2058,1.0731239103421555,0.561297562094824,"neurotransmitter receptor transport, postsynapt...",OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of T-helper 2 cell cytokine production,0.08450377095829845,0.27460120451764475,3/2058,1.0731239103421555,0.561297562094824,positive regulation of T-helper 2 cell cytokine...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.11528715814334428,0.2756030591140203,33/2332,0.9382190661492832,0.5597159661948719,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARRO...,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_INHIBITORY_INTERNEURONS,0.12449540631544496,0.27598168662881833,6/2057,0.9048466730554722,0.5591197355432096,DESCARTES_FETAL_CEREBELLUM_INHIBITORY_INTERNEURONS,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,0.1248504935708468,0.2760208209214937,10/2057,0.9036097364149843,0.5590581568106564,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,WikiPathways,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,0.04335193106882739,0.27604434740407185,5/1231,1.3629915525393934,0.5590211415372622,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,response to osmotic stress,0.035657341700741016,0.2773570618126029,16/1775,1.4478510371486757,0.5569607720342823,response to osmotic stress,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Male,GO_CC,glutamatergic synapse,0.19850633100979576,0.27925114399907636,1/6,0.7022256376224122,0.5540050390486345,glutamatergic synapse,OUD vs Control Male,GO CC
OUD_vs_Control_Male,GO_CC,dendrite,0.21408850061505724,0.27925114399907636,1/6,0.6694066594386241,0.5540050390486345,dendrite,OUD vs Control Male,GO CC
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON,0.19275679879520224,0.2801262825524632,4/2407,0.7149902948481245,0.5526461420439154,FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURON_CELL,0.19275679879520224,0.2801262825524632,4/2407,0.7149902948481245,0.5526461420439154,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURO...,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_CC,axon terminus,0.03947806255733203,0.2819861611238002,19/1867,1.403644169105398,0.5497722047836361,axon terminus,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,DO,autoimmune thrombocytopenic purpura,0.09482911650861654,0.28297526794142974,6/1094,1.0230582955993577,0.5482515201857148,autoimmune thrombocytopenic purpura,OUD vs Control Female,DO
OUD_vs_Control_Female,KEGG,Nicotinate and nicotinamide metabolism,0.09596067016547795,0.2834734673313225,9/1075,1.0179067276888596,0.5474875841461959,Nicotinate and nicotinamide metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,GO_BP,ectopic germ cell programmed cell death,0.08902315124404099,0.285511302326678,5/2058,1.0504970366129711,0.5443766949804719,ectopic germ cell programmed cell death,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cellular response to fluid shear stress,0.08902315124404099,0.285511302326678,5/2058,1.0504970366129711,0.5443766949804719,cellular response to fluid shear stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.08902315124404099,0.285511302326678,5/2058,1.0504970366129711,0.5443766949804719,negative regulation of endoplasmic reticulum st...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of microglial cell activation,0.08902315124404099,0.285511302326678,5/2058,1.0504970366129711,0.5443766949804719,regulation of microglial cell activation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,peripheral nervous system neuron differentiation,0.09075845959537944,0.2870877021337231,4/2058,1.0421128838195368,0.541985410811939,peripheral nervous system neuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_CC,hippocampal mossy fiber to CA3 synapse,0.0552365715022318,0.28767724317141863,11/2168,1.257773285630534,0.5410944917974534,hippocampal mossy fiber to CA3 synapse,OUD vs Control Female,GO CC
OUD_vs_Control_Male,GO_BP,neuron projection development,0.2854145219717874,0.28770394327102633,1/5,0.544523933632848,0.5410541856275354,neuron projection development,OUD vs Control Male,GO BP
OUD_vs_Control_Female,KEGG,Cortisol synthesis and secretion,0.10013274610941215,0.28872892450635507,13/1075,0.9994238732802389,0.5395097068561333,Cortisol synthesis and secretion,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,GO_MF,opioid receptor binding,0.024408865532628384,0.29009673280505105,3/1824,1.6124524051124642,0.5374571623821959,opioid receptor binding,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,0.12499706542542428,0.29026963906228176,32/2332,0.903100182867986,0.5371983871007061,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,KEGG,Serotonergic synapse,0.10571576405581795,0.29063968660564926,21/1075,0.9758602470163016,0.536645083441208,Serotonergic synapse,OUD vs Control Female,KEGG
OUD_vs_Control_Female,Reactome,Regulation of innate immune responses to cytosolic DNA,0.02571989240668011,0.2918792951183891,5/1379,1.5897308525162002,0.5347967112290305,Regulation of innate immune responses to cytoso...,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of axon extension involved in axon guidance,0.03998582706299076,0.29380195609220483,3/1775,1.3980939166486357,0.5319453170644054,positive regulation of axon extension involved ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of cortisol biosynthetic process,0.03998582706299076,0.29380195609220483,3/1775,1.3980939166486357,0.5319453170644054,regulation of cortisol biosynthetic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,glutamate secretion,0.04038125505688002,0.2940634959835174,7/1775,1.3938201872297487,0.5315588839488424,glutamate secretion,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,synapse maturation,0.040575877168976045,0.29508350299913805,9/1775,1.391732082825741,0.5300550695807256,synapse maturation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,chemokine-mediated signaling pathway,0.04093948916982187,0.295964602294254,12/1775,1.3878575806308078,0.5287602279530776,chemokine-mediated signaling pathway,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of axon extension,0.04100447719073349,0.295964602294254,8/1775,1.3871687210102002,0.5287602279530776,negative regulation of axon extension,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,response to pain,0.04100447719073349,0.295964602294254,8/1775,1.3871687210102002,0.5287602279530776,response to pain,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter receptor localization to postsynaptic specialization membrane,0.04100447719073349,0.295964602294254,8/1775,1.3871687210102002,0.5287602279530776,neurotransmitter receptor localization to posts...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of neuron apoptotic process,0.041093154411151626,0.2963138732294316,26/1775,1.3862305199507021,0.5282480146490708,negative regulation of neuron apoptotic process,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,cellular response to chemical stress,0.09414196166748028,0.29643626375411214,49/2058,1.0262167563960454,0.5280686691645404,cellular response to chemical stress,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of type 2 immune response,0.042046150040857065,0.29735522456779206,5/1775,1.3762737642550853,0.5267244264903167,positive regulation of type 2 immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of axon extension involved in axon guidance,0.042046150040857065,0.29735522456779206,5/1775,1.3762737642550853,0.5267244264903167,regulation of axon extension involved in axon g...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,stress response to metal ion,0.042046150040857065,0.29735522456779206,5/1775,1.3762737642550853,0.5267244264903167,stress response to metal ion,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,glutamatergic neuron differentiation,0.042046150040857065,0.29735522456779206,5/1775,1.3762737642550853,0.5267244264903167,glutamatergic neuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_COMPLEMENT_SYSTEM,0.040107383492403385,0.29764128808748125,17/1002,1.3967756694039457,0.5263068246556678,WP_COMPLEMENT_SYSTEM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,0.04029390407122077,0.29764128808748125,8/1002,1.3947606518360876,0.5263068246556678,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.07887131455635926,0.29857113016206865,28/2013,1.103080920682593,0.5249521879621607,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARRO...,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_CC,symmetric synapse,0.0433896144283526,0.2998469289764204,4/1867,1.362614209109849,0.5231003948349542,symmetric synapse,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,synapse-associated extracellular matrix,0.0433896144283526,0.2998469289764204,4/1867,1.362614209109849,0.5231003948349542,synapse-associated extracellular matrix,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,GO_MF,cytokine receptor activity,0.04838980286850876,0.3011320817913891,18/2121,1.3152461471266155,0.5212429734717823,cytokine receptor activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_INHIBITORY_INTERNEURONS,0.2116095409775604,0.302949523581066,6/2407,0.6744647548764899,0.5186297261391523,DESCARTES_FETAL_CEREBELLUM_INHIBITORY_INTERNEURONS,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.044575246330927125,0.3041971711036419,30/1775,1.3509062481555965,0.5168448290068559,regulation of adaptive immune response based on...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,axon extension,0.044962852459806926,0.3056131559419425,19/1775,1.3471461447642186,0.5148279543175176,axon extension,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,presynapse assembly,0.04506989386440606,0.3056131559419425,10/1775,1.3461134646527202,0.5148279543175176,presynapse assembly,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,KEGG,Amphetamine addiction,0.024582614676948847,0.3056971606335437,14/889,1.60937192619411,0.5147085950551045,Amphetamine addiction,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Glutamatergic synapse,0.03318601375252851,0.3056971606335437,21/889,1.4790449111723216,0.5147085950551045,Glutamatergic synapse,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,GO_CC,ionotropic glutamate receptor complex,0.04537184728667612,0.30607992217202146,9/1867,1.3432135383430241,0.5141651577462942,ionotropic glutamate receptor complex,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS,0.2145392949652513,0.3063784732259394,7/2407,0.6684931509216092,0.5137417523802249,DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_MF,axon guidance receptor activity,0.05126900310479336,0.3109576492660293,4/2121,1.2901451270748423,0.5072987554828189,axon guidance receptor activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,G protein-coupled neurotransmitter receptor activity,0.05126900310479336,0.3109576492660293,4/2121,1.2901451270748423,0.5072987554828189,G protein-coupled neurotransmitter receptor act...,OUD vs Control Female,GO MF
OUD_vs_Control_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.13790439823588385,0.3113393087141919,32/2332,0.860421882489024,0.506766043211097,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE...,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,regulation of neurotransmitter secretion,0.0463327440197348,0.3121516557175101,15/1775,1.334111978291573,0.5056343571380381,regulation of neurotransmitter secretion,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of dendrite extension,0.04647261223802495,0.3121516557175101,6/1775,1.33280291502545,0.5056343571380381,positive regulation of dendrite extension,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of response to endoplasmic reticulum stress,0.10122467186042525,0.31362577367548344,10/2058,0.994713622407784,0.5035882543259459,negative regulation of response to endoplasmic ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,DO,autoimmune disease of skin and connective tissue,0.11406535261337039,0.3165160066278508,6/1094,0.9428462526359955,0.4996043222520889,autoimmune disease of skin and connective tissue,OUD vs Control Female,DO
OUD_vs_Control_Female,DO,autoimmune disease of blood,0.11406535261337039,0.3165160066278508,6/1094,0.9428462526359955,0.4996043222520889,autoimmune disease of blood,OUD vs Control Female,DO
OUD_vs_Control_Female,GO_CC,AMPA glutamate receptor complex,0.06547475359231061,0.3193721462864415,7/2168,1.1839261273235193,0.49570296309291745,AMPA glutamate receptor complex,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,stress fiber,0.06564018871992969,0.3193721462864415,17/2168,1.1828301789914875,0.49570296309291745,stress fiber,OUD vs Control Female,GO CC
OUD_Effect_Male_vs_Female,WikiPathways,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,0.045349706840495316,0.31961210089210107,10/1002,1.3434255160562942,0.49537678614409925,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,0.04689044429626098,0.31961210089210107,5/1002,1.3289156522152918,0.49537678614409925,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_CHEMOKINE_SIGNALING,0.04746052291972406,0.31961210089210107,27/1002,1.3236674810386222,0.49537678614409925,WP_CHEMOKINE_SIGNALING,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,DO,substance abuse,0.11610027983070961,0.3201923506910097,49/1094,0.9351667335018518,0.49458904747095395,substance abuse,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_ASTROCYTES,0.15032339455162763,0.3202201477688318,7/2057,0.8229734257069258,0.49455134640313353,DESCARTES_MAIN_FETAL_ASTROCYTES,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_MF,structural constituent of synapse,0.05414122005700459,0.3202558387824229,7/2121,1.266471961752537,0.494502943619586,structural constituent of synapse,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of axonogenesis,0.04855465988196376,0.3205740784845991,11/1775,1.313769083698139,0.4940715974723003,negative regulation of axonogenesis,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,DO,opioid abuse,0.04795303711123794,0.3210127086715272,5/920,1.319183881530207,0.49347777383605507,opioid abuse,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,0.1524336809174852,0.32136791492397654,21/2057,0.8169190630456914,0.4929974849685756,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,WikiPathways,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.054472046034709926,0.3215476520679336,8/1231,1.2638263118042314,0.4927546572759364,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICROR...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,0.05567737868021938,0.3215476520679336,3/1231,1.2543212197249802,0.4927546572759364,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,0.1446481637915797,0.3222340438923531,32/2332,0.839687075049155,0.4918285784619731,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,Reactome,Linoleic acid (LA) metabolism,0.005507808595926721,0.32364834691092215,4/1194,2.2590211604952137,0.48992660687345096,Linoleic acid (LA) metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",0.005640379040507658,0.32364834691092215,9/1194,2.248691709905027,0.48992660687345096,"Turbulent (oscillatory, disturbed) flow shear s...",OUD Effect Male vs Female,Reactome
OUD_vs_Control_Female,GO_BP,response to osmotic stress,0.10542987847629078,0.32552062600482645,16/2058,0.9770362940710877,0.487421487967439,response to osmotic stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_MF,chemokine receptor activity,0.0560093053027713,0.3255540870723582,6/2121,1.2517398139594338,0.48737684806142345,chemokine receptor activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,WikiPathways,WP_COMPLEMENT_AND_COAGULATION_CASCADES,0.06085937401823967,0.3261887312488385,14/1231,1.2156725189811777,0.4865310464869799,WP_COMPLEMENT_AND_COAGULATION_CASCADES,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,0.06085937401823967,0.3261887312488385,14/1231,1.2156725189811777,0.4865310464869799,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COA...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,GO_BP,mature B cell differentiation involved in immune response,0.10666077702455719,0.32852209405420624,7/2058,0.9719952568030737,0.4834354175709864,mature B cell differentiation involved in immun...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_CHOLESTEROL_METABOLISM,0.05198156280480963,0.3292664387789585,14/1002,1.284150667749544,0.48245253347241324,WP_CHOLESTEROL_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.0523337386138742,0.3292664387789585,7/1002,1.2812182390539766,0.48245253347241324,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICROR...,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,GO_MF,CCR5 chemokine receptor binding,0.05772499740597367,0.32980083842184277,3/2121,1.2386360779269636,0.4817482446238318,CCR5 chemokine receptor binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_BP,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.10780133277932229,0.3304316908571822,5/2058,0.9673758698067273,0.4809183072826935,regulation of oxidative stress-induced neuron i...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of T-helper 17 type immune response,0.10780133277932229,0.3304316908571822,5/2058,0.9673758698067273,0.4809183072826935,positive regulation of T-helper 17 type immune ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_CC,synapse-associated extracellular matrix,0.06932436228762441,0.33148200817990525,4/2168,1.159114116791422,0.4795400387832979,synapse-associated extracellular matrix,OUD vs Control Female,GO CC
OUD_Effect_Male_vs_Female,C8_CellType,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.16324455806333815,0.33223368328670033,13/2057,0.7871612874951917,0.4785563390009015,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_3_INTERNEURON,0.16408607340810138,0.33223368328670033,2/2057,0.7849282775616195,0.4785563390009015,FAN_EMBRYONIC_CTX_IN_3_INTERNEURON,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C2_ASCL1_POS_ASTROCYTE,0.16408607340810138,0.33223368328670033,2/2057,0.7849282775616195,0.4785563390009015,ZHONG_PFC_C2_ASCL1_POS_ASTROCYTE,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_BP,negative regulation of neuron apoptotic process,0.11072594230484845,0.3329454282428572,27/2058,0.9557506150752236,0.4776269441369007,negative regulation of neuron apoptotic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of immunoglobulin mediated immune response,0.11385543298306823,0.3329454282428572,4/2058,0.9436462407776927,0.4776269441369007,negative regulation of immunoglobulin mediated ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of response to osmotic stress,0.11385543298306823,0.3329454282428572,4/2058,0.9436462407776927,0.4776269441369007,regulation of response to osmotic stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,detection of mechanical stimulus involved in sensory perception of pain,0.11385543298306823,0.3329454282428572,4/2058,0.9436462407776927,0.4776269441369007,detection of mechanical stimulus involved in se...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of synapse organization,0.11385543298306823,0.3329454282428572,4/2058,0.9436462407776927,0.4776269441369007,negative regulation of synapse organization,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,assembly of actomyosin apparatus involved in cytokinesis,0.11426012202006416,0.3329454282428572,3/2058,0.9421053164857599,0.4776269441369007,assembly of actomyosin apparatus involved in cy...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of L-glutamate import across plasma membrane,0.11426012202006416,0.3329454282428572,3/2058,0.9421053164857599,0.4776269441369007,regulation of L-glutamate import across plasma ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,natural killer cell cytokine production,0.11426012202006416,0.3329454282428572,3/2058,0.9421053164857599,0.4776269441369007,natural killer cell cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of T cell cytokine production,0.11426012202006416,0.3329454282428572,3/2058,0.9421053164857599,0.4776269441369007,negative regulation of T cell cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of natural killer cell cytokine production,0.11426012202006416,0.3329454282428572,3/2058,0.9421053164857599,0.4776269441369007,regulation of natural killer cell cytokine prod...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,0.11426012202006416,0.3329454282428572,3/2058,0.9421053164857599,0.4776269441369007,adenylate cyclase-inhibiting G protein-coupled ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,spinal cord association neuron differentiation,0.11426012202006416,0.3329454282428572,3/2058,0.9421053164857599,0.4776269441369007,spinal cord association neuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,astrocyte cell migration,0.11426012202006416,0.3329454282428572,3/2058,0.9421053164857599,0.4776269441369007,astrocyte cell migration,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,autophagic cell death,0.11426012202006416,0.3329454282428572,3/2058,0.9421053164857599,0.4776269441369007,autophagic cell death,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,protein localization to axon,0.11426012202006416,0.3329454282428572,3/2058,0.9421053164857599,0.4776269441369007,protein localization to axon,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of translation at synapse,0.11426012202006416,0.3329454282428572,3/2058,0.9421053164857599,0.4776269441369007,regulation of translation at synapse,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of cardiac muscle hypertrophy in response to stress,0.11426012202006416,0.3329454282428572,3/2058,0.9421053164857599,0.4776269441369007,regulation of cardiac muscle hypertrophy in res...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,KEGG,Chemokine signaling pathway,0.0404432562333596,0.33296075699500144,29/889,1.3931538850481833,0.47760694975144685,Chemokine signaling pathway,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,innate immune response activating cell surface receptor signaling pathway,0.051760203395404235,0.33541523874290585,16/1775,1.2860040257449172,0.4744172102105099,innate immune response activating cell surface ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,0.05508562196160048,0.33559239952532743,19/1002,1.2589617426652255,0.4741878836049241,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AN...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.05651715681543992,0.33559239952532743,6/1002,1.2478196941416622,0.4741878836049241,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,0.05950686954793169,0.33559239952532743,12/1002,1.2254328958756662,0.4741878836049241,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_IRON_METABOLISM_DISORDERS,0.059562094750190565,0.33559239952532743,5/1002,1.2250300368693048,0.4741878836049241,WP_IRON_METABOLISM_DISORDERS,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,ectopic germ cell programmed cell death,0.05273391351376973,0.33650320018694224,5/1775,1.2779099974080184,0.47301080122627076,ectopic germ cell programmed cell death,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of sensory perception of pain,0.05273391351376973,0.33650320018694224,5/1775,1.2779099974080184,0.47301080122627076,regulation of sensory perception of pain,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter-gated ion channel clustering,0.05273391351376973,0.33650320018694224,5/1775,1.2779099974080184,0.47301080122627076,neurotransmitter-gated ion channel clustering,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,L-glutamate import across plasma membrane,0.05273391351376973,0.33650320018694224,5/1775,1.2779099974080184,0.47301080122627076,L-glutamate import across plasma membrane,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.05273391351376973,0.33650320018694224,5/1775,1.2779099974080184,0.47301080122627076,negative regulation of endoplasmic reticulum st...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of chemokine production,0.0532399768745068,0.3384442782299028,13/1775,1.2737621418389153,0.47051282372711584,positive regulation of chemokine production,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of immune response to tumor cell,0.11721172300595793,0.3390815397403652,6/2058,0.9310289499033488,0.4696958534160323,regulation of immune response to tumor cell,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of immune effector process,0.05413889456759918,0.33912018299744257,54/1775,1.2664906160958602,0.46964636208397886,regulation of immune effector process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of axon extension,0.05540126207058061,0.33912018299744257,8/1775,1.256480341696737,0.46964636208397886,positive regulation of axon extension,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,dendrite extension,0.05540126207058061,0.33912018299744257,8/1775,1.256480341696737,0.46964636208397886,dendrite extension,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,chemokine production,0.05647049270275884,0.33912018299744257,16/1775,1.2481784230448474,0.46964636208397886,chemokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of chemokine production,0.05647049270275884,0.33912018299744257,16/1775,1.2481784230448474,0.46964636208397886,regulation of chemokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of glutamate secretion,0.058464227333889486,0.33912018299744257,3/1775,1.2331097856018138,0.46964636208397886,positive regulation of glutamate secretion,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,meiotic cytokinesis,0.058464227333889486,0.33912018299744257,3/1775,1.2331097856018138,0.46964636208397886,meiotic cytokinesis,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cortisol biosynthetic process,0.058464227333889486,0.33912018299744257,3/1775,1.2331097856018138,0.46964636208397886,cortisol biosynthetic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,"neurotransmitter receptor transport, postsynaptic endosome to lysosome",0.058464227333889486,0.33912018299744257,3/1775,1.2331097856018138,0.46964636208397886,"neurotransmitter receptor transport, postsynapt...",OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_CC,apical dendrite,0.05168402133350974,0.34055362894173086,5/1867,1.2866437029268765,0.46781448751183274,apical dendrite,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of immune response,0.05983040134249186,0.3456815411422055,30/1775,1.223078083899639,0.46132381048974547,negative regulation of immune response,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,Hallmark,HALLMARK_HEME_METABOLISM,0.15562845698533406,0.3457321584465436,37/703,0.8079109884406402,0.4612602224641822,HALLMARK_HEME_METABOLISM,OUD vs Control Female,Hallmark
OUD_Effect_Male_vs_Female,GO_CC,neuronal dense core vesicle,0.054747480520491165,0.3472787943463992,6/1867,1.2616358622636437,0.45932173491415845,neuronal dense core vesicle,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.06086150928577509,0.3483548967886057,11/1775,1.2156572819095603,0.4579780802540756,negative regulation of adaptive immune response...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuron projection regeneration,0.06086150928577509,0.3483548967886057,11/1775,1.2156572819095603,0.4579780802540756,neuron projection regeneration,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,"CD4-positive, alpha-beta T cell differentiation involved in immune response",0.060956186562465736,0.3483548967886057,15/1775,1.214982210413238,0.4579780802540756,"CD4-positive, alpha-beta T cell differentiation...",OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,postsynapse assembly,0.060956186562465736,0.3483548967886057,15/1775,1.214982210413238,0.4579780802540756,postsynapse assembly,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,0.16388661565106488,0.3518975722573769,31/2332,0.7854565130935566,0.4535837293536736,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE...,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,Reactome,Glucose metabolism,0.03463645041484474,0.3562895688872041,17/1379,1.4604666213958575,0.44819689233055005,Glucose metabolism,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,WikiPathways,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.06427609742893833,0.35682686440329736,17/1002,1.191950499620715,0.44754245636174433,WP_APOPTOSIS_MODULATION_AND_SIGNALING,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,GO_BP,macrophage cytokine production,0.12485395165117959,0.3568527391095816,8/2058,0.9035977075926278,0.4475109653618342,macrophage cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of macrophage cytokine production,0.12485395165117959,0.3568527391095816,8/2058,0.9035977075926278,0.4475109653618342,regulation of macrophage cytokine production,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,DO,glucose metabolism disease,0.060013217286797066,0.35869570324776007,89/920,1.221753090240253,0.4452738256294821,glucose metabolism disease,OUD Effect Male vs Female,DO
OUD_vs_Control_Female,KEGG,Adipocytokine signaling pathway,0.13856636504825348,0.35894848414974606,14/1075,0.8583421755443718,0.4449678763656794,Adipocytokine signaling pathway,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,glutamate metabolic process,0.06579378330715056,0.3604197341135963,7/1775,1.1818151398655046,0.44319143805366495,glutamate metabolic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of neuron projection regeneration,0.06579378330715056,0.3604197341135963,7/1775,1.1818151398655046,0.44319143805366495,regulation of neuron projection regeneration,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,Reactome,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",0.009093393317065872,0.3608573064141538,9/1194,2.0412740239421723,0.44266449695280763,"Glutamate binding, activation of AMPA receptors...",OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Glucose metabolism,0.009407338537597185,0.3608573064141538,17/1194,2.026533226936596,0.44266449695280763,Glucose metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Vitamin C (ascorbate) metabolism,0.009967142903484974,0.3608573064141538,4/1194,2.0014293150158657,0.44266449695280763,Vitamin C (ascorbate) metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Metabolism of carbohydrates and carbohydrate derivatives,0.010369462827992927,0.3608573064141538,47/1194,1.9842437408993885,0.44266449695280763,Metabolism of carbohydrates and carbohydrate de...,OUD Effect Male vs Female,Reactome
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_MAJOR_TYPES_INTERNEURON,0.25859720724241925,0.36177266344270537,4/2407,0.5873761696557637,0.4415642527457495,ZHONG_PFC_MAJOR_TYPES_INTERNEURON,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,alpha-beta T cell activation involved in immune response,0.06645593544544923,0.3623010399412422,15/1775,1.1774662244114062,0.44093041937397875,alpha-beta T cell activation involved in immune...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,alpha-beta T cell differentiation involved in immune response,0.06645593544544923,0.3623010399412422,15/1775,1.1774662244114062,0.44093041937397875,alpha-beta T cell differentiation involved in i...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,T cell differentiation involved in immune response,0.06675840567931658,0.3623675821190948,16/1775,1.1754940436665942,0.4408506618134699,T cell differentiation involved in immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_OPIOID_RECEPTOR_PATHWAYS,0.06713602680989124,0.3636424532743649,9/1002,1.1730443643927184,0.4393254209766629,WP_OPIOID_RECEPTOR_PATHWAYS,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,GO_BP,detection of temperature stimulus involved in sensory perception of pain,0.12833112626072038,0.36433747998315436,5/2058,0.8916679942581697,0.4384961498873774,detection of temperature stimulus involved in s...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,activation of immune response,0.06728291910954166,0.36494533189578093,76/1775,1.1720951746764863,0.437772187143982,activation of immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,0.07024515521861083,0.3682992513197998,21/1002,1.1533836235136987,0.43379916397976026,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter uptake,0.06883956110879015,0.37011328359294704,9/1775,1.162161907209065,0.43166532752961345,neurotransmitter uptake,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,T-helper 1 type immune response,0.06883956110879015,0.37011328359294704,9/1775,1.162161907209065,0.43166532752961345,T-helper 1 type immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,KEGG,Dopaminergic synapse,0.05996447518891314,0.370494793131499,22/889,1.2221059629264193,0.43121789113984316,Dopaminergic synapse,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,regulation of adaptive immune response,0.06905797791866541,0.37101638246295404,31/1775,1.1607861423436798,0.43060691341412105,regulation of adaptive immune response,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_LIMBIC_SYSTEM_NEURONS,0.2694100818232291,0.373099004071161,2/2407,0.5695861562066876,0.4281759102381214,DESCARTES_MAIN_FETAL_LIMBIC_SYSTEM_NEURONS,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C6_PLXNA4_POS_EXCITATORY_NEURON,0.2694100818232291,0.373099004071161,2/2407,0.5695861562066876,0.4281759102381214,ZHONG_PFC_C6_PLXNA4_POS_EXCITATORY_NEURON,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,KEGG,Phenylalanine metabolism,0.14990854510246443,0.37368506895107073,4/1075,0.8241736107469467,0.42749425457665313,Phenylalanine metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,GO_BP,response to oxidative stress,0.13563054988780235,0.3741198787704876,59/2058,0.8676424774795897,0.4269892150550344,response to oxidative stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cellular response to osmotic stress,0.136788248068724,0.3741198787704876,11/2058,0.8639512126900307,0.4269892150550344,cellular response to osmotic stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,G protein-coupled glutamate receptor signaling pathway,0.13922707330688572,0.3741198787704876,4/2058,0.8562763060721745,0.4269892150550344,G protein-coupled glutamate receptor signaling ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of axon regeneration,0.13922707330688572,0.3741198787704876,4/2058,0.8562763060721745,0.4269892150550344,negative regulation of axon regeneration,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,immune complex clearance,0.14140621386113086,0.3741198787704876,2/2058,0.849531505770337,0.4269892150550344,immune complex clearance,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of glutamate secretion,0.14140621386113086,0.3741198787704876,2/2058,0.849531505770337,0.4269892150550344,negative regulation of glutamate secretion,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,C-X-C chemokine receptor CXCR4 signaling pathway,0.14140621386113086,0.3741198787704876,2/2058,0.849531505770337,0.4269892150550344,C-X-C chemokine receptor CXCR4 signaling pathway,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,NMDA selective glutamate receptor signaling pathway,0.14140621386113086,0.3741198787704876,2/2058,0.849531505770337,0.4269892150550344,NMDA selective glutamate receptor signaling pat...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,response to psychosocial stress,0.14140621386113086,0.3741198787704876,2/2058,0.849531505770337,0.4269892150550344,response to psychosocial stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of forebrain neuron differentiation,0.14140621386113086,0.3741198787704876,2/2058,0.849531505770337,0.4269892150550344,regulation of forebrain neuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,0.0770513620815015,0.3745844211196707,5/1231,1.1132196796029086,0.4264502887932795,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,0.0789392672695145,0.3745844211196707,8/1231,1.1027069091323387,0.4264502887932795,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_PHOSPHOINOSITIDES_METABOLISM,0.0803583828288845,0.37652198243722607,12/1231,1.0949688117888794,0.4242096633610381,WP_PHOSPHOINOSITIDES_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,Reactome,Keratan sulfate/keratin metabolism,0.03949764869612044,0.37848997545384555,9/1379,1.4034287572518804,0.42194561857535345,Keratan sulfate/keratin metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Glutamate Neurotransmitter Release Cycle,0.040846547455393026,0.37893188619743046,7/1379,1.3888446462169672,0.4214388483620118,Glutamate Neurotransmitter Release Cycle,OUD vs Control Female,Reactome
OUD_vs_Control_Female,GO_BP,regulation of cytokine-mediated signaling pathway,0.14568773405995183,0.38144494152738817,27/2058,0.8365770114031208,0.41856814005897247,regulation of cytokine-mediated signaling pathway,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,immune response-inhibiting signal transduction,0.14727971288329378,0.38144494152738817,3/2058,0.8318570711452877,0.41856814005897247,immune response-inhibiting signal transduction,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of natural killer cell mediated immune response to tumor cell,0.14727971288329378,0.38144494152738817,3/2058,0.8318570711452877,0.41856814005897247,regulation of natural killer cell mediated immu...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of humoral immune response mediated by circulating immunoglobulin,0.14727971288329378,0.38144494152738817,3/2058,0.8318570711452877,0.41856814005897247,negative regulation of humoral immune response ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of axon regeneration,0.14727971288329378,0.38144494152738817,3/2058,0.8318570711452877,0.41856814005897247,positive regulation of axon regeneration,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,amino acid neurotransmitter reuptake,0.14727971288329378,0.38144494152738817,3/2058,0.8318570711452877,0.41856814005897247,amino acid neurotransmitter reuptake,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of synapse assembly,0.14727971288329378,0.38144494152738817,3/2058,0.8318570711452877,0.41856814005897247,negative regulation of synapse assembly,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of chemokine-mediated signaling pathway,0.14727971288329378,0.38144494152738817,3/2058,0.8318570711452877,0.41856814005897247,regulation of chemokine-mediated signaling pathway,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of neuron projection regeneration,0.14727971288329378,0.38144494152738817,3/2058,0.8318570711452877,0.41856814005897247,positive regulation of neuron projection regene...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.14727971288329378,0.38144494152738817,3/2058,0.8318570711452877,0.41856814005897247,positive regulation of endoplasmic reticulum st...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,0.1239688523010939,0.3815390072084204,28/2013,0.9066874194588052,0.41846105469634215,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12...,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,DO,substance dependence,0.14432722947938934,0.381956910339394,23/1094,0.8406517250601105,0.417985628337915,substance dependence,OUD vs Control Female,DO
OUD_vs_Control_Female,Reactome,Transmission across Chemical Synapses,0.04249093744252632,0.3832900459559169,47/1379,1.3717036873236368,0.4164724592286935,Transmission across Chemical Synapses,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,GO_BP,type 2 immune response,0.07266042216000874,0.38336973098053395,8/1775,1.138702083197366,0.41638217989580767,type 2 immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,detection of mechanical stimulus involved in sensory perception of pain,0.07384800151563048,0.3843963560845451,4/1775,1.1316612531276278,0.4152207379126375,detection of mechanical stimulus involved in se...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,presynapse organization,0.14974046333041124,0.38742293110996684,11/2058,0.824660827401852,0.4118146774739286,presynapse organization,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,DO,opiate dependence,0.0690316159516043,0.38745105462320184,12/920,1.1609519601529001,0.4117831526406268,opiate dependence,OUD Effect Male vs Female,DO
OUD_vs_Control_Female,KEGG,Amphetamine addiction,0.16127346806597873,0.3879585525503264,13/1075,0.7924370747704618,0.4112146696639935,Amphetamine addiction,OUD vs Control Female,KEGG
OUD_vs_Control_Female,WikiPathways,WP_GLYCOSPHINGOLIPID_METABOLISM,0.08605641813453191,0.38880775495943887,6/1231,1.0652167342095493,0.4102650814450843,WP_GLYCOSPHINGOLIPID_METABOLISM,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of immune response,0.07507855794754756,0.38942369090565043,97/1775,1.124484077572231,0.4095776313557296,positive regulation of immune response,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of stress fiber assembly,0.15256145623606082,0.39232296156315843,10/2058,0.8165551744962197,0.4063562730880248,positive regulation of stress fiber assembly,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,DO,metal metabolism disorder,0.07683922401651955,0.3932657275050996,12/920,1.114417029638627,0.40531390002801493,metal metabolism disorder,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,KEGG,Fructose and mannose metabolism,0.0725063124109837,0.3946233787339347,7/889,1.139624182037021,0.40381718934642175,Fructose and mannose metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Fluid shear stress and atherosclerosis,0.07413444976215537,0.3946233787339347,22/889,1.1299799314963428,0.40381718934642175,Fluid shear stress and atherosclerosis,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,immune response-regulating signaling pathway,0.08001907724263137,0.397453922271554,73/1775,1.0968064610892883,0.40071321282672007,immune response-regulating signaling pathway,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of translation at synapse,0.08019328628837338,0.397453922271554,3/1775,1.0958619889472607,0.40071321282672007,regulation of translation at synapse,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,humoral immune response mediated by circulating immunoglobulin,0.15490953739528643,0.3975559118395879,9/2058,0.809921842985568,0.40060178399917273,humoral immune response mediated by circulating...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,T-helper 17 type immune response,0.0807120425879375,0.39814693040528526,10/1775,1.0930616618169864,0.39995662820643213,T-helper 17 type immune response,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of response to cytokine stimulus,0.1561215557966948,0.39897038525264683,28/2058,0.8065371294984442,0.39905933989893777,regulation of response to cytokine stimulus,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neurotransmitter receptor internalization,0.1565124652865822,0.39897038525264683,8/2058,0.8054510677687049,0.39905933989893777,neurotransmitter receptor internalization,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,G protein-coupled dopamine receptor signaling pathway,0.15692730395390966,0.39897038525264683,7/2058,0.8043014864648935,0.39905933989893777,G protein-coupled dopamine receptor signaling p...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of response to oxidative stress,0.15692730395390966,0.39897038525264683,7/2058,0.8043014864648935,0.39905933989893777,regulation of response to oxidative stress,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,KEGG,Adipocytokine signaling pathway,0.07647933835893292,0.4009371374574362,13/889,1.1164558779012475,0.39692371465033954,Adipocytokine signaling pathway,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_LIMBIC_SYSTEM_NEURONS,0.21163111265854895,0.4014071344818833,2/2057,0.6744204847339773,0.39641491276886853,DESCARTES_MAIN_FETAL_LIMBIC_SYSTEM_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_EX_1_EXCITATORY_NEURON,0.21163111265854895,0.4014071344818833,2/2057,0.6744204847339773,0.39641491276886853,FAN_EMBRYONIC_CTX_EX_1_EXCITATORY_NEURON,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_BP,postsynapse assembly,0.1580686918871407,0.4014702321121543,15/2058,0.8011541407389734,0.3963466509051158,postsynapse assembly,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,0.1357947452692087,0.40291839156612963,28/2013,0.8671170352450621,0.3947829084036651,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCEL...,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,positive regulation of neuron apoptotic process,0.15930086269533264,0.4039263219541773,12/2058,0.7977818722666147,0.3936978450053608,positive regulation of neuron apoptotic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,DO,drug-induced mental disorder,0.1749734698234214,0.40425969218462443,2/1094,0.7570277957865446,0.39333955902368684,drug-induced mental disorder,OUD vs Control Female,DO
OUD_vs_Control_Female,DO,drug psychosis,0.1749734698234214,0.40425969218462443,2/1094,0.7570277957865446,0.39333955902368684,drug psychosis,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,GO_BP,regulation of neuron apoptotic process,0.08443763452309105,0.4126503667224815,35/1775,1.0734639417305385,0.3844177645968518,regulation of neuron apoptotic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,response to axon injury,0.08508228278131691,0.414423966792441,14/1775,1.0701608663712192,0.38255513660083973,response to axon injury,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_GRANULE_NEURONS,0.31549879019759863,0.4152891423687241,6/2407,0.5010023017495282,0.3816494232628421,DESCARTES_FETAL_CEREBELLUM_GRANULE_NEURONS,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_BP,neuron cell-cell adhesion,0.16659942356958288,0.4172929330251604,4/2058,0.7783265055761847,0.3795589701269321,neuron cell-cell adhesion,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,response to L-glutamate,0.16659942356958288,0.4172929330251604,4/2058,0.7783265055761847,0.3795589701269321,response to L-glutamate,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.14611784270626385,0.4214837949466652,27/2013,0.8352967483659631,0.37521911831215277,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,KEGG,Central carbon metabolism in cancer,0.083977362303989,0.4219134514130051,13/889,1.0758377705031845,0.3747766282533031,Central carbon metabolism in cancer,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter reuptake,0.0870848283548484,0.4227781600989505,7/1775,1.0600574998223198,0.37388745559709463,neurotransmitter reuptake,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of dendrite development,0.16985308755539777,0.424326325978834,17/2058,0.7699265542041129,0.372300022976109,regulation of dendrite development,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_3,0.22968464928247953,0.4279773191641646,4/2057,0.6388680294226894,0.36857924599348774,FAN_EMBRYONIC_CTX_MICROGLIA_3,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,protein localization to postsynapse,0.08946266905408895,0.4309089265833819,10/1775,1.0483581491080156,0.36561450910088783,protein localization to postsynapse,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of response to cytokine stimulus,0.09088765526987909,0.431305369434065,26/1775,1.0414951004111332,0.3652151351740808,regulation of response to cytokine stimulus,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of innate immune response,0.09126256447935528,0.431305369434065,62/1775,1.0397073317107965,0.3652151351740808,regulation of innate immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,response to laminar fluid shear stress,0.0916472152051298,0.431305369434065,4/1775,1.0378807269856698,0.3652151351740808,response to laminar fluid shear stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,response to morphine,0.0916472152051298,0.431305369434065,4/1775,1.0378807269856698,0.3652151351740808,response to morphine,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of axon regeneration,0.0916472152051298,0.431305369434065,4/1775,1.0378807269856698,0.3652151351740808,negative regulation of axon regeneration,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of production of molecular mediator of immune response,0.09283523160046034,0.43141265348739916,8/1775,1.032287174795088,0.3651071210342077,negative regulation of production of molecular ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,axon extension involved in axon guidance,0.09332121437096562,0.43141265348739916,5/1775,1.0300196184511752,0.3651071210342077,axon extension involved in axon guidance,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuron projection extension involved in neuron projection guidance,0.09332121437096562,0.43141265348739916,5/1775,1.0300196184511752,0.3651071210342077,neuron projection extension involved in neuron ...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,central nervous system projection neuron axonogenesis,0.17628260963839473,0.4335630085940112,6/2058,0.7537905289406208,0.3629477787040229,central nervous system projection neuron axonog...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,peripheral nervous system axon ensheathment,0.17628260963839473,0.4335630085940112,6/2058,0.7537905289406208,0.3629477787040229,peripheral nervous system axon ensheathment,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_MF,cytokine receptor binding,0.049126878470110595,0.43399787824931924,32/1824,1.3086808301308954,0.36251239368303095,cytokine receptor binding,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,WikiPathways,WP_CHEMOKINE_SIGNALING,0.10797912331595513,0.4358499069619008,30/1231,0.9666602028935656,0.36066304238437863,WP_CHEMOKINE_SIGNALING,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,0.10898746884045406,0.4358499069619008,8/1231,0.9626234334933033,0.36066304238437863,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TO...,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,C8_CellType,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.23866508333380132,0.4384740015307005,117/2057,0.6222111135640723,0.3580561521873064,BUSSLINGER_DUODENAL_IMMUNE_CELLS,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,forebrain neuron development,0.09903158606406334,0.43923398711423506,7/1775,1.0042262653471314,0.35730406235330486,forebrain neuron development,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of adaptive immune response,0.09996121713700712,0.43923398711423506,11/1775,1.000168464503693,0.35730406235330486,negative regulation of adaptive immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,axonal transport,0.10040226878980137,0.43923398711423506,12/1775,0.9982564733288622,0.35730406235330486,axonal transport,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cortisol metabolic process,0.10483207340090324,0.43923398711423506,3/1775,0.9795058245090277,0.35730406235330486,cortisol metabolic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,G protein-coupled opioid receptor signaling pathway,0.10483207340090324,0.43923398711423506,3/1775,0.9795058245090277,0.35730406235330486,G protein-coupled opioid receptor signaling pat...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of translational initiation in response to stress,0.10483207340090324,0.43923398711423506,3/1775,0.9795058245090277,0.35730406235330486,regulation of translational initiation in respo...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,response to nitrosative stress,0.10483207340090324,0.43923398711423506,3/1775,0.9795058245090277,0.35730406235330486,response to nitrosative stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of synapse assembly,0.10483207340090324,0.43923398711423506,3/1775,0.9795058245090277,0.35730406235330486,negative regulation of synapse assembly,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,motor neuron migration,0.10483207340090324,0.43923398711423506,3/1775,0.9795058245090277,0.35730406235330486,motor neuron migration,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.10483207340090324,0.43923398711423506,3/1775,0.9795058245090277,0.35730406235330486,positive regulation of endoplasmic reticulum st...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of receptor localization to synapse,0.10488220679508939,0.43923398711423506,6/1775,0.9792981833617627,0.35730406235330486,regulation of receptor localization to synapse,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuron maturation,0.10699307982405312,0.43923398711423506,9/1775,0.9706443110196311,0.35730406235330486,neuron maturation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of tumor necrosis factor superfamily cytokine production,0.10923302113413266,0.43923398711423506,11/1775,0.9616460545937761,0.35730406235330486,negative regulation of tumor necrosis factor su...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,axon midline choice point recognition,0.10949055668389654,0.43923398711423506,2/1775,0.9606233361382769,0.35730406235330486,axon midline choice point recognition,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of translational initiation in response to stress,0.10949055668389654,0.43923398711423506,2/1775,0.9606233361382769,0.35730406235330486,negative regulation of translational initiation...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of translation in response to endoplasmic reticulum stress,0.10949055668389654,0.43923398711423506,2/1775,0.9606233361382769,0.35730406235330486,positive regulation of translation in response ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,NMDA glutamate receptor clustering,0.10949055668389654,0.43923398711423506,2/1775,0.9606233361382769,0.35730406235330486,NMDA glutamate receptor clustering,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of glutamate receptor clustering,0.10949055668389654,0.43923398711423506,2/1775,0.9606233361382769,0.35730406235330486,regulation of glutamate receptor clustering,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of hippocampal neuron apoptotic process,0.10949055668389654,0.43923398711423506,2/1775,0.9606233361382769,0.35730406235330486,regulation of hippocampal neuron apoptotic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of AMPA glutamate receptor clustering,0.10949055668389654,0.43923398711423506,2/1775,0.9606233361382769,0.35730406235330486,regulation of AMPA glutamate receptor clustering,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,response to psychosocial stress,0.10949055668389654,0.43923398711423506,2/1775,0.9606233361382769,0.35730406235330486,response to psychosocial stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,motor neuron axon guidance,0.10958455015018645,0.43923398711423506,5/1775,0.9602506708287456,0.35730406235330486,motor neuron axon guidance,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of axonogenesis,0.1805038369803299,0.43948464265909276,13/2058,0.7435135618376963,0.35705629630111413,positive regulation of axonogenesis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,natural killer cell mediated immune response to tumor cell,0.18290223411176632,0.43948464265909276,3/2058,0.7377809896767473,0.35705629630111413,natural killer cell mediated immune response to...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of macrophage cytokine production,0.18290223411176632,0.43948464265909276,3/2058,0.7377809896767473,0.35705629630111413,negative regulation of macrophage cytokine prod...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cerebral cortex GABAergic interneuron differentiation,0.18290223411176632,0.43948464265909276,3/2058,0.7377809896767473,0.35705629630111413,cerebral cortex GABAergic interneuron different...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of astrocyte differentiation,0.18290223411176632,0.43948464265909276,3/2058,0.7377809896767473,0.35705629630111413,positive regulation of astrocyte differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,granzyme-mediated programmed cell death signaling pathway,0.18290223411176632,0.43948464265909276,3/2058,0.7377809896767473,0.35705629630111413,granzyme-mediated programmed cell death signali...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of execution phase of apoptosis,0.18290223411176632,0.43948464265909276,3/2058,0.7377809896767473,0.35705629630111413,negative regulation of execution phase of apopt...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of hydrogen peroxide-mediated programmed cell death,0.18290223411176632,0.43948464265909276,3/2058,0.7377809896767473,0.35705629630111413,regulation of hydrogen peroxide-mediated progra...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,protein localization to presynapse,0.18290223411176632,0.43948464265909276,3/2058,0.7377809896767473,0.35705629630111413,protein localization to presynapse,OUD vs Control Female,GO BP
OUD_vs_Control_Female,KEGG,Inositol phosphate metabolism,0.19183942814254853,0.439779592905066,14/1075,0.7170621288391891,0.35676492707697016,Inositol phosphate metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Intestinal immune network for IgA production,0.19340480391573672,0.439779592905066,9/1075,0.7135327428270339,0.35676492707697016,Intestinal immune network for IgA production,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of immune response to tumor cell,0.11126971523227344,0.44046757563690586,4/1775,0.9536230234212207,0.35608605601529486,positive regulation of immune response to tumor...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of glutamate secretion,0.11126971523227344,0.44046757563690586,4/1775,0.9536230234212207,0.35608605601529486,regulation of glutamate secretion,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,DO,substance-related disorder,0.1978421604667008,0.4407707996792144,61/1094,0.7036811540585899,0.35578718447896407,substance-related disorder,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,GO_CC,neurotransmitter receptor complex,0.07533834589034927,0.44163857935721984,9/1867,1.1229839192877804,0.35493299580846255,neurotransmitter receptor complex,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,GO_MF,neurotransmitter transmembrane transporter activity,0.08715456370771045,0.44580849978418446,5/2121,1.0597098668307197,0.35085165551890746,neurotransmitter transmembrane transporter acti...,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_BP,regulation of axon diameter,0.19348601308082716,0.44891348207025905,2/2058,0.7133504242438713,0.3478373513798268,regulation of axon diameter,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,chemokine (C-X-C motif) ligand 12 signaling pathway,0.19348601308082716,0.44891348207025905,2/2058,0.7133504242438713,0.3478373513798268,chemokine (C-X-C motif) ligand 12 signaling pat...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,radial glia-guided pyramidal neuron migration,0.19348601308082716,0.44891348207025905,2/2058,0.7133504242438713,0.3478373513798268,radial glia-guided pyramidal neuron migration,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of protein localization to synapse,0.19348601308082716,0.44891348207025905,2/2058,0.7133504242438713,0.3478373513798268,positive regulation of protein localization to ...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,0.16630608265132288,0.44905007094922234,27/2013,0.7790918661527307,0.34770523065692854,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,central nervous system neuron axonogenesis,0.19542746750657114,0.4497469007440456,7/2058,0.7090143958466146,0.34703182074371547,central nervous system neuron axonogenesis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of neurotransmitter secretion,0.19567562413886927,0.4497469007440456,4/2058,0.7084632722537821,0.34703182074371547,positive regulation of neurotransmitter secretion,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,GABAergic neuron differentiation,0.19567562413886927,0.4497469007440456,4/2058,0.7084632722537821,0.34703182074371547,GABAergic neuron differentiation,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.16928430575808745,0.4534101911233656,25/2013,0.77138330319408,0.34350872263274457,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_...,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,muscle hypertrophy in response to stress,0.19900654092834358,0.45397808393267236,5/2058,0.7011326490053593,0.34296511246634537,muscle hypertrophy in response to stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cardiac muscle hypertrophy in response to stress,0.19900654092834358,0.45397808393267236,5/2058,0.7011326490053593,0.34296511246634537,cardiac muscle hypertrophy in response to stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,response to immobilization stress,0.19900654092834358,0.45397808393267236,5/2058,0.7011326490053593,0.34296511246634537,response to immobilization stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of neurotransmitter transport,0.19900654092834358,0.45397808393267236,5/2058,0.7011326490053593,0.34296511246634537,positive regulation of neurotransmitter transport,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,0.23451858882268176,0.45430400188632425,28/2332,0.6298227277755151,0.3426534375426424,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_...,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.2360227894877876,0.4554071407463371,29/2332,0.6270460611360354,0.3416001639658967,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,negative regulation of neuron differentiation,0.20047147181057404,0.4569093958052491,12/2058,0.6979474211323828,0.3401699110963707,negative regulation of neuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,KEGG,Platinum drug resistance,0.2053891296936504,0.457594867812263,13/1075,0.687422545349209,0.3395188550483218,Platinum drug resistance,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,0.1733622877096946,0.4592827981085547,27/2013,0.7610453706479691,0.3379198202612276,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,cellular response to osmotic stress,0.11897872680820037,0.4603506606678032,10/1775,0.9245306827730597,0.3369112292385189,cellular response to osmotic stress,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,0.12192654471738686,0.46109277063174214,3/1231,0.9139017335179213,0.33621168693122144,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.11962468447805352,0.4614959229043266,42/1775,0.9221791947082745,0.335832131405078,adaptive immune response based on somatic recom...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of axon regeneration,0.11972269994477527,0.4614959229043266,6/1775,0.9218234976629894,0.335832131405078,regulation of axon regeneration,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,Reactome,Activation of kainate receptors upon glutamate binding,0.058089968448222604,0.46222686384141587,8/1379,1.2358988594123328,0.33514481766466536,Activation of kainate receptors upon glutamate ...,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,GO_CC,neuron projection cytoplasm,0.08186075645164169,0.46281327517860094,15/1867,1.0869242464821502,0.3345941923863935,neuron projection cytoplasm,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,WikiPathways,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.12410206147045981,0.4646031949522239,9/1231,0.9062210043368106,0.33291780799822446,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,GO_CC,immunological synapse,0.11075822689404692,0.46777078566419816,10/2168,0.9556240054029439,0.32996690527381284,immunological synapse,OUD vs Control Female,GO CC
OUD_vs_Control_Female,Reactome,Acetylcholine Neurotransmitter Release Cycle,0.0611674856775852,0.4686992996029568,5/1379,1.2134793710436869,0.32910569546378443,Acetylcholine Neurotransmitter Release Cycle,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Linoleic acid (LA) metabolism,0.061551755661332024,0.4686992996029568,3/1379,1.2107595550291013,0.32910569546378443,Linoleic acid (LA) metabolism,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,DO,heroin dependence,0.1145602278027825,0.46902176346503016,8/920,0.9409661314416575,0.3288070047615116,heroin dependence,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,DO,drug dependence,0.11911873452166762,0.46902176346503016,13/920,0.9240199290333824,0.3288070047615116,drug dependence,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,DO,glycogen metabolism disorder,0.12975431863197825,0.46902176346503016,5/920,0.8868781785521447,0.3288070047615116,glycogen metabolism disorder,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,DO,morphine dependence,0.12975431863197825,0.46902176346503016,5/920,0.8868781785521447,0.3288070047615116,morphine dependence,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,DO,drug-induced mental disorder,0.13046590976259725,0.46902176346503016,2/920,0.8845029529700936,0.3288070047615116,drug-induced mental disorder,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,DO,drug psychosis,0.13046590976259725,0.46902176346503016,2/920,0.8845029529700936,0.3288070047615116,drug psychosis,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,DO,autosomal dominant distal hereditary motor neuronopathy,0.13241217112890621,0.46902176346503016,3/920,0.878072093361718,0.3288070047615116,autosomal dominant distal hereditary motor neur...,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,DO,plasma protein metabolism disease,0.13241217112890621,0.46902176346503016,3/920,0.878072093361718,0.3288070047615116,plasma protein metabolism disease,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of innate immune response,0.12229175981698824,0.4696897615947512,15/1775,0.9126028053232962,0.3281889065643888,negative regulation of innate immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuron projection organization,0.12229175981698824,0.4696897615947512,15/1775,0.9126028053232962,0.3281889065643888,neuron projection organization,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,0.12831881289728322,0.4709237222092414,12/1231,0.8917096667854735,0.3270494319503935,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTC...,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,DO,autoimmune disease of endocrine system,0.13392456257237578,0.4730500655567671,10/920,0.8731397634558585,0.3250928929949701,autoimmune disease of endocrine system,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,GO_MF,chemokine receptor binding,0.06093492122301818,0.4748324993416323,8/1824,1.2151337459901863,0.3234595639345742,chemokine receptor binding,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,GO_BP,cellular response to oxidative stress,0.2102249275345384,0.4760057292005288,36/2058,0.6773157885512153,0.3223878200837052,cellular response to oxidative stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.2561482868140914,0.4790612105022086,30/2332,0.5915085444516053,0.3196089924623296,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_N...,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,immune response-activating signaling pathway,0.12592971303475498,0.4804396514532071,66/1775,0.8998717862976555,0.3183611567714341,immune response-activating signaling pathway,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,muscle hypertrophy in response to stress,0.12711564401467587,0.4804396514532071,5/1775,0.8958009979026499,0.3183611567714341,muscle hypertrophy in response to stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of dopamine secretion,0.12711564401467587,0.4804396514532071,5/1775,0.8958009979026499,0.3183611567714341,regulation of dopamine secretion,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cardiac muscle hypertrophy in response to stress,0.12711564401467587,0.4804396514532071,5/1775,0.8958009979026499,0.3183611567714341,cardiac muscle hypertrophy in response to stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,anterograde axonal transport,0.12976178362624674,0.48245769839246694,9/1775,0.8868531935451187,0.31654075933593684,anterograde axonal transport,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of cytokine-mediated signaling pathway,0.13063275555584675,0.48245769839246694,24/1775,0.8839479120845997,0.31654075933593684,regulation of cytokine-mediated signaling pathway,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of macrophage cytokine production,0.1319939268221677,0.48245769839246694,3/1775,0.8794460506751911,0.31654075933593684,negative regulation of macrophage cytokine prod...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,"CD4-positive, alpha-beta T cell cytokine production",0.13256927375270913,0.48245769839246694,4/1775,0.8775571228841818,0.31654075933593684,"CD4-positive, alpha-beta T cell cytokine produc...",OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,DO,autoimmune thyroiditis,0.22948905369035075,0.48259082223828426,4/1094,0.6392380248772812,0.31642094162567885,autoimmune thyroiditis,OUD vs Control Female,DO
OUD_vs_Control_Female,DO,newborn respiratory distress syndrome,0.23797990165338292,0.48259082223828426,3/1094,0.623459719286359,0.31642094162567885,newborn respiratory distress syndrome,OUD vs Control Female,DO
OUD_vs_Control_Female,GO_MF,glutamate receptor binding,0.09806619825635904,0.48429091823720083,10/2121,1.0084806607179986,0.31489367507167504,glutamate receptor binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,KEGG,Thiamine metabolism,0.22517440901207658,0.48716979056700843,3/1075,0.6474809684226899,0.3123196501716113,Thiamine metabolism,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of cytokine production involved in immune response,0.1355384577994624,0.4893889823834295,6/1775,0.8679374602113681,0.31034581214798324,negative regulation of cytokine production invo...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of type 2 immune response,0.1355384577994624,0.4893889823834295,6/1775,0.8679374602113681,0.31034581214798324,regulation of type 2 immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,response to arsenic-containing substance,0.1355384577994624,0.4893889823834295,6/1775,0.8679374602113681,0.31034581214798324,response to arsenic-containing substance,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,stress response to copper ion,0.2204784628553016,0.4916230830119532,3/2058,0.6566338276016931,0.30836773402527595,stress response to copper ion,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,immune response to tumor cell,0.22112758802957425,0.49177484321788817,6/2058,0.6553570711635738,0.30823369139863355,immune response to tumor cell,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,programmed cell death involved in cell development,0.22503319058369137,0.4949906558103522,5/2058,0.6477534222251459,0.3054029993862401,programmed cell death involved in cell development,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neutrophil activation involved in immune response,0.22614775925167727,0.4949906558103522,4/2058,0.6456077110330438,0.3054029993862401,neutrophil activation involved in immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,axonal transport of mitochondrion,0.22614775925167727,0.4949906558103522,4/2058,0.6456077110330438,0.3054029993862401,axonal transport of mitochondrion,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of axonogenesis,0.13800595998613455,0.4973218205281821,12/1775,0.8601021575610969,0.30336248521361847,positive regulation of axonogenesis,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_DISORDERS_OF_GALACTOSE_METABOLISM,0.14044660206119067,0.49825104064565257,4/1231,0.8524887635747282,0.3025517855603547,WP_DISORDERS_OF_GALACTOSE_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,0.14044660206119067,0.49825104064565257,4/1231,0.8524887635747282,0.3025517855603547,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,Reactome,Response of endothelial cells to shear stress,0.023190003551941004,0.4992622434545414,18/1194,1.6346991848424672,0.30167127608260114,Response of endothelial cells to shear stress,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Bile acid and bile salt metabolism,0.025294745018457503,0.4992622434545414,10/1194,1.5969696941022227,0.30167127608260114,Bile acid and bile salt metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Glycosaminoglycan metabolism,0.02549175611101937,0.4992622434545414,23/1194,1.5936002452268951,0.30167127608260114,Glycosaminoglycan metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,RUNX3 Regulates Immune Response and Cell Migration,0.026614361525787316,0.4992622434545414,3/1194,1.5748839480203791,0.30167127608260114,RUNX3 Regulates Immune Response and Cell Migration,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Protein-protein interactions at synapses,0.027005772237317833,0.4992622434545414,17/1194,1.568543399437752,0.30167127608260114,Protein-protein interactions at synapses,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,GO_BP,regulation of T-helper 17 type immune response,0.13986149376460455,0.501222994623228,7/1775,0.8543018376697775,0.2999690130791171,regulation of T-helper 17 type immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of stress fiber assembly,0.1420303671135503,0.5048977042630075,9/1775,0.8476187904065754,0.29679660400876096,positive regulation of stress fiber assembly,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.20967205226042424,0.5078489607602589,26/2013,0.6784594539312533,0.294265431932175,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H...,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,programmed cell death involved in cell development,0.1458323140548749,0.5088589988772713,5/1775,0.8361462328028642,0.29340254083177936,programmed cell death involved in cell development,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of T-helper 1 type immune response,0.1517257304012351,0.5088589988772713,2/1775,0.8189407631572352,0.29340254083177936,negative regulation of T-helper 1 type immune r...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of dopamine secretion,0.1517257304012351,0.5088589988772713,2/1775,0.8189407631572352,0.29340254083177936,positive regulation of dopamine secretion,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,chemokine (C-X-C motif) ligand 12 signaling pathway,0.1517257304012351,0.5088589988772713,2/1775,0.8189407631572352,0.29340254083177936,chemokine (C-X-C motif) ligand 12 signaling pat...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,glutamate reuptake,0.1517257304012351,0.5088589988772713,2/1775,0.8189407631572352,0.29340254083177936,glutamate reuptake,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,chemorepulsion of axon,0.1517257304012351,0.5088589988772713,2/1775,0.8189407631572352,0.29340254083177936,chemorepulsion of axon,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cellular response to nitrosative stress,0.1517257304012351,0.5088589988772713,2/1775,0.8189407631572352,0.29340254083177936,cellular response to nitrosative stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of translation at postsynapse,0.1517257304012351,0.5088589988772713,2/1775,0.8189407631572352,0.29340254083177936,regulation of translation at postsynapse,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of cardiac muscle hypertrophy in response to stress,0.1517257304012351,0.5088589988772713,2/1775,0.8189407631572352,0.29340254083177936,negative regulation of cardiac muscle hypertrop...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,KEGG,Porphyrin metabolism,0.24159028756556075,0.509859257193576,6/1075,0.6169205292457279,0.2925496910781556,Porphyrin metabolism,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_CHODL_POS_NEURON_CELL,0.2938627994407989,0.510360445737948,8/2057,0.5318553884770585,0.2921229919346316,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_CHODL_POS_N...,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_BP,regulation of cytokine production involved in immune response,0.15439255971195778,0.5110980838405974,18/1775,0.8113736324581713,0.2914957472564926,regulation of cytokine production involved in i...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,0.15537937667812043,0.5110980838405974,4/1775,0.8086066251056558,0.2914957472564926,regulation of neurotransmitter receptor localiz...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of postsynapse organization,0.2346218113986157,0.5117738652414822,23/2058,0.6296316165608842,0.2909218960010317,regulation of postsynapse organization,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_MF,adenylate cyclase inhibiting G protein-coupled glutamate receptor activity,0.11261119119024494,0.5136543162192644,3/2121,0.9484184475783071,0.28932905817315524,adenylate cyclase inhibiting G protein-coupled ...,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,G protein-coupled glutamate receptor activity,0.11261119119024494,0.5136543162192644,3/2121,0.9484184475783071,0.28932905817315524,G protein-coupled glutamate receptor activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.2841557875007136,0.5158276956770348,28/2332,0.5464434941009426,0.2874953435536477,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,mitochondrial outer membrane permeabilization involved in programmed cell death,0.237206226428998,0.5162285219170507,7/2058,0.6248739153572461,0.2871580041141371,mitochondrial outer membrane permeabilization i...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,programmed necrotic cell death,0.24017540764791043,0.5198932688260838,9/2058,0.6194714635009212,0.284085805437382,programmed necrotic cell death,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,"complement activation, classical pathway",0.24483818842217955,0.5198932688260838,6/2058,0.611120842541424,0.284085805437382,"complement activation, classical pathway",OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,branchiomotor neuron axon guidance,0.2474219639614748,0.5198932688260838,2/2058,0.6065617501237541,0.284085805437382,branchiomotor neuron axon guidance,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neuronal signal transduction,0.2474219639614748,0.5198932688260838,2/2058,0.6065617501237541,0.284085805437382,neuronal signal transduction,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of dendrite morphogenesis,0.2474219639614748,0.5198932688260838,2/2058,0.6065617501237541,0.284085805437382,negative regulation of dendrite morphogenesis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,"negative regulation of synaptic transmission, glutamatergic",0.2474219639614748,0.5198932688260838,2/2058,0.6065617501237541,0.284085805437382,"negative regulation of synaptic transmission, g...",OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of oxidative phosphorylation,0.2474219639614748,0.5198932688260838,2/2058,0.6065617501237541,0.284085805437382,negative regulation of oxidative phosphorylation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of hydrogen peroxide-mediated programmed cell death,0.2474219639614748,0.5198932688260838,2/2058,0.6065617501237541,0.284085805437382,negative regulation of hydrogen peroxide-mediat...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.2474219639614748,0.5198932688260838,2/2058,0.6065617501237541,0.284085805437382,regulation of intrinsic apoptotic signaling pat...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of cortisol biosynthetic process,0.2474219639614748,0.5198932688260838,2/2058,0.6065617501237541,0.284085805437382,regulation of cortisol biosynthetic process,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,peripheral nervous system neuron development,0.16127154651463996,0.520470480305036,3/1775,0.7924422493607075,0.2836038974775341,peripheral nervous system neuron development,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,interneuron migration,0.16127154651463996,0.520470480305036,3/1775,0.7924422493607075,0.2836038974775341,interneuron migration,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,KEGG,Axon guidance,0.12335818452519408,0.5205113639721604,28/889,0.9088320308016468,0.2835697843925868,Axon guidance,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Cocaine addiction,0.12575293798817677,0.5221556026905719,9/889,0.9004818596545574,0.28220005768771395,Cocaine addiction,OUD Effect Male vs Female,KEGG
OUD_vs_Control_Female,GO_BP,intrinsic apoptotic signaling pathway in response to oxidative stress,0.24878220071226292,0.5226072870450377,10/2058,0.6041806947568144,0.2818245389229196,intrinsic apoptotic signaling pathway in respon...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cytokine production involved in immune response,0.16299730585642233,0.5239707974536653,18/1775,0.7878195738865879,0.28069291694402554,cytokine production involved in immune response,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,DO,autoimmune disease of the nervous system,0.26211732187836634,0.5242346437567327,6/1094,0.5815042779942033,0.2804742823302222,autoimmune disease of the nervous system,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,GO_BP,cellular response to chemical stress,0.1633141625278381,0.5245308582498904,41/1775,0.7869761518157573,0.2802289570920964,cellular response to chemical stress,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,C2_Curated,SA_MMP_CYTOKINE_CONNECTION,0.02764177385508088,0.5251937032465367,6/62,1.5584340904311913,0.2796804894783624,SA_MMP_CYTOKINE_CONNECTION,OUD vs Control Female,C2 Curated
OUD_Effect_Male_vs_Female,GO_BP,vesicle-mediated transport in synapse,0.1636002170633836,0.5252202516373576,35/1775,0.78621612444607,0.2796585365719186,vesicle-mediated transport in synapse,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,0.2519885574781246,0.5255184841148068,5/2058,0.598619179603122,0.2794120038833414,immune response-regulating cell surface recepto...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of macrophage cytokine production,0.2519885574781246,0.5255184841148068,5/2058,0.598619179603122,0.2794120038833414,positive regulation of macrophage cytokine prod...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of postsynaptic neurotransmitter receptor internalization,0.2519885574781246,0.5255184841148068,5/2058,0.598619179603122,0.2794120038833414,regulation of postsynaptic neurotransmitter rec...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of immune response to tumor cell,0.16564080025042366,0.5285414689118725,5/1775,0.7808326799838131,0.27692093264593115,regulation of immune response to tumor cell,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of postsynaptic neurotransmitter receptor internalization,0.16564080025042366,0.5285414689118725,5/1775,0.7808326799838131,0.27692093264593115,regulation of postsynaptic neurotransmitter rec...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,Reactome,Opioid Signalling,0.07093595613962805,0.528713334108499,18/1379,1.1491335730716168,0.27677973658426214,Opioid Signalling,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,GO_MF,glutamate receptor activity,0.07556379818845511,0.5289465873191858,6/1824,1.1216862205380547,0.2765881805237979,glutamate receptor activity,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,GO_BP,behavioral response to pain,0.25770680631097226,0.5294232666179212,4/2058,0.5888741111182368,0.27619697663168735,behavioral response to pain,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,chemokine (C-X-C motif) ligand 2 production,0.25770680631097226,0.5294232666179212,4/2058,0.5888741111182368,0.27619697663168735,chemokine (C-X-C motif) ligand 2 production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of chemokine (C-X-C motif) ligand 2 production,0.25770680631097226,0.5294232666179212,4/2058,0.5888741111182368,0.27619697663168735,regulation of chemokine (C-X-C motif) ligand 2 ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,Reactome,Inositol phosphate metabolism,0.0716965640295927,0.5321276629875678,11/1379,1.1445016568669808,0.27398416341962334,Inositol phosphate metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_ASTROCYTES,0.42526401281260584,0.5341730892646147,6/2407,0.3713413671053398,0.2723179947838843,DESCARTES_MAIN_FETAL_ASTROCYTES,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_CC,axonal growth cone,0.10276808424005082,0.53632647046997,6/1867,0.9881417393341952,0.2705707678414372,axonal growth cone,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,Reactome,"Unblocking of NMDA receptors, glutamate binding and activation",0.07564833346183598,0.5365541070942318,6/1379,1.1212006350737196,0.2703864764424747,"Unblocking of NMDA receptors, glutamate binding...",OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,0.23445559306335859,0.5372848774245922,26/2013,0.6299394024747997,0.2697953830372588,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE...,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,regulation of neurotransmitter receptor activity,0.16987900881807327,0.5376334379763034,6/1775,0.7698602816235358,0.26951372827828,regulation of neurotransmitter receptor activity,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,Reactome,MECP2 regulates neuronal receptors and channels,0.0770601163156024,0.5378102952223326,5/1379,1.1131703397924422,0.26937088839859785,MECP2 regulates neuronal receptors and channels,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of response to endoplasmic reticulum stress,0.17092867866379843,0.538176554611403,7/1775,0.7671850646021435,0.26907522597895656,positive regulation of response to endoplasmic ...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_CC,kainate selective glutamate receptor complex,0.14044592451091756,0.5384839133321816,2/2168,0.8524908587272652,0.2688272662850708,kainate selective glutamate receptor complex,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,neuronal dense core vesicle lumen,0.14044592451091756,0.5384839133321816,2/2168,0.8524908587272652,0.2688272662850708,neuronal dense core vesicle lumen,OUD vs Control Female,GO CC
OUD_Effect_Male_vs_Female,WikiPathways,WP_RETINOL_METABOLISM,0.120149217048326,0.5387725246515394,4/1002,0.9202790549283252,0.2685945597502267,WP_RETINOL_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,0.12727543926142368,0.5387725246515394,5/1002,0.8952553954221644,0.2685945597502267,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,0.1291045368153696,0.5387725246515394,2/1002,0.8890584960816743,0.2685945597502267,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_VITAMIN_D_METABOLISM,0.13058989670361815,0.5387725246515394,3/1002,0.8840904216489855,0.2685945597502267,WP_VITAMIN_D_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_CC,axon cytoplasm,0.10611027073414876,0.5390117522223027,11/1867,0.9742425773872062,0.26840176566733437,axon cytoplasm,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,neuronal dense core vesicle lumen,0.10843648191766325,0.5390117522223027,2/1867,0.9648245809894732,0.26840176566733437,neuronal dense core vesicle lumen,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_MF,immune receptor activity,0.10664689094895859,0.5395817508496489,21/1824,0.9720518009120932,0.26794274698997644,immune receptor activity,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,high-affinity L-glutamate transmembrane transporter activity,0.10775607672009414,0.5395817508496489,2/1824,0.967558229180315,0.26794274698997644,high-affinity L-glutamate transmembrane transpo...,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,glutamate:sodium symporter activity,0.10775607672009414,0.5395817508496489,2/1824,0.967558229180315,0.26794274698997644,glutamate:sodium symporter activity,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,DO,newborn respiratory distress syndrome,0.16520906590033146,0.5397114821251762,3/920,0.7819661243131186,0.2678383424117919,newborn respiratory distress syndrome,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,GO_BP,T cell activation involved in immune response,0.17185223922097828,0.5405619850008041,18/1775,0.764844804667408,0.26715449930486435,T cell activation involved in immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_GRANULE_NEURONS,0.3178194903000685,0.5416173813863667,3/2057,0.49781947317577213,0.26630740688003635,DESCARTES_MAIN_FETAL_GRANULE_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON,0.3178194903000685,0.5416173813863667,3/2057,0.49781947317577213,0.26630740688003635,FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,0.31863661802708526,0.5418809845034422,24/2057,0.49670431612662663,0.26609608882913544,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_...,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_BP,neuron fate commitment,0.26659117621742207,0.5426440273939769,10/2058,0.5741542292038596,0.2654849726854603,neuron fate commitment,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter secretion,0.1732354787569466,0.5431146403483982,21/1775,0.761363159371498,0.26510849008745957,neurotransmitter secretion,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,signal release from synapse,0.1732354787569466,0.5431146403483982,21/1775,0.761363159371498,0.26510849008745957,signal release from synapse,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_MF,C-C chemokine binding,0.1258089420876075,0.5439389194233485,5/2121,0.9002884895641349,0.2644498658289016,C-C chemokine binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,G protein-coupled opioid receptor activity,0.13991683703118482,0.5439389194233485,2/2121,0.854130021106776,0.2644498658289016,G protein-coupled opioid receptor activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,high-affinity L-glutamate transmembrane transporter activity,0.13991683703118482,0.5439389194233485,2/2121,0.854130021106776,0.2644498658289016,high-affinity L-glutamate transmembrane transpo...,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,kainate selective glutamate receptor activity,0.13991683703118482,0.5439389194233485,2/2121,0.854130021106776,0.2644498658289016,kainate selective glutamate receptor activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,glutamate:sodium symporter activity,0.13991683703118482,0.5439389194233485,2/2121,0.854130021106776,0.2644498658289016,glutamate:sodium symporter activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,CXCR chemokine receptor binding,0.14524533869906617,0.5439389194233485,3/2121,0.8378977963542064,0.2644498658289016,CXCR chemokine receptor binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,Reactome,Triglyceride metabolism,0.07968466153521399,0.5475207798454742,8/1379,1.0986252677093113,0.2615993935636997,Triglyceride metabolism,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,KEGG,Cholesterol metabolism,0.13862160899321174,0.5504199149031768,9/889,0.8581690645654083,0.2593058611531944,Cholesterol metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Fatty acid metabolism,0.14281174912500924,0.5552007325534067,10/889,0.8452360616756829,0.255549969527819,Fatty acid metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,behavioral response to pain,0.17951954934275183,0.5578226807840894,4/1775,0.7458882506545574,0.2535038315200913,behavioral response to pain,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_MF,ionotropic glutamate receptor binding,0.1521204117642947,0.5609021350075536,6/2121,0.8178125076969592,0.2511129068968219,ionotropic glutamate receptor binding,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of response to endoplasmic reticulum stress,0.18524381957447422,0.561995014157204,8/1775,0.7322562727925067,0.2502675373377342,negative regulation of response to endoplasmic ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,response to toxic substance,0.1857006970309581,0.561995014157204,32/1775,0.7311864661248901,0.2502675373377342,response to toxic substance,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter receptor transport,0.18643822589946413,0.561995014157204,5/1775,0.7294650383598066,0.2502675373377342,neurotransmitter receptor transport,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,G protein-coupled dopamine receptor signaling pathway,0.18827771558767875,0.561995014157204,6/1775,0.7252010797179147,0.2502675373377342,G protein-coupled dopamine receptor signaling p...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,dopaminergic neuron differentiation,0.18827771558767875,0.561995014157204,6/1775,0.7252010797179147,0.2502675373377342,dopaminergic neuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,postsynaptic neurotransmitter receptor internalization,0.18827771558767875,0.561995014157204,6/1775,0.7252010797179147,0.2502675373377342,postsynaptic neurotransmitter receptor internal...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of response to oxidative stress,0.18827771558767875,0.561995014157204,6/1775,0.7252010797179147,0.2502675373377342,regulation of response to oxidative stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,adaptive immune response,0.18846521131346364,0.561995014157204,58/1775,0.7247688042324458,0.2502675373377342,adaptive immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,microglia differentiation,0.19225567778212296,0.561995014157204,3/1775,0.7161208255549626,0.2502675373377342,microglia differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,peripheral nervous system neuron differentiation,0.19225567778212296,0.561995014157204,3/1775,0.7161208255549626,0.2502675373377342,peripheral nervous system neuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,axon choice point recognition,0.19642169173653276,0.561995014157204,2/1775,0.7068105527950972,0.2502675373377342,axon choice point recognition,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,branchiomotor neuron axon guidance,0.19642169173653276,0.561995014157204,2/1775,0.7068105527950972,0.2502675373377342,branchiomotor neuron axon guidance,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,T-helper 1 cell cytokine production,0.19642169173653276,0.561995014157204,2/1775,0.7068105527950972,0.2502675373377342,T-helper 1 cell cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,"negative regulation of complement activation, classical pathway",0.19642169173653276,0.561995014157204,2/1775,0.7068105527950972,0.2502675373377342,"negative regulation of complement activation, c...",OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuron fate determination,0.19642169173653276,0.561995014157204,2/1775,0.7068105527950972,0.2502675373377342,neuron fate determination,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,"negative regulation of synaptic transmission, glutamatergic",0.19642169173653276,0.561995014157204,2/1775,0.7068105527950972,0.2502675373377342,"negative regulation of synaptic transmission, g...",OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,spontaneous neurotransmitter secretion,0.19642169173653276,0.561995014157204,2/1775,0.7068105527950972,0.2502675373377342,spontaneous neurotransmitter secretion,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,hippocampal neuron apoptotic process,0.19642169173653276,0.561995014157204,2/1775,0.7068105527950972,0.2502675373377342,hippocampal neuron apoptotic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of glutamate receptor signaling pathway,0.19642169173653276,0.561995014157204,2/1775,0.7068105527950972,0.2502675373377342,regulation of glutamate receptor signaling pathway,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of complement-dependent cytotoxicity,0.19642169173653276,0.561995014157204,2/1775,0.7068105527950972,0.2502675373377342,regulation of complement-dependent cytotoxicity,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of microglial cell activation,0.19642169173653276,0.561995014157204,2/1775,0.7068105527950972,0.2502675373377342,positive regulation of microglial cell activation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of T-helper 1 cell cytokine production,0.19642169173653276,0.561995014157204,2/1775,0.7068105527950972,0.2502675373377342,regulation of T-helper 1 cell cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of T-helper 1 cell cytokine production,0.19642169173653276,0.561995014157204,2/1775,0.7068105527950972,0.2502675373377342,positive regulation of T-helper 1 cell cytokine...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,0.4564442165154501,0.5630389736657647,3/2407,0.340612291382381,0.24946154216081096,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,GO_BP,neurotransmitter receptor transport,0.2796839229624998,0.5635853019061801,5/2058,0.5533324974087568,0.24904034165259747,neurotransmitter receptor transport,OUD vs Control Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_APOPTOSIS_MODULATION_BY_HSP70,0.17489150160213524,0.5640440203185747,5/1231,0.7572312934199446,0.248687000563796,WP_APOPTOSIS_MODULATION_BY_HSP70,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_MF,CCR chemokine receptor binding,0.12348393616528242,0.5646084632917668,5/1824,0.9083895354288758,0.24825261621147773,CCR chemokine receptor binding,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,0.25565585982556693,0.5646216450907353,20/2013,0.5923442484655372,0.24824247694489013,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCEL...,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,WikiPathways,WP_OPIOID_RECEPTOR_PATHWAYS,0.17761843936023633,0.5654946039460516,9/1231,0.7505119501750575,0.24757153483690744,WP_OPIOID_RECEPTOR_PATHWAYS,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,Reactome,SARS-CoV-1 activates/modulates innate immune responses,0.03403169093729768,0.5658866240148946,9/1194,1.4681164715185577,0.2472705714563956,SARS-CoV-1 activates/modulates innate immune re...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Sema3A PAK dependent Axon repulsion,0.03575756758943352,0.5658866240148946,5/1194,1.446632031778138,0.2472705714563956,Sema3A PAK dependent Axon repulsion,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Cytokine Signaling in Immune system,0.03852357695215474,0.5658866240148946,101/1194,1.4142733950038662,0.2472705714563956,Cytokine Signaling in Immune system,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Diseases associated with glycosaminoglycan metabolism,0.0396666197491992,0.5658866240148946,9/1194,1.4015748070080378,0.2472705714563956,Diseases associated with glycosaminoglycan meta...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Heparan sulfate/heparin (HS-GAG) metabolism,0.04219824848157609,0.5658866240148946,12/1194,1.3747055748812849,0.2472705714563956,Heparan sulfate/heparin (HS-GAG) metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,MECP2 regulates neuronal receptors and channels,0.04576404583660785,0.5658866240148946,5/1194,1.3394755880864837,0.2472705714563956,MECP2 regulates neuronal receptors and channels,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,0.04748244086561759,0.5658866240148946,4/1194,1.3234669639545582,0.2472705714563956,alpha-linolenic (omega3) and linoleic (omega6) ...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,alpha-linolenic acid (ALA) metabolism,0.04748244086561759,0.5658866240148946,4/1194,1.3234669639545582,0.2472705714563956,alpha-linolenic acid (ALA) metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,GO_BP,innate immune response,0.19929261533552176,0.5685792031779529,110/1775,0.7005087935145239,0.24520902946835915,innate immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_MF,type 5 metabotropic glutamate receptor binding,0.149429682313827,0.5709126049276053,2/1824,0.8255631268531711,0.24343036829114237,type 5 metabotropic glutamate receptor binding,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,neurotransmitter transmembrane transporter activity,0.1516722585785267,0.5709126049276053,4/1824,0.8190938460293933,0.24343036829114237,neurotransmitter transmembrane transporter acti...,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_BP,complement activation,0.20089396752455843,0.5711538968469762,8/1775,0.6970331041185056,0.24324685577150015,complement activation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuron recognition,0.20089396752455843,0.5711538968469762,8/1775,0.6970331041185056,0.24324685577150015,neuron recognition,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_PURKINJE_NEURONS,0.34147409277263013,0.5723889505901874,9/2057,0.46664224013088534,0.24230875846227298,DESCARTES_FETAL_CEREBELLUM_PURKINJE_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.4670512379476667,0.5744033135356379,4/2407,0.3306354724589598,0.24078306346267037,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,WikiPathways,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,0.18284647508769042,0.5750623618152777,2/1231,0.7379134075694206,0.24028505631264147,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,dopamine transport,0.2046819368277775,0.575587067973421,7/1775,0.6889204821160021,0.23988897215529856,dopamine transport,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of neurotransmitter uptake,0.2048010002564844,0.575587067973421,4/1775,0.6886679265789665,0.23988897215529856,regulation of neurotransmitter uptake,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,DO,alcohol dependence,0.20474513460316685,0.576302711461146,10/920,0.6887864096657256,0.23934933709078796,alcohol dependence,OUD Effect Male vs Female,DO
OUD_vs_Control_Female,GO_BP,regulation of translation in response to stress,0.2900507263235351,0.5786159092471338,4/2058,0.5375260426669636,0.2376096294449426,regulation of translation in response to stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,immunological synapse formation,0.29908692679242666,0.5786159092471338,3/2058,0.5242025697369654,0.2376096294449426,immunological synapse formation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,hydrogen peroxide-mediated programmed cell death,0.29908692679242666,0.5786159092471338,3/2058,0.5242025697369654,0.2376096294449426,hydrogen peroxide-mediated programmed cell death,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of response to endoplasmic reticulum stress,0.301134192424722,0.5786159092471338,14/2058,0.5212399295144863,0.2376096294449426,regulation of response to endoplasmic reticulum...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,noradrenergic neuron differentiation,0.30172802829586653,0.5786159092471338,2/2058,0.5203843452149837,0.2376096294449426,noradrenergic neuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of neuron maturation,0.30172802829586653,0.5786159092471338,2/2058,0.5203843452149837,0.2376096294449426,regulation of neuron maturation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,interneuron migration from the subpallium to the cortex,0.30172802829586653,0.5786159092471338,2/2058,0.5203843452149837,0.2376096294449426,interneuron migration from the subpallium to th...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,substrate-independent telencephalic tangential interneuron migration,0.30172802829586653,0.5786159092471338,2/2058,0.5203843452149837,0.2376096294449426,substrate-independent telencephalic tangential ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of translation in response to stress,0.30172802829586653,0.5786159092471338,2/2058,0.5203843452149837,0.2376096294449426,positive regulation of translation in response ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,meiotic cytokinesis,0.30172802829586653,0.5786159092471338,2/2058,0.5203843452149837,0.2376096294449426,meiotic cytokinesis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cortisol biosynthetic process,0.30172802829586653,0.5786159092471338,2/2058,0.5203843452149837,0.2376096294449426,cortisol biosynthetic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of dopamine uptake involved in synaptic transmission,0.30172802829586653,0.5786159092471338,2/2058,0.5203843452149837,0.2376096294449426,regulation of dopamine uptake involved in synap...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,ventral spinal cord interneuron fate commitment,0.30172802829586653,0.5786159092471338,2/2058,0.5203843452149837,0.2376096294449426,ventral spinal cord interneuron fate commitment,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of synapse maturation,0.30172802829586653,0.5786159092471338,2/2058,0.5203843452149837,0.2376096294449426,positive regulation of synapse maturation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neurotransmitter loading into synaptic vesicle,0.30172802829586653,0.5786159092471338,2/2058,0.5203843452149837,0.2376096294449426,neurotransmitter loading into synaptic vesicle,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of microglial cell activation,0.30172802829586653,0.5786159092471338,2/2058,0.5203843452149837,0.2376096294449426,negative regulation of microglial cell activation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of synapse pruning,0.30172802829586653,0.5786159092471338,2/2058,0.5203843452149837,0.2376096294449426,regulation of synapse pruning,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of dendrite development,0.30172802829586653,0.5786159092471338,2/2058,0.5203843452149837,0.2376096294449426,negative regulation of dendrite development,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,L-glutamate transmembrane transport,0.20740188619988217,0.5797950866591157,6/1775,0.6831872982725532,0.23672546929470725,L-glutamate transmembrane transport,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of T-helper 1 type immune response,0.20811496490394274,0.5800248453461534,5/1775,0.6816966898915391,0.2365534030480399,regulation of T-helper 1 type immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,dopamine secretion,0.20811496490394274,0.5800248453461534,5/1775,0.6816966898915391,0.2365534030480399,dopamine secretion,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,Reactome,Glycogen metabolism,0.08542145320112209,0.5801402941342616,7/1379,1.0684330445708659,0.23646696919465632,Glycogen metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,GO_BP,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.3044342593576415,0.5826320988761697,7/2058,0.5165064760382416,0.2346055925185448,regulation of oxidative stress-induced intrinsi...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_MF,chemokine activity,0.16117425203109378,0.5838772682243514,5/1824,0.7927043365629391,0.23367843257008913,chemokine activity,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,GO_CC,inhibitory synapse,0.1648617025548301,0.588690714702226,4/2168,0.7828802194362089,0.2301128141715039,inhibitory synapse,OUD vs Control Female,GO CC
OUD_Effect_Male_vs_Female,C8_CellType,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,0.3568636616353461,0.5921186109892761,2/2057,0.4474976727075996,0.2275912883135066,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,KEGG,Purine metabolism,0.29477350761601706,0.5922003876186159,21/1075,0.5305115507084457,0.22753131268368199,Purine metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Metabolism of xenobiotics by cytochrome P450,0.29677139269310415,0.5922003876186159,9/1075,0.5275779652336907,0.22753131268368199,Metabolism of xenobiotics by cytochrome P450,OUD vs Control Female,KEGG
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,0.4885064281864827,0.5954575396829316,2/2407,0.3111297170884015,0.22514920133292163,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,DO,nicotine dependence,0.3232121696808214,0.5971903276190071,7/1094,0.49051229540448865,0.2238872349317909,nicotine dependence,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of innate immune response,0.21635965574572974,0.5973739491411666,48/1775,0.6648237182442498,0.22375372045121916,positive regulation of innate immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.21681139753539386,0.5973739491411666,17/1775,0.6639178911529241,0.22375372045121916,positive regulation of adaptive immune response...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,axon regeneration,0.21705327587625237,0.5973739491411666,8/1775,0.6634336551869779,0.22375372045121916,axon regeneration,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,immune system development,0.3150462891263524,0.5982611668680369,28/2058,0.5016256314954172,0.22310918629763068,immune system development,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,0.1561325643013759,0.5983760713073035,10/1002,0.8065065074343543,0.223025781966759,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.28758774891645605,0.5991390448487516,26/2013,0.5412296186066298,0.22247237727189556,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARRO...,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,innate immune response activating cell surface receptor signaling pathway,0.31662884091758814,0.6008375389310585,14/2058,0.4994495288896817,0.22124294144776377,innate immune response activating cell surface ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,Reactome,Serotonin Neurotransmitter Release Cycle,0.09494523365156948,0.602009542754179,5/1379,1.0225268324096322,0.22039662446869587,Serotonin Neurotransmitter Release Cycle,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Norepinephrine Neurotransmitter Release Cycle,0.09494523365156948,0.602009542754179,5/1379,1.0225268324096322,0.22039662446869587,Norepinephrine Neurotransmitter Release Cycle,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Programmed Cell Death,0.0951827616701417,0.602009542754179,33/1379,1.0214416985632795,0.22039662446869587,Programmed Cell Death,OUD vs Control Female,Reactome
OUD_vs_Control_Female,GO_BP,forebrain neuron development,0.3195817226715916,0.6043331632545961,6/2058,0.4954180665603389,0.2187235728485346,forebrain neuron development,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neurotransmitter receptor localization to postsynaptic specialization membrane,0.3195817226715916,0.6043331632545961,6/2058,0.4954180665603389,0.2187235728485346,neurotransmitter receptor localization to posts...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of postsynapse assembly,0.22243944074530456,0.6045225272122596,7/1775,0.6527882054919792,0.21858751074748173,regulation of postsynapse assembly,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of response to endoplasmic reticulum stress,0.22428678996060963,0.6045225272122596,13/1775,0.6491963047325021,0.21858751074748173,regulation of response to endoplasmic reticulum...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of T cell mediated immune response to tumor cell,0.2245486804002574,0.6045225272122596,3/1775,0.6486894928015356,0.21858751074748173,regulation of T cell mediated immune response t...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of immunoglobulin mediated immune response,0.2245486804002574,0.6045225272122596,3/1775,0.6486894928015356,0.21858751074748173,negative regulation of immunoglobulin mediated ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,"complement activation, alternative pathway",0.2245486804002574,0.6045225272122596,3/1775,0.6486894928015356,0.21858751074748173,"complement activation, alternative pathway",OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of response to osmotic stress,0.2245486804002574,0.6045225272122596,3/1775,0.6486894928015356,0.21858751074748173,regulation of response to osmotic stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of synapse organization,0.2245486804002574,0.6045225272122596,3/1775,0.6486894928015356,0.21858751074748173,negative regulation of synapse organization,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,0.19865622008536699,0.6065528031295017,6/1231,0.7018978322876482,0.2171313858780848,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMO...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,GO_BP,regulation of dendrite morphogenesis,0.3221291143006693,0.6066747209983911,10/2058,0.4919700215053253,0.21704410091820822,regulation of dendrite morphogenesis,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,intrinsic apoptotic signaling pathway in response to oxidative stress,0.22665535529901043,0.6069306782694336,9/1775,0.6446340151919565,0.21686090985440443,intrinsic apoptotic signaling pathway in respon...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,0.296844798485547,0.6076199746045816,26/2013,0.5274705566716134,0.21636795778825085,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CEL...,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,detection of stimulus involved in sensory perception of pain,0.23055686884064955,0.6086092273685632,5/1775,0.6372219345803191,0.21566146741513326,detection of stimulus involved in sensory perce...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of protein localization to synapse,0.23055686884064955,0.6086092273685632,5/1775,0.6372219345803191,0.21566146741513326,regulation of protein localization to synapse,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,0.2310315381119005,0.6086092273685632,4/1775,0.6363287305275588,0.21566146741513326,neuron intrinsic apoptotic signaling pathway in...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_MF,complement binding,0.1753754111184664,0.6103096823997426,4/1824,0.7560312978807777,0.21444974002304987,complement binding,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,structural constituent of synapse,0.18155769342219819,0.6103096823997426,5/1824,0.7409853433359663,0.21444974002304987,structural constituent of synapse,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,cytokine activity,0.19242186995688892,0.6103096823997426,24/1824,0.7157455691910227,0.21444974002304987,cytokine activity,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,NMDA glutamate receptor activity,0.19358491136650433,0.6103096823997426,2/1824,0.7131284960236866,0.21444974002304987,NMDA glutamate receptor activity,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,CCR5 chemokine receptor binding,0.19358491136650433,0.6103096823997426,2/1824,0.7131284960236866,0.21444974002304987,CCR5 chemokine receptor binding,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,WikiPathways,WP_GABA_METABOLISM_AKA_GHB,0.163027473749353,0.611462917374639,3/1002,0.7877392011647126,0.2136298759423353,WP_GABA_METABOLISM_AKA_GHB,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,0.163027473749353,0.611462917374639,3/1002,0.7877392011647126,0.2136298759423353,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,immune response-inhibiting cell surface receptor signaling pathway,0.2424075132040807,0.6127424147138987,2/1775,0.6154539237280817,0.21272205627872007,immune response-inhibiting cell surface recepto...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of T cell mediated immune response to tumor cell,0.2424075132040807,0.6127424147138987,2/1775,0.6154539237280817,0.21272205627872007,positive regulation of T cell mediated immune r...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,glutamate catabolic process,0.2424075132040807,0.6127424147138987,2/1775,0.6154539237280817,0.21272205627872007,glutamate catabolic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of neuron maturation,0.2424075132040807,0.6127424147138987,2/1775,0.6154539237280817,0.21272205627872007,regulation of neuron maturation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,"regulation of complement activation, classical pathway",0.2424075132040807,0.6127424147138987,2/1775,0.6154539237280817,0.21272205627872007,"regulation of complement activation, classical ...",OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of translation in response to stress,0.2424075132040807,0.6127424147138987,2/1775,0.6154539237280817,0.21272205627872007,positive regulation of translation in response ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,microglial cell proliferation,0.2424075132040807,0.6127424147138987,2/1775,0.6154539237280817,0.21272205627872007,microglial cell proliferation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of dendrite development,0.2424075132040807,0.6127424147138987,2/1775,0.6154539237280817,0.21272205627872007,negative regulation of dendrite development,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of T-helper 2 cell cytokine production,0.2424075132040807,0.6127424147138987,2/1775,0.6154539237280817,0.21272205627872007,positive regulation of T-helper 2 cell cytokine...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,DO,autoimmune hepatitis,0.3411059634466738,0.6154942315635574,4/1094,0.4671106878944371,0.2107760129387666,autoimmune hepatitis,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,WikiPathways,WP_OXIDATIVE_STRESS_RESPONSE,0.166407743738029,0.6189056478926693,6/1002,0.7788264678022391,0.20837555408626376,WP_OXIDATIVE_STRESS_RESPONSE,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_MF,C-C chemokine binding,0.20022931864501542,0.6194360194785871,4/1824,0.6984723304856206,0.20800354452981365,C-C chemokine binding,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,Reactome,Nicotinate metabolism,0.09967815039078332,0.619554298718685,7/1379,1.0014000292977583,0.20792062536458722,Nicotinate metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,DO,lipid metabolism disorder,0.3464481930108713,0.6196560749523895,19/1094,0.46036169949857336,0.20784928823293422,lipid metabolism disorder,OUD vs Control Female,DO
OUD_vs_Control_Female,DO,neuronal ceroid lipofuscinosis,0.3467235900306118,0.6196560749523895,5/1094,0.46001660924757054,0.20784928823293422,neuronal ceroid lipofuscinosis,OUD vs Control Female,DO
OUD_vs_Control_Female,KEGG,Arginine and proline metabolism,0.31899765309091094,0.6199728399054992,9/1075,0.49621251209459405,0.20762733588487056,Arginine and proline metabolism,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,DO,adult respiratory distress syndrome,0.2421803195737796,0.6207101280132847,7/920,0.6158611520591242,0.20711116825340284,adult respiratory distress syndrome,OUD Effect Male vs Female,DO
OUD_vs_Control_Female,GO_BP,B cell activation involved in immune response,0.332320065632877,0.622548435790857,14/2058,0.4784434350362465,0.2058268537448816,B cell activation involved in immune response,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuron projection arborization,0.24752201915622732,0.6227280108860491,6/1775,0.6063861608811697,0.20570159886886125,neuron projection arborization,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_CC,astrocyte end-foot,0.130352610830398,0.6235063373067476,3/1867,0.8848802659311733,0.20515912800201655,astrocyte end-foot,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,GO_BP,neuron maturation,0.3335339611174411,0.6237486329073284,8/2058,0.47685993873398336,0.20499039322659643,neuron maturation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,KEGG,beta-Alanine metabolism,0.32492864627818097,0.6244438788809734,6/1075,0.4882119988054688,0.2045065872138319,beta-Alanine metabolism,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,Reactome,Cellular response to heat stress,0.05602290140529988,0.624733336682544,16/1194,1.2516344029797515,0.20430531884830347,Cellular response to heat stress,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Regulation of MITF-M-dependent genes involved in apoptosis,0.05727069524011435,0.624733336682544,5/1194,1.242067544717777,0.20430531884830347,Regulation of MITF-M-dependent genes involved i...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.058643394674165086,0.624733336682544,19/1194,1.2317808977532505,0.20430531884830347,SARS-CoV-2 activates/modulates innate and adapt...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Metabolism of steroids,0.05916955654012331,0.624733336682544,24/1194,1.2279016856308655,0.20430531884830347,Metabolism of steroids,OUD Effect Male vs Female,Reactome
OUD_vs_Control_Female,GO_BP,regulation of postsynaptic membrane neurotransmitter receptor levels,0.3363430197767618,0.6254682120072061,18/2058,0.4732175809257044,0.20379475743445874,regulation of postsynaptic membrane neurotransm...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,immunoglobulin production involved in immunoglobulin-mediated immune response,0.3378874006255429,0.6254682120072061,9/2058,0.4712280021902404,0.20379475743445874,immunoglobulin production involved in immunoglo...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,dendritic cell cytokine production,0.33905189016381176,0.6254682120072061,3/2058,0.4697338301531413,0.20379475743445874,dendritic cell cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of dendritic cell cytokine production,0.33905189016381176,0.6254682120072061,3/2058,0.4697338301531413,0.20379475743445874,regulation of dendritic cell cytokine production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neuron remodeling,0.33905189016381176,0.6254682120072061,3/2058,0.4697338301531413,0.20379475743445874,neuron remodeling,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,response to morphine,0.33905189016381176,0.6254682120072061,3/2058,0.4697338301531413,0.20379475743445874,response to morphine,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of short-term neuronal synaptic plasticity,0.33905189016381176,0.6254682120072061,3/2058,0.4697338301531413,0.20379475743445874,regulation of short-term neuronal synaptic plas...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,programmed cell death in response to reactive oxygen species,0.33905189016381176,0.6254682120072061,3/2058,0.4697338301531413,0.20379475743445874,programmed cell death in response to reactive o...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_MF,AMPA glutamate receptor activity,0.1915566791204476,0.6258149196605962,2/2121,0.7177027006133834,0.2035540873243237,AMPA glutamate receptor activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,opioid receptor binding,0.1915566791204476,0.6258149196605962,2/2121,0.7177027006133834,0.2035540873243237,opioid receptor binding,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,WikiPathways,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,0.1750251979400336,0.6271390010255307,11/1002,0.7568994225220915,0.2026361901296242,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RE...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.31709066256235907,0.6277382435027307,24/2013,0.4988165465485945,0.20222141215498693,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,GO_CC,paranode region of axon,0.1813448244700778,0.6312924433435345,3/2168,0.7414948345481747,0.19976940920558836,paranode region of axon,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,juxtaparanode region of axon,0.1813448244700778,0.6312924433435345,3/2168,0.7414948345481747,0.19976940920558836,juxtaparanode region of axon,OUD vs Control Female,GO CC
OUD_Effect_Male_vs_Female,GO_BP,regulation of dendrite development,0.25291999464686615,0.6317361243613732,14/1775,0.597016836050803,0.19946428827542825,regulation of dendrite development,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,dendritic cell cytokine production,0.2577740466990393,0.6317361243613732,3/1775,0.5887608105776109,0.19946428827542825,dendritic cell cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,T cell mediated immune response to tumor cell,0.2577740466990393,0.6317361243613732,3/1775,0.5887608105776109,0.19946428827542825,T cell mediated immune response to tumor cell,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of dendritic cell cytokine production,0.2577740466990393,0.6317361243613732,3/1775,0.5887608105776109,0.19946428827542825,regulation of dendritic cell cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuron remodeling,0.2577740466990393,0.6317361243613732,3/1775,0.5887608105776109,0.19946428827542825,neuron remodeling,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of short-term neuronal synaptic plasticity,0.2577740466990393,0.6317361243613732,3/1775,0.5887608105776109,0.19946428827542825,regulation of short-term neuronal synaptic plas...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of astrocyte differentiation,0.2577740466990393,0.6317361243613732,3/1775,0.5887608105776109,0.19946428827542825,negative regulation of astrocyte differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of T-helper 17 type immune response,0.2577740466990393,0.6317361243613732,3/1775,0.5887608105776109,0.19946428827542825,negative regulation of T-helper 17 type immune ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,retinal ganglion cell axon guidance,0.25801975765894836,0.6317361243613732,4/1775,0.5883470370068463,0.19946428827542825,retinal ganglion cell axon guidance,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of chemokine production,0.25801975765894836,0.6317361243613732,4/1775,0.5883470370068463,0.19946428827542825,negative regulation of chemokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of stress-activated MAPK cascade,0.25801975765894836,0.6317361243613732,4/1775,0.5883470370068463,0.19946428827542825,positive regulation of stress-activated MAPK ca...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of stress-activated protein kinase signaling cascade,0.25801975765894836,0.6317361243613732,4/1775,0.5883470370068463,0.19946428827542825,positive regulation of stress-activated protein...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of cytokine production involved in inflammatory response,0.25801975765894836,0.6317361243613732,4/1775,0.5883470370068463,0.19946428827542825,positive regulation of cytokine production invo...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of cellular response to oxidative stress,0.25801975765894836,0.6317361243613732,4/1775,0.5883470370068463,0.19946428827542825,regulation of cellular response to oxidative st...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of cytokine production,0.258253020165001,0.632096826393871,36/1775,0.5879545908796883,0.19921639015489764,negative regulation of cytokine production,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.3814207580420756,0.6329298137537439,28/2332,0.4185956750608316,0.19864444668004563,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_C...,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,L-glutamate import,0.2594375135194149,0.6339411667559125,7/1775,0.5859672266461082,0.1979510451764027,L-glutamate import,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_APOPTOSIS,0.18418740570104064,0.6361296573739136,14/1002,0.734740069152946,0.19645435645366735,WP_APOPTOSIS,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,0.18809930313839013,0.6368384478452221,8/1002,0.725612813400777,0.19597072481974948,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_H...,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,GO_BP,regulation of stress fiber assembly,0.3481793047099462,0.6376576579902138,14/2058,0.45819704630708247,0.19541242025866476,regulation of stress fiber assembly,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,innate immune response in mucosa,0.35529028723181,0.6376576579902138,2/2058,0.44941666489819265,0.19541242025866476,innate immune response in mucosa,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of T cell tolerance induction,0.35529028723181,0.6376576579902138,2/2058,0.44941666489819265,0.19541242025866476,positive regulation of T cell tolerance induction,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,adenylate cyclase-activating dopamine receptor signaling pathway,0.35529028723181,0.6376576579902138,2/2058,0.44941666489819265,0.19541242025866476,adenylate cyclase-activating dopamine receptor ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,intrinsic apoptotic signaling pathway in response to osmotic stress,0.35529028723181,0.6376576579902138,2/2058,0.44941666489819265,0.19541242025866476,intrinsic apoptotic signaling pathway in respon...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of long-term neuronal synaptic plasticity,0.35529028723181,0.6376576579902138,2/2058,0.44941666489819265,0.19541242025866476,positive regulation of long-term neuronal synap...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of synapse structural plasticity,0.35529028723181,0.6376576579902138,2/2058,0.44941666489819265,0.19541242025866476,regulation of synapse structural plasticity,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,axonogenesis involved in innervation,0.35529028723181,0.6376576579902138,2/2058,0.44941666489819265,0.19541242025866476,axonogenesis involved in innervation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,anterograde axonal protein transport,0.35529028723181,0.6376576579902138,2/2058,0.44941666489819265,0.19541242025866476,anterograde axonal protein transport,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.35529028723181,0.6376576579902138,2/2058,0.44941666489819265,0.19541242025866476,positive regulation of oxidative stress-induced...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of stress-activated MAPK cascade,0.3559564607817236,0.6376576579902138,4/2058,0.44860312000079033,0.19541242025866476,positive regulation of stress-activated MAPK ca...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of stress-activated protein kinase signaling cascade,0.3559564607817236,0.6376576579902138,4/2058,0.44860312000079033,0.19541242025866476,positive regulation of stress-activated protein...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of cellular response to oxidative stress,0.3559564607817236,0.6376576579902138,4/2058,0.44860312000079033,0.19541242025866476,regulation of cellular response to oxidative st...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,KEGG,Dopaminergic synapse,0.336566337870687,0.6385435166776868,21/1075,0.47292932272760013,0.19480950026588897,Dopaminergic synapse,OUD vs Control Female,KEGG
OUD_vs_Control_Female,DO,mineral metabolism disease,0.37984467408542144,0.6412326327988429,5/1094,0.4203939585884529,0.1929843841908771,mineral metabolism disease,OUD vs Control Female,DO
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_6_INTERNEURON,0.543090097266076,0.6420462555914586,1/2407,0.2651281160840219,0.19243368248491557,FAN_EMBRYONIC_CTX_IN_6_INTERNEURON,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,WikiPathways,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.19780340206742356,0.6427696232249268,7/1002,0.7037662431412504,0.19194465583140627,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,KEGG,beta-Alanine metabolism,0.1840548922031685,0.6432625525484474,6/889,0.7350526344596218,0.1916117302643951,beta-Alanine metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Starch and sucrose metabolism,0.1840548922031685,0.6432625525484474,6/889,0.7350526344596218,0.1916117302643951,Starch and sucrose metabolism,OUD Effect Male vs Female,KEGG
OUD_vs_Control_Female,Reactome,Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF),0.10743311419502075,0.6449653510888789,6/1379,0.9688618350651342,0.19046361596178243,Formation of neuronal progenitor and neuronal B...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,KEGG,Riboflavin metabolism,0.3470884653892836,0.6453577876904172,2/1075,0.4595598187717508,0.19019944483956072,Riboflavin metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,"Glycine, serine and threonine metabolism",0.34982442682765874,0.6453577876904172,7/1075,0.4561498687679145,0.19019944483956072,"Glycine, serine and threonine metabolism",OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,mitochondrial outer membrane permeabilization involved in programmed cell death,0.2683595401997677,0.649912551257587,6/1775,0.5712829609043615,0.1871450757590778,mitochondrial outer membrane permeabilization i...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_CC,basal dendrite,0.15033043770461024,0.6543413920901193,2/1867,0.8229530780369616,0.1841956063900824,basal dendrite,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,glycinergic synapse,0.15033043770461024,0.6543413920901193,2/1867,0.8229530780369616,0.1841956063900824,glycinergic synapse,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_MF,L-glutamate transmembrane transporter activity,0.22045380979879167,0.6559759935233406,3/1824,0.6566823914609499,0.18311205402543207,L-glutamate transmembrane transporter activity,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,chemokine receptor activity,0.22604758045658904,0.6559759935233406,4/1824,0.6458001371586662,0.18311205402543207,chemokine receptor activity,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,G protein-coupled glutamate receptor binding,0.23906958176673557,0.6559759935233406,2/1824,0.6214756782181584,0.18311205402543207,G protein-coupled glutamate receptor binding,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS,0.4151997628917993,0.6582042752819608,5/2057,0.381742903172153,0.18163930112804139,DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,WikiPathways,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,0.2078347972448786,0.6593078652095938,6/1002,0.6822817378844096,0.18091174331173332,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,0.40711364435852043,0.6604920663718653,26/2332,0.3902843420560846,0.18013239463024674,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CE...,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,KEGG,Carbon metabolism,0.36702139442534953,0.6610228255618861,18/1075,0.43530861909925167,0.17978354377544908,Carbon metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,DO,morphine dependence,0.41680544857111756,0.6634193729570925,4/1094,0.3800666124798749,0.178211850504934,morphine dependence,OUD vs Control Female,DO
OUD_vs_Control_Female,DO,substance-induced psychosis,0.4195636790928109,0.6634193729570925,2/1094,0.377202114978749,0.178211850504934,substance-induced psychosis,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,Reactome,Activation of kainate receptors upon glutamate binding,0.07263967084671344,0.6637412030757586,7/1194,1.1388261324079505,0.17800122181401193,Activation of kainate receptors upon glutamate ...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,KEGG,Butanoate metabolism,0.19572942351629602,0.6639449072219453,5/889,0.70834388302754,0.17786795599668095,Butanoate metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,immune response to tumor cell,0.27726909327285537,0.6643714505038328,5/1775,0.5570985378116929,0.17758903840463833,immune response to tumor cell,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of adaptive immune response,0.282846966976019,0.6643714505038328,17/1775,0.5484484739242467,0.17758903840463833,positive regulation of adaptive immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,production of molecular mediator of immune response,0.2849627073986145,0.6643714505038328,28/1775,0.5452119716782314,0.17758903840463833,production of molecular mediator of immune resp...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,retrograde axonal transport,0.2855785184261635,0.6643714505038328,4/1775,0.5442744638421269,0.17758903840463833,retrograde axonal transport,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,response to immobilization stress,0.2855785184261635,0.6643714505038328,4/1775,0.5442744638421269,0.17758903840463833,response to immobilization stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,assembly of actomyosin apparatus involved in cytokinesis,0.2887544351799971,0.6643714505038328,2/1775,0.539471336417873,0.17758903840463833,assembly of actomyosin apparatus involved in cy...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,intrinsic apoptotic signaling pathway in response to osmotic stress,0.2887544351799971,0.6643714505038328,2/1775,0.539471336417873,0.17758903840463833,intrinsic apoptotic signaling pathway in respon...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,"regulation of synaptic transmission, dopaminergic",0.2887544351799971,0.6643714505038328,2/1775,0.539471336417873,0.17758903840463833,"regulation of synaptic transmission, dopaminergic",OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,astrocyte cell migration,0.2887544351799971,0.6643714505038328,2/1775,0.539471336417873,0.17758903840463833,astrocyte cell migration,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of long-term neuronal synaptic plasticity,0.2887544351799971,0.6643714505038328,2/1775,0.539471336417873,0.17758903840463833,positive regulation of long-term neuronal synap...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,axonogenesis involved in innervation,0.2887544351799971,0.6643714505038328,2/1775,0.539471336417873,0.17758903840463833,axonogenesis involved in innervation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of cardiac muscle hypertrophy in response to stress,0.2887544351799971,0.6643714505038328,2/1775,0.539471336417873,0.17758903840463833,regulation of cardiac muscle hypertrophy in res...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cellular response to arsenic-containing substance,0.2915827385759854,0.6643714505038328,3/1775,0.5352381894181544,0.17758903840463833,cellular response to arsenic-containing substance,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,synapse pruning,0.2915827385759854,0.6643714505038328,3/1775,0.5352381894181544,0.17758903840463833,synapse pruning,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,Reactome,Neurotransmitter release cycle,0.07331594843285726,0.6644257826727689,10/1194,1.134801542917006,0.1775535233379558,Neurotransmitter release cycle,OUD Effect Male vs Female,Reactome
OUD_vs_Control_Female,Reactome,TRIF-mediated programmed cell death,0.11944822153868097,0.6644881195942238,3/1379,0.9228203120646855,0.17751277941770574,TRIF-mediated programmed cell death,OUD vs Control Female,Reactome
OUD_vs_Control_Female,GO_BP,positive regulation of neuron projection development,0.3742551632946593,0.6646541335545395,23/2058,0.42683219933518207,0.17740428998087063,positive regulation of neuron projection develo...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,anterograde axonal transport,0.3772469767191112,0.6665950304752479,8/2058,0.4233742320015931,0.17613792836709152,anterograde axonal transport,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cellular response to dopamine,0.3772469767191112,0.6665950304752479,8/2058,0.4233742320015931,0.17613792836709152,cellular response to dopamine,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cellular response to arsenic-containing substance,0.3788486132240184,0.6665950304752479,3/2058,0.4215342981473196,0.17613792836709152,cellular response to arsenic-containing substance,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,KEGG,"Alanine, aspartate and glutamate metabolism",0.20425853973083935,0.6667307051591549,6/889,0.6898197772413207,0.17604954371331433,"Alanine, aspartate and glutamate metabolism",OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,GO_CC,dendrite cytoplasm,0.1629257666444492,0.6681602589279895,5/1867,0.7880102267621895,0.1751193590503974,dendrite cytoplasm,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,parallel fiber to Purkinje cell synapse,0.1629257666444492,0.6681602589279895,5/1867,0.7880102267621895,0.1751193590503974,parallel fiber to Purkinje cell synapse,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,Reactome,Regulation of Complement cascade,0.12260860758417066,0.6697780768340255,9/1379,0.9114790396456135,0.1740690718839831,Regulation of Complement cascade,OUD vs Control Female,Reactome
OUD_vs_Control_Female,GO_MF,C-C chemokine receptor activity,0.222766931744237,0.6743432979020846,4/2121,0.6521492768146243,0.17111895446208136,C-C chemokine receptor activity,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,DO,substance dependence,0.2770650789954222,0.6773248046700673,18/920,0.5574182088092666,0.1692030195743859,substance dependence,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,WikiPathways,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,0.21727043121530112,0.6782107228672358,7/1002,0.6629993736970041,0.16863534808011382,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_F...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,0.2178998589549628,0.6782107228672358,5/1002,0.6617430508693992,0.16863534808011382,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMO...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.22804645181478475,0.6782107228672358,2/1002,0.6419766805782615,0.16863534808011382,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREA...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,0.22804645181478475,0.6782107228672358,2/1002,0.6419766805782615,0.16863534808011382,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMM...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,0.2335560105238163,0.6782107228672358,3/1002,0.6316089517384841,0.16863534808011382,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_DISORDERS_OF_GALACTOSE_METABOLISM,0.2335560105238163,0.6782107228672358,3/1002,0.6316089517384841,0.16863534808011382,WP_DISORDERS_OF_GALACTOSE_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,KEGG,Cholinergic synapse,0.20980931644528553,0.6784488176641943,17/889,0.6781752311522543,0.1684829100446874,Cholinergic synapse,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,response to fluid shear stress,0.3013059997334782,0.6802043057212193,5/1775,0.5209922203837292,0.16736062329267085,response to fluid shear stress,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,Reactome,Neurotransmitter receptors and postsynaptic signal transmission,0.12707196679480895,0.6835461455414953,34/1379,0.89595024810174,0.16523216130456472,Neurotransmitter receptors and postsynaptic sig...,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,GO_BP,innate immune response-activating signaling pathway,0.30419648719542486,0.6848378216474901,36/1775,0.5168458054061353,0.16441226281802382,innate immune response-activating signaling pat...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,Reactome,Chondroitin sulfate/dermatan sulfate metabolism,0.08179100961907484,0.6852897061409543,10/1194,1.0872944308935413,0.16412579174857272,Chondroitin sulfate/dermatan sulfate metabolism,OUD Effect Male vs Female,Reactome
OUD_vs_Control_Female,GO_BP,response to arsenic-containing substance,0.39421612582011156,0.6885448819930726,5/2058,0.40426561442631453,0.1620677455063563,response to arsenic-containing substance,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,immunoglobulin mediated immune response,0.30625068070741235,0.6888298949856324,17/1775,0.5139229373142865,0.1618880129110236,immunoglobulin mediated immune response,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,KEGG,Histidine metabolism,0.39556455706466376,0.6907320184276362,4/1075,0.40278262850260566,0.16069041209266846,Histidine metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,GO_BP,execution phase of apoptosis,0.3981275849572858,0.6927989964239195,12/2058,0.39997773053020536,0.15939275010137607,execution phase of apoptosis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,KEGG,Sulfur metabolism,0.405222116088623,0.6929782279057742,2/1075,0.3923068598736057,0.15928040990322548,Sulfur metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,WikiPathways,WP_POSTCOVID_NEUROINFLAMMATION,0.23561588653933102,0.6938096263707573,5/1231,0.6277954303375527,0.15875967876507782,WP_POSTCOVID_NEUROINFLAMMATION,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,GO_BP,positive regulation of dendritic cell cytokine production,0.4072929308189397,0.6948152864608877,2/2058,0.39009312768215615,0.1581306353133367,positive regulation of dendritic cell cytokine ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,ventral spinal cord interneuron differentiation,0.4072929308189397,0.6948152864608877,2/2058,0.39009312768215615,0.1581306353133367,ventral spinal cord interneuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,olfactory bulb interneuron differentiation,0.4072929308189397,0.6948152864608877,2/2058,0.39009312768215615,0.1581306353133367,olfactory bulb interneuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cortisol metabolic process,0.4072929308189397,0.6948152864608877,2/2058,0.39009312768215615,0.1581306353133367,cortisol metabolic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of translation in response to endoplasmic reticulum stress,0.4072929308189397,0.6948152864608877,2/2058,0.39009312768215615,0.1581306353133367,regulation of translation in response to endopl...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of translational initiation in response to stress,0.4072929308189397,0.6948152864608877,2/2058,0.39009312768215615,0.1581306353133367,regulation of translational initiation in respo...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of axon extension involved in axon guidance,0.4072929308189397,0.6948152864608877,2/2058,0.39009312768215615,0.1581306353133367,negative regulation of axon extension involved ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,response to nitrosative stress,0.4072929308189397,0.6948152864608877,2/2058,0.39009312768215615,0.1581306353133367,response to nitrosative stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,AMPA glutamate receptor clustering,0.4072929308189397,0.6948152864608877,2/2058,0.39009312768215615,0.1581306353133367,AMPA glutamate receptor clustering,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,glutamate receptor clustering,0.4072929308189397,0.6948152864608877,2/2058,0.39009312768215615,0.1581306353133367,glutamate receptor clustering,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of axon guidance,0.4072929308189397,0.6948152864608877,2/2058,0.39009312768215615,0.1581306353133367,regulation of axon guidance,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of response to oxidative stress,0.4072929308189397,0.6948152864608877,2/2058,0.39009312768215615,0.1581306353133367,negative regulation of response to oxidative st...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,DO,cocaine dependence,0.4456862020853265,0.6950582437283068,5/1094,0.3509708109462707,0.1579788013523881,cocaine dependence,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,WikiPathways,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,0.24313182830039407,0.695320190783324,5/1002,0.6141581841002368,0.15781515934087964,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_MF,cytokine binding,0.2816892468904742,0.6953702912212266,18/1824,0.5502297313076772,0.15778386791548624,cytokine binding,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,DO,autoimmune thrombocytopenic purpura,0.2915184621699697,0.6962211757506284,4/920,0.5353339357089408,0.15725277166967142,autoimmune thrombocytopenic purpura,OUD Effect Male vs Female,DO
OUD_vs_Control_Female,GO_MF,complement component C3b binding,0.24508935180623728,0.6977543791218388,2/2121,0.610675556770155,0.1562974291890523,complement component C3b binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,NMDA glutamate receptor activity,0.24508935180623728,0.6977543791218388,2/2121,0.610675556770155,0.1562974291890523,NMDA glutamate receptor activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,Reactome,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",0.13179039481574145,0.6982509171111121,7/1379,0.8801162409599975,0.15598848520657252,"Glutamate binding, activation of AMPA receptors...",OUD vs Control Female,Reactome
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_3_INTERNEURON,0.60935400856815225,0.6983417288736543,1/2407,0.21513032756463624,0.15593200625040304,FAN_EMBRYONIC_CTX_IN_3_INTERNEURON,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_5_INTERNEURON,0.60935400856815225,0.6983417288736543,1/2407,0.21513032756463624,0.15593200625040304,FAN_EMBRYONIC_CTX_IN_5_INTERNEURON,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,WikiPathways,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,0.23972060202727696,0.7031175138201627,9/1231,0.6202946402997809,0.15297208417142605,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_H...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_NAD_METABOLISM,0.24470957572715366,0.7038943394468319,4/1231,0.6113490359441027,0.15249252727706175,WP_NAD_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,0.24470957572715366,0.7038943394468319,4/1231,0.6113490359441027,0.15249252727706175,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,0.24643102329142602,0.7050961371457385,2/1231,0.6083046195751227,0.1517516645895659,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,0.25101312824323624,0.7056173614732807,3/1231,0.6003035638795426,0.1514307420779327,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,GO_BP,antifungal innate immune response,0.4180999680279789,0.7080185541283048,3/2058,0.3787198656599964,0.1499553611662251,antifungal innate immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of programmed necrotic cell death,0.4180999680279789,0.7080185541283048,3/2058,0.3787198656599964,0.1499553611662251,negative regulation of programmed necrotic cell...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of dendrite development,0.4180999680279789,0.7080185541283048,3/2058,0.3787198656599964,0.1499553611662251,positive regulation of dendrite development,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,somatic recombination of immunoglobulin genes involved in immune response,0.42127160678931985,0.7085010297192307,8/2058,0.37543781082392486,0.14965951422237145,somatic recombination of immunoglobulin genes i...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,somatic diversification of immunoglobulins involved in immune response,0.42127160678931985,0.7085010297192307,8/2058,0.37543781082392486,0.14965951422237145,somatic diversification of immunoglobulins invo...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,antiviral innate immune response,0.42127160678931985,0.7085010297192307,8/2058,0.37543781082392486,0.14965951422237145,antiviral innate immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,response to dopamine,0.42127160678931985,0.7085010297192307,8/2058,0.37543781082392486,0.14965951422237145,response to dopamine,OUD vs Control Female,GO BP
OUD_vs_Control_Female,Reactome,"Sensory perception of sweet, bitter, and umami (glutamate) taste",0.1363044308309702,0.7087658581228653,5/1379,0.8654900263798238,0.14949721096576535,"Sensory perception of sweet, bitter, and umami ...",OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,DO,autoimmune disease of the nervous system,0.3001335069141605,0.7099494001943524,5/920,0.5226855172189001,0.14877260339285833,autoimmune disease of the nervous system,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,DO,cocaine dependence,0.3001335069141605,0.7099494001943524,5/920,0.5226855172189001,0.14877260339285833,cocaine dependence,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,GO_BP,cytokine production involved in inflammatory response,0.3222642163172789,0.7103225447486615,8/1775,0.49178791514767267,0.14854440114582476,cytokine production involved in inflammatory re...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of cytokine production involved in inflammatory response,0.3222642163172789,0.7103225447486615,8/1775,0.49178791514767267,0.14854440114582476,regulation of cytokine production involved in i...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of neurotransmitter secretion,0.3256570524666875,0.7103225447486615,3/1775,0.48723951225666895,0.14854440114582476,positive regulation of neurotransmitter secretion,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of T-helper 1 type immune response,0.3256570524666875,0.7103225447486615,3/1775,0.48723951225666895,0.14854440114582476,positive regulation of T-helper 1 type immune r...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of humoral immune response mediated by circulating immunoglobulin,0.3256570524666875,0.7103225447486615,3/1775,0.48723951225666895,0.14854440114582476,regulation of humoral immune response mediated ...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,KEGG,Glutathione metabolism,0.419238018049655,0.7104328975816814,8/1075,0.3775393408131782,0.14847693615486096,Glutathione metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,GO_BP,stress fiber assembly,0.4247929140627324,0.7112876734262107,16/2058,0.37182273629834134,0.14795471753491188,stress fiber assembly,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,activation of innate immune response,0.33328948781766105,0.7117595008586828,38/1775,0.4771783840735818,0.14766672700087347,activation of innate immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,immune response-inhibiting signal transduction,0.3347350256247701,0.7117595008586828,2/1775,0.4752988420500609,0.14766672700087347,immune response-inhibiting signal transduction,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of humoral immune response mediated by circulating immunoglobulin,0.3347350256247701,0.7117595008586828,2/1775,0.4752988420500609,0.14766672700087347,negative regulation of humoral immune response ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,amino acid neurotransmitter reuptake,0.3347350256247701,0.7117595008586828,2/1775,0.4752988420500609,0.14766672700087347,amino acid neurotransmitter reuptake,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of chemokine-mediated signaling pathway,0.3347350256247701,0.7117595008586828,2/1775,0.4752988420500609,0.14766672700087347,regulation of chemokine-mediated signaling pathway,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,complement-dependent cytotoxicity,0.3347350256247701,0.7117595008586828,2/1775,0.4752988420500609,0.14766672700087347,complement-dependent cytotoxicity,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of axon guidance,0.3347350256247701,0.7117595008586828,2/1775,0.4752988420500609,0.14766672700087347,regulation of axon guidance,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_ENS_NEURONS,0.623172216742756,0.712672857148759,4/2407,0.2053919173128375,0.14710978142332534,DESCARTES_MAIN_FETAL_ENS_NEURONS,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_CC,axon hillock,0.19469787048057813,0.7133327151228078,2/1867,0.7106387985754575,0.14670785775206444,axon hillock,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,WikiPathways,WP_GLYCOSPHINGOLIPID_METABOLISM,0.25705635238403146,0.7135203898894992,4/1002,0.5899716593665109,0.14659361177152133,WP_GLYCOSPHINGOLIPID_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,0.25808110916344745,0.7137407964044059,7/1002,0.5882437834698004,0.1464594788813683,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,DO,plasma protein metabolism disease,0.47590758529917054,0.7150650531408508,2/1094,0.3224773731013889,0.145654446401803,plasma protein metabolism disease,OUD vs Control Female,DO
OUD_vs_Control_Female,Reactome,Alternative complement activation,0.14607216374412751,0.716334514972579,2/1379,0.8354325375505248,0.14488412283131719,Alternative complement activation,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Drug-mediated inhibition of CDK4/CDK6 activity,0.14607216374412751,0.716334514972579,2/1379,0.8354325375505248,0.14488412283131719,Drug-mediated inhibition of CDK4/CDK6 activity,OUD vs Control Female,Reactome
OUD_vs_Control_Female,DO,autoimmune disease of gastrointestinal tract,0.4779860639218473,0.7172528565150286,5/1094,0.32058476541731845,0.14432771346712392,autoimmune disease of gastrointestinal tract,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,DO,substance abuse,0.31060242696408863,0.7198280624060206,38/920,0.5077951551335596,0.14277122643759566,substance abuse,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,DO,glucose intolerance,0.31167813011394707,0.7198280624060206,3/920,0.5062936703059401,0.14277122643759566,glucose intolerance,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,GO_BP,regulation of long-term neuronal synaptic plasticity,0.3416967038813732,0.720315063642161,4/1775,0.4663592105282363,0.14247750291279823,regulation of long-term neuronal synaptic plast...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,KEGG,Linoleic acid metabolism,0.43200316462232435,0.721403342864464,4/1075,0.36451307176615555,0.14182184956377883,Linoleic acid metabolism,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,DO,autoimmune disease of blood,0.32277144025490045,0.7226224458629108,4/920,0.49110489987446126,0.14108855264482223,autoimmune disease of blood,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,DO,substance-induced psychosis,0.33319490382543104,0.7226224458629108,2/920,0.47730164969448063,0.14108855264482223,substance-induced psychosis,OUD Effect Male vs Female,DO
OUD_vs_Control_Female,WikiPathways,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,0.2679202747315772,0.7258203806364546,5/1231,0.5719944201324669,0.13917084121443674,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRU...,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,Reactome,Triglyceride metabolism,0.09572347881641145,0.7274662786442309,7/1194,1.0189815264886344,0.13818713339107033,Triglyceride metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Metabolism of lipids,0.10075826043290784,0.7274662786442309,97/1194,0.9967193390988017,0.13818713339107033,Metabolism of lipids,OUD Effect Male vs Female,Reactome
OUD_vs_Control_Female,Reactome,Regulation of pyruvate metabolism,0.14954949399812373,0.7286913017803314,7/1379,0.825215052068935,0.13745641451713164,Regulation of pyruvate metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Neurotransmitter release cycle,0.1515384065788943,0.7305666990018819,10/1379,0.819477283654043,0.13634012786641814,Neurotransmitter release cycle,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,SARS-CoV-1 activates/modulates innate immune responses,0.15161759772171735,0.7305666990018819,8/1379,0.8192503887442405,0.13634012786641814,SARS-CoV-1 activates/modulates innate immune re...,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_6_INTERNEURON,0.48390508743226957,0.7316716479105296,1/2057,0.31523981200555784,0.13568377344080423,FAN_EMBRYONIC_CTX_IN_6_INTERNEURON,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,KEGG,Cysteine and methionine metabolism,0.24685867158947686,0.7322331004574685,8/889,0.6075516123889005,0.1353506428116241,Cysteine and methionine metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Ether lipid metabolism,0.24760483454775667,0.7322331004574685,7/889,0.606240879858239,0.1353506428116241,Ether lipid metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Complement and coagulation cascades,0.25148245185252993,0.737397697804876,12/889,0.59949231410508,0.13229822261842872,Complement and coagulation cascades,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,WikiPathways,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,0.2756741731034572,0.7400463134284188,6/1002,0.5596039194366712,0.13074110048927723,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,0.27935523089682035,0.7400463134284188,2/1002,0.5538431921099553,0.13074110048927723,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,mast cell activation involved in immune response,0.35781809552698274,0.7433111525824724,7/1775,0.4463377001331074,0.12882935102768323,mast cell activation involved in immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of microglial cell activation,0.3597125876244003,0.7433111525824724,3/1775,0.44404436440510325,0.12882935102768323,regulation of microglial cell activation,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of response to endoplasmic reticulum stress,0.4486241671184228,0.7435765335627171,6/2058,0.34811733493612657,0.12867432452821037,positive regulation of response to endoplasmic ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of long-term neuronal synaptic plasticity,0.4541350615393476,0.7435765335627171,4/2058,0.3428149670590679,0.12867432452821037,regulation of long-term neuronal synaptic plast...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of execution phase of apoptosis,0.4541350615393476,0.7435765335627171,4/2058,0.3428149670590679,0.12867432452821037,regulation of execution phase of apoptosis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,somatic diversification of immune receptors,0.45422032326840267,0.7435765335627171,11/2058,0.3427334379589509,0.12867432452821037,somatic diversification of immune receptors,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,natural killer cell activation involved in immune response,0.4564904097832396,0.7435765335627171,3/2058,0.34056834194560587,0.12867432452821037,natural killer cell activation involved in immu...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neurotransmitter-gated ion channel clustering,0.4564904097832396,0.7435765335627171,3/2058,0.34056834194560587,0.12867432452821037,neurotransmitter-gated ion channel clustering,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of neuron migration,0.4564904097832396,0.7435765335627171,3/2058,0.34056834194560587,0.12867432452821037,positive regulation of neuron migration,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of tolerance induction,0.4571575300872003,0.7435765335627171,2/2058,0.3399341223395151,0.12867432452821037,positive regulation of tolerance induction,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,dopamine uptake involved in synaptic transmission,0.4571575300872003,0.7435765335627171,2/2058,0.3399341223395151,0.12867432452821037,dopamine uptake involved in synaptic transmission,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of dopamine receptor signaling pathway,0.4571575300872003,0.7435765335627171,2/2058,0.3399341223395151,0.12867432452821037,regulation of dopamine receptor signaling pathway,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,chemokine (C-C motif) ligand 5 production,0.4571575300872003,0.7435765335627171,2/2058,0.3399341223395151,0.12867432452821037,chemokine (C-C motif) ligand 5 production,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of chemokine (C-C motif) ligand 5 production,0.4571575300872003,0.7435765335627171,2/2058,0.3399341223395151,0.12867432452821037,regulation of chemokine (C-C motif) ligand 5 pr...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,DO,autoimmune thyroiditis,0.3496912673236381,0.7436099293340769,3/920,0.4563152129881835,0.12865481977936452,autoimmune thyroiditis,OUD Effect Male vs Female,DO
OUD_vs_Control_Female,KEGG,Folate transport and metabolism,0.452783085290663,0.7452506284209955,5/1075,0.3441098055435895,0.12769764908311343,Folate transport and metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,WikiPathways,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,0.2826674170232237,0.7456833182903019,4/1231,0.5487242496022895,0.12744557241894552,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,Reactome,Keratan sulfate/keratin metabolism,0.10861867088785375,0.7457010950187228,7/1194,0.9640955157544255,0.1274352191726718,Keratan sulfate/keratin metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Regulation of commissural axon pathfinding by SLIT and ROBO,0.11060007812900949,0.7457010950187228,3/1194,0.9562445662412147,0.1274352191726718,Regulation of commissural axon pathfinding by S...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,NFE2L2 regulating inflammation associated genes,0.11396220179676249,0.7457010950187228,2/1194,0.9432391686029118,0.1274352191726718,NFE2L2 regulating inflammation associated genes,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,GO_MF,CXCR chemokine receptor binding,0.33055723558958183,0.7490816916241279,2/1824,0.48075333209782345,0.12547081743143465,CXCR chemokine receptor binding,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,DO,motor neuron disease,0.3540199865190303,0.7491296305009566,21/920,0.450972218793695,0.1254430248371924,motor neuron disease,OUD Effect Male vs Female,DO
OUD_vs_Control_Female,GO_CC,proximal dendrite,0.24591772501429535,0.7494635429007096,2/2168,0.6092101674854653,0.12524948823549747,proximal dendrite,OUD vs Control Female,GO CC
OUD_Effect_Male_vs_Female,GO_MF,cytokine receptor activity,0.3329926030155448,0.7510513186952548,12/1824,0.4775654136564781,0.12433038701086506,cytokine receptor activity,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_BP,response to endoplasmic reticulum stress,0.36482592282395804,0.7524662541699976,34/1775,0.43791431031232897,0.12351297208811587,response to endoplasmic reticulum stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of dendrite morphogenesis,0.37478998041317346,0.7533293355093477,5/1775,0.4262120280015346,0.12301512031231052,positive regulation of dendrite morphogenesis,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of cytokine production involved in immune response,0.3757206401948436,0.7533293355093477,11/1775,0.42513494633532406,0.12301512031231052,positive regulation of cytokine production invo...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of production of molecular mediator of immune response,0.3780149670520498,0.7533293355093477,23/1775,0.42249100444999194,0.12301512031231052,regulation of production of molecular mediator ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cellular response to dopamine,0.3780265857879544,0.7533293355093477,7/1775,0.42247765610195076,0.12301512031231052,cellular response to dopamine,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,T-helper 2 cell cytokine production,0.3797886031364597,0.7533293355093477,2/1775,0.4204580719034,0.12301512031231052,T-helper 2 cell cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of dopamine receptor signaling pathway,0.3797886031364597,0.7533293355093477,2/1775,0.4204580719034,0.12301512031231052,regulation of dopamine receptor signaling pathway,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of execution phase of apoptosis,0.3797886031364597,0.7533293355093477,2/1775,0.4204580719034,0.12301512031231052,negative regulation of execution phase of apopt...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of T-helper 2 cell cytokine production,0.3797886031364597,0.7533293355093477,2/1775,0.4204580719034,0.12301512031231052,regulation of T-helper 2 cell cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,Reactome,"Unblocking of NMDA receptors, glutamate binding and activation",0.11799507186997867,0.7533739733849717,5/1194,0.9281361308664875,0.12298938733228898,"Unblocking of NMDA receptors, glutamate binding...",OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Negative regulation of NMDA receptor-mediated neuronal transmission,0.11799507186997867,0.7533739733849717,5/1194,0.9281361308664875,0.12298938733228898,Negative regulation of NMDA receptor-mediated n...,OUD Effect Male vs Female,Reactome
OUD_vs_Control_Female,GO_CC,parallel fiber to Purkinje cell synapse,0.2493114479090564,0.7542804533103088,5/2168,0.6032577790590673,0.12246714659860607,parallel fiber to Purkinje cell synapse,OUD vs Control Female,GO CC
OUD_vs_Control_Female,WikiPathways,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,0.297827064764673,0.754889486414627,3/1231,0.526035838672947,0.1221166231434297,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_DOPAMINERGIC_NEUROGENESIS,0.3011062477771397,0.754889486414627,5/1231,0.5212802330392657,0.1221166231434297,WP_DOPAMINERGIC_NEUROGENESIS,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,0.3020750260171726,0.754889486414627,8/1231,0.5198851784383005,0.1221166231434297,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_OXIDATIVE_DAMAGE_RESPONSE,0.3020750260171726,0.754889486414627,8/1231,0.5198851784383005,0.1221166231434297,WP_OXIDATIVE_DAMAGE_RESPONSE,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.3105587187458182,0.754889486414627,2/1231,0.5078562736956947,0.1221166231434297,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREA...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_OXIDATIVE_STRESS_RESPONSE,0.3131018138283487,0.754889486414627,6/1231,0.5043144164668879,0.1221166231434297,WP_OXIDATIVE_STRESS_RESPONSE,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,KEGG,Histidine metabolism,0.26401685056925195,0.7549572751814972,4/889,0.5783683539040206,0.1220776254276941,Histidine metabolism,OUD Effect Male vs Female,KEGG
OUD_vs_Control_Female,WikiPathways,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,0.316525443190401,0.7582361902792564,11/1231,0.49959137445208257,0.12019549073062723,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPE...,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,BioCarta,BIOCARTA_STRESS_PATHWAY,0.12092530717930548,0.759759509946324,6/207,0.9174828007258798,0.11932385512908149,BIOCARTA_STRESS_PATHWAY,OUD Effect Male vs Female,BioCarta
OUD_vs_Control_Female,GO_BP,presynapse assembly,0.4693211566915255,0.7599530719641475,7/2058,0.3285298676343369,0.11921322510903429,presynapse assembly,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_CC,dendrite terminus,0.2573807747547684,0.7620669202703462,3/2168,0.5894238961641205,0.11800688977847647,dendrite terminus,OUD vs Control Female,GO CC
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,0.4589176624913278,0.7630876626818257,22/2013,0.33826522717152974,0.11742556790082023,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CE...,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,somatic diversification of immune receptors via germline recombination within a single locus,0.47687584033267727,0.7702212204864297,10/2058,0.3215946794029617,0.11338452023262859,somatic diversification of immune receptors via...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of immune effector process,0.3913776896688142,0.7724001985142124,30/1775,0.40740393475845765,0.11215762327480766,positive regulation of immune effector process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,chemokine (C-X-C motif) ligand 2 production,0.3934987823022099,0.7724001985142124,3/1775,0.4050566072445586,0.11215762327480766,chemokine (C-X-C motif) ligand 2 production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.3934987823022099,0.7724001985142124,3/1775,0.4050566072445586,0.11215762327480766,regulation of oxidative stress-induced neuron i...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of chemokine (C-X-C motif) ligand 2 production,0.3934987823022099,0.7724001985142124,3/1775,0.4050566072445586,0.11215762327480766,regulation of chemokine (C-X-C motif) ligand 2 ...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,postsynaptic neurotransmitter receptor internalization,0.47947999536900743,0.7724617438083184,5/2058,0.31922950753833584,0.11212301981815012,postsynaptic neurotransmitter receptor internal...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of synapse maturation,0.4858534503715023,0.7733938494950586,4/2058,0.31349470870653434,0.11159928602682477,regulation of synapse maturation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,receptor localization to synapse,0.4908662231682648,0.7733938494950586,11/2058,0.3090368509645473,0.11159928602682477,receptor localization to synapse,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of cellular response to osmotic stress,0.5044933435335799,0.7733938494950586,2/2058,0.29714455962668757,0.11159928602682477,regulation of cellular response to osmotic stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,dendrite arborization,0.5044933435335799,0.7733938494950586,2/2058,0.29714455962668757,0.11159928602682477,dendrite arborization,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.5044933435335799,0.7733938494950586,2/2058,0.29714455962668757,0.11159928602682477,negative regulation of oxidative stress-induced...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,interneuron migration,0.5044933435335799,0.7733938494950586,2/2058,0.29714455962668757,0.11159928602682477,interneuron migration,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of chemokine (C-X-C motif) ligand 2 production,0.5044933435335799,0.7733938494950586,2/2058,0.29714455962668757,0.11159928602682477,positive regulation of chemokine (C-X-C motif) ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.51679624997695,0.7733938494950586,4/2058,0.28668064636789975,0.11159928602682477,negative regulation of oxidative stress-induced...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,response to endoplasmic reticulum stress,0.5177058674122903,0.7733938494950586,37/2058,0.2859169129197458,0.11159928602682477,response to endoplasmic reticulum stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,tolerance induction dependent upon immune response,0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,tolerance induction dependent upon immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of T cell mediated immune response to tumor cell,0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,negative regulation of T cell mediated immune r...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of translation in response to stress,0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,negative regulation of translation in response ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of translational initiation in response to stress,0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,negative regulation of translational initiation...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of mast cell activation involved in immune response,0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,regulation of mast cell activation involved in ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of translation in response to endoplasmic reticulum stress,0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,positive regulation of translation in response ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of dopamine receptor signaling pathway,0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,positive regulation of dopamine receptor signal...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of astrocyte activation,0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,regulation of astrocyte activation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,microglial cell mediated cytotoxicity,0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,microglial cell mediated cytotoxicity,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,NMDA glutamate receptor clustering,0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,NMDA glutamate receptor clustering,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of glutamate receptor clustering,0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,regulation of glutamate receptor clustering,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,"regulation of glutamate secretion, neurotransmission",0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,"regulation of glutamate secretion, neurotransmi...",OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of microglial cell mediated cytotoxicity,0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,regulation of microglial cell mediated cytotoxi...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,axonemal central apparatus assembly,0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,axonemal central apparatus assembly,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of AMPA glutamate receptor clustering,0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,regulation of AMPA glutamate receptor clustering,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of antifungal innate immune response,0.5214849430230565,0.7733938494950586,1/2058,0.2827582265594126,0.11159928602682477,regulation of antifungal innate immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,0.5207534366960855,0.7737452709921709,27/2332,0.28336785525785274,0.11140199230239907,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CEL...,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,"synaptic transmission, dopaminergic",0.3980664838261563,0.7740527880674789,4/1775,0.4000443873546658,0.11122942073226065,"synaptic transmission, dopaminergic",OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.3980664838261563,0.7740527880674789,4/1775,0.4000443873546658,0.11122942073226065,negative regulation of oxidative stress-induced...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,central nervous system neuron axonogenesis,0.3993922951347495,0.7740527880674789,5/1775,0.3986003175643104,0.11122942073226065,central nervous system neuron axonogenesis,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.47224132951094444,0.774666584975529,24/2013,0.3258360071067541,0.11088517679914753,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,regulation of postsynapse assembly,0.5238308190767744,0.7758155451891485,6/2058,0.2808089538656566,0.11024152259336198,regulation of postsynapse assembly,OUD vs Control Female,GO BP
OUD_vs_Control_Female,KEGG,Apoptosis - multiple species,0.48402559512432297,0.7787368721836133,5/1075,0.31513167238998563,0.10860926153504942,Apoptosis - multiple species,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Nitrogen metabolism,0.4867105451147583,0.7787368721836133,3/1075,0.3127292441909742,0.10860926153504942,Nitrogen metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,GO_BP,negative regulation of cytokine-mediated signaling pathway,0.5269140622266713,0.7796240116512345,11/2058,0.27826021086742353,0.10811479350638788,negative regulation of cytokine-mediated signal...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_CC,ribbon synapse,0.22206019760380746,0.7799635039803154,3/1867,0.6535292780572033,0.10792571832334188,ribbon synapse,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,cholinergic synapse,0.22206019760380746,0.7799635039803154,3/1867,0.6535292780572033,0.10792571832334188,cholinergic synapse,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,DO,autoimmune disease of central nervous system,0.3833905869995624,0.780488795947891,2/920,0.4163585541192296,0.10763332692946996,autoimmune disease of central nervous system,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,WikiPathways,WP_PHOSPHOINOSITIDES_METABOLISM,0.3009787112148129,0.780889783392384,8/1002,0.5214642217779334,0.10741025913465242,WP_PHOSPHOINOSITIDES_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,DO,alcohol dependence,0.5365580077784405,0.78098998909973,9/1094,0.2703833191849915,0.1073545329685521,alcohol dependence,OUD vs Control Female,DO
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_GRANULE_NEURONS,0.6972141308209328,0.7816386990427873,2/2407,0.15663381938854315,0.10699394677562223,DESCARTES_MAIN_FETAL_GRANULE_NEURONS,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,DO,complement deficiency,0.5467286716821476,0.7818871140516345,3/1094,0.2622281501310629,0.10685594423345944,complement deficiency,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,GO_MF,C-C chemokine receptor activity,0.35414482187273877,0.7821487242430005,3/1824,0.45081910385440077,0.10671065873449875,C-C chemokine receptor activity,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,BioCarta,BIOCARTA_CYTOKINE_PATHWAY,0.05387466226387404,0.7827671517162875,5/265,1.2686154393814784,0.10636740750008647,BIOCARTA_CYTOKINE_PATHWAY,OUD vs Control Female,BioCarta
OUD_Effect_Male_vs_Female,KEGG,Inositol phosphate metabolism,0.28636172611982685,0.7829510677793471,11/889,0.5430850284233034,0.10626537926704561,Inositol phosphate metabolism,OUD Effect Male vs Female,KEGG
OUD_vs_Control_Female,WikiPathways,WP_AXON_GUIDANCE,0.34122771454243833,0.7885144069445096,13/1231,0.46695570263920777,0.10319036726933103,WP_AXON_GUIDANCE,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,antiviral innate immune response,0.4185184248840649,0.7914285210045485,7/1775,0.3782854178395622,0.1015883029558865,antiviral innate immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,response to dopamine,0.4185184248840649,0.7914285210045485,7/1775,0.3782854178395622,0.1015883029558865,response to dopamine,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,microglial cell activation,0.421299886744114,0.7914285210045485,6/1775,0.37540865762229286,0.1015883029558865,microglial cell activation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.4234920144608234,0.7914285210045485,2/1775,0.3731547744910002,0.1015883029558865,negative regulation of oxidative stress-induced...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,stress response to copper ion,0.4234920144608234,0.7914285210045485,2/1775,0.3731547744910002,0.1015883029558865,stress response to copper ion,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of chemokine (C-X-C motif) ligand 2 production,0.4234920144608234,0.7914285210045485,2/1775,0.3731547744910002,0.1015883029558865,positive regulation of chemokine (C-X-C motif) ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of neuron migration,0.4234920144608234,0.7914285210045485,2/1775,0.3731547744910002,0.1015883029558865,negative regulation of neuron migration,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,central nervous system projection neuron axonogenesis,0.4259847529904073,0.7914285210045485,4/1775,0.37060594505369726,0.1015883029558865,central nervous system projection neuron axonog...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,peripheral nervous system axon ensheathment,0.4259847529904073,0.7914285210045485,4/1775,0.37060594505369726,0.1015883029558865,peripheral nervous system axon ensheathment,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,detection of temperature stimulus involved in sensory perception of pain,0.426798390898514,0.7914285210045485,3/1775,0.36977722660748696,0.1015883029558865,detection of temperature stimulus involved in s...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of dendrite morphogenesis,0.43443359830736816,0.7914285210045485,8/1775,0.36207659457198493,0.1015883029558865,regulation of dendrite morphogenesis,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuron cellular homeostasis,0.43443359830736816,0.7914285210045485,8/1775,0.36207659457198493,0.1015883029558865,neuron cellular homeostasis,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,macrophage cytokine production,0.4481887448030444,0.7914285210045485,5/1775,0.3485390539395256,0.1015883029558865,macrophage cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of macrophage cytokine production,0.4481887448030444,0.7914285210045485,5/1775,0.3485390539395256,0.1015883029558865,regulation of macrophage cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,dopamine metabolic process,0.4481887448030444,0.7914285210045485,5/1775,0.3485390539395256,0.1015883029558865,dopamine metabolic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cellular response to oxidative stress,0.4544378255047029,0.7914285210045485,28/1775,0.34252552693551835,0.1015883029558865,cellular response to oxidative stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,somatic diversification of immune receptors via somatic mutation,0.46553498476604205,0.7914285210045485,2/1775,0.33204767640137417,0.1015883029558865,somatic diversification of immune receptors via...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of T cell tolerance induction,0.46553498476604205,0.7914285210045485,2/1775,0.33204767640137417,0.1015883029558865,regulation of T cell tolerance induction,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,microglial cell activation involved in immune response,0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,microglial cell activation involved in immune r...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,T cell proliferation involved in immune response,0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,T cell proliferation involved in immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,tolerance induction dependent upon immune response,0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,tolerance induction dependent upon immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of T cell mediated immune response to tumor cell,0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,negative regulation of T cell mediated immune r...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of glutamate secretion,0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,negative regulation of glutamate secretion,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,commitment of neuronal cell to specific neuron type in forebrain,0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,commitment of neuronal cell to specific neuron ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of translation in response to stress,0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,negative regulation of translation in response ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,C-X-C chemokine receptor CXCR4 signaling pathway,0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,C-X-C chemokine receptor CXCR4 signaling pathway,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of dopamine receptor signaling pathway,0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,positive regulation of dopamine receptor signal...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,microglial cell mediated cytotoxicity,0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,microglial cell mediated cytotoxicity,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,NMDA selective glutamate receptor signaling pathway,0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,NMDA selective glutamate receptor signaling pat...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation protein catabolic process at postsynapse,0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,regulation protein catabolic process at postsyn...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,pyroptotic cell death,0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,pyroptotic cell death,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,"regulation of glutamate secretion, neurotransmission",0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,"regulation of glutamate secretion, neurotransmi...",OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of microglial cell mediated cytotoxicity,0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,regulation of microglial cell mediated cytotoxi...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of inhibitory synapse assembly,0.466894405525321,0.7914285210045485,1/1775,0.3307813298902235,0.1015883029558865,regulation of inhibitory synapse assembly,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,protein localization to synapse,0.5377400416319187,0.7915059880037099,12/2058,0.26942762353343735,0.10154579520828132,protein localization to synapse,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.33037942124370867,0.7918617874253969,2/1002,0.48098701195286153,0.10135061411327384,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,0.33037942124370867,0.7918617874253969,2/1002,0.48098701195286153,0.10135061411327384,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,KEGG,Choline metabolism in cancer,0.31186862662983567,0.7941168644010601,14/889,0.5060283122157846,0.10011558091067235,Choline metabolism in cancer,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Sulfur metabolism,0.31334221868368084,0.7941168644010601,2/889,0.5039810857883268,0.10011558091067235,Sulfur metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Nicotinate and nicotinamide metabolism,0.31464046196109374,0.7941168644010601,6/889,0.5021854289584464,0.10011558091067235,Nicotinate and nicotinamide metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Arachidonic acid metabolism,0.3228855910224418,0.7941168644010601,8/889,0.4909513352215164,0.10011558091067235,Arachidonic acid metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Taurine and hypotaurine metabolism,0.3236140979206632,0.7941168644010601,3/889,0.4899725670480691,0.10011558091067235,Taurine and hypotaurine metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,GO_CC,photoreceptor ribbon synapse,0.24037924177864478,0.7950286206686694,2/1867,0.6191030390413262,0.0996172366583281,photoreceptor ribbon synapse,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,Reactome,Metabolism of fat-soluble vitamins,0.12768102058470776,0.7957866810831528,8/1194,0.8938736545605807,0.09920333382559055,Metabolism of fat-soluble vitamins,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,GO_BP,myeloid cell activation involved in immune response,0.47025129159647827,0.7960180091351203,11/1775,0.3276700029387679,0.09907710665990427,myeloid cell activation involved in immune resp...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.49780134468461945,0.7975298097018961,23/2013,0.3029439345889736,0.09825307510828683,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_C...,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,WikiPathways,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,0.3498304039717543,0.7979515256757538,4/1002,0.45614244842124063,0.09802349056777111,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE...,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,GO_BP,axonemal dynein complex assembly,0.546836981308376,0.7979708957000299,4/2058,0.26214212278915944,0.09801294833270358,axonemal dynein complex assembly,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of T cell tolerance induction,0.5490567762063616,0.7979708957000299,2/2058,0.2603827442234949,0.09801294833270358,regulation of T cell tolerance induction,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,KEGG,Drug metabolism - cytochrome P450,0.3302814098629597,0.7991424322558325,7/889,0.4811158702115356,0.09737580888382082,Drug metabolism - cytochrome P450,OUD Effect Male vs Female,KEGG
OUD_vs_Control_Female,Reactome,Negative regulation of NMDA receptor-mediated neuronal transmission,0.18417138267983976,0.7996674577404621,5/1379,0.7347778513908881,0.09709057712430258,Negative regulation of NMDA receptor-mediated n...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Metabolism of water-soluble vitamins and cofactors,0.19031497342695064,0.7996674577404621,21/1379,0.7205270413457727,0.09709057712430258,Metabolism of water-soluble vitamins and cofactors,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Nicotinate metabolism,0.12985184579646555,0.8012135166164897,6/1194,0.8865518726536826,0.09625173269044393,Nicotinate metabolism,OUD Effect Male vs Female,Reactome
OUD_vs_Control_Female,Reactome,Response of endothelial cells to shear stress,0.19544069997760094,0.8105312657326836,16/1379,0.7089849905911836,0.09123022785645073,Response of endothelial cells to shear stress,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,RUNX3 Regulates Immune Response and Cell Migration,0.19952247757944971,0.8105312657326836,2/1379,0.7000081709605465,0.09123022785645073,RUNX3 Regulates Immune Response and Cell Migration,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,KEGG,"Glycine, serine and threonine metabolism",0.3379148053450169,0.811571676495363,6/889,0.4711927796995559,0.09067311806601398,"Glycine, serine and threonine metabolism",OUD Effect Male vs Female,KEGG
OUD_vs_Control_Female,GO_BP,neuron projection arborization,0.5602828554988424,0.811962425862763,5/2058,0.25159266662071594,0.09046406757905566,neuron projection arborization,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,dopamine metabolic process,0.5857874099760191,0.8138003595939318,5/2058,0.23225996661942455,0.08948212258100609,dopamine metabolic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,eosinophil activation involved in immune response,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,eosinophil activation involved in immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,B cell proliferation involved in immune response,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,B cell proliferation involved in immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,tolerance induction to self antigen,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,tolerance induction to self antigen,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,adenylate cyclase-inhibiting dopamine receptor signaling pathway,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,adenylate cyclase-inhibiting dopamine receptor ...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,spinal cord motor neuron cell fate specification,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,spinal cord motor neuron cell fate specification,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,gonadotrophin-releasing hormone neuronal migrat...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cerebral cortex GABAergic interneuron migration,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,cerebral cortex GABAergic interneuron migration,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,hypothalamic tangential migration using cell-axon interactions,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,hypothalamic tangential migration using cell-ax...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,olfactory bulb interneuron development,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,olfactory bulb interneuron development,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,anterior/posterior axon guidance,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,anterior/posterior axon guidance,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,dopaminergic neuron axon guidance,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,dopaminergic neuron axon guidance,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,dopamine catabolic process,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,dopamine catabolic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of dopamine metabolic process,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,positive regulation of dopamine metabolic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,response to cortisol,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,response to cortisol,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of neurotransmitter uptake,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,positive regulation of neurotransmitter uptake,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,phospholipase C-activating dopamine receptor signaling pathway,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,phospholipase C-activating dopamine receptor si...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cellular response to nitrosative stress,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,cellular response to nitrosative stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of chemokine (C-C motif) ligand 5 production,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,negative regulation of chemokine (C-C motif) li...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of chemokine (C-C motif) ligand 5 production,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,positive regulation of chemokine (C-C motif) li...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,intracellular glutamate homeostasis,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,intracellular glutamate homeostasis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,sympathetic neuron projection extension,0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,sympathetic neuron projection extension,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,"regulation of translation at synapse, modulating synaptic transmission",0.5870847290115022,0.8138003595939318,1/2058,0.23129921615153543,0.08948212258100609,"regulation of translation at synapse, modulatin...",OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of T cell mediated immune response to tumor cell,0.5907184177753511,0.8138003595939318,2/2058,0.2286194882356545,0.08948212258100609,regulation of T cell mediated immune response t...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,Reactome,Dopamine Neurotransmitter Release Cycle,0.21011163550476358,0.8141026535063186,5/1379,0.6775498966868982,0.08932082970481499,Dopamine Neurotransmitter Release Cycle,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",0.2105836880871944,0.8141026535063186,6/1379,0.6765752725051638,0.08932082970481499,"Turbulent (oscillatory, disturbed) flow shear s...",OUD vs Control Female,Reactome
OUD_vs_Control_Female,GO_BP,negative regulation of response to cytokine stimulus,0.5962154039343839,0.8188332509333833,11/2058,0.2245968076437407,0.08680452995227643,negative regulation of response to cytokine sti...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of oxidative phosphorylation,0.5970591933417371,0.8188332509333833,3/2058,0.2239826101314223,0.08680452995227643,regulation of oxidative phosphorylation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,motor neuron axon guidance,0.5970591933417371,0.8188332509333833,3/2058,0.2239826101314223,0.08680452995227643,motor neuron axon guidance,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,axonal transport,0.5984001831533622,0.8205246075750062,9/2058,0.22300828221832372,0.08590838990182549,axonal transport,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_MF,NAD+-protein-glutamate ADP-ribosyltransferase activity,0.41872026318312894,0.8218151708480751,2/1824,0.3780760217319342,0.08522584585001639,NAD+-protein-glutamate ADP-ribosyltransferase a...,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activity,0.41872026318312894,0.8218151708480751,2/1824,0.3780760217319342,0.08522584585001639,NAD+-histone H2BE35 glutamate ADP-ribosyltransf...,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,NAD+-histone H2BE2 glutamate ADP-ribosyltransferase activity,0.41872026318312894,0.8218151708480751,2/1824,0.3780760217319342,0.08522584585001639,NAD+-histone H2BE2 glutamate ADP-ribosyltransfe...,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,NAD+-histone H2BE18 glutamate ADP-ribosyltransferase activity,0.41872026318312894,0.8218151708480751,2/1824,0.3780760217319342,0.08522584585001639,NAD+-histone H2BE18 glutamate ADP-ribosyltransf...,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,G protein-coupled opioid receptor activity,0.4636390673307542,0.8218151708480751,1/1824,0.33381997648039846,0.08522584585001639,G protein-coupled opioid receptor activity,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,oxidative RNA demethylase activity,0.4636390673307542,0.8218151708480751,1/1824,0.33381997648039846,0.08522584585001639,oxidative RNA demethylase activity,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,WikiPathways,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.37221996969631155,0.8226582942844964,6/1002,0.42920033057047974,0.08478051925053226,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,0.37694721068845416,0.8226582942844964,5/1002,0.4237194660063246,0.08478051925053226,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TO...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_ALANINE_AND_ASPARTATE_METABOLISM,0.3803268023787313,0.8226582942844964,2/1002,0.4198430679225643,0.08478051925053226,WP_ALANINE_AND_ASPARTATE_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,regulation of stress fiber assembly,0.5013759445699122,0.8231513144131495,11/1775,0.29983650681809687,0.0845203239926915,regulation of stress fiber assembly,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,immunological synapse formation,0.505699368827006,0.8231513144131495,2/1775,0.2961075884183147,0.0845203239926915,immunological synapse formation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,hydrogen peroxide-mediated programmed cell death,0.505699368827006,0.8231513144131495,2/1775,0.2961075884183147,0.0845203239926915,hydrogen peroxide-mediated programmed cell death,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,commissural neuron axon guidance,0.505699368827006,0.8231513144131495,2/1775,0.2961075884183147,0.0845203239926915,commissural neuron axon guidance,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,myeloid leukocyte cytokine production,0.5078702330857034,0.8231513144131495,6/1775,0.2942472409722815,0.0845203239926915,myeloid leukocyte cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.5191661841845963,0.8231513144131495,5/1775,0.28469360299564267,0.0845203239926915,regulation of oxidative stress-induced intrinsi...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,spinal cord motor neuron differentiation,0.5220745216251592,0.8231513144131495,3/1775,0.2822675007896632,0.0845203239926915,spinal cord motor neuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,astrocyte activation,0.5220745216251592,0.8231513144131495,3/1775,0.2822675007896632,0.0845203239926915,astrocyte activation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of neurotransmitter transport,0.5220745216251592,0.8231513144131495,3/1775,0.2822675007896632,0.0845203239926915,positive regulation of neurotransmitter transport,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,eosinophil activation involved in immune response,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,eosinophil activation involved in immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,B cell proliferation involved in immune response,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,B cell proliferation involved in immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,adenylate cyclase-inhibiting dopamine receptor signaling pathway,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,adenylate cyclase-inhibiting dopamine receptor ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,spinal cord motor neuron cell fate specification,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,spinal cord motor neuron cell fate specification,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,gonadotrophin-releasing hormone neuronal migrat...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cerebral cortex GABAergic interneuron migration,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,cerebral cortex GABAergic interneuron migration,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,hypothalamic tangential migration using cell-axon interactions,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,hypothalamic tangential migration using cell-ax...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,olfactory bulb interneuron development,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,olfactory bulb interneuron development,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of axon diameter,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,regulation of axon diameter,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,mast cell cytokine production,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,mast cell cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of mast cell cytokine production,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,regulation of mast cell cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,anterior/posterior axon guidance,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,anterior/posterior axon guidance,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,dopamine catabolic process,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,dopamine catabolic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of dopamine metabolic process,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,positive regulation of dopamine metabolic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,response to cortisol,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,response to cortisol,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of chemokine (C-C motif) ligand 5 production,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,positive regulation of chemokine (C-C motif) li...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,intracellular glutamate homeostasis,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,intracellular glutamate homeostasis,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,sympathetic neuron projection extension,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,sympathetic neuron projection extension,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,anterograde axonal transport of mitochondrion,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,anterograde axonal transport of mitochondrion,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,postsynapse to nucleus signaling pathway,0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,postsynapse to nucleus signaling pathway,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,"regulation of translation at synapse, modulating synaptic transmission",0.5299281405501377,0.8231513144131495,1/1775,0.2757830177169482,0.0845203239926915,"regulation of translation at synapse, modulatin...",OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,stress fiber assembly,0.5305947706896994,0.8233174131693543,13/1775,0.27523703454931525,0.08443269915985141,stress fiber assembly,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_MF,glutamate binding,0.35230815760236955,0.8236925360703444,2/2121,0.45307730072827207,0.08423486937888644,glutamate binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_BP,protein localization to postsynapse,0.6025056960822339,0.8252627022223297,7/2058,0.22003884291842332,0.08340778240193904,protein localization to postsynapse,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C2_Curated,SA_MMP_CYTOKINE_CONNECTION,0.08300641043834077,0.8265256505505465,4/42,1.0808883665336513,0.08274366390777922,SA_MMP_CYTOKINE_CONNECTION,OUD Effect Male vs Female,C2 Curated
OUD_vs_Control_Female,Reactome,Intrinsic Pathway for Apoptosis,0.21474447425759657,0.8265547707201584,10/1379,0.6680780024923403,0.08272836310472922,Intrinsic Pathway for Apoptosis,OUD vs Control Female,Reactome
OUD_vs_Control_Female,GO_CC,nuclear stress granule,0.2999958343765481,0.8292243661172359,2/2168,0.5228847756798011,0.08132794498292052,nuclear stress granule,OUD vs Control Female,GO CC
OUD_Effect_Male_vs_Female,GO_BP,cellular response to toxic substance,0.5367458384403305,0.8299405671960312,14/1775,0.2702313141006695,0.0809530067359411,cellular response to toxic substance,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,immune effector process,0.5367665978569947,0.8299405671960312,70/1775,0.27021451746226816,0.0809530067359411,immune effector process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuron fate commitment,0.5370070916772145,0.8299405671960312,7/1775,0.2700199790007325,0.0809530067359411,neuron fate commitment,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,humoral immune response,0.5378334144864614,0.8303832043387446,23/1775,0.2693522194494882,0.08072144361985988,humoral immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,astrocyte development,0.5419651803928532,0.8303832043387446,5/1775,0.2660286146590401,0.08072144361985988,astrocyte development,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,T cell tolerance induction,0.543841726077462,0.8303832043387446,2/1775,0.2645274743689748,0.08072144361985988,T cell tolerance induction,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,programmed cell death in response to reactive oxygen species,0.543841726077462,0.8303832043387446,2/1775,0.2645274743689748,0.08072144361985988,programmed cell death in response to reactive o...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of execution phase of apoptosis,0.543841726077462,0.8303832043387446,2/1775,0.2645274743689748,0.08072144361985988,positive regulation of execution phase of apopt...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of motor neuron apoptotic process,0.543841726077462,0.8303832043387446,2/1775,0.2645274743689748,0.08072144361985988,regulation of motor neuron apoptotic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of neuron differentiation,0.54420540857042,0.8304213236588047,8/1775,0.2642371463111012,0.08070150748640184,negative regulation of neuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,DO,substance-related disorder,0.4711360020531621,0.8311579642387953,47/920,0.32685370770060324,0.08031642931128745,substance-related disorder,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,DO,autoimmune disease of gastrointestinal tract,0.5367003332067418,0.8311579642387953,4/920,0.27026813508411346,0.08031642931128745,autoimmune disease of gastrointestinal tract,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,DO,autoimmune disease of skin and connective tissue,0.5633779352582933,0.8311579642387953,3/920,0.24920016619514598,0.08031642931128745,autoimmune disease of skin and connective tissue,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,DO,post-traumatic stress disorder,0.5636083335820965,0.8311579642387953,2/920,0.24902259398361504,0.08031642931128745,post-traumatic stress disorder,OUD Effect Male vs Female,DO
OUD_vs_Control_Female,DO,motor neuron disease,0.687698257386157,0.8317141911540835,21/1094,0.1626020761502488,0.08002588828776759,motor neuron disease,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,WikiPathways,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,0.3897396736621241,0.8335791887107753,7/1002,0.40922538282537857,0.07905313658401292,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_COR...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,Reactome,Metabolism of vitamins and cofactors,0.1548648372525865,0.833698638790623,28/1194,0.8100471795339618,0.07899090759041169,Metabolism of vitamins and cofactors,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,TP53 Regulates Transcription of Cell Death Genes,0.15547158059739485,0.833698638790623,8/1194,0.8083489861723478,0.07899090759041169,TP53 Regulates Transcription of Cell Death Genes,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Metabolism of water-soluble vitamins and cofactors,0.1563691135853563,0.833698638790623,19/1194,0.8058490257270773,0.07899090759041169,Metabolism of water-soluble vitamins and cofactors,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Glutamate Neurotransmitter Release Cycle,0.15637437987749672,0.833698638790623,5/1194,0.8058343995451441,0.07899090759041169,Glutamate Neurotransmitter Release Cycle,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Surfactant metabolism,0.15637437987749672,0.833698638790623,5/1194,0.8058343995451441,0.07899090759041169,Surfactant metabolism,OUD Effect Male vs Female,Reactome
OUD_vs_Control_Female,GO_BP,neuron cellular homeostasis,0.6098207604814986,0.8340823725242548,8/2058,0.21479779478027486,0.07879105707664924,neuron cellular homeostasis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,KEGG,Drug metabolism - cytochrome P450,0.5322634076373768,0.8360667224988931,7/1075,0.2738733899373825,0.07775906220597079,Drug metabolism - cytochrome P450,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,DO,lipid metabolism disorder,0.58695235519619815,0.8361097072299309,14/920,0.23139715039663203,0.07773673438078675,lipid metabolism disorder,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,GO_BP,regulation of neuron migration,0.5493688072244118,0.8370155093456967,6/1775,0.26013600315152574,0.0772664947416859,regulation of neuron migration,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuronal stem cell population maintenance,0.5518669162429792,0.8370155093456967,3/1775,0.2581656405855447,0.0772664947416859,neuronal stem cell population maintenance,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of immunoglobulin mediated immune response,0.5743869526366276,0.8370155093456967,7/1775,0.24079543377667606,0.0772664947416859,regulation of immunoglobulin mediated immune re...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of humoral immune response,0.579878724291959,0.8370155093456967,2/1775,0.23666282519229978,0.0772664947416859,positive regulation of humoral immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,dendrite self-avoidance,0.579878724291959,0.8370155093456967,2/1775,0.23666282519229978,0.0772664947416859,dendrite self-avoidance,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,response to L-glutamate,0.579878724291959,0.8370155093456967,2/1775,0.23666282519229978,0.0772664947416859,response to L-glutamate,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,0.5805264906559255,0.8370155093456967,3/1775,0.23617795769423855,0.0772664947416859,immune response-regulating cell surface recepto...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of execution phase of apoptosis,0.5805264906559255,0.8370155093456967,3/1775,0.23617795769423855,0.0772664947416859,regulation of execution phase of apoptosis,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of natural killer cell cytokine production,0.5855125486857389,0.8370155093456967,1/1775,0.23246379270678308,0.0772664947416859,positive regulation of natural killer cell cyto...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of natural killer cell mediated immune response to tumor cell,0.5855125486857389,0.8370155093456967,1/1775,0.23246379270678308,0.0772664947416859,positive regulation of natural killer cell medi...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of humoral immune response mediated by circulating immunoglobulin,0.5855125486857389,0.8370155093456967,1/1775,0.23246379270678308,0.0772664947416859,positive regulation of humoral immune response ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,forebrain neuron fate commitment,0.5855125486857389,0.8370155093456967,1/1775,0.23246379270678308,0.0772664947416859,forebrain neuron fate commitment,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cerebral cortex GABAergic interneuron development,0.5855125486857389,0.8370155093456967,1/1775,0.23246379270678308,0.0772664947416859,cerebral cortex GABAergic interneuron development,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuronal signal transduction,0.5855125486857389,0.8370155093456967,1/1775,0.23246379270678308,0.0772664947416859,neuronal signal transduction,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of dendrite morphogenesis,0.5855125486857389,0.8370155093456967,1/1775,0.23246379270678308,0.0772664947416859,negative regulation of dendrite morphogenesis,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of stress granule assembly,0.5855125486857389,0.8370155093456967,1/1775,0.23246379270678308,0.0772664947416859,positive regulation of stress granule assembly,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of chemokine-mediated signaling pathway,0.5855125486857389,0.8370155093456967,1/1775,0.23246379270678308,0.0772664947416859,negative regulation of chemokine-mediated signa...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,stress-induced premature senescence,0.5855125486857389,0.8370155093456967,1/1775,0.23246379270678308,0.0772664947416859,stress-induced premature senescence,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,anterograde dendritic transport of neurotransmitter receptor complex,0.5855125486857389,0.8370155093456967,1/1775,0.23246379270678308,0.0772664947416859,anterograde dendritic transport of neurotransmi...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.5855125486857389,0.8370155093456967,1/1775,0.23246379270678308,0.0772664947416859,regulation of intrinsic apoptotic signaling pat...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cellular response to L-glutamate,0.5855125486857389,0.8370155093456967,1/1775,0.23246379270678308,0.0772664947416859,cellular response to L-glutamate,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,anterograde neuronal dense core vesicle transport,0.5855125486857389,0.8370155093456967,1/1775,0.23246379270678308,0.0772664947416859,anterograde neuronal dense core vesicle transport,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,Reactome,Fatty acid metabolism,0.2237802542442257,0.8381654508693892,27/1379,0.6501782370708535,0.07667024472624606,Fatty acid metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,0.22919703346684264,0.8381654508693892,3/1379,0.6397910078098755,0.07667024472624606,alpha-linolenic (omega3) and linoleic (omega6) ...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,alpha-linolenic acid (ALA) metabolism,0.22919703346684264,0.8381654508693892,3/1379,0.6397910078098755,0.07667024472624606,alpha-linolenic acid (ALA) metabolism,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,KEGG,Retinol metabolism,0.373135244618453,0.8383428223245761,7/889,0.42813372758636004,0.07657834963004652,Retinol metabolism,OUD Effect Male vs Female,KEGG
OUD_vs_Control_Female,Reactome,Metabolism of porphyrins,0.23713229900732738,0.8392670300883076,5/1379,0.625009288175734,0.07609983745160477,Metabolism of porphyrins,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,GO_MF,dopamine receptor binding,0.5005759475203068,0.8395236679922763,2/1824,0.30053002190750505,0.07596705565035168,dopamine receptor binding,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,complement component C1q complex binding,0.5264809443341394,0.8395236679922763,1/1824,0.27861734322550086,0.07596705565035168,complement component C1q complex binding,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,AMPA glutamate receptor activity,0.5264809443341394,0.8395236679922763,1/1824,0.27861734322550086,0.07596705565035168,AMPA glutamate receptor activity,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,C-X-C chemokine receptor activity,0.5264809443341394,0.8395236679922763,1/1824,0.27861734322550086,0.07596705565035168,C-X-C chemokine receptor activity,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,GO_BP,axoneme assembly,0.6290518525785792,0.8434588441616417,11/2058,0.20131355429941408,0.0739361035781839,axoneme assembly,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,T cell mediated immune response to tumor cell,0.6294363451002034,0.8434588441616417,2/2058,0.20104818353792747,0.0739361035781839,T cell mediated immune response to tumor cell,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,T cell tolerance induction,0.6294363451002034,0.8434588441616417,2/2058,0.20104818353792747,0.0739361035781839,T cell tolerance induction,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,calcium ion-regulated exocytosis of neurotransmitter,0.6294363451002034,0.8434588441616417,2/2058,0.20104818353792747,0.0739361035781839,calcium ion-regulated exocytosis of neurotransm...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of execution phase of apoptosis,0.6294363451002034,0.8434588441616417,2/2058,0.20104818353792747,0.0739361035781839,positive regulation of execution phase of apopt...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,glutamate metabolic process,0.6306155786548491,0.8434588441616417,4/2058,0.20023530469457482,0.0739361035781839,glutamate metabolic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,stress-activated protein kinase signaling cascade,0.6428496346209455,0.8434588441616417,7/2058,0.19189059860161126,0.0739361035781839,stress-activated protein kinase signaling cascade,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of natural killer cell cytokine production,0.6436951898531736,0.8434588441616417,1/2058,0.19131973621518042,0.0739361035781839,positive regulation of natural killer cell cyto...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,peripheral nervous system axon regeneration,0.6436951898531736,0.8434588441616417,1/2058,0.19131973621518042,0.0739361035781839,peripheral nervous system axon regeneration,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cerebral cortex GABAergic interneuron development,0.6436951898531736,0.8434588441616417,1/2058,0.19131973621518042,0.0739361035781839,cerebral cortex GABAergic interneuron development,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of cytokinesis,0.6436951898531736,0.8434588441616417,1/2058,0.19131973621518042,0.0739361035781839,negative regulation of cytokinesis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of chemokine-mediated signaling pathway,0.6436951898531736,0.8434588441616417,1/2058,0.19131973621518042,0.0739361035781839,negative regulation of chemokine-mediated signa...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,stress-induced premature senescence,0.6436951898531736,0.8434588441616417,1/2058,0.19131973621518042,0.0739361035781839,stress-induced premature senescence,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of glutamate receptor signaling pathway,0.6436951898531736,0.8434588441616417,1/2058,0.19131973621518042,0.0739361035781839,regulation of glutamate receptor signaling pathway,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cellular response to L-glutamate,0.6436951898531736,0.8434588441616417,1/2058,0.19131973621518042,0.0739361035781839,cellular response to L-glutamate,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,anterograde neuronal dense core vesicle transport,0.6436951898531736,0.8434588441616417,1/2058,0.19131973621518042,0.0739361035781839,anterograde neuronal dense core vesicle transport,OUD vs Control Female,GO BP
OUD_vs_Control_Female,WikiPathways,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,0.402996231425479,0.8478878683244763,5/1231,0.3946990150965373,0.07166157862525316,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,0.40516520956176316,0.8478878683244763,7/1231,0.3923678534006708,0.07166157862525316,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_F...,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,execution phase of apoptosis,0.5991081570401642,0.8532998634838125,9/1775,0.22249476731763806,0.06889832384847185,execution phase of apoptosis,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,0.6087825094477866,0.8552446326498316,25/2332,0.2155378335033006,0.06790964268265434,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,OUD vs Control Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_CC,NMDA selective glutamate receptor complex,0.2864531953902292,0.8557703582175401,2/1867,0.5429463288250724,0.06764276048529778,NMDA selective glutamate receptor complex,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,KEGG,Glycerophospholipid metabolism,0.3948431607082083,0.8558524613782845,13/889,0.4035753802352157,0.06760109599090423,Glycerophospholipid metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,response to oxidative stress,0.6019812622366241,0.8570600433121119,43/1775,0.22041702673866473,0.06698875151241418,response to oxidative stress,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,sperm axoneme assembly,0.6562168663744423,0.8571763348680501,4/2058,0.1829526113787819,0.06692982757198657,sperm axoneme assembly,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of presynapse assembly,0.6562168663744423,0.8571763348680501,4/2058,0.1829526113787819,0.06692982757198657,regulation of presynapse assembly,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of synapse maturation,0.6079961827336675,0.8577375772587199,3/1775,0.2160991474096802,0.0666455631780054,regulation of synapse maturation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,immune system development,0.612960676474565,0.8577375772587199,21/1775,0.212567386065434,0.0666455631780054,immune system development,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of dopamine metabolic process,0.6137749472019951,0.8577375772587199,2/1775,0.21199084238510243,0.0666455631780054,regulation of dopamine metabolic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,GABAergic neuron differentiation,0.6137749472019951,0.8577375772587199,2/1775,0.21199084238510243,0.0666455631780054,GABAergic neuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,humoral immune response mediated by circulating immunoglobulin,0.6275409665633134,0.8577375772587199,5/1775,0.20235791770086708,0.0666455631780054,humoral immune response mediated by circulating...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,"complement activation, lectin pathway",0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,"complement activation, lectin pathway",OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of immune response to tumor cell,0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,negative regulation of immune response to tumor...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,noradrenergic neuron differentiation,0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,noradrenergic neuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,interneuron migration from the subpallium to the cortex,0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,interneuron migration from the subpallium to th...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,substrate-independent telencephalic tangential interneuron migration,0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,substrate-independent telencephalic tangential ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,hypothalamus gonadotrophin-releasing hormone neuron differentiation,0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,hypothalamus gonadotrophin-releasing hormone ne...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,hypothalamus gonadotrophin-releasing hormone neuron development,0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,hypothalamus gonadotrophin-releasing hormone ne...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,ventral spinal cord interneuron fate commitment,0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,ventral spinal cord interneuron fate commitment,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,"glutamate secretion, neurotransmission",0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,"glutamate secretion, neurotransmission",OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cellular response to laminar fluid shear stress,0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,cellular response to laminar fluid shear stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of synapse maturation,0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,positive regulation of synapse maturation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter loading into synaptic vesicle,0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,neurotransmitter loading into synaptic vesicle,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation protein catabolic process at synapse,0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,regulation protein catabolic process at synapse,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of microglial cell activation,0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,negative regulation of microglial cell activation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of dopaminergic neuron differentiation,0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,regulation of dopaminergic neuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of synapse pruning,0.6345275537545473,0.8577375772587199,1/1775,0.19754951433564974,0.0666455631780054,regulation of synapse pruning,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_MF,complement component C3b binding,0.5819636164954123,0.8583963343307331,1/1824,0.23510416595010616,0.06631214563592434,complement component C3b binding,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,GO_BP,cytokinetic process,0.6592992769862331,0.8585882360752501,6/2058,0.18091740052061017,0.06621506629054774,cytokinetic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,KEGG,Nucleotide metabolism,0.5617540270398031,0.8595555863349469,12/1075,0.250453805575685,0.06572603281294785,Nucleotide metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,alpha-Linolenic acid metabolism,0.5654309070466219,0.8595555863349469,3/1075,0.24762045620563952,0.06572603281294785,alpha-Linolenic acid metabolism,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,Reactome,Retinoid metabolism and transport,0.16860209269929669,0.8597670607449122,7/1194,0.7731370391886402,0.06561919751948993,Retinoid metabolism and transport,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,SUMOylation of immune response proteins,0.16948281714684188,0.8597670607449122,3/1194,0.7708743257593191,0.06561919751948993,SUMOylation of immune response proteins,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,WikiPathways,WP_MELATONIN_METABOLISM_AND_EFFECTS,0.4041977493659771,0.8608630179856658,5/1002,0.3934061090311507,0.0650659487389267,WP_MELATONIN_METABOLISM_AND_EFFECTS,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,0.4310975257660099,0.8610256428216556,8/1231,0.3654244697215061,0.06498391431857377,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUT...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_ESTROGEN_METABOLISM_WP697,0.4338278924947233,0.8610256428216556,2/1231,0.36268252893057956,0.06498391431857377,WP_ESTROGEN_METABOLISM_WP697,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.4338278924947233,0.8610256428216556,2/1231,0.36268252893057956,0.06498391431857377,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.4338278924947233,0.8610256428216556,2/1231,0.36268252893057956,0.06498391431857377,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERG...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,0.4338278924947233,0.8610256428216556,2/1231,0.36268252893057956,0.06498391431857377,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_TLR4_SIGNALING_AND_TOLERANCE,0.43683741989171454,0.8610256428216556,5/1231,0.35968016664851926,0.06498391431857377,WP_TLR4_SIGNALING_AND_TOLERANCE,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_RETINOL_METABOLISM,0.4379163016116545,0.8610256428216556,3/1231,0.3586088877190101,0.06498391431857377,WP_RETINOL_METABOLISM,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of neuron apoptotic process,0.6444742149304332,0.864196090008614,7/1775,0.1907944538535489,0.06338770295365315,positive regulation of neuron apoptotic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,stress-activated protein kinase signaling cascade,0.6453112521731452,0.864196090008614,6/1775,0.19023076211416526,0.06338770295365315,stress-activated protein kinase signaling cascade,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,macrophage activation involved in immune response,0.6455327421491944,0.864196090008614,2/1775,0.19008172493265896,0.06338770295365315,macrophage activation involved in immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of tolerance induction,0.6455327421491944,0.864196090008614,2/1775,0.19008172493265896,0.06338770295365315,regulation of tolerance induction,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,axonal transport of mitochondrion,0.6455327421491944,0.864196090008614,2/1775,0.19008172493265896,0.06338770295365315,axonal transport of mitochondrion,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cellular response to fluid shear stress,0.6455327421491944,0.864196090008614,2/1775,0.19008172493265896,0.06338770295365315,cellular response to fluid shear stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of neuron migration,0.6455327421491944,0.864196090008614,2/1775,0.19008172493265896,0.06338770295365315,positive regulation of neuron migration,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,DO,autoimmune disease of peripheral nervous system,0.7169542835658518,0.8659763903989839,1/920,0.14450853614262527,0.06249394823578696,autoimmune disease of peripheral nervous system,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,DO,autosomal recessive distal hereditary motor neuronopathy,0.7169542835658518,0.8659763903989839,1/920,0.14450853614262527,0.06249394823578696,autosomal recessive distal hereditary motor neu...,OUD Effect Male vs Female,DO
OUD_vs_Control_Female,GO_BP,regulation of presynapse organization,0.6805943658234679,0.8686210086180843,4/2058,0.16711165045311863,0.06116967092524134,regulation of presynapse organization,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,vesicle-mediated transport in synapse,0.6899713640376712,0.8686210086180843,32/2058,0.16116893346346256,0.06116967092524134,vesicle-mediated transport in synapse,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,"complement activation, lectin pathway",0.6925476415042177,0.8686210086180843,1/2058,0.15955034539606255,0.06116967092524134,"complement activation, lectin pathway",OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of immune response to tumor cell,0.6925476415042177,0.8686210086180843,1/2058,0.15955034539606255,0.06116967092524134,negative regulation of immune response to tumor...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of T cell mediated immune response to tumor cell,0.6925476415042177,0.8686210086180843,1/2058,0.15955034539606255,0.06116967092524134,positive regulation of T cell mediated immune r...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,glutamate catabolic process,0.6925476415042177,0.8686210086180843,1/2058,0.15955034539606255,0.06116967092524134,glutamate catabolic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neuron-neuron synaptic transmission,0.6925476415042177,0.8686210086180843,1/2058,0.15955034539606255,0.06116967092524134,neuron-neuron synaptic transmission,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,hypothalamus gonadotrophin-releasing hormone neuron differentiation,0.6925476415042177,0.8686210086180843,1/2058,0.15955034539606255,0.06116967092524134,hypothalamus gonadotrophin-releasing hormone ne...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,hypothalamus gonadotrophin-releasing hormone neuron development,0.6925476415042177,0.8686210086180843,1/2058,0.15955034539606255,0.06116967092524134,hypothalamus gonadotrophin-releasing hormone ne...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,retinal bipolar neuron differentiation,0.6925476415042177,0.8686210086180843,1/2058,0.15955034539606255,0.06116967092524134,retinal bipolar neuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,"glutamate secretion, neurotransmission",0.6925476415042177,0.8686210086180843,1/2058,0.15955034539606255,0.06116967092524134,"glutamate secretion, neurotransmission",OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cellular response to laminar fluid shear stress,0.6925476415042177,0.8686210086180843,1/2058,0.15955034539606255,0.06116967092524134,cellular response to laminar fluid shear stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of neuron projection arborization,0.6925476415042177,0.8686210086180843,1/2058,0.15955034539606255,0.06116967092524134,positive regulation of neuron projection arbori...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of dopaminergic neuron differentiation,0.6925476415042177,0.8686210086180843,1/2058,0.15955034539606255,0.06116967092524134,regulation of dopaminergic neuron differentiation,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,leukocyte activation involved in immune response,0.6501799425851783,0.8689939083616185,32/1775,0.18696643219291756,0.06098326794052514,leukocyte activation involved in immune response,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,KEGG,Cocaine addiction,0.5810590870601098,0.8690622867333816,7/1075,0.23577970258490344,0.06094909603096621,Cocaine addiction,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,regulation of stress-activated MAPK cascade,0.6514247005898188,0.8692359711244771,4/1775,0.18613577796875524,0.060862309804775666,regulation of stress-activated MAPK cascade,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,tolerance induction,0.6592277121499103,0.8696520095523677,3/1775,0.18096454436188142,0.060654495156623515,tolerance induction,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of neuron projection development,0.6664006494082765,0.8696520095523677,17/1775,0.1762645883805402,0.060654495156623515,positive regulation of neuron projection develo...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of T-helper 17 type immune response,0.6751837962488398,0.8696520095523677,2/1775,0.1705779889004068,0.060654495156623515,positive regulation of T-helper 17 type immune ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of L-glutamate import across plasma membrane,0.677749193576366,0.8696520095523677,1/1775,0.16893099049486554,0.060654495156623515,regulation of L-glutamate import across plasma ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,innate immune response in mucosa,0.677749193576366,0.8696520095523677,1/1775,0.16893099049486554,0.060654495156623515,innate immune response in mucosa,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,natural killer cell cytokine production,0.677749193576366,0.8696520095523677,1/1775,0.16893099049486554,0.060654495156623515,natural killer cell cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of T cell tolerance induction,0.677749193576366,0.8696520095523677,1/1775,0.16893099049486554,0.060654495156623515,positive regulation of T cell tolerance induction,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of T cell cytokine production,0.677749193576366,0.8696520095523677,1/1775,0.16893099049486554,0.060654495156623515,negative regulation of T cell cytokine production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of natural killer cell cytokine production,0.677749193576366,0.8696520095523677,1/1775,0.16893099049486554,0.060654495156623515,regulation of natural killer cell cytokine prod...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,adenylate cyclase-activating dopamine receptor signaling pathway,0.677749193576366,0.8696520095523677,1/1775,0.16893099049486554,0.060654495156623515,adenylate cyclase-activating dopamine receptor ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,autophagic cell death,0.677749193576366,0.8696520095523677,1/1775,0.16893099049486554,0.060654495156623515,autophagic cell death,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of neurotransmitter transport,0.677749193576366,0.8696520095523677,1/1775,0.16893099049486554,0.060654495156623515,negative regulation of neurotransmitter transport,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of synapse structural plasticity,0.677749193576366,0.8696520095523677,1/1775,0.16893099049486554,0.060654495156623515,regulation of synapse structural plasticity,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuronal dense core vesicle exocytosis,0.677749193576366,0.8696520095523677,1/1775,0.16893099049486554,0.060654495156623515,neuronal dense core vesicle exocytosis,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,protein localization to axon,0.677749193576366,0.8696520095523677,1/1775,0.16893099049486554,0.060654495156623515,protein localization to axon,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.677749193576366,0.8696520095523677,1/1775,0.16893099049486554,0.060654495156623515,positive regulation of oxidative stress-induced...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,0.65875033644611,0.8705295237688498,19/2057,0.18127914997043798,0.060216495319232934,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_BP,mucosal immune response,0.6981858757755017,0.871530943261553,2/2058,0.1560289411632123,0.059717188876215896,mucosal immune response,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of dopamine metabolic process,0.6981858757755017,0.871530943261553,2/2058,0.1560289411632123,0.059717188876215896,regulation of dopamine metabolic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,dopamine uptake,0.6981858757755017,0.871530943261553,2/2058,0.1560289411632123,0.059717188876215896,dopamine uptake,OUD vs Control Female,GO BP
OUD_vs_Control_Female,Reactome,"Metabolism of ingested SeMet, Sec, MeSec into H2Se",0.25471076634669687,0.8716658326922953,2/1379,0.5939526974936304,0.0596499770314449,"Metabolism of ingested SeMet, Sec, MeSec into H2Se",OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,GO_BP,cell activation involved in immune response,0.6814955664635013,0.8736970352691393,32/1775,0.16653696516562433,0.0586391379845164,cell activation involved in immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cytokinetic process,0.6849400357752187,0.876280042290265,5/1775,0.16434744788254077,0.05735707946496668,cytokinetic process,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,positive regulation of dendrite morphogenesis,0.7037337928565357,0.8764454382256757,4/2058,0.15259159392251484,0.05727511506941269,positive regulation of dendrite morphogenesis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,Reactome,Complement cascade,0.25791161290477976,0.877754277491727,9/1379,0.5885291025812608,0.056627045443896365,Complement cascade,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,DO,autoimmune hepatitis,0.7312824868881016,0.878235443777044,2/920,0.13591482714861178,0.05638903964546821,autoimmune hepatitis,OUD Effect Male vs Female,DO
OUD_vs_Control_Female,KEGG,Ether lipid metabolism,0.6026637606842218,0.8813206864300118,6/1075,0.21992492269843142,0.05486603596324654,Ether lipid metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Fatty acid metabolism,0.6066026212799085,0.8813206864300118,8/1075,0.21709571732746524,0.05486603596324654,Fatty acid metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Ascorbate and aldarate metabolism,0.6071889612904442,0.8813206864300118,2/1075,0.21667613252467277,0.05486603596324654,Ascorbate and aldarate metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,WikiPathways,WP_FOLATE_METABOLISM,0.44987440088797714,0.8817566386876263,10/1231,0.34690871870239737,0.0546512618736288,WP_FOLATE_METABOLISM,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,regulation of stress-activated protein kinase signaling cascade,0.6926921636255674,0.8819025209392501,4/1775,0.15945972547623288,0.05457941595409666,regulation of stress-activated protein kinase s...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.6079165054761992,0.8822666710396314,22/2013,0.21615606497232545,0.05440012659551901,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_N...,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of production of molecular mediator of immune response,0.6965250491421091,0.8857091522199537,14/1775,0.1570632604193766,0.0527088676423021,positive regulation of production of molecular ...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,Hallmark,HALLMARK_XENOBIOTIC_METABOLISM,0.5673323638572967,0.8864568185270261,31/703,0.24616244110702662,0.05234241509091379,HALLMARK_XENOBIOTIC_METABOLISM,OUD vs Control Female,Hallmark
OUD_Effect_Male_vs_Female,GO_BP,mature B cell differentiation involved in immune response,0.7054341383209192,0.886839164450275,3/1775,0.15154352719525316,0.05215513589013468,mature B cell differentiation involved in immun...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of dendritic cell cytokine production,0.7158618789043212,0.886839164450275,1/1775,0.14517076402762494,0.05215513589013468,positive regulation of dendritic cell cytokine ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of natural killer cell mediated immune response to tumor cell,0.7158618789043212,0.886839164450275,1/1775,0.14517076402762494,0.05215513589013468,regulation of natural killer cell mediated immu...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,activation-induced cell death of T cells,0.7158618789043212,0.886839164450275,1/1775,0.14517076402762494,0.05215513589013468,activation-induced cell death of T cells,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,ventral spinal cord interneuron differentiation,0.7158618789043212,0.886839164450275,1/1775,0.14517076402762494,0.05215513589013468,ventral spinal cord interneuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,olfactory bulb interneuron differentiation,0.7158618789043212,0.886839164450275,1/1775,0.14517076402762494,0.05215513589013468,olfactory bulb interneuron differentiation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of axon regeneration,0.7158618789043212,0.886839164450275,1/1775,0.14517076402762494,0.05215513589013468,positive regulation of axon regeneration,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of axon extension involved in axon guidance,0.7158618789043212,0.886839164450275,1/1775,0.14517076402762494,0.05215513589013468,negative regulation of axon extension involved ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of neuron projection regeneration,0.7158618789043212,0.886839164450275,1/1775,0.14517076402762494,0.05215513589013468,positive regulation of neuron projection regene...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of response to oxidative stress,0.7158618789043212,0.886839164450275,1/1775,0.14517076402762494,0.05215513589013468,negative regulation of response to oxidative st...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuron projection maintenance,0.7158618789043212,0.886839164450275,1/1775,0.14517076402762494,0.05215513589013468,neuron projection maintenance,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_MF,structural constituent of postsynapse,0.6700325609961748,0.8895942784205991,2/1824,0.17390409175087815,0.05080801899307938,structural constituent of postsynapse,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_BP,programmed necrotic cell death,0.7197171792408616,0.8904154505158178,5/1775,0.14283813082582406,0.050407312716985564,programmed necrotic cell death,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,stress-activated MAPK cascade,0.7171856136507535,0.8911586980714175,6/2058,0.14436843073109976,0.05004494965613016,stress-activated MAPK cascade,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_AXON_GUIDANCE,0.44468028455626685,0.8917882933691809,10/1002,0.3519521251007145,0.04973823299396514,WP_AXON_GUIDANCE,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_APOPTOSIS_MODULATION_BY_HSP70,0.4568332174490429,0.8917882933691809,3/1002,0.34024232501104984,0.04973823299396514,WP_APOPTOSIS_MODULATION_BY_HSP70,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.47313537702732456,0.8917882933691809,4/1002,0.32501457790082666,0.04973823299396514,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_TLR4_SIGNALING_AND_TOLERANCE,0.47313537702732456,0.8917882933691809,4/1002,0.32501457790082666,0.04973823299396514,WP_TLR4_SIGNALING_AND_TOLERANCE,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,0.47483297209855724,0.8917882933691809,2/1002,0.32345913153868333,0.04973823299396514,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNA...,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,0.46533867970653797,0.8923219296924368,6/1231,0.3322308467039187,0.04947843366716486,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_VITAMIN_B12_METABOLISM,0.48264393313034204,0.8923219296924368,8/1231,0.3163731485530721,0.04947843366716486,WP_VITAMIN_B12_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,0.49092459729258897,0.8923219296924368,2/1231,0.3089852074584532,0.04947843366716486,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,0.49107649821999877,0.8923219296924368,19/1231,0.30885084969572224,0.04947843366716486,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,KEGG,alpha-Linolenic acid metabolism,0.4311326699836334,0.8925092613510252,3/889,0.36538906632257995,0.04938726862442279,alpha-Linolenic acid metabolism,OUD Effect Male vs Female,KEGG
OUD_vs_Control_Female,GO_BP,regulation of tolerance induction,0.728397809024534,0.8941119258306824,2/2058,0.13763136920603844,0.04860811238073395,regulation of tolerance induction,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neuronal dense core vesicle exocytosis,0.7347048107882685,0.8941119258306824,1/2058,0.1338871164208224,0.04860811238073395,neuronal dense core vesicle exocytosis,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,"complement activation, classical pathway",0.7266677046262628,0.8949835702918156,3/1775,0.13866414077587902,0.048184937194810894,"complement activation, classical pathway",OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,axonal fasciculation,0.7283985930342364,0.8949835702918156,2/1775,0.1376309017541872,0.048184937194810894,axonal fasciculation,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,motor neuron apoptotic process,0.7283985930342364,0.8949835702918156,2/1775,0.1376309017541872,0.048184937194810894,motor neuron apoptotic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuron projection fasciculation,0.7283985930342364,0.8949835702918156,2/1775,0.1376309017541872,0.048184937194810894,neuron projection fasciculation,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,DO,autoimmune disease of central nervous system,0.8157351704596183,0.8957360212088012,1/1094,0.08845081266248728,0.04781996067706492,autoimmune disease of central nervous system,OUD vs Control Female,DO
OUD_vs_Control_Female,DO,autosomal dominant distal hereditary motor neuronopathy,0.8157351704596183,0.8957360212088012,1/1094,0.08845081266248728,0.04781996067706492,autosomal dominant distal hereditary motor neur...,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,KEGG,Intestinal immune network for IgA production,0.4551887018038626,0.8960653972767224,6/889,0.34180852606187,0.04766029319504976,Intestinal immune network for IgA production,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Sphingolipid metabolism,0.4591210784129647,0.8960653972767224,7/889,0.33807276816123377,0.04766029319504976,Sphingolipid metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Caffeine metabolism,0.4876583544356029,0.8960653972767224,1/889,0.3118843311647877,0.04766029319504976,Caffeine metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Vitamin B6 metabolism,0.4876583544356029,0.8960653972767224,1/889,0.3118843311647877,0.04766029319504976,Vitamin B6 metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Apoptosis,0.4893666140338495,0.8960653972767224,17/889,0.31036566276406985,0.04766029319504976,Apoptosis,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Galactose metabolism,0.5001827556726479,0.8960653972767224,4/889,0.3008712851071341,0.04766029319504976,Galactose metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Folate transport and metabolism,0.5001827556726479,0.8960653972767224,4/889,0.3008712851071341,0.04766029319504976,Folate transport and metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Pyruvate metabolism,0.5010158685167916,0.8960653972767224,6/889,0.3001485186434538,0.04766029319504976,Pyruvate metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of immunoglobulin mediated immune response,0.7303520331554696,0.8961860533631095,4/1775,0.13646775740688305,0.0476018189529601,positive regulation of immunoglobulin mediated ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of cytokine-mediated signaling pathway,0.7307600677856456,0.896387641521585,8/1775,0.13622519259231008,0.047504139705003,negative regulation of cytokine-mediated signal...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,lymphocyte activation involved in immune response,0.7347459769590043,0.8980212985296928,22/1775,0.13386278319245518,0.046713362971640617,lymphocyte activation involved in immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,stress-activated MAPK cascade,0.7360435862166509,0.8980212985296928,5/1775,0.13309646732975436,0.046713362971640617,stress-activated MAPK cascade,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,sperm axoneme assembly,0.7466817653356216,0.8980212985296928,3/1775,0.12686445441811559,0.046713362971640617,sperm axoneme assembly,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,antimicrobial humoral immune response mediated by antimicrobial peptide,0.7493078175553807,0.8980212985296928,7/1775,0.12533973636833023,0.046713362971640617,antimicrobial humoral immune response mediated ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,natural killer cell mediated immune response to tumor cell,0.749469206481107,0.8980212985296928,1/1775,0.12524620635148306,0.046713362971640617,natural killer cell mediated immune response to...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of tolerance induction,0.749469206481107,0.8980212985296928,1/1775,0.12524620635148306,0.046713362971640617,positive regulation of tolerance induction,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cerebral cortex GABAergic interneuron differentiation,0.749469206481107,0.8980212985296928,1/1775,0.12524620635148306,0.046713362971640617,cerebral cortex GABAergic interneuron different...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of stress granule assembly,0.749469206481107,0.8980212985296928,1/1775,0.12524620635148306,0.046713362971640617,regulation of stress granule assembly,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,chemokine (C-C motif) ligand 5 production,0.749469206481107,0.8980212985296928,1/1775,0.12524620635148306,0.046713362971640617,chemokine (C-C motif) ligand 5 production,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of chemokine (C-C motif) ligand 5 production,0.749469206481107,0.8980212985296928,1/1775,0.12524620635148306,0.046713362971640617,regulation of chemokine (C-C motif) ligand 5 pr...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,"neurotransmitter receptor transport, endosome to postsynaptic membrane",0.749469206481107,0.8980212985296928,1/1775,0.12524620635148306,0.046713362971640617,"neurotransmitter receptor transport, endosome t...",OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,"neurotransmitter receptor transport, endosome to plasma membrane",0.749469206481107,0.8980212985296928,1/1775,0.12524620635148306,0.046713362971640617,"neurotransmitter receptor transport, endosome t...",OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of motor neuron apoptotic process,0.749469206481107,0.8980212985296928,1/1775,0.12524620635148306,0.046713362971640617,negative regulation of motor neuron apoptotic p...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,somatic recombination of immunoglobulin genes involved in immune response,0.751664250629147,0.8980212985296928,5/1775,0.12397610443488377,0.046713362971640617,somatic recombination of immunoglobulin genes i...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,somatic diversification of immunoglobulins involved in immune response,0.751664250629147,0.8980212985296928,5/1775,0.12397610443488377,0.046713362971640617,somatic diversification of immunoglobulins invo...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_ENS_NEURONS,0.7149230852697888,0.9024800675164927,3/2057,0.14574067909360824,0.04456238129287855,DESCARTES_MAIN_FETAL_ENS_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,GO_MF,complement receptor activity,0.712378249437175,0.9031840890792119,1/1824,0.14728934902577634,0.044223721753997615,complement receptor activity,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,GO_MF,toxic substance binding,0.712378249437175,0.9031840890792119,1/1824,0.14728934902577634,0.044223721753997615,toxic substance binding,OUD Effect Male vs Female,GO MF
OUD_Effect_Male_vs_Female,WikiPathways,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,0.5016125424975176,0.9080339185945148,1/1002,0.2996316127886646,0.041897928589812915,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,DO,calcium metabolism disease,0.8410163770145713,0.9104560886609848,2/1094,0.07519554715356465,0.0407409954067924,calcium metabolism disease,OUD vs Control Female,DO
OUD_vs_Control_Female,WikiPathways,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,0.5126093522728992,0.9114414497453696,4/1231,0.2902134746179044,0.040271224835906935,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE...,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of type 2 immune response,0.7791034966647696,0.9117432327715801,1/1775,0.10840484650611537,0.040127451464542996,negative regulation of type 2 immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,dopamine biosynthetic process,0.7791034966647696,0.9117432327715801,1/1775,0.10840484650611537,0.040127451464542996,dopamine biosynthetic process,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuronal ion channel clustering,0.7791034966647696,0.9117432327715801,1/1775,0.10840484650611537,0.040127451464542996,neuronal ion channel clustering,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of cellular response to osmotic stress,0.7791034966647696,0.9117432327715801,1/1775,0.10840484650611537,0.040127451464542996,regulation of cellular response to osmotic stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of response to cytokine stimulus,0.779741672041723,0.9122946390479174,8/1775,0.10804925498779784,0.03986487719007797,negative regulation of response to cytokine sti...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cytoskeleton-dependent cytokinesis,0.7820342148919002,0.91260232878238,12/1775,0.10677424564387338,0.039718427327496926,cytoskeleton-dependent cytokinesis,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,stress granule assembly,0.7831742036916584,0.91260232878238,3/1775,0.10614162582553971,0.039718427327496926,stress granule assembly,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_MF,axon guidance receptor activity,0.7460878216935904,0.9138393385602852,1/1824,0.12721004889183568,0.03913015055703834,axon guidance receptor activity,OUD Effect Male vs Female,GO MF
OUD_vs_Control_Female,GO_BP,tolerance induction,0.7586160970965202,0.9147346543587455,3/2058,0.11997794622850505,0.03870486752948832,tolerance induction,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of stress fiber assembly,0.7586160970965202,0.9147346543587455,3/2058,0.11997794622850505,0.03870486752948832,negative regulation of stress fiber assembly,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of protein localization to synapse,0.7586160970965202,0.9147346543587455,3/2058,0.11997794622850505,0.03870486752948832,regulation of protein localization to synapse,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,0.5169087401002856,0.915342594579284,6/1002,0.28658612454495197,0.038416327695476274,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,0.518701510566692,0.915342594579284,2/1002,0.28508248724870605,0.038416327695476274,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_GANGLIO_SPHINGOLIPID_METABOLISM,0.518701510566692,0.915342594579284,2/1002,0.28508248724870605,0.038416327695476274,WP_GANGLIO_SPHINGOLIPID_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,0.5261704450959063,0.915342594579284,3/1002,0.27887354981215384,0.038416327695476274,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_POSTCOVID_NEUROINFLAMMATION,0.5261704450959063,0.915342594579284,3/1002,0.27887354981215384,0.038416327695476274,WP_POSTCOVID_NEUROINFLAMMATION,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,GO_BP,regulation of stress-activated MAPK cascade,0.7657585365565172,0.9169939315412361,4/2058,0.11590815304737712,0.03763353838327811,regulation of stress-activated MAPK cascade,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of cellular response to stress,0.7664050685890073,0.9169939315412361,64/2058,0.11554163173097612,0.03763353838327811,regulation of cellular response to stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,activation-induced cell death of T cells,0.7710839085626385,0.9169939315412361,1/2058,0.11289835989595763,0.03763353838327811,activation-induced cell death of T cells,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neuron projection maintenance,0.7710839085626385,0.9169939315412361,1/2058,0.11289835989595763,0.03763353838327811,neuron projection maintenance,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,0.5589456027696038,0.9177202638066796,3/1002,0.2526304560966399,0.03728967871054076,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRU...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,0.5589456027696038,0.9177202638066796,3/1002,0.2526304560966399,0.03728967871054076,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,0.5600505721633462,0.9177202638066796,2/1002,0.2517727547441242,0.03728967871054076,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_ENERGY_METABOLISM,0.5624521793169271,0.9177202638066796,6/1002,0.24991439613505587,0.03728967871054076,WP_ENERGY_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,0.5664339641508778,0.9177202638066796,1/1002,0.2468507136497288,0.03728967871054076,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,0.5664339641508778,0.9177202638066796,1/1002,0.2468507136497288,0.03728967871054076,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,GO_CC,NMDA selective glutamate receptor complex,0.3533668526890522,0.9187538169915358,2/2168,0.4517741915847784,0.0368008436139604,NMDA selective glutamate receptor complex,OUD vs Control Female,GO CC
OUD_vs_Control_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,0.6890452863905674,0.9202381127452972,24/2332,0.16175223384969936,0.03609978388125901,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12...,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,WikiPathways,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,0.5253242660020844,0.920862536874242,3/1231,0.2795725376179883,0.035805194920007,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STR...,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,immunoglobulin production involved in immunoglobulin-mediated immune response,0.7943654387646439,0.9219753514461033,5/1775,0.09997965937712663,0.03528068943881728,immunoglobulin production involved in immunoglo...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,KEGG,Amino sugar and nucleotide sugar metabolism,0.525338213077693,0.9220637815624453,5/889,0.2795610074870538,0.03523903662255827,Amino sugar and nucleotide sugar metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Linoleic acid metabolism,0.5318347477740493,0.9220637815624453,3/889,0.2742232911610244,0.03523903662255827,Linoleic acid metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Phenylalanine metabolism,0.538297491550622,0.9220637815624453,2/889,0.26897764397822127,0.03523903662255827,Phenylalanine metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Phosphonate and phosphinate metabolism,0.5518273771049111,0.9220637815624453,1/889,0.25819675722643526,0.03523903662255827,Phosphonate and phosphinate metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,D-Amino acid metabolism,0.5518273771049111,0.9220637815624453,1/889,0.25819675722643526,0.03523903662255827,D-Amino acid metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Serotonergic synapse,0.5616507805226271,0.9220637815624453,13/889,0.25053363324334266,0.03523903662255827,Serotonergic synapse,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Metabolism of xenobiotics by cytochrome P450,0.5669467458850628,0.9220637815624453,6/889,0.2464577330902387,0.03523903662255827,Metabolism of xenobiotics by cytochrome P450,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Purine metabolism,0.5713657191373053,0.9220637815624453,15/889,0.24308582001928888,0.03523903662255827,Purine metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Viral protein interaction with cytokine and cytokine receptor,0.5728795039123766,0.9220637815624453,9/889,0.24193671536076708,0.03523903662255827,Viral protein interaction with cytokine and cyt...,OUD Effect Male vs Female,KEGG
OUD_vs_Control_Female,Reactome,Vitamin B5 (pantothenate) metabolism,0.3025533302376636,0.9230491629006676,4/1379,0.5191980623782865,0.034775167221252276,Vitamin B5 (pantothenate) metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,STING mediated induction of host immune responses,0.3098175232645972,0.9230491629006676,3/1379,0.5088940222065819,0.034775167221252276,STING mediated induction of host immune responses,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Defects in cobalamin (B12) metabolism,0.3098175232645972,0.9230491629006676,3/1379,0.5088940222065819,0.034775167221252276,Defects in cobalamin (B12) metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Na+/Cl- dependent neurotransmitter transporters,0.3098175232645972,0.9230491629006676,3/1379,0.5088940222065819,0.034775167221252276,Na+/Cl- dependent neurotransmitter transporters,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,GO_BP,somatic diversification of immune receptors,0.7983498175766324,0.924234953972218,7/1775,0.09780676960958984,0.03421761076841063,somatic diversification of immune receptors,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of cellular response to stress,0.8017309524675413,0.924234953972218,54/1775,0.09597134924985665,0.03421761076841063,regulation of cellular response to stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,complement receptor mediated signaling pathway,0.8052342059896633,0.924234953972218,1/1775,0.09407778475577823,0.03421761076841063,complement receptor mediated signaling pathway,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cellular response to salt stress,0.8052342059896633,0.924234953972218,1/1775,0.09407778475577823,0.03421761076841063,cellular response to salt stress,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,organ or tissue specific immune response,0.7811453756618336,0.9246284889535643,2/2058,0.10726813389171364,0.034032729538734485,organ or tissue specific immune response,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,cytokinesis,0.8080684670616106,0.9258986719486129,18/1775,0.09255184020646945,0.03343653882719847,cytokinesis,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neuron fate specification,0.8128026461153224,0.9271345319755268,2/1775,0.0900148911927687,0.03285724292625399,neuron fate specification,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of macrophage cytokine production,0.8128026461153224,0.9271345319755268,2/1775,0.0900148911927687,0.03285724292625399,positive regulation of macrophage cytokine prod...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of cytokine production involved in inflammatory response,0.8128026461153224,0.9271345319755268,2/1775,0.0900148911927687,0.03285724292625399,negative regulation of cytokine production invo...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,0.7667170967408933,0.9281455139759224,1/2057,0.1153648524638073,0.032383930071419036,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,KEGG,Drug metabolism - other enzymes,0.6485006341624705,0.9295175756328744,8/1075,0.18808959488733842,0.03174239402741432,Drug metabolism - other enzymes,OUD vs Control Female,KEGG
OUD_vs_Control_Female,WikiPathways,WP_AMINO_ACID_METABOLISM,0.5392407287751704,0.9299483979944818,13/1231,0.2682173130337573,0.03154114939016011,WP_AMINO_ACID_METABOLISM,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,Reactome,Opioid Signalling,0.19449580892277543,0.9303421962614848,14/1194,0.7110897525970011,0.03135728089410347,Opioid Signalling,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Chemokine receptors bind chemokines,0.20305774834920617,0.9303421962614848,7/1194,0.6923804338956847,0.03135728089410347,Chemokine receptors bind chemokines,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Diseases associated with surfactant metabolism,0.20371286021587687,0.9303421962614848,2/1194,0.6909815535010838,0.03135728089410347,Diseases associated with surfactant metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,KEGG,Tyrosine metabolism,0.5811227278887587,0.930872517821808,4/889,0.23573213883820202,0.031109791196356283,Tyrosine metabolism,OUD Effect Male vs Female,KEGG
OUD_vs_Control_Female,WikiPathways,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,0.5460390019614324,0.9308902893850506,12/1231,0.2627763358086487,0.031101500030777725,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,KEGG,Arginine and proline metabolism,0.5879736911887551,0.9321276520840835,6/889,0.23064210594285414,0.03052460824744246,Arginine and proline metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,0.6925741361466744,0.9331363914011608,21/2013,0.1595337310056082,0.030054873184114997,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CE...,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,regulation of stress-activated protein kinase signaling cascade,0.8011443315636617,0.9336703216361603,4/2058,0.09628923578218608,0.029806445792585828,regulation of stress-activated protein kinase s...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,negative regulation of motor neuron apoptotic process,0.8024765464101823,0.9336703216361603,1/2058,0.09556765165017365,0.029806445792585828,negative regulation of motor neuron apoptotic p...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_GRANULE_NEURONS,0.7761350563058471,0.9351523180816161,3/2057,0.11006269999847298,0.02911764526149156,DESCARTES_FETAL_CEREBELLUM_GRANULE_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,DO,neuronal ceroid lipofuscinosis,0.8572468389777448,0.9378049047269031,2/920,0.0668941076327367,0.027887500227731347,neuronal ceroid lipofuscinosis,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,WikiPathways,WP_TRYPTOPHAN_METABOLISM,0.6126530581158824,0.9399137212069147,4/1002,0.21278539432487634,0.02691201036144574,WP_TRYPTOPHAN_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_AMINO_ACID_METABOLISM,0.6197378761455316,0.9399137212069147,10/1002,0.20779196052560628,0.02691201036144574,WP_AMINO_ACID_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_BENZOAPYRENE_METABOLISM,0.6228318828735598,0.9399137212069147,1/1002,0.20562916392401304,0.02691201036144574,WP_BENZOAPYRENE_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,0.6228318828735598,0.9399137212069147,1/1002,0.20562916392401304,0.02691201036144574,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MO...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_COMPLEMENT_AND_COAGULATION_CASCADES,0.6237483210584392,0.9399137212069147,7/1002,0.2049906103561875,0.02691201036144574,WP_COMPLEMENT_AND_COAGULATION_CASCADES,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,0.6237483210584392,0.9399137212069147,7/1002,0.2049906103561875,0.02691201036144574,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COA...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,0.6309820345127024,0.9399137212069147,5/1002,0.19998300592713628,0.02691201036144574,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_S...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_NAD_METABOLISM,0.6349086063781808,0.9399137212069147,2/1002,0.19728878589269763,0.02691201036144574,WP_NAD_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,somatic diversification of immune receptors via germline recombination within a single locus,0.8400860733477392,0.9415287998261042,6/1775,0.07567621481323684,0.02616639108623167,somatic diversification of immune receptors via...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,G protein-coupled glutamate receptor signaling pathway,0.8485920345407538,0.9415287998261042,1/1775,0.07130104913225034,0.02616639108623167,G protein-coupled glutamate receptor signaling ...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,calcium ion-regulated exocytosis of neurotransmitter,0.8485920345407538,0.9415287998261042,1/1775,0.07130104913225034,0.02616639108623167,calcium ion-regulated exocytosis of neurotransm...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter receptor transport to postsynaptic membrane,0.8485920345407538,0.9415287998261042,1/1775,0.07130104913225034,0.02616639108623167,neurotransmitter receptor transport to postsyna...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,0.6425572420155424,0.942907958903134,7/1002,0.19208817728206506,0.02553069845182832,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPE...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,0.6485701379187183,0.942907958903134,3/1002,0.18804305140106367,0.02553069845182832,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,0.6485701379187183,0.942907958903134,3/1002,0.18804305140106367,0.02553069845182832,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,0.6536700853500519,0.942907958903134,9/1002,0.18464138969321386,0.02553069845182832,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,0.6684238873013392,0.942907958903134,2/1002,0.17494803822540242,0.02553069845182832,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STR...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,0.6684238873013392,0.942907958903134,2/1002,0.17494803822540242,0.02553069845182832,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_SERINE_METABOLISM,0.6718999760130941,0.942907958903134,1/1002,0.17269537441462737,0.02553069845182832,WP_SERINE_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,0.7094009390677593,0.944282351748449,19/2013,0.14910824096743658,0.024898127024510257,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_...,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,DO,nicotine dependence,0.8675403086390263,0.9447049474903387,3/920,0.061710337386877416,0.02470381020521316,nicotine dependence,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,DO,mineral metabolism disease,0.8720431146053792,0.9453937059767573,2/920,0.05946204262211004,0.024387293368690215,mineral metabolism disease,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,KEGG,Platinum drug resistance,0.6126485929771097,0.9456601618742306,8/889,0.2127885595619887,0.024264906239823733,Platinum drug resistance,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Glycerolipid metabolism,0.6197012030994233,0.9456601618742306,7/889,0.20781766070213087,0.024264906239823733,Glycerolipid metabolism,OUD Effect Male vs Female,KEGG
OUD_vs_Control_Female,GO_BP,regulation of programmed necrotic cell death,0.8173118792708194,0.9459754724822719,3/2058,0.08761218875491425,0.024120123961525512,regulation of programmed necrotic cell death,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,response to salt stress,0.8246761213081701,0.9479153431304179,2/2058,0.08371658035409207,0.023230447106051835,response to salt stress,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,dopamine biosynthetic process,0.8295659284898734,0.9479153431304179,1/2058,0.08114909337492525,0.023230447106051835,dopamine biosynthetic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,neuronal ion channel clustering,0.8295659284898734,0.9479153431304179,1/2058,0.08114909337492525,0.023230447106051835,neuronal ion channel clustering,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of stress fiber assembly,0.8598506583435298,0.9492334684498915,2/1775,0.06557697188363423,0.022626957657754385,negative regulation of stress fiber assembly,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,axonemal dynein complex assembly,0.8598506583435298,0.9492334684498915,2/1775,0.06557697188363423,0.022626957657754385,axonemal dynein complex assembly,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter receptor transport to plasma membrane,0.866506255224007,0.9492334684498915,1/1775,0.06222829780930963,0.022626957657754385,neurotransmitter receptor transport to plasma m...,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,DO,post-traumatic stress disorder,0.9063947112232524,0.9493282901394718,1/1094,0.0426826372281307,0.022583576886602324,post-traumatic stress disorder,OUD vs Control Female,DO
OUD_vs_Control_Female,GO_MF,structural constituent of postsynapse,0.4893738947677809,0.9539202792898327,3/2121,0.3103592014343461,0.020487918494226678,structural constituent of postsynapse,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,oxidative phosphorylation uncoupler activity,0.5191286585621491,0.9539202792898327,1/2121,0.28472499517846966,0.020487918494226678,oxidative phosphorylation uncoupler activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,dopamine binding,0.5191286585621491,0.9539202792898327,1/2121,0.28472499517846966,0.020487918494226678,dopamine binding,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,KEGG,Nitrogen metabolism,0.6468485192589506,0.9540399774818855,2/889,0.1891974116844209,0.020433426516014833,Nitrogen metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,Reactome,"Sensory perception of sweet, bitter, and umami (glutamate) taste",0.2166235486332042,0.9542404420804439,4/1194,0.6642943340192946,0.02034218136315509,"Sensory perception of sweet, bitter, and umami ...",OUD Effect Male vs Female,Reactome
OUD_vs_Control_Female,KEGG,Glyoxylate and dicarboxylate metabolism,0.686082033964508,0.9555150594485455,4/1075,0.16362395314441758,0.019762463832553166,Glyoxylate and dicarboxylate metabolism,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,Reactome,Defects in cobalamin (B12) metabolism,0.23509772434530612,0.9555669870812552,3/1194,0.6287515746566832,0.019738862664418485,Defects in cobalamin (B12) metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,0.23509772434530612,0.9555669870812552,3/1194,0.6287515746566832,0.019738862664418485,TP53 regulates transcription of several additio...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Regulation of Complement cascade,0.2399290451515796,0.9555669870812552,7/1194,0.6199171743518479,0.019738862664418485,Regulation of Complement cascade,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,"Cobalamin (Cbl, vitamin B12) transport and metabolism",0.24390062843119317,0.9555669870812552,4/1194,0.6127870806873033,0.019738862664418485,"Cobalamin (Cbl, vitamin B12) transport and meta...",OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,DNA Damage/Telomere Stress Induced Senescence,0.24525569630160945,0.9555669870812552,5/1194,0.6103808969199732,0.019738862664418485,DNA Damage/Telomere Stress Induced Senescence,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Diseases of Immune System,0.24525569630160945,0.9555669870812552,5/1194,0.6103808969199732,0.019738862664418485,Diseases of Immune System,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,MECP2 regulates transcription of neuronal ligands,0.25097362821616875,0.9555669870812552,2/1194,0.600371910877168,0.019738862664418485,MECP2 regulates transcription of neuronal ligands,OUD Effect Male vs Female,Reactome
OUD_vs_Control_Female,WikiPathways,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.5804770119224101,0.9563930791517988,6/1231,0.23621497453510532,0.01936357527589793,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_BENZENE_METABOLISM,0.5811028648125514,0.9563930791517988,1/1231,0.23574698350251763,0.01936357527589793,WP_BENZENE_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,0.5935204955446665,0.9563930791517988,2/1231,0.22656427932394205,0.01936357527589793,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_IN...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,0.5935204955446665,0.9563930791517988,2/1231,0.22656427932394205,0.01936357527589793,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNA...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_PURINE_METABOLISM,0.5935204955446665,0.9563930791517988,2/1231,0.22656427932394205,0.01936357527589793,WP_PURINE_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_MELATONIN_METABOLISM_AND_EFFECTS,0.5956595821831338,0.9563930791517988,5/1231,0.22500186746930992,0.01936357527589793,WP_MELATONIN_METABOLISM_AND_EFFECTS,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,mucosal immune response,0.8823019619753827,0.9568462002844205,1/1775,0.05438275503130409,0.019157863409822676,mucosal immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,antifungal innate immune response,0.8823019619753827,0.9568462002844205,1/1775,0.05438275503130409,0.019157863409822676,antifungal innate immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of programmed necrotic cell death,0.8823019619753827,0.9568462002844205,1/1775,0.05438275503130409,0.019157863409822676,negative regulation of programmed necrotic cell...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,dopamine uptake,0.8823019619753827,0.9568462002844205,1/1775,0.05438275503130409,0.019157863409822676,dopamine uptake,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of dendrite development,0.8823019619753827,0.9568462002844205,1/1775,0.05438275503130409,0.019157863409822676,positive regulation of dendrite development,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,retrograde axonal transport,0.8433816290549281,0.9588116221658787,2/2058,0.07397586322981806,0.01826671033725983,retrograde axonal transport,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,spinal cord motor neuron differentiation,0.8433816290549281,0.9588116221658787,2/2058,0.07397586322981806,0.01826671033725983,spinal cord motor neuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.737232377086017,0.9596035642968407,24/2332,0.13239560009291276,0.0179081475825157,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WE...,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,somatic diversification of immune receptors via somatic mutation,0.852941691180166,0.9597956657880521,1/2058,0.06908065706724016,0.01782121557111402,somatic diversification of immune receptors via...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,microglia differentiation,0.852941691180166,0.9597956657880521,1/2058,0.06908065706724016,0.01782121557111402,microglia differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cellular response to salt stress,0.852941691180166,0.9597956657880521,1/2058,0.06908065706724016,0.01782121557111402,cellular response to salt stress,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_CODEINE_AND_MORPHINE_METABOLISM,0.7145900453592673,0.9608327658505841,1/1002,0.14594303805752518,0.01735219525391386,WP_CODEINE_AND_MORPHINE_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_ESTROGEN_METABOLISM_WP697,0.7145900453592673,0.9608327658505841,1/1002,0.14594303805752518,0.01735219525391386,WP_ESTROGEN_METABOLISM_WP697,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.7145900453592673,0.9608327658505841,1/1002,0.14594303805752518,0.01735219525391386,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERG...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_LIPID_METABOLISM_PATHWAY,0.7244328752694784,0.9608327658505841,3/1002,0.1400018493240779,0.01735219525391386,WP_LIPID_METABOLISM_PATHWAY,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_ONECARBON_METABOLISM,0.7244328752694784,0.9608327658505841,3/1002,0.1400018493240779,0.01735219525391386,WP_ONECARBON_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,0.7279421749225616,0.9608327658505841,2/1002,0.13790311809007794,0.01735219525391386,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_ESTROGEN_METABOLISM_WP5276,0.7279421749225616,0.9608327658505841,2/1002,0.13790311809007794,0.01735219525391386,WP_ESTROGEN_METABOLISM_WP5276,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,axoneme assembly,0.888774248248987,0.9615967337262871,7/1775,0.051208537331574065,0.017007020515066015,axoneme assembly,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.8164882220507101,0.9623737257024221,2/2057,0.08805007563677723,0.016656242420309136,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,GO_CC,axonemal dynein complex,0.3763085661790013,0.9633499294182434,3/2168,0.424455895414051,0.01621593010220142,axonemal dynein complex,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,axonemal A tubule inner sheath,0.3763085661790013,0.9633499294182434,3/2168,0.424455895414051,0.01621593010220142,axonemal A tubule inner sheath,OUD vs Control Female,GO CC
OUD_vs_Control_Female,Reactome,Pyruvate metabolism,0.3313187557669169,0.9633601045741409,8/1379,0.4797539782577481,0.01621134299362683,Pyruvate metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Metabolism of vitamins and cofactors,0.3321182332563913,0.9633601045741409,29/1379,0.4787072810253165,0.01621134299362683,Metabolism of vitamins and cofactors,OUD vs Control Female,Reactome
OUD_vs_Control_Female,GO_MF,complement component C1q complex binding,0.5846430544504895,0.9635323749058365,1/2121,0.233109205362847,0.016133688370499562,complement component C1q complex binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,C-X-C chemokine receptor activity,0.5846430544504895,0.9635323749058365,1/2121,0.233109205362847,0.016133688370499562,C-X-C chemokine receptor activity,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,type 5 metabotropic glutamate receptor binding,0.5846430544504895,0.9635323749058365,1/2121,0.233109205362847,0.016133688370499562,type 5 metabotropic glutamate receptor binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,dopamine receptor binding,0.5870985796917284,0.9635323749058365,2/2121,0.23128897026582315,0.016133688370499562,dopamine receptor binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,neurotransmitter receptor regulator activity,0.5870985796917284,0.9635323749058365,2/2121,0.23128897026582315,0.016133688370499562,neurotransmitter receptor regulator activity,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.7447325696293036,0.9642085534013085,20/2013,0.12799965260086338,0.01582902025135928,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_...,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,GO_BP,neutrophil activation involved in immune response,0.896229563141629,0.9644138166652059,1/1775,0.047580734494032634,0.015736576334324768,neutrophil activation involved in immune response,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,natural killer cell activation involved in immune response,0.896229563141629,0.9644138166652059,1/1775,0.047580734494032634,0.015736576334324768,natural killer cell activation involved in immu...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,0.7466872629590533,0.9650540512460403,3/1002,0.12686125683268995,0.015448361785216112,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_VITAMIN_B12_METABOLISM,0.7489707038301517,0.9650540512460403,5/1002,0.1255351695017853,0.015448361785216112,WP_VITAMIN_B12_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_GLYOXYLATE_METABOLISM,0.751730405690438,0.9650540512460403,1/1002,0.12393788322933878,0.015448361785216112,WP_GLYOXYLATE_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,0.751730405690438,0.9650540512460403,1/1002,0.12393788322933878,0.015448361785216112,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMIN...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,0.751730405690438,0.9650540512460403,1/1002,0.12393788322933878,0.015448361785216112,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,0.7541481989869719,0.9650540512460403,2/1002,0.12254330177226012,0.015448361785216112,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,BioCarta,BIOCARTA_CYTOKINE_PATHWAY,0.536657761484878,0.9651268939024387,2/207,0.27030258521588535,0.015415582305327937,BIOCARTA_CYTOKINE_PATHWAY,OUD Effect Male vs Female,BioCarta
OUD_Effect_Male_vs_Female,BioCarta,BIOCARTA_UCALPAIN_PATHWAY,0.8702401119762995,0.9651268939024387,1/207,0.06036090264697979,0.015415582305327937,BIOCARTA_UCALPAIN_PATHWAY,OUD Effect Male vs Female,BioCarta
OUD_Effect_Male_vs_Female,BioCarta,BIOCARTA_MCALPAIN_PATHWAY,0.919233823428686,0.9651268939024387,1/207,0.036574004056297155,0.015415582305327937,BIOCARTA_MCALPAIN_PATHWAY,OUD Effect Male vs Female,BioCarta
OUD_vs_Control_Female,GO_BP,neuronal stem cell population maintenance,0.8602558719709847,0.9651889987594497,2/2058,0.06537235427123682,0.015387636830899484,neuronal stem cell population maintenance,OUD vs Control Female,GO BP
OUD_vs_Control_Female,KEGG,Autoimmune thyroid disease,0.7018058346135323,0.9656848284282203,5/1075,0.15378302550515544,0.015164591605662987,Autoimmune thyroid disease,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Cobalamin transport and metabolism,0.6782333436242218,0.965714966641896,2/889,0.16862086304504442,0.015151037850580015,Cobalamin transport and metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Nucleotide metabolism,0.6851150535082156,0.9665000195866035,9/889,0.1642364899558358,0.014798132834234472,Nucleotide metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Porphyrin metabolism,0.6990365528369973,0.9665000195866035,3/889,0.15550011426812083,0.014798132834234472,Porphyrin metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Pyrimidine metabolism,0.7018283013845148,0.9665000195866035,6/889,0.15376912274457918,0.014798132834234472,Pyrimidine metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Carbon metabolism,0.7146915278296846,0.9665000195866035,12/889,0.14588136612693717,0.014798132834234472,Carbon metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Glutathione metabolism,0.71727761084676,0.9665000195866035,5/889,0.14431272505116505,0.014798132834234472,Glutathione metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Drug metabolism - other enzymes,0.7346553547740607,0.9665000195866035,6/889,0.1339163515594615,0.014798132834234472,Drug metabolism - other enzymes,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Cytokine-cytokine receptor interaction,0.7348416124977775,0.9665000195866035,26/889,0.13380625850876893,0.014798132834234472,Cytokine-cytokine receptor interaction,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Glyoxylate and dicarboxylate metabolism,0.7435388648786458,0.9665000195866035,3/889,0.128696325916473,0.014798132834234472,Glyoxylate and dicarboxylate metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Apoptosis - multiple species,0.7435388648786458,0.9665000195866035,3/889,0.128696325916473,0.014798132834234472,Apoptosis - multiple species,OUD Effect Male vs Female,KEGG
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,0.9083518055981372,0.9670308628073192,5/2407,0.041745916193863426,0.014559665179640231,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,OUD vs Control Female,C8 CellType
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.7535060026129333,0.9670920033535857,19/2013,0.12291328363960777,0.014532207770043873,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,GO_BP,cytoskeleton-dependent cytokinesis,0.8624439226661768,0.9673443320495168,13/2058,0.064269133783257,0.014418908656617753,cytoskeleton-dependent cytokinesis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,mitotic cytokinetic process,0.8634036487824159,0.9678170430172778,3/2058,0.06378612032797852,0.014206734342307646,mitotic cytokinetic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,Reactome,Glycosphingolipid metabolism,0.3385350786851271,0.9682653713937214,9/1379,0.4703963234631362,0.014005599781091633,Glycosphingolipid metabolism,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,DO,complement deficiency,0.920024142617543,0.9684060466116208,1/920,0.03620077605878562,0.013942507538996566,complement deficiency,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,WikiPathways,WP_COMPLEMENT_ACTIVATION,0.7781458572912947,0.9686802596664248,2/1002,0.10893899031156777,0.013819550480266932,WP_COMPLEMENT_ACTIVATION,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,0.7781458572912947,0.9686802596664248,2/1002,0.10893899031156777,0.013819550480266932,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_OXIDATIVE_DAMAGE_RESPONSE,0.7821523534993224,0.9686802596664248,4/1002,0.10670864356489178,0.013819550480266932,WP_OXIDATIVE_DAMAGE_RESPONSE,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_FOLATE_METABOLISM,0.7827554640893696,0.9686802596664248,6/1002,0.10637389207185292,0.013819550480266932,WP_FOLATE_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,0.7840418920520669,0.9686802596664248,1/1002,0.10566073195715271,0.013819550480266932,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECI...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,0.7840418920520669,0.9686802596664248,1/1002,0.10566073195715271,0.013819550480266932,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GL...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,0.804882944159252,0.9686802596664248,3/1002,0.09426727541123385,0.013819550480266932,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,0.8121517938660223,0.9686802596664248,1/1002,0.0903627920921001,0.013819550480266932,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,0.8121517938660223,0.9686802596664248,1/1002,0.0903627920921001,0.013819550480266932,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_IN...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,0.8121517938660223,0.9686802596664248,1/1002,0.0903627920921001,0.013819550480266932,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_PURINE_METABOLISM,0.8121517938660223,0.9686802596664248,1/1002,0.0903627920921001,0.013819550480266932,WP_PURINE_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,0.8121517938660223,0.9686802596664248,1/1002,0.0903627920921001,0.013819550480266932,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREA...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.761103087187685,0.9703797842583664,20/2013,0.11855651646899046,0.013058259623439511,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE...,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,KEGG,Choline metabolism in cancer,0.7120985273327354,0.9720710055653213,13/1075,0.14745991237923645,0.012302010589250411,Choline metabolism in cancer,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,B cell activation involved in immune response,0.9139172606120611,0.9733182886384336,7/1775,0.039093120334151236,0.011745116160086966,B cell activation involved in immune response,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,neuron fate specification,0.8754491938821394,0.9743273684687691,2/2058,0.05776905284367609,0.011295098119354082,neuron fate specification,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,organ or tissue specific immune response,0.9193376576773757,0.9754813712054592,1/1775,0.036524950057853375,0.01078101992392158,organ or tissue specific immune response,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,Hallmark,HALLMARK_FATTY_ACID_METABOLISM,0.6639438248257061,0.975653047345619,24/703,0.17786866400587265,0.010704594640425617,HALLMARK_FATTY_ACID_METABOLISM,OUD vs Control Female,Hallmark
OUD_Effect_Male_vs_Female,DO,calcium metabolism disease,0.9396219613460062,0.9759860820193574,1/920,0.027046841213370924,0.010556375514958487,calcium metabolism disease,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,WikiPathways,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,0.8366059841409665,0.9762558238430136,1/1002,0.0774790332886112,0.010436362328123306,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,0.8366059841409665,0.9762558238430136,1/1002,0.0774790332886112,0.010436362328123306,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPEN...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,0.838209643964338,0.9763307721505311,2/1002,0.07664734672765605,0.010403022309846395,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,0.8499294670176004,0.9763307721505311,22/1002,0.07061711352811141,0.010403022309846395,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,0.854700035794392,0.9763307721505311,2/1002,0.06818627785283377,0.010403022309846395,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,0.8763856194980515,0.9763307721505311,1/1002,0.057304757336666304,0.010403022309846395,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_GLUTATHIONE_METABOLISM,0.8763856194980515,0.9763307721505311,1/1002,0.057304757336666304,0.010403022309846395,WP_GLUTATHIONE_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,0.8763856194980515,0.9763307721505311,1/1002,0.057304757336666304,0.010403022309846395,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_TAMOXIFEN_METABOLISM,0.8763856194980515,0.9763307721505311,1/1002,0.057304757336666304,0.010403022309846395,WP_TAMOXIFEN_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,KEGG,Cortisol synthesis and secretion,0.7648342301834453,0.9765042200866129,6/889,0.11643268343185678,0.010325875513485887,Cortisol synthesis and secretion,OUD Effect Male vs Female,KEGG
OUD_vs_Control_Female,GO_MF,D1 dopamine receptor binding,0.6412353382245317,0.9767315342928717,1/2121,0.19298255186215715,0.010224790628406564,D1 dopamine receptor binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,WikiPathways,WP_NEUROINFLAMMATION,0.6386985486299297,0.9773031147206447,2/1231,0.19470407072588677,0.009970717106270233,WP_NEUROINFLAMMATION,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,0.6408739071364711,0.9773031147206447,3/1231,0.19322741014059017,0.009970717106270233,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.6458635084047541,0.9773031147206447,4/1231,0.1898592526083525,0.009970717106270233,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,0.6480372331167764,0.9773031147206447,1/1231,0.1884000409309162,0.009970717106270233,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of myeloid leukocyte cytokine production involved in immune response,0.9230548294606152,0.9776884030361213,2/1775,0.03477250111389667,0.009799536218783175,positive regulation of myeloid leukocyte cytoki...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,mitotic cytokinetic process,0.9230548294606152,0.9776884030361213,2/1775,0.03477250111389667,0.009799536218783175,mitotic cytokinetic process,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_BP,neurotransmitter receptor transport to postsynaptic membrane,0.8905181670049557,0.9785165721403271,1/2058,0.050357216291106864,0.009431814739601606,neurotransmitter receptor transport to postsyna...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of neuron projection arborization,0.8905181670049557,0.9785165721403271,1/2058,0.050357216291106864,0.009431814739601606,regulation of neuron projection arborization,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,midbrain dopaminergic neuron differentiation,0.8905181670049557,0.9785165721403271,1/2058,0.050357216291106864,0.009431814739601606,midbrain dopaminergic neuron differentiation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of motor neuron apoptotic process,0.8905181670049557,0.9785165721403271,1/2058,0.050357216291106864,0.009431814739601606,regulation of motor neuron apoptotic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,Reactome,IL-6-type cytokine receptor ligand interactions,0.3506203370838553,0.9797901545453831,3/1379,0.4551628970638403,0.008866928880601423,IL-6-type cytokine receptor ligand interactions,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,KEGG,Thiamine metabolism,0.7705214126737852,0.9801485617100355,1/889,0.11321528779974495,0.008708093041167063,Thiamine metabolism,OUD Effect Male vs Female,KEGG
OUD_vs_Control_Female,Reactome,Axonal growth inhibition (RHOA activation),0.3645845054988839,0.9805873779396587,2/1379,0.43820179239888235,0.008513701265688333,Axonal growth inhibition (RHOA activation),OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,GO_BP,response to salt stress,0.9373021766360985,0.9849888267596336,1/1775,0.028120374438634355,0.006568695902548752,response to salt stress,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,0.9063822763096996,0.986164735432086,2/1002,0.042688595395490685,0.006050531597092661,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,0.9064878495230035,0.986164735432086,1/1002,0.042638012771426016,0.006050531597092661,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,GO_BP,neurotransmitter receptor transport to plasma membrane,0.9055370719712136,0.9863211160631846,1/2058,0.043093765313519605,0.005981669003981063,neurotransmitter receptor transport to plasma m...,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of cytokinesis,0.9421706584255358,0.9875278508061739,6/1775,0.02587042491449165,0.005450647315805984,regulation of cytokinesis,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,KEGG,"Alanine, aspartate and glutamate metabolism",0.7353478122739736,0.988123622743152,4/1075,0.1335071953070811,0.0051887180474005775,"Alanine, aspartate and glutamate metabolism",OUD vs Control Female,KEGG
OUD_vs_Control_Female,WikiPathways,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,0.6578702110089757,0.9881316677453365,6/1231,0.18185977842622728,0.0051851821681319086,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_S...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,GO_MF,G protein-coupled glutamate receptor binding,0.6901200772471303,0.988247227811545,1/2121,0.1610753377428137,0.005134395247412664,G protein-coupled glutamate receptor binding,OUD vs Control Female,GO MF
OUD_vs_Control_Female,Reactome,Metabolism of fat-soluble vitamins,0.3702493971034118,0.9882681176098655,7/1379,0.4315056399907501,0.005125215127298684,Metabolism of fat-soluble vitamins,OUD vs Control Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Axon guidance,0.26471309636236784,0.9884137074474679,68/1194,0.577224571969481,0.005061240376881372,Axon guidance,OUD Effect Male vs Female,Reactome
OUD_vs_Control_Female,Reactome,"Cell death signalling via NRAGE, NRIF and NADE",0.3709852690567736,0.9887319519255526,12/1379,0.43064333484417483,0.0049214309285822285,"Cell death signalling via NRAGE, NRIF and NADE",OUD vs Control Female,Reactome
OUD_vs_Control_Female,WikiPathways,WP_COMPLEMENT_ACTIVATION,0.6746820373797071,0.9916166978567831,3/1231,0.1709008522735181,0.00365616874769777,WP_COMPLEMENT_ACTIVATION,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,0.6746820373797071,0.9916166978567831,3/1231,0.1709008522735181,0.00365616874769777,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,0.679825585412362,0.9916166978567831,2/1231,0.16760249465982968,0.00365616874769777,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_BENZOAPYRENE_METABOLISM,0.7042836521786024,0.9916166978567831,1/1231,0.15225239232756554,0.00365616874769777,WP_BENZOAPYRENE_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,0.7042836521786024,0.9916166978567831,1/1231,0.15225239232756554,0.00365616874769777,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MO...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,0.7042836521786024,0.9916166978567831,1/1231,0.15225239232756554,0.00365616874769777,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMM...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,0.706080326913617,0.9916166978567831,3/1231,0.15114588881945937,0.00365616874769777,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,GO_BP,regulation of receptor localization to synapse,0.9123397810760844,0.99190581108429,2/2058,0.03984338802652541,0.0035295654148142846,regulation of receptor localization to synapse,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,cytokinesis,0.9146407970020124,0.9929304578546203,19/2058,0.03874943107943717,0.00308116724238145,cytokinesis,OUD vs Control Female,GO BP
OUD_Effect_Male_vs_Female,GO_CC,AMPA glutamate receptor complex,0.39387187045684047,0.9934453705884699,4/1867,0.404645034528765,0.002856009685810928,AMPA glutamate receptor complex,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,WikiPathways,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,0.71704239830477845,0.9947794911304655,2/1231,0.14445516398992483,0.0022731769411875767,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_TAMOXIFEN_METABOLISM,0.71704239830477845,0.9947794911304655,2/1231,0.14445516398992483,0.0022731769411875767,WP_TAMOXIFEN_METABOLISM,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,Reactome,TRIF-mediated programmed cell death,0.29845889992263763,0.9958094216021639,2/1194,0.5251154660949365,0.0018237690723348777,TRIF-mediated programmed cell death,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Defective Intrinsic Pathway for Apoptosis,0.30036247014636397,0.9958094216021639,4/1194,0.522354332741661,0.0018237690723348777,Defective Intrinsic Pathway for Apoptosis,OUD Effect Male vs Female,Reactome
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,0.79539873365478575,0.9959348831575728,23/2332,0.09941510478475876,0.0017690559636823716,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CE...,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,KEGG,Pyrimidine metabolism,0.7469688549169679,0.9959584732226238,7/1075,0.12669750584147335,0.0017587692331734119,Pyrimidine metabolism,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of cytokinesis,0.9627827580002906,0.9960949194805458,2/1775,0.016471695892209915,0.001699274987485379,positive regulation of cytokinesis,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,GO_CC,A axonemal microtubule,0.4186505023857535,0.9969483581218336,4/2168,0.3781483832966536,0.0013273375394895297,A axonemal microtubule,OUD vs Control Female,GO CC
OUD_vs_Control_Female,BioCarta,BIOCARTA_STRESS_PATHWAY,0.2762022006038704,0.9975439503508445,6/265,0.5587728655607528,0.0010679608298239422,BIOCARTA_STRESS_PATHWAY,OUD vs Control Female,BioCarta
OUD_vs_Control_Female,BioCarta,BIOCARTA_UCALPAIN_PATHWAY,0.7257260666704921,0.9975439503508445,2/265,0.13922727762419482,0.0010679608298239422,BIOCARTA_UCALPAIN_PATHWAY,OUD vs Control Female,BioCarta
OUD_vs_Control_Female,BioCarta,BIOCARTA_TCAPOPTOSIS_PATHWAY,0.8428150398603254,0.9975439503508445,1/265,0.07426772309945133,0.0010679608298239422,BIOCARTA_TCAPOPTOSIS_PATHWAY,OUD vs Control Female,BioCarta
OUD_vs_Control_Female,BioCarta,BIOCARTA_MCALPAIN_PATHWAY,0.9630613537844721,0.9975439503508445,1/265,0.016346044379862503,0.0010679608298239422,BIOCARTA_MCALPAIN_PATHWAY,OUD vs Control Female,BioCarta
OUD_Effect_Male_vs_Female,WikiPathways,WP_NANOMATERIAL_INDUCED_APOPTOSIS,0.9292651769758236,0.9980017192272359,1/1002,0.03186033717544153,8.687105660772122e-4,WP_NANOMATERIAL_INDUCED_APOPTOSIS,OUD Effect Male vs Female,WikiPathways
OUD_vs_Control_Female,GO_BP,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,0.9296787989516169,0.9987710908239025,1/2058,0.03166707288456287,5.340366824797992e-4,regulation of neurotransmitter receptor localiz...,OUD vs Control Female,GO BP
OUD_vs_Control_Female,DO,combined oxidative phosphorylation deficiency,0.995814459082619,0.9988644267980329,3/1094,0.0018215721214089827,4.934534046998209e-4,combined oxidative phosphorylation deficiency,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,GO_BP,mitotic cytokinesis,0.9705049719219684,0.9990882631193323,6/1775,0.013002235368102357,3.9614291272757434e-4,mitotic cytokinesis,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,DO,combined oxidative phosphorylation deficiency,0.9968349337311172,0.99921742089483,2/920,0.0013767507202055958,3.400028439479201e-4,combined oxidative phosphorylation deficiency,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,Hallmark,HALLMARK_COMPLEMENT,0.580394744027459,0.9993379550137019,26/572,0.23627652912576827,2.876177027588084e-4,HALLMARK_COMPLEMENT,OUD Effect Male vs Female,Hallmark
OUD_Effect_Male_vs_Female,KEGG,Ascorbate and aldarate metabolism,0.8244505397701458,0.9998429074110091,1/889,0.08383539332353396,6.822980388523073e-5,Ascorbate and aldarate metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Selenocompound metabolism,0.8657167920443896,0.9998429074110091,1/889,0.06262415852349734,6.822980388523073e-5,Selenocompound metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Autoimmune thyroid disease,0.8712916638963368,0.9998429074110091,3/889,0.05983644106880605,6.822980388523073e-5,Autoimmune thyroid disease,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Tryptophan metabolism,0.89278586376089,0.9998429074110091,3/889,0.049252694906546206,6.822980388523073e-5,Tryptophan metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Lipoic acid metabolism,0.8972909353088535,0.9998429074110091,1/889,0.04706671959464526,6.822980388523073e-5,Lipoic acid metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Propanoate metabolism,0.92314798885224425,0.9998429074110091,2/889,0.03472867211596105,6.822980388523073e-5,Propanoate metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,2-Oxocarboxylic acid metabolism,0.9765194365652856,0.9998429074110091,1/889,0.010319108127234113,6.822980388523073e-5,2-Oxocarboxylic acid metabolism,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,KEGG,Oxidative phosphorylation,0.9997891278313353,0.9998429074110091,5/889,9.159027649758498e-5,6.822980388523073e-5,Oxidative phosphorylation,OUD Effect Male vs Female,KEGG
OUD_Effect_Male_vs_Female,WikiPathways,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,0.9384818600278685,0.9999949020973222,1/1002,0.027574117465582283,2.2139966456121434e-6,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_DOPAMINERGIC_NEUROGENESIS,0.9595366173210302,0.9999949020973222,1/1002,0.017938447299508622,2.2139966456121434e-6,WP_DOPAMINERGIC_NEUROGENESIS,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,0.9693996892576788,0.9999949020973222,1/1002,0.013497123826893762,2.2139966456121434e-6,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STR...,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,0.9736737567735776,0.9999949020973222,2/1002,0.011586535284870204,2.2139966456121434e-6,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_OXIDATIVE_PHOSPHORYLATION,0.9872541020922327,0.9999949020973222,3/1002,0.005571053071469063,2.2139966456121434e-6,WP_OXIDATIVE_PHOSPHORYLATION,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,WikiPathways,WP_PYRIMIDINE_METABOLISM,0.9949694185304736,0.9999949020973222,4/1002,0.0021902675633904307,2.2139966456121434e-6,WP_PYRIMIDINE_METABOLISM,OUD Effect Male vs Female,WikiPathways
OUD_Effect_Male_vs_Female,Hallmark,HALLMARK_XENOBIOTIC_METABOLISM,0.668185932816598,0.999996471122097,24/572,0.1751026717156006,1.5325749047209423e-6,HALLMARK_XENOBIOTIC_METABOLISM,OUD Effect Male vs Female,Hallmark
OUD_Effect_Male_vs_Female,Hallmark,HALLMARK_FATTY_ACID_METABOLISM,0.7797033483751998,0.999996471122097,18/572,0.10807060073154993,1.5325749047209423e-6,HALLMARK_FATTY_ACID_METABOLISM,OUD Effect Male vs Female,Hallmark
OUD_Effect_Male_vs_Female,Hallmark,HALLMARK_BILE_ACID_METABOLISM,0.9355759862639872,0.999996471122097,10/572,0.028920933898884785,1.5325749047209423e-6,HALLMARK_BILE_ACID_METABOLISM,OUD Effect Male vs Female,Hallmark
OUD_Effect_Male_vs_Female,Hallmark,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.9999895380738487,0.999996471122097,10/572,4.543580564925549e-6,1.5325749047209423e-6,HALLMARK_OXIDATIVE_PHOSPHORYLATION,OUD Effect Male vs Female,Hallmark
OUD_vs_Control_Female,KEGG,Cobalamin transport and metabolism,0.7808638151894791,0.9999998197716712,2/1075,0.10742470167826214,7.82721757411216e-8,Cobalamin transport and metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Sphingolipid metabolism,0.8049566644644051,0.9999998197716712,6/1075,0.09422749962042454,7.82721757411216e-8,Sphingolipid metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Glycerolipid metabolism,0.8099880249521856,0.9999998197716712,7/1075,0.0915214017826222,7.82721757411216e-8,Glycerolipid metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Pyruvate metabolism,0.8321974132953532,0.9999998197716712,5/1075,0.07977363845090653,7.82721757411216e-8,Pyruvate metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Retinol metabolism,0.859520322915743,0.9999998197716712,5/1075,0.06574385018598301,7.82721757411216e-8,Retinol metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Cholesterol metabolism,0.8717231502216275,0.9999998197716712,5/1075,0.05962142036743216,7.82721757411216e-8,Cholesterol metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Tyrosine metabolism,0.882733304888603,0.9999998197716712,3/1075,0.05417048748711867,7.82721757411216e-8,Tyrosine metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Butanoate metabolism,0.9101569915325672,0.9999998197716712,2/1075,0.0408836904527707,7.82721757411216e-8,Butanoate metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Lipoic acid metabolism,0.9387721696475948,0.9999998197716712,1/1075,0.027439793751367167,7.82721757411216e-8,Lipoic acid metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,2-Oxocarboxylic acid metabolism,0.9397936418258491,0.9999998197716712,2/1075,0.026967497522568475,7.82721757411216e-8,2-Oxocarboxylic acid metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Cysteine and methionine metabolism,0.9461147177548278,0.9999998197716712,4/1075,0.02405620158200749,7.82721757411216e-8,Cysteine and methionine metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Tryptophan metabolism,0.953980872156524,0.9999998197716712,3/1075,0.020460333052878574,7.82721757411216e-8,Tryptophan metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Propanoate metabolism,0.965134569585263,0.9999998197716712,2/1075,0.015412128362161662,7.82721757411216e-8,Propanoate metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Glycerophospholipid metabolism,0.9922923108209163,0.9999998197716712,7/1075,0.0033603739382739844,7.82721757411216e-8,Glycerophospholipid metabolism,OUD vs Control Female,KEGG
OUD_vs_Control_Female,KEGG,Oxidative phosphorylation,0.9999997901926629,0.9999998197716712,3/1075,9.111817830631467e-8,7.82721757411216e-8,Oxidative phosphorylation,OUD vs Control Female,KEGG
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.8406161713771506,0.9999998600952271,19/2013,0.07540225949795397,6.075987510307257e-8,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WE...,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,0.9271183899799089,0.9999998600952271,17/2013,0.03286480433229618,6.075987510307257e-8,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,0.9950182760838346,0.9999998600952271,12/2013,0.0021689422397357353,6.075987510307257e-8,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,OUD Effect Male vs Female,C7 Immunologic
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,0.9993887516418052,0.9999998600952271,10/2013,2.655429536539649e-4,6.075987510307257e-8,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WE...,OUD Effect Male vs Female,C7 Immunologic
OUD_vs_Control_Female,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,0.9329475503190946,0.9999998722760689,20/2332,0.030142771309536232,5.546980202533575e-8,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.9701029716315648,0.9999998722760689,18/2332,0.013182165076133307,5.546980202533575e-8,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_...,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,0.9701029716315648,0.9999998722760689,18/2332,0.013182165076133307,5.546980202533575e-8,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WE...,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,0.9779668713794416,0.9999998722760689,17/2332,0.009675856685597293,5.546980202533575e-8,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.9917763723812991,0.9999998722760689,15/2332,0.0035862423512731507,5.546980202533575e-8,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,OUD vs Control Female,C7 Immunologic
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C1_MICROGLIA,0.9591650478695737,0.9999998880762061,27/2407,0.018106655382460025,4.8607888804450224e-8,ZHONG_PFC_C1_MICROGLIA,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_1,0.9995253708958711,0.9999998880762061,9/2407,2.0617773372181696e-4,4.8607888804450224e-8,FAN_EMBRYONIC_CTX_MICROGLIA_1,OUD vs Control Female,C8 CellType
OUD_vs_Control_Female,WikiPathways,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.7515475867628845,0.9999999154747237,1/1231,0.12404351539080725,3.670886264450231e-8,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSC...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_SERINE_METABOLISM,0.7515475867628845,0.9999999154747237,1/1231,0.12404351539080725,3.670886264450231e-8,WP_SERINE_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,0.7654027407397174,0.9999999154747237,6/1231,0.11610998699523455,3.670886264450231e-8,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_COR...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_ENERGY_METABOLISM,0.7654027407397174,0.9999999154747237,6/1231,0.11610998699523455,3.670886264450231e-8,WP_ENERGY_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_TRYPTOPHAN_METABOLISM,0.7750277062329513,0.9999999154747237,4/1231,0.11068277175303623,3.670886264450231e-8,WP_TRYPTOPHAN_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_CHOLESTEROL_METABOLISM,0.7792448628572693,0.9999999154747237,9/1231,0.10832605211187923,3.670886264450231e-8,WP_CHOLESTEROL_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,0.7805779473363981,0.9999999154747237,2/1231,0.10758372244421488,3.670886264450231e-8,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,0.7862859687600271,0.9999999154747237,3/1231,0.10441947423131434,3.670886264450231e-8,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,0.7862859687600271,0.9999999154747237,3/1231,0.10441947423131434,3.670886264450231e-8,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STR...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_ALANINE_AND_ASPARTATE_METABOLISM,0.8246334320190509,0.9999999154747237,1/1231,0.08373906215281517,3.670886264450231e-8,WP_ALANINE_AND_ASPARTATE_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_GLYOXYLATE_METABOLISM,0.8246334320190509,0.9999999154747237,1/1231,0.08373906215281517,3.670886264450231e-8,WP_GLYOXYLATE_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_VITAMIN_D_METABOLISM,0.8246334320190509,0.9999999154747237,1/1231,0.08373906215281517,3.670886264450231e-8,WP_VITAMIN_D_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,0.8312365125849783,0.9999999154747237,2/1231,0.08027538837448106,3.670886264450231e-8,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_ESTROGEN_METABOLISM_WP5276,0.8312365125849783,0.9999999154747237,2/1231,0.08027538837448106,3.670886264450231e-8,WP_ESTROGEN_METABOLISM_WP5276,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_NANOMATERIAL_INDUCED_APOPTOSIS,0.8312365125849783,0.9999999154747237,2/1231,0.08027538837448106,3.670886264450231e-8,WP_NANOMATERIAL_INDUCED_APOPTOSIS,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_ONECARBON_METABOLISM,0.8474504734115476,0.9999999154747237,3/1231,0.07188567336390894,3.670886264450231e-8,WP_ONECARBON_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,0.8523879131903681,0.9999999154747237,2/1231,0.06936271718395447,3.670886264450231e-8,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,0.8523879131903681,0.9999999154747237,2/1231,0.06936271718395447,3.670886264450231e-8,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,0.8526729495128227,0.9999999154747237,1/1231,0.06921751450427896,3.670886264450231e-8,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECI...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_GABA_METABOLISM_AKA_GHB,0.8526729495128227,0.9999999154747237,1/1231,0.06921751450427896,3.670886264450231e-8,WP_GABA_METABOLISM_AKA_GHB,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,0.8532302497370442,0.9999999154747237,5/1231,0.06893375582341166,3.670886264450231e-8,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,0.8641541322331294,0.9999999154747237,3/1231,0.06340878899296967,3.670886264450231e-8,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,0.8762322635099279,0.9999999154747237,1/1231,0.057380759824401474,3.670886264450231e-8,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_GANGLIO_SPHINGOLIPID_METABOLISM,0.8960267397499276,0.9999999154747237,1/1231,0.04767902967653609,3.670886264450231e-8,WP_GANGLIO_SPHINGOLIPID_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,0.8960267397499276,0.9999999154747237,1/1231,0.04767902967653609,3.670886264450231e-8,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,0.8960267397499276,0.9999999154747237,1/1231,0.04767902967653609,3.670886264450231e-8,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPEN...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.9126575977758943,0.9999999154747237,1/1231,0.03969212639516211,3.670886264450231e-8,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENE...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,0.9454573708120502,0.9999999154747237,6/1231,0.024358048033603995,3.670886264450231e-8,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RE...,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_LIPID_METABOLISM_PATHWAY,0.9518449432313779,0.9999999154747237,2/1231,0.021433792984861033,3.670886264450231e-8,WP_LIPID_METABOLISM_PATHWAY,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,0.9742339201823429,0.9999999154747237,1/1231,0.01133675354523748,3.670886264450231e-8,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,0.9847360031874046,0.9999999154747237,1/1231,0.00668018343750566,3.670886264450231e-8,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,0.9871810233664944,0.9999999154747237,1/1231,0.005603201696600325,3.670886264450231e-8,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,0.9871810233664944,0.9999999154747237,1/1231,0.005603201696600325,3.670886264450231e-8,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_PYRIMIDINE_METABOLISM,0.9923718694185908,0.9999999154747237,6/1231,0.0033255550905106975,3.670886264450231e-8,WP_PYRIMIDINE_METABOLISM,OUD vs Control Female,WikiPathways
OUD_vs_Control_Female,WikiPathways,WP_OXIDATIVE_PHOSPHORYLATION,0.9995887809112886,0.9999999154747237,2/1231,1.7862691099612961e-4,3.670886264450231e-8,WP_OXIDATIVE_PHOSPHORYLATION,OUD vs Control Female,WikiPathways
OUD_Effect_Male_vs_Female,DO,mitochondrial metabolism disease,0.9999999549662354,0.9999999549662354,6/920,1.9557915908227105e-8,1.9557915908227105e-8,mitochondrial metabolism disease,OUD Effect Male vs Female,DO
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,0.8945848861568821,0.999999988220885,1/2057,0.048378443424834765,5.115604683588627e-9,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C1_MICROGLIA,0.9203617731074665,0.999999988220885,24/2057,0.036041427892633926,5.115604683588627e-9,ZHONG_PFC_C1_MICROGLIA,OUD Effect Male vs Female,C8 CellType
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_1,0.995687238494966,0.999999988220885,9/2057,0.0018770590932198127,5.115604683588627e-9,FAN_EMBRYONIC_CTX_MICROGLIA_1,OUD Effect Male vs Female,C8 CellType
OUD_vs_Control_Female,DO,mitochondrial metabolism disease,0.9999999899970164,0.9999999899970164,8/1094,4.344240581182888e-9,4.344240581182888e-9,mitochondrial metabolism disease,OUD vs Control Female,DO
OUD_Effect_Male_vs_Female,GO_CC,cytoplasmic stress granule,0.41185055168554663,0.9999999997244939,12/1867,0.3852603479300769,1.1965076265126782e-10,cytoplasmic stress granule,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,dendrite terminus,0.4625116823805727,0.9999999997244939,2/1867,0.33487729313177705,1.1965076265126782e-10,dendrite terminus,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,neuronal dense core vesicle membrane,0.46491677665782727,0.9999999997244939,1/1867,0.3326247818907811,1.1965076265126782e-10,neuronal dense core vesicle membrane,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,myelin sheath abaxonal region,0.5278340444484707,0.9999999997244939,1/1867,0.27750260191573145,1.1965076265126782e-10,myelin sheath abaxonal region,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,"asymmetric, glutamatergic, excitatory synapse",0.5766829631084606,0.9999999997244939,2/1867,0.23906287872136847,1.1965076265126782e-10,"asymmetric, glutamatergic, excitatory synapse",OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,cerebellar climbing fiber to Purkinje cell synapse,0.6323535255856635,0.9999999997244939,1/1867,0.1990400557597013,1.1965076265126782e-10,cerebellar climbing fiber to Purkinje cell synapse,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,stress fiber,0.6809791620907444,0.9999999997244939,9/1867,0.16686617726117098,1.1965076265126782e-10,stress fiber,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,axoneme,0.7390008163346489,0.9999999997244939,15/1867,0.1313550818630395,1.1965076265126782e-10,axoneme,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,paranode region of axon,0.7474155192672902,0.9999999997244939,1/1867,0.1264378887419697,1.1965076265126782e-10,paranode region of axon,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,dopaminergic synapse,0.8264797782465974,0.9999999997244939,1/1867,0.08276776798890968,1.1965076265126782e-10,dopaminergic synapse,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,dynein axonemal particle,0.8468945651905512,0.9999999997244939,1/1867,0.07217065413935428,1.1965076265126782e-10,dynein axonemal particle,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,axonemal dynein complex,0.864908671996024,0.9999999997244939,1/1867,0.06302974842208774,1.1965076265126782e-10,axonemal dynein complex,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,axonemal A tubule inner sheath,0.864908671996024,0.9999999997244939,1/1867,0.06302974842208774,1.1965076265126782e-10,axonemal A tubule inner sheath,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,axonemal microtubule,0.9131525678754352,0.9999999997244939,2/1867,0.03945665526870233,1.1965076265126782e-10,axonemal microtubule,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,immunological synapse,0.9325095721279043,0.9999999997244939,3/1867,0.03034670150212455,1.1965076265126782e-10,immunological synapse,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,A axonemal microtubule,0.9503875190551228,0.9999999997244939,1/1867,0.022099275688934546,1.1965076265126782e-10,A axonemal microtubule,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,axonemal microtubule doublet inner sheath,0.9562281459498883,0.9999999997244939,1/1867,0.01943847727814476,1.1965076265126782e-10,axonemal microtubule doublet inner sheath,OUD Effect Male vs Female,GO CC
OUD_Effect_Male_vs_Female,GO_CC,axonemal doublet microtubule,0.9699402747416551,0.9999999997244939,1/1867,0.013255007124173549,1.1965076265126782e-10,axonemal doublet microtubule,OUD Effect Male vs Female,GO CC
OUD_vs_Control_Female,Hallmark,HALLMARK_BILE_ACID_METABOLISM,0.7400128511700577,0.9999999999615625,16/703,0.1307607381828348,1.669318347558481e-11,HALLMARK_BILE_ACID_METABOLISM,OUD vs Control Female,Hallmark
OUD_vs_Control_Female,Hallmark,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.9999999999615625,0.9999999999615625,6/703,1.669318347558481e-11,1.669318347558481e-11,HALLMARK_OXIDATIVE_PHOSPHORYLATION,OUD vs Control Female,Hallmark
OUD_Effect_Male_vs_Female,GO_BP,cellular component disassembly involved in execution phase of apoptosis,0.9771217173074442,0.9999999999639921,1/1775,0.010051334067863932,1.5638016361642927e-11,cellular component disassembly involved in exec...,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,regulation of programmed necrotic cell death,0.9798313290896079,0.9999999999639921,1/1775,0.008848678542458388,1.5638016361642927e-11,regulation of programmed necrotic cell death,OUD Effect Male vs Female,GO BP
OUD_Effect_Male_vs_Female,GO_BP,oxidative phosphorylation,0.9999700084605535,0.9999999999639921,4/1775,1.3025355411602934e-5,1.5638016361642927e-11,oxidative phosphorylation,OUD Effect Male vs Female,GO BP
OUD_vs_Control_Female,Reactome,Oxidative Stress Induced Senescence,0.38384634630509845,0.9999999999999936,10/1379,0.4158425889299645,2.7965496530045417e-15,Oxidative Stress Induced Senescence,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,NRIF signals cell death from the nucleus,0.39112829285146156,0.9999999999999936,3/1379,0.40768076756911314,2.7965496530045417e-15,NRIF signals cell death from the nucleus,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Sema3A PAK dependent Axon repulsion,0.39112829285146156,0.9999999999999936,3/1379,0.40768076756911314,2.7965496530045417e-15,Sema3A PAK dependent Axon repulsion,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Diseases of programmed cell death,0.39448409248455574,0.9999999999999936,7/1379,0.40397050496525655,2.7965496530045417e-15,Diseases of programmed cell death,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,p75NTR regulates axonogenesis,0.4173125422444557,0.9999999999999936,2/1379,0.37953856245890627,2.7965496530045417e-15,p75NTR regulates axonogenesis,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Regulation of commissural axon pathfinding by SLIT and ROBO,0.4173125422444557,0.9999999999999936,2/1379,0.37953856245890627,2.7965496530045417e-15,Regulation of commissural axon pathfinding by S...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Apoptosis,0.4241523593712902,0.9999999999999936,23/1379,0.37247811286818266,2.7965496530045417e-15,Apoptosis,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Metabolism of folate and pterines,0.43095986345782844,0.9999999999999936,3/1379,0.36556317506076735,2.7965496530045417e-15,Metabolism of folate and pterines,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Translocation of ZAP-70 to Immunological synapse,0.43095986345782844,0.9999999999999936,3/1379,0.36556317506076735,2.7965496530045417e-15,Translocation of ZAP-70 to Immunological synapse,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Surfactant metabolism,0.43696337029814325,0.9999999999999936,4/1379,0.3595549674784146,2.7965496530045417e-15,Surfactant metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Retinoid metabolism and transport,0.441876545888668,0.9999999999999936,6/1379,0.35469904949326864,2.7965496530045417e-15,Retinoid metabolism and transport,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Creatine metabolism,0.46771897228863957,0.9999999999999936,2/1379,0.33001501325773375,2.7965496530045417e-15,Creatine metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",0.46771897228863957,0.9999999999999936,2/1379,0.33001501325773375,2.7965496530045417e-15,"Regulation of glycolysis by fructose 2,6-bispho...",OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,ATF4 activates genes in response to endoplasmic reticulum  stress,0.46971198093307165,0.9999999999999936,4/1379,0.3281683621357614,2.7965496530045417e-15,ATF4 activates genes in response to endoplasmic...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Class C/3 (Metabotropic glutamate/pheromone receptors),0.46979931606674696,0.9999999999999936,3/1379,0.3280876198033129,2.7965496530045417e-15,Class C/3 (Metabotropic glutamate/pheromone rec...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Integration of energy metabolism,0.47374746895066744,0.9999999999999936,15/1379,0.3244530972849687,2.7965496530045417e-15,Integration of energy metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,0.483016754517838,0.9999999999999936,10/1379,0.31603780451050956,2.7965496530045417e-15,High laminar flow shear stress activates signal...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Diseases of metabolism,0.502077506376009,0.9999999999999936,35/1379,0.2992292350598331,2.7965496530045417e-15,Diseases of metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Regulation of lipid metabolism by PPARalpha,0.5029073534874324,0.9999999999999936,16/1379,0.2985120140993625,2.7965496530045417e-15,Regulation of lipid metabolism by PPARalpha,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,SUMOylation of immune response proteins,0.5154233600529988,0.9999999999999936,2/1379,0.2878359022146611,2.7965496530045417e-15,SUMOylation of immune response proteins,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Metabolism of amino acids and derivatives,0.5222679279707914,0.9999999999999936,46/1379,0.2821066429988765,2.7965496530045417e-15,Metabolism of amino acids and derivatives,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,NFE2L2 regulating inflammation associated genes,0.5287965807347825,0.9999999999999936,1/1379,0.2767113617160945,2.7965496530045417e-15,NFE2L2 regulating inflammation associated genes,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Cellular responses to stress,0.553099831336535,0.9999999999999936,97/1379,0.25719647396551776,2.7965496530045417e-15,Cellular responses to stress,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,DNA Damage/Telomere Stress Induced Senescence,0.5630086767052324,0.9999999999999936,4/1379,0.2494849120471146,2.7965496530045417e-15,DNA Damage/Telomere Stress Induced Senescence,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Cellular response to heat stress,0.5662288936294846,0.9999999999999936,12/1379,0.2470079731487994,2.7965496530045417e-15,Cellular response to heat stress,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,"Cobalamin (Cbl, vitamin B12) transport and metabolism",0.5780951612010765,0.9999999999999936,3/1379,0.238000665761481,2.7965496530045417e-15,"Cobalamin (Cbl, vitamin B12) transport and meta...",OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Phenylalanine metabolism,0.5946514013658494,0.9999999999999936,1/1379,0.22573755331353274,2.7965496530045417e-15,Phenylalanine metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,TLR3-mediated TICAM1-dependent programmed cell death,0.5946514013658494,0.9999999999999936,1/1379,0.22573755331353274,2.7965496530045417e-15,TLR3-mediated TICAM1-dependent programmed cell ...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,0.6019265564020291,0.9999999999999936,2/1379,0.2204564956111831,2.7965496530045417e-15,TP53 regulates transcription of several additio...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Defects in vitamin and cofactor metabolism,0.6109526201646591,0.9999999999999936,3/1379,0.21399246831537475,2.7965496530045417e-15,Defects in vitamin and cofactor metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Defective Intrinsic Pathway for Apoptosis,0.6420467844269072,0.9999999999999936,3/1379,0.19243332476890898,2.7965496530045417e-15,Defective Intrinsic Pathway for Apoptosis,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Apoptosis induced DNA fragmentation,0.6513081738690416,0.9999999999999936,1/1379,0.18621347142833544,2.7965496530045417e-15,Apoptosis induced DNA fragmentation,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Vitamin B2 (riboflavin) metabolism,0.6513081738690416,0.9999999999999936,1/1379,0.18621347142833544,2.7965496530045417e-15,Vitamin B2 (riboflavin) metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Fructose metabolism,0.6513081738690416,0.9999999999999936,1/1379,0.18621347142833544,2.7965496530045417e-15,Fructose metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Diseases associated with surfactant metabolism,0.6513081738690416,0.9999999999999936,1/1379,0.18621347142833544,2.7965496530045417e-15,Diseases associated with surfactant metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Cobalamin (Cbl) metabolism,0.6513081738690416,0.9999999999999936,1/1379,0.18621347142833544,2.7965496530045417e-15,Cobalamin (Cbl) metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Sphingolipid metabolism,0.6543018632572066,0.9999999999999936,13/1379,0.1842218429582917,2.7965496530045417e-15,Sphingolipid metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Drug ADME,0.6555076110453562,0.9999999999999936,11/1379,0.18342226138684878,2.7965496530045417e-15,Drug ADME,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Metabolism of nucleotides,0.6622967594406203,0.9999999999999936,12/1379,0.1789473699123447,2.7965496530045417e-15,Metabolism of nucleotides,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",0.6713444150167309,0.9999999999999936,3/1379,0.1730546196725272,2.7965496530045417e-15,FOXO-mediated transcription of oxidative stress...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Peptide hormone metabolism,0.6918366828571194,0.9999999999999936,9/1379,0.15999641436550596,2.7965496530045417e-15,Peptide hormone metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Diseases of carbohydrate metabolism,0.6960084720510874,0.9999999999999936,4/1379,0.1573854739775926,2.7965496530045417e-15,Diseases of carbohydrate metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,ADORA2B mediated anti-inflammatory cytokines production,0.6963218263863138,0.9999999999999936,5/1379,0.15718999153909408,2.7965496530045417e-15,ADORA2B mediated anti-inflammatory cytokines pr...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,MECP2 regulates transcription of neuronal ligands,0.7000508021746261,0.9999999999999936,1/1379,0.15487044240926062,2.7965496530045417e-15,MECP2 regulates transcription of neuronal ligands,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Cellular response to chemical stress,0.7254320086742836,0.9999999999999936,24/1379,0.13940328569530797,2.7965496530045417e-15,Cellular response to chemical stress,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Regulation of MITF-M-dependent genes involved in apoptosis,0.738819642225585,0.9999999999999936,2/1379,0.13146156694486197,2.7965496530045417e-15,Regulation of MITF-M-dependent genes involved i...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,PI Metabolism,0.7402583564650185,0.9999999999999936,10/1379,0.13061668134337567,2.7965496530045417e-15,PI Metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.7598350685096052,0.9999999999999936,13/1379,0.11928066641600518,2.7965496530045417e-15,SARS-CoV-2 activates/modulates innate and adapt...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Initial triggering of complement,0.7660463916477183,0.9999999999999936,2/1379,0.11574492876618289,2.7965496530045417e-15,Initial triggering of complement,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Metabolism of steroid hormones,0.7707699091785103,0.9999999999999936,3/1379,0.11307524852205698,2.7965496530045417e-15,Metabolism of steroid hormones,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Caspase activation via Dependence Receptors in the absence of ligand,0.7780587055940538,0.9999999999999936,1/1379,0.10898763366108942,2.7965496530045417e-15,Caspase activation via Dependence Receptors in ...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Phenylalanine and tyrosine metabolism,0.7780587055940538,0.9999999999999936,1/1379,0.10898763366108942,2.7965496530045417e-15,Phenylalanine and tyrosine metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Diseases of the neuronal system,0.7780587055940538,0.9999999999999936,1/1379,0.10898763366108942,2.7965496530045417e-15,Diseases of the neuronal system,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Vitamin D (calciferol) metabolism,0.8357898897311041,0.9999999999999936,1/1379,0.0779028866747441,2.7965496530045417e-15,Vitamin D (calciferol) metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Bile acid and bile salt metabolism,0.8570741450525277,0.9999999999999936,4/1379,0.06698160585475273,2.7965496530045417e-15,Bile acid and bile salt metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Metabolism of lipids,0.8587356212553808,0.9999999999999936,90/1379,0.06614052173643933,2.7965496530045417e-15,Metabolism of lipids,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Glutamate and glutamine metabolism,0.8785120995569426,0.9999999999999936,1/1379,0.056252252683624084,2.7965496530045417e-15,Glutamate and glutamine metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,FOXO-mediated transcription of cell death genes,0.9101252896454916,0.9999999999999936,1/1379,0.040898817727003545,2.7965496530045417e-15,FOXO-mediated transcription of cell death genes,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Metabolism of steroids,0.9126368063990484,0.9999999999999936,15/1379,0.03970202022951022,2.7965496530045417e-15,Metabolism of steroids,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Hyaluronan metabolism,0.922700089318672,0.9999999999999936,1/1379,0.03493943734848011,2.7965496530045417e-15,Hyaluronan metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Glyoxylate metabolism and glycine degradation,0.922700089318672,0.9999999999999936,1/1379,0.03493943734848011,2.7965496530045417e-15,Glyoxylate metabolism and glycine degradation,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Adaptive Immune System,0.9405671679823239,0.9999999999999936,87/1379,0.026610185076401366,2.7965496530045417e-15,Adaptive Immune System,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Metabolism of nitric oxide: NOS3 activation and regulation,0.9428204859042107,0.9999999999999936,1/1379,0.025570989556180836,2.7965496530045417e-15,Metabolism of nitric oxide: NOS3 activation and...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Activation of ATR in response to replication stress,0.9734138273641126,0.9999999999999936,2/1379,0.011702488886346828,2.7965496530045417e-15,Activation of ATR in response to replication st...,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Regulation of Apoptosis,0.9794314692904733,0.9999999999999936,2/1379,0.009025946142143021,2.7965496530045417e-15,Regulation of Apoptosis,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Phospholipid metabolism,0.9799078287376609,0.9999999999999936,19/1379,0.008814772627070472,2.7965496530045417e-15,Phospholipid metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Sulfur amino acid metabolism,0.982891996696939,0.9999999999999936,1/1379,0.00749420120703102,2.7965496530045417e-15,Sulfur amino acid metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Metabolism of cofactors,0.982891996696939,0.9999999999999936,1/1379,0.00749420120703102,2.7965496530045417e-15,Metabolism of cofactors,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Peroxisomal lipid metabolism,0.9852883335740259,0.9999999999999936,1/1379,0.006436659496297288,2.7965496530045417e-15,Peroxisomal lipid metabolism,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Metabolism of polyamines,0.9917467781151466,0.9999999999999936,2/1379,0.0035992017427314985,2.7965496530045417e-15,Metabolism of polyamines,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Metabolism of non-coding RNA,0.9957519575324996,0.9999999999999936,2/1379,0.0018488311453709544,2.7965496530045417e-15,Metabolism of non-coding RNA,OUD vs Control Female,Reactome
OUD_vs_Control_Female,Reactome,Metabolism of RNA,0.9999999999952334,0.9999999999999936,44/1379,2.070121772454875e-12,2.7965496530045417e-15,Metabolism of RNA,OUD vs Control Female,Reactome
OUD_vs_Control_Female,GO_MF,NAD+-protein-glutamate ADP-ribosyltransferase activity,0.827541526350997,0.9999999999999971,1/2121,0.08221020394186203,1.2536257065192751e-15,NAD+-protein-glutamate ADP-ribosyltransferase a...,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activity,0.827541526350997,0.9999999999999971,1/2121,0.08221020394186203,1.2536257065192751e-15,NAD+-histone H2BE35 glutamate ADP-ribosyltransf...,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,NAD+-histone H2BE2 glutamate ADP-ribosyltransferase activity,0.827541526350997,0.9999999999999971,1/2121,0.08221020394186203,1.2536257065192751e-15,NAD+-histone H2BE2 glutamate ADP-ribosyltransfe...,OUD vs Control Female,GO MF
OUD_vs_Control_Female,GO_MF,NAD+-histone H2BE18 glutamate ADP-ribosyltransferase activity,0.827541526350997,0.9999999999999971,1/2121,0.08221020394186203,1.2536257065192751e-15,NAD+-histone H2BE18 glutamate ADP-ribosyltransf...,OUD vs Control Female,GO MF
OUD_Effect_Male_vs_Female,Reactome,Metabolism of folate and pterines,0.3391395555078043,0.9999999999999981,3/1194,0.4696215533746442,8.196783465702948e-16,Metabolism of folate and pterines,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Regulation of pyruvate metabolism,0.3438023974174456,0.9999999999999981,5/1194,0.4636910991977237,8.196783465702948e-16,Regulation of pyruvate metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Aspartate and asparagine metabolism,0.3454236053710449,0.9999999999999981,2/1194,0.46164798717361755,8.196783465702948e-16,Aspartate and asparagine metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Diseases of the neuronal system,0.3454236053710449,0.9999999999999981,2/1194,0.46164798717361755,8.196783465702948e-16,Diseases of the neuronal system,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Fatty acid metabolism,0.35672627019781217,0.9999999999999981,22/1194,0.4476649069727069,8.196783465702948e-16,Fatty acid metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Integration of energy metabolism,0.363076249847776,0.9999999999999981,14/1194,0.4400021589565776,8.196783465702948e-16,Integration of energy metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Serotonin Neurotransmitter Release Cycle,0.3739684043024597,0.9999999999999981,3/1194,0.42716508875336995,8.196783465702948e-16,Serotonin Neurotransmitter Release Cycle,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,ADORA2B mediated anti-inflammatory cytokines production,0.3760344991823695,0.9999999999999981,6/1194,0.42477230901591456,8.196783465702948e-16,ADORA2B mediated anti-inflammatory cytokines pr...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Inositol phosphate metabolism,0.3807918988320279,0.9999999999999981,7/1194,0.4193122995994645,8.196783465702948e-16,Inositol phosphate metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Phospholipid metabolism,0.3879995084761872,0.9999999999999981,26/1194,0.41116882457644954,8.196783465702948e-16,Phospholipid metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",0.39129935699204643,0.9999999999999981,2/1194,0.40749086575900684,8.196783465702948e-16,"Regulation of glycolysis by fructose 2,6-bispho...",OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Complement cascade,0.40156528780478795,0.9999999999999981,7/1194,0.39624383561998033,8.196783465702948e-16,Complement cascade,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Diseases of programmed cell death,0.42135645655792076,0.9999999999999981,6/1194,0.3753503468810025,8.196783465702948e-16,Diseases of programmed cell death,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,PI Metabolism,0.4219039543943982,0.9999999999999981,11/1194,0.374786404071501,8.196783465702948e-16,PI Metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Sphingolipid metabolism,0.43542452859230574,0.9999999999999981,13/1194,0.36108710967196533,8.196783465702948e-16,Sphingolipid metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Vitamin D (calciferol) metabolism,0.43566266496108774,0.9999999999999981,2/1194,0.36084965625916277,8.196783465702948e-16,Vitamin D (calciferol) metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,0.44069801475757575,0.9999999999999981,9/1194,0.3558589058816673,8.196783465702948e-16,High laminar flow shear stress activates signal...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Glycogen metabolism,0.4441414638738508,0.9999999999999981,4/1194,0.3524786803480134,8.196783465702948e-16,Glycogen metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Arachidonate metabolism,0.4635455216147406,0.9999999999999981,7/1194,0.3339076103537234,8.196783465702948e-16,Arachidonate metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Activation of ATR in response to replication stress,0.4690645194359847,0.9999999999999981,5/1194,0.3287674163300308,8.196783465702948e-16,Activation of ATR in response to replication st...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Alternative complement activation,0.47517810286705264,0.9999999999999981,1/1194,0.3231435807017794,8.196783465702948e-16,Alternative complement activation,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,NFE2L2 regulating ER-stress associated genes,0.47517810286705264,0.9999999999999981,1/1194,0.3231435807017794,8.196783465702948e-16,NFE2L2 regulating ER-stress associated genes,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Innate Immune System,0.48087705733654384,0.9999999999999981,112/1194,0.3179659426388643,8.196783465702948e-16,Innate Immune System,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Glycosphingolipid metabolism,0.4839168353398219,0.9999999999999981,7/1194,0.3152292686373946,8.196783465702948e-16,Glycosphingolipid metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Regulation of lipid metabolism by PPARalpha,0.4908656600393284,0.9999999999999981,14/1194,0.3090373491938375,8.196783465702948e-16,Regulation of lipid metabolism by PPARalpha,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Defects in vitamin and cofactor metabolism,0.5074429215110297,0.9999999999999981,3/1194,0.2946128012313034,8.196783465702948e-16,Defects in vitamin and cofactor metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Pyruvate metabolism,0.5100910792724931,0.9999999999999981,6/1194,0.29235227156116317,8.196783465702948e-16,Pyruvate metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Na+/Cl- dependent neurotransmitter transporters,0.5187266675905391,0.9999999999999981,2/1194,0.28506142447661237,8.196783465702948e-16,Na+/Cl- dependent neurotransmitter transporters,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Glutamate and glutamine metabolism,0.5187266675905391,0.9999999999999981,2/1194,0.28506142447661237,8.196783465702948e-16,Glutamate and glutamine metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Dopamine Neurotransmitter Release Cycle,0.5385049892157298,0.9999999999999981,3/1194,0.2688102686355951,8.196783465702948e-16,Dopamine Neurotransmitter Release Cycle,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Phenylalanine metabolism,0.5386864990540132,0.9999999999999981,1/1194,0.26866390891630254,8.196783465702948e-16,Phenylalanine metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Sialic acid metabolism,0.5524167637940416,0.9999999999999981,4/1194,0.2577331506712846,8.196783465702948e-16,Sialic acid metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Metabolism of porphyrins,0.5684114036465285,0.9999999999999981,3/1194,0.2453372177060723,8.196783465702948e-16,Metabolism of porphyrins,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Acetylcholine Neurotransmitter Release Cycle,0.5932144949605265,0.9999999999999981,2/1194,0.22678824570086645,8.196783465702948e-16,Acetylcholine Neurotransmitter Release Cycle,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Metabolism of non-coding RNA,0.5932572695822859,0.9999999999999981,6/1194,0.22675693137420683,8.196783465702948e-16,Metabolism of non-coding RNA,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,"Metabolism of ingested SeMet, Sec, MeSec into H2Se",0.5945154388603691,0.9999999999999981,1/1194,0.2258368627865784,8.196783465702948e-16,"Metabolism of ingested SeMet, Sec, MeSec into H2Se",OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,DEx/H-box helicases activate type I IFN and inflammatory cytokines production,0.5945154388603691,0.9999999999999981,1/1194,0.2258368627865784,8.196783465702948e-16,DEx/H-box helicases activate type I IFN and inf...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Modulation by Mtb of host immune system,0.5945154388603691,0.9999999999999981,1/1194,0.2258368627865784,8.196783465702948e-16,Modulation by Mtb of host immune system,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Cobalamin (Cbl) metabolism,0.5945154388603691,0.9999999999999981,1/1194,0.2258368627865784,8.196783465702948e-16,Cobalamin (Cbl) metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,ATF4 activates genes in response to endoplasmic reticulum  stress,0.5970909505478759,0.9999999999999981,3/1194,0.22395951089308855,8.196783465702948e-16,ATF4 activates genes in response to endoplasmic...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Programmed Cell Death,0.6002009959133032,0.9999999999999981,22/1194,0.22170328828588592,8.196783465702948e-16,Programmed Cell Death,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Diseases of metabolism,0.6075515594692322,0.9999999999999981,29/1194,0.21641686004601307,8.196783465702948e-16,Diseases of metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Cellular response to mitochondrial stress,0.6435928403809693,0.9999999999999981,1/1194,0.191388795835178,8.196783465702948e-16,Cellular response to mitochondrial stress,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Intrinsic Pathway for Apoptosis,0.6504176012121482,0.9999999999999981,6/1194,0.18680771463742046,8.196783465702948e-16,Intrinsic Pathway for Apoptosis,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Oxidative Stress Induced Senescence,0.6527355072825701,0.9999999999999981,7/1194,0.1852627620589532,8.196783465702948e-16,Oxidative Stress Induced Senescence,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Peptide hormone metabolism,0.6554474161746373,0.9999999999999981,8/1194,0.1834621442198486,8.196783465702948e-16,Peptide hormone metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Norepinephrine Neurotransmitter Release Cycle,0.6587314972106931,0.9999999999999981,2/1194,0.1812915702949941,8.196783465702948e-16,Norepinephrine Neurotransmitter Release Cycle,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Drug ADME,0.714602017684128,0.9999999999999981,9/1194,0.14593576189813814,8.196783465702948e-16,Drug ADME,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,"Cell death signalling via NRAGE, NRIF and NADE",0.7149601944887154,0.9999999999999981,8/1194,0.14571813693336436,8.196783465702948e-16,"Cell death signalling via NRAGE, NRIF and NADE",OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Phenylalanine and tyrosine metabolism,0.7246580248901737,0.9999999999999981,1/1194,0.13986689403777164,8.196783465702948e-16,Phenylalanine and tyrosine metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Creatine metabolism,0.7579938916799862,0.9999999999999981,1/1194,0.12033429413096036,8.196783465702948e-16,Creatine metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Regulation of necroptotic cell death,0.7613995680625552,0.9999999999999981,3/1194,0.11838737389425737,8.196783465702948e-16,Regulation of necroptotic cell death,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Cellular responses to stress,0.7689324622149993,0.9999999999999981,79/1194,0.11411180398977598,8.196783465702948e-16,Cellular responses to stress,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Mitotic Telophase/Cytokinesis,0.7872967304726133,0.9999999999999981,1/1194,0.10386155211526592,8.196783465702948e-16,Mitotic Telophase/Cytokinesis,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF),0.8053545058985965,0.9999999999999981,2/1194,0.09401290712893949,8.196783465702948e-16,Formation of neuronal progenitor and neuronal B...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Regulation of innate immune responses to cytosolic DNA,0.8130541040847532,0.9999999999999981,1/1194,0.08988055363884617,8.196783465702948e-16,Regulation of innate immune responses to cytoso...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,STING mediated induction of host immune responses,0.8356946761227698,0.9999999999999981,1/1194,0.07795236454081736,8.196783465702948e-16,STING mediated induction of host immune responses,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Sulfur amino acid metabolism,0.8552017098282529,0.9999999999999981,2/1194,0.06793143950153174,8.196783465702948e-16,Sulfur amino acid metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Metabolism of Angiotensinogen to Angiotensins,0.8555953209502614,0.9999999999999981,1/1194,0.06773159914847424,8.196783465702948e-16,Metabolism of Angiotensinogen to Angiotensins,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Metabolism of amine-derived hormones,0.8555953209502614,0.9999999999999981,1/1194,0.06773159914847424,8.196783465702948e-16,Metabolism of amine-derived hormones,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Metabolism of steroid hormones,0.869035434798896,0.9999999999999981,2/1194,0.06096251489324533,8.196783465702948e-16,Metabolism of steroid hormones,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,NRIF signals cell death from the nucleus,0.8730873760162436,0.9999999999999981,1/1194,0.05894229120527356,8.196783465702948e-16,NRIF signals cell death from the nucleus,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,FOXO-mediated transcription of cell death genes,0.8730873760162436,0.9999999999999981,1/1194,0.05894229120527356,8.196783465702948e-16,FOXO-mediated transcription of cell death genes,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Hyaluronan metabolism,0.88846213992012,0.9999999999999981,1/1194,0.05136107407601474,8.196783465702948e-16,Hyaluronan metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Glyoxylate metabolism and glycine degradation,0.88846213992012,0.9999999999999981,1/1194,0.05136107407601474,8.196783465702948e-16,Glyoxylate metabolism and glycine degradation,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Metabolism of nucleotides,0.8889306174275927,0.9999999999999981,8/1194,0.05113213514255546,8.196783465702948e-16,Metabolism of nucleotides,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Apoptosis,0.9126402516117128,0.9999999999999981,14/1194,0.03970038076678585,8.196783465702948e-16,Apoptosis,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Initial triggering of complement,0.9138532193848047,0.9999999999999981,1/1194,0.03912355386169482,8.196783465702948e-16,Initial triggering of complement,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Metabolism of nitric oxide: NOS3 activation and regulation,0.9138532193848047,0.9999999999999981,1/1194,0.03912355386169482,8.196783465702948e-16,Metabolism of nitric oxide: NOS3 activation and...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Diseases of carbohydrate metabolism,0.9216326604081901,0.9999999999999981,2/1194,0.0354421433135244,8.196783465702948e-16,Diseases of carbohydrate metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Cellular response to chemical stress,0.928829604790467,0.9999999999999981,17/1194,0.03206395068524982,8.196783465702948e-16,Cellular response to chemical stress,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Adaptive Immune System,0.9309595935619537,0.9999999999999981,75/1194,0.03106916829244432,8.196783465702948e-16,Adaptive Immune System,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",0.95484825516744,0.9999999999999981,1/1194,0.020065641169909363,8.196783465702948e-16,FOXO-mediated transcription of oxidative stress...,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Metabolism of cofactors,0.9693618291375409,0.9999999999999981,1/1194,0.013514085625553566,8.196783465702948e-16,Metabolism of cofactors,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Peroxisomal lipid metabolism,0.9730776215204536,0.9999999999999981,1/1194,0.011852515072406295,8.196783465702948e-16,Peroxisomal lipid metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Regulation of Apoptosis,0.9935126435668091,0.9999999999999981,1/1194,0.002826601632820444,8.196783465702948e-16,Regulation of Apoptosis,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Metabolism of polyamines,0.9973795157600317,0.9999999999999981,1/1194,0.0011395555920280112,8.196783465702948e-16,Metabolism of polyamines,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Metabolism of amino acids and derivatives,0.9999254243296104,0.9999999999999981,20/1194,3.2389009865511875e-5,8.196783465702948e-16,Metabolism of amino acids and derivatives,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Selenoamino acid metabolism,0.9999987747572602,0.9999999999999981,1/1194,5.321164868826402e-7,8.196783465702948e-16,Selenoamino acid metabolism,OUD Effect Male vs Female,Reactome
OUD_Effect_Male_vs_Female,Reactome,Metabolism of RNA,0.9999999999999981,0.9999999999999981,28/1194,8.196783465702948e-16,8.196783465702948e-16,Metabolism of RNA,OUD Effect Male vs Female,Reactome
OUD_vs_Control_Female,GO_BP,positive regulation of cytokinesis,0.9333240851496616,1,3/2058,0.02996752672212396,-0,positive regulation of cytokinesis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,mitotic cytokinesis,0.9513564919622188,1,8/2058,0.021656713892348054,-0,mitotic cytokinesis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,regulation of cytokinesis,0.9527975361044145,1,7/2058,0.020999374591652038,-0,regulation of cytokinesis,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,motor neuron apoptotic process,0.954836347186885,1,1/2058,0.020071057321078323,-0,motor neuron apoptotic process,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,stress granule assembly,0.9933775022420195,1,1/2058,0.002885680019058906,-0,stress granule assembly,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_BP,oxidative phosphorylation,0.9997635829125253,1,7/2058,1.0268677545042647e-4,-0,oxidative phosphorylation,OUD vs Control Female,GO BP
OUD_vs_Control_Female,GO_CC,astrocyte end-foot,0.4549657502564588,1,2/2168,0.3420212957263743,-0,astrocyte end-foot,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,axonemal microtubule,0.4757780021841226,1,5/2168,0.3225956416407072,-0,axonemal microtubule,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,symmetric synapse,0.502221904601571,1,2/2168,0.29910434928910606,-0,symmetric synapse,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,neuronal dense core vesicle membrane,0.5199647293784038,1,1/2168,0.2840261147418278,-0,neuronal dense core vesicle membrane,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,neuron projection cytoplasm,0.5318066574193947,1,12/2168,0.27424623025678435,-0,neuron projection cytoplasm,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,axonemal doublet microtubule,0.5434700601204641,1,4/2168,0.26482437629273015,-0,axonemal doublet microtubule,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,neuronal ribonucleoprotein granule,0.5855092857902706,1,1/2168,0.23246621291357203,-0,neuronal ribonucleoprotein granule,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,glycinergic synapse,0.5855092857902706,1,1/2168,0.23246621291357203,-0,glycinergic synapse,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,ribbon synapse,0.5883826440685402,1,2/2168,0.2303401464415008,-0,ribbon synapse,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,dopaminergic synapse,0.5883826440685402,1,2/2168,0.2303401464415008,-0,dopaminergic synapse,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,axon cytoplasm,0.624092064062294,1,8/2168,0.20475133986082097,-0,axon cytoplasm,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,axon hillock,0.6421078792529333,1,1/2168,0.19239200085896815,-0,axon hillock,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,dendrite cytoplasm,0.6827451384787422,1,3/2168,0.16574138359302268,-0,dendrite cytoplasm,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,axonemal microtubule doublet inner sheath,0.6827451384787422,1,3/2168,0.16574138359302268,-0,axonemal microtubule doublet inner sheath,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,axoneme,0.7851359289786494,1,17/2168,0.10505514822937913,-0,axoneme,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,dynein axonemal particle,0.8894662255081391,1,1/2168,0.05087053814096248,-0,dynein axonemal particle,OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,"asymmetric, glutamatergic, excitatory synapse",0.9045681427691901,1,1/2168,0.043558711375834926,-0,"asymmetric, glutamatergic, excitatory synapse",OUD vs Control Female,GO CC
OUD_vs_Control_Female,GO_CC,cytoplasmic stress granule,0.9772730779262679,1,7/2168,0.009984065078175326,-0,cytoplasmic stress granule,OUD vs Control Female,GO CC
